You can search and download the CCASAnet publication list at our Zotero group library.
2023
76770
IP6F4TRX
2023
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-76fcdc72976c268d5ea621c330527a4d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22XYQ4UJJS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Person%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPerson%20AK%2C%20Crabtree-Ramirez%20B%2C%20Kim%20A%2C%20Veloso%20V%2C%20Maruri%20F%2C%20Wandeler%20G%2C%20et%20al.%20Cryptococcal%20Meningitis%20and%20Clinical%20Outcomes%20in%20Persons%20With%20Human%20Immunodeficiency%20Virus%3A%20A%20Global%20View.%20Clin%20Infect%20Dis.%202023%20Jun%2016%3B76%2812%29%3A2116%26%23x2013%3B25.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DXYQ4UJJS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cryptococcal%20Meningitis%20and%20Clinical%20Outcomes%20in%20Persons%20With%20Human%20Immunodeficiency%20Virus%3A%20A%20Global%20View%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22John%20Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darma%22%2C%22lastName%22%3A%22Imran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kinh%22%2C%22lastName%22%3A%22Van%20Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Nalitya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Cryptococcal%20meningitis%20%28CM%29%20is%20a%20major%20cause%20of%20morbidity%20and%20mortality%20in%20persons%20with%20human%20immunodeficiency%20virus%20%28HIV%3B%20PWH%29.%20Little%20is%20known%20about%20CM%20outcomes%20and%20availability%20of%20diagnostic%20and%20treatment%20modalities%20globally.%5CnMETHODS%3A%20In%20this%20retrospective%20cohort%20study%2C%20we%20investigated%20CM%20incidence%20and%20all-cause%20mortality%20in%20PWH%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20cohort%20from%201996%20to%202017.%20We%20estimated%20incidence%20using%20quasi-Poisson%20models%20adjusted%20for%20sex%2C%20age%2C%20calendar%20year%2C%20CD4%20cell%20count%20%28CD4%29%2C%20and%20antiretroviral%20therapy%20%28ART%29%20status.%20Mortality%20after%20CM%20diagnosis%20was%20examined%20using%20multivariable%20Cox%20models.%20A%20site%20survey%20from%202017%20assessed%20availability%20of%20CM%20diagnostic%20and%20treatment%20modalities.%5CnRESULTS%3A%20Among%20518%20852%20PWH%2C%20there%20were%203857%20cases%20of%20CM%20with%20an%20estimated%20incidence%20of%201.54%20per%201000%20person-years.%20Mortality%20over%20a%20median%20of%202.6%20years%20of%20post-CM%20diagnosis%20follow-up%20was%2031.6%25%2C%20with%2029%25%20lost%20to%20follow-up.%20In%20total%2C%202478%20%2864%25%29%20were%20diagnosed%20with%20CM%20after%20ART%20start%20with%20a%20median%20of%20253%20days%20from%20ART%20start%20to%20CM%20diagnosis.%20Older%20age%20%28hazard%20%5BHR%5D%2C%201.31%20for%2050%20vs%2035%20years%29%2C%20lower%20CD4%20%28HR%2C%201.15%20for%20200%20vs%20350%20cells%5C%2Fmm3%29%2C%20and%20earlier%20year%20of%20CM%20diagnosis%20%28HR%2C%200.51%20for%202015%20vs%202000%29%20were%20associated%20with%20higher%20mortality.%20Of%2089%20sites%2C%2034%25%20reported%20access%20to%20amphotericin%20B%3B%2012%25%20had%20access%20to%20flucytosine.%5CnCONCLUSIONS%3A%20Mortality%20after%20CM%20diagnosis%20was%20high.%20A%20substantial%20portion%20of%20CM%20cases%20occurred%20after%20ART%20start%2C%20though%20incidence%20and%20mortality%20may%20be%20higher%20than%20reported%20due%20to%20ascertainment%20bias.%20Many%20sites%20lacked%20access%20to%20recommended%20CM%20treatment.%22%2C%22date%22%3A%222023-06-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciad076%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A23%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22WHS786YM%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vreeman%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVreeman%20RC%2C%20Yiannoutsos%20CT%2C%20Yusoff%20NKN%2C%20Wester%20CW%2C%20Edmonds%20A%2C%20Ofner%20S%2C%20et%20al.%20Global%20HIV%20prevention%2C%20care%20and%20treatment%20services%20for%20children%3A%20a%20cross-sectional%20survey%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20BMJ%20Open.%202023%20Mar%2013%3B13%283%29%3Ae069399.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DWHS786YM%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20HIV%20prevention%2C%20care%20and%20treatment%20services%20for%20children%3A%20a%20cross-sectional%20survey%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20C.%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nik%20Khairulddin%20Nik%22%2C%22lastName%22%3A%22Yusoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Ofner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pagakrong%22%2C%22lastName%22%3A%22Lumbiganon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%20C%5Cu00e9lia%22%2C%22lastName%22%3A%22de%20Menezes%20Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ounoo%20Elom%22%2C%22lastName%22%3A%22Takassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Scanlon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20assess%20access%20children%20with%20HIV%20have%20to%20comprehensive%20HIV%20care%20services%2C%20to%20longitudinally%20evaluate%20the%20implementation%20and%20scale-up%20of%20services%2C%20and%20to%20use%20site%20services%20and%20clinical%20cohort%20data%20to%20explore%20whether%20access%20to%20these%20services%20influences%20retention%20in%20care.%5CnMETHODS%3A%20A%20cross-sectional%20standardised%20survey%20was%20completed%20in%202014-2015%20by%20sites%20providing%20paediatric%20HIV%20care%20across%20regions%20of%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20We%20developed%20a%20comprehensiveness%20score%20based%20on%20the%20WHO%27s%20nine%20categories%20of%20essential%20services%20to%20categorise%20sites%20as%20%27low%27%20%280-5%29%2C%20%27medium%27%2C%20%286-7%29%20or%20%27high%27%20%288-9%29.%20When%20available%2C%20comprehensiveness%20scores%20were%20compared%20with%20scores%20from%20a%202009%20survey.%20We%20used%20patient-level%20data%20with%20site%20services%20to%20investigate%20the%20relationship%20between%20the%20comprehensiveness%20of%20services%20and%20retention.%5CnRESULTS%3A%20Survey%20data%20from%20174%20IeDEA%20sites%20in%2032%20countries%20were%20analysed.%20Of%20the%20WHO%20essential%20services%2C%20sites%20were%20most%20likely%20to%20offer%20antiretroviral%20therapy%20%28ART%29%20provision%20and%20counselling%20%28n%3D173%3B%2099%25%29%2C%20co-trimoxazole%20prophylaxis%20%28168%3B%2097%25%29%2C%20prevention%20of%20perinatal%20transmission%20services%20%28167%3B%2096%25%29%2C%20outreach%20for%20patient%20engagement%20and%20follow-up%20%28166%3B%2095%25%29%2C%20CD4%20cell%20count%20testing%20%28126%3B%2088%25%29%2C%20tuberculosis%20screening%20%28151%3B%2087%25%29%20and%20select%20immunisation%20services%20%28126%3B%2072%25%29.%20Sites%20were%20less%20likely%20to%20offer%20nutrition%5C%2Ffood%20support%20%2897%3B%2056%25%29%2C%20viral%20load%20testing%20%2899%3B%2069%25%29%20and%20HIV%20counselling%20and%20testing%20%2869%3B%2040%25%29.%2010%25%20of%20sites%20rated%20%27low%27%2C%2059%25%20%27medium%27%20and%2031%25%20%27high%27%20in%20the%20comprehensiveness%20score.%20The%20mean%20comprehensiveness%20of%20services%20score%20increased%20significantly%20from%205.6%20in%202009%20to%207.3%20in%202014%20%28p%3C0.001%3B%20n%3D30%29.%20Patient-level%20analysis%20of%20lost%20to%20follow-up%20after%20ART%20initiation%20estimated%20the%20hazard%20was%20highest%20in%20sites%20rated%20%27low%27%20and%20lowest%20in%20sites%20rated%20%27high%27.%5CnCONCLUSION%3A%20This%20global%20assessment%20suggests%20the%20potential%20care%20impact%20of%20scaling-up%20and%20sustaining%20comprehensive%20paediatric%20HIV%20services.%20Meeting%20recommendations%20for%20comprehensive%20HIV%20services%20should%20remain%20a%20global%20priority.%22%2C%22date%22%3A%222023-03-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2022-069399%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A24%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22BA4BNNXN%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ridolfi%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERidolfi%20F%2C%20Peetluk%20L%2C%20Amorim%20G%2C%20Turner%20M%2C%20Figueiredo%20M%2C%20Cordeiro-Santos%20M%2C%20et%20al.%20Tuberculosis%20Treatment%20Outcomes%20in%20Brazil%3A%20Different%20Predictors%20for%20Each%20Type%20of%20Unsuccessful%20Outcome.%20Clin%20Infect%20Dis.%202023%20Feb%208%3B76%283%29%3Ae930%26%23x2013%3B7.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DBA4BNNXN%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20Treatment%20Outcomes%20in%20Brazil%3A%20Different%20Predictors%20for%20Each%20Type%20of%20Unsuccessful%20Outcome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felipe%22%2C%22lastName%22%3A%22Ridolfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29%5Cu2013Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Successful%20tuberculosis%20%28TB%29%20treatment%20is%20necessary%20for%20disease%20control.%20The%20World%20Health%20Organization%20%28WHO%29%20has%20a%20target%20TB%20treatment%20success%20rate%20of%20%5Cu226590%25.%20We%20assessed%20whether%20the%20different%20types%20of%20unfavorable%20TB%20treatment%20outcome%20had%20different%20predictors.%5CnMETHODS%3A%20Using%20data%20from%20Regional%20Prospective%20Observational%20Research%20for%20Tuberculosis-Brazil%2C%20we%20evaluated%20biological%20and%20behavioral%20factors%20associated%20with%20each%20component%20of%20unsuccessful%20TB%20outcomes%2C%20recently%20updated%20by%20WHO%20%28death%2C%20loss%20to%20follow-up%20%5BLTFU%5D%2C%20and%20treatment%20failure%29.%20We%20included%20culture-confirmed%2C%20drug-susceptible%2C%20pulmonary%20TB%20participants%20receiving%20standard%20treatment%20in%202015-2019.%20Multinomial%20logistic%20regression%20models%20with%20inverse%20probability%20weighting%20were%20used%20to%20evaluate%20the%20distinct%20determinants%20of%20each%20unsuccessful%20outcome.%5CnRESULTS%3A%20Of%20915%20participants%20included%2C%20727%20%2879%25%29%20were%20successfully%20treated%2C%20118%20%2813%25%29%20were%20LTFU%2C%2044%20%285%25%29%20had%20treatment%20failure%2C%20and%2026%20%283%25%29%20died.%20LTFU%20was%20associated%20with%20current%20drug-use%20%28adjusted%20odds%20ratio%20%5BaOR%5D%20%3D%205.3%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%203.0-9.4%29%2C%20current%20tobacco%20use%20%28aOR%20%3D%202.9%3B%2095%25%20CI%2C%201.7-4.9%29%2C%20and%20being%20a%20person%20with%20HIV%20%28PWH%29%20%28aOR%20%3D%202.0%3B%2095%25%20CI%2C%201.1-3.5%29.%20Treatment%20failure%20was%20associated%20with%20PWH%20%28aOR%20%3D%202.7%3B%2095%25%20CI%2C%201.2-6.2%29%20and%20having%20diabetes%20%28aOR%20%3D%202.2%3B%2095%25%20CI%2C%201.1-4.4%29.%20Death%20was%20associated%20with%20anemia%20%28aOR%20%3D%205.3%3B%2095%25%20CI%2C%201.4-19.7%29%2C%20diabetes%20%28aOR%20%3D%203.1%3B%2095%25%20CI%2C%201.4-6.7%29%2C%20and%20PWH%20%28aOR%20%3D%203.9%3B%2095%25%20CI%2C%201.3-11.4%29.%20Direct%20observed%20therapy%20was%20protective%20for%20treatment%20failure%20%28aOR%20%3D%200.5%3B%2095%25%20CI%2C%20.3-.9%29%20and%20death%20%28aOR%20%3D%200.5%3B%2095%25%20CI%2C%20.2-1.0%29.%5CnCONCLUSIONS%3A%20The%20treatment%20success%20rate%20was%20below%20the%20WHO%20target.%20Behavioral%20factors%20were%20most%20associated%20with%20LTFU%2C%20whereas%20clinical%20comorbidities%20were%20correlated%20with%20treatment%20failure%20and%20death.%20Because%20determinants%20of%20unsuccessful%20outcomes%20are%20distinct%2C%20different%20intervention%20strategies%20may%20be%20needed%20to%20improve%20TB%20outcomes.%22%2C%22date%22%3A%222023-02-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciac541%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A23%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22AXCAVDNM%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrazier%20E%2C%20Maruri%20F%2C%20Wester%20CW%2C%20Musick%20B%2C%20Freeman%20A%2C%20Parcesepe%20A%2C%20et%20al.%20Design%20and%20implementation%20of%20a%20global%20site%20assessment%20survey%20among%20HIV%20clinics%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium.%20PLoS%20One.%202023%3B18%283%29%3Ae0268167.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DAXCAVDNM%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Design%20and%20implementation%20of%20a%20global%20site%20assessment%20survey%20among%20HIV%20clinics%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Hossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedikt%22%2C%22lastName%22%3A%22Christ%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20E.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Timely%20descriptions%20of%20HIV%20service%20characteristics%20and%20their%20evolution%20over%20time%20across%20diverse%20settings%20are%20important%20for%20monitoring%20the%20scale-up%20of%20evidence-based%20program%20strategies%2C%20understanding%20the%20implementation%20landscape%2C%20and%20examining%20service%20delivery%20factors%20that%20influence%20HIV%20care%20outcomes.%5CnMETHODS%3A%20The%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20undertakes%20periodic%20cross-sectional%20surveys%20on%20service%20availability%20and%20care%20at%20participating%20HIV%20treatment%20sites%20to%20characterize%20trends%20and%20inform%20the%20scientific%20agenda%20for%20HIV%20care%20and%20implementation%20science%20communities.%20IeDEA%27s%202020%20general%20site%20assessment%20survey%20was%20developed%20through%20a%20consultative%2C%2018-month%20process%20that%20engaged%20diverse%20researchers%20in%20identifying%20content%20from%20previous%20surveys%20that%20should%20be%20retained%20for%20longitudinal%20analyses%20and%20in%20developing%20expanded%20and%20new%20content%20to%20address%20gaps%20in%20the%20literature.%20An%20iterative%20review%20process%20was%20undertaken%20to%20standardize%20the%20format%20of%20new%20survey%20questions%20and%20align%20them%20with%20best%20practices%20in%20survey%20design%20and%20measurement%20and%20lessons%20learned%20through%20prior%20IeDEA%20site%20assessment%20surveys.%5CnRESULTS%3A%20The%20survey%20questionnaire%20developed%20through%20this%20process%20included%20eight%20content%20domains%20covered%20in%20prior%20surveys%20%28patient%20population%2C%20staffing%20and%20community%20linkages%2C%20HIV%20testing%20and%20diagnosis%2C%20new%20patient%20care%2C%20treatment%20monitoring%20and%20retention%2C%20routine%20HIV%20care%20and%20screening%2C%20pharmacy%2C%20record-keeping%20and%20patient%20tracing%29%2C%20along%20with%20expanded%20content%20related%20to%20antiretroviral%20therapy%20%28differentiated%20service%20delivery%20and%20roll-out%20of%20dolutegravir-based%20regimens%29%3B%20mental%20health%20and%20substance%20use%20disorders%3B%20care%20for%20pregnant%5C%2Fpostpartum%20women%20and%20HIV-exposed%20infants%3B%20tuberculosis%20preventive%20therapy%3B%20and%20pediatric%5C%2Fadolescent%20tuberculosis%20care%3B%20and%20new%20content%20related%20to%20Kaposi%27s%20sarcoma%20diagnostics%2C%20the%20impact%20of%20COVID-19%20on%20service%20delivery%2C%20and%20structural%20barriers%20to%20HIV%20care.%20The%20survey%20was%20distributed%20to%20238%20HIV%20treatment%20sites%20in%20late%202020%2C%20with%20a%2095%25%20response%20rate.%5CnCONCLUSION%3A%20IeDEA%27s%20approach%20for%20site%20survey%20development%20has%20broad%20relevance%20for%20HIV%20research%20networks%20and%20other%20priority%20health%20conditions.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0268167%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A23%3A54Z%22%7D%7D%5D%7D
1.
Person AK, Crabtree-Ramirez B, Kim A, Veloso V, Maruri F, Wandeler G, et al. Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clin Infect Dis. 2023 Jun 16;76(12):2116–25. Cite
1.
Vreeman RC, Yiannoutsos CT, Yusoff NKN, Wester CW, Edmonds A, Ofner S, et al. Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open. 2023 Mar 13;13(3):e069399. Cite
1.
Ridolfi F, Peetluk L, Amorim G, Turner M, Figueiredo M, Cordeiro-Santos M, et al. Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome. Clin Infect Dis. 2023 Feb 8;76(3):e930–7. Cite
1.
Brazier E, Maruri F, Wester CW, Musick B, Freeman A, Parcesepe A, et al. Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. PLoS One. 2023;18(3):e0268167. Cite
2022
76770
IP6F4TRX
2022
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-0786e4c9313b1ab4e1c5caec70e0bd71%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Y7R5MCJS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrazier%20E%2C%20Ajeh%20R%2C%20Maruri%20F%2C%20Musick%20B%2C%20Freeman%20A%2C%20Wester%20CW%2C%20et%20al.%20Service%20delivery%20challenges%20in%20HIV%20care%20during%20the%20first%20year%20of%20the%20COVID-19%20pandemic%3A%20results%20from%20a%20site%20assessment%20survey%20across%20the%20global%20IeDEA%20consortium.%20J%20Int%20AIDS%20Soc.%202022%20Dec%3B25%2812%29%3Ae26036.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DY7R5MCJS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Service%20delivery%20challenges%20in%20HIV%20care%20during%20the%20first%20year%20of%20the%20COVID-19%20pandemic%3A%20results%20from%20a%20site%20assessment%20survey%20across%20the%20global%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Man-Po%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinei%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree%20Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelline%22%2C%22lastName%22%3A%22d%27Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christella%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Tanser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Interruptions%20in%20treatment%20pose%20risks%20for%20people%20with%20HIV%20%28PWH%29%20and%20threaten%20progress%20in%20ending%20the%20HIV%20epidemic%3B%20however%2C%20the%20COVID-19%20pandemic%27s%20impact%20on%20HIV%20service%20delivery%20across%20diverse%20settings%20is%20not%20broadly%20documented.%5CnMETHODS%3A%20From%20September%202020%20to%20March%202021%2C%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium%20surveyed%20238%20HIV%20care%20sites%20across%20seven%20geographic%20regions%20to%20document%20constraints%20in%20HIV%20service%20delivery%20during%20the%20first%20year%20of%20the%20pandemic%20and%20strategies%20for%20ensuring%20care%20continuity%20for%20PWH.%20Descriptive%20statistics%20were%20stratified%20by%20national%20HIV%20prevalence%20%28%3C1%25%2C%201-4.9%25%20and%20%5Cu22655%25%29%20and%20country%20income%20levels.%5CnRESULTS%3A%20Questions%20about%20pandemic-related%20consequences%20for%20HIV%20care%20were%20completed%20by%20225%20%2895%25%29%20sites%20in%2042%20countries%20with%20low%20%28n%20%3D%2082%29%2C%20medium%20%28n%20%3D%2086%29%20and%20high%20%28n%20%3D%2057%29%20HIV%20prevalence%2C%20including%20low-%20%28n%20%3D%2057%29%2C%20lower-middle%20%28n%20%3D%2079%29%2C%20upper-middle%20%28n%20%3D%2039%29%20and%20high-%20%28n%20%3D%2050%29%20income%20countries.%20Most%20sites%20reported%20being%20subject%20to%20pandemic-related%20restrictions%20on%20travel%2C%20service%20provision%20or%20other%20operations%20%2875%25%29%2C%20and%20experiencing%20negative%20impacts%20%2876%25%29%20on%20clinic%20operations%2C%20including%20decreased%20hours%5C%2Fdays%2C%20reduced%20provider%20availability%2C%20clinic%20reconfiguration%20for%20COVID-19%20services%2C%20record-keeping%20interruptions%20and%20suspension%20of%20partner%20support.%20Almost%20all%20sites%20in%20low-prevalence%20and%20high-income%20countries%20reported%20increased%20use%20of%20telemedicine%20%2885%25%20and%20100%25%2C%20respectively%29%2C%20compared%20with%20less%20than%20half%20of%20sites%20in%20high-prevalence%20and%20lower-income%20settings.%20Few%20sites%20in%20high-prevalence%20settings%20%282%25%29%20reported%20suspending%20antiretroviral%20therapy%20%28ART%29%20clinic%20services%2C%20and%20many%20reported%20adopting%20mitigation%20strategies%20to%20support%20adherence%2C%20including%20multi-month%20dispensing%20of%20ART%20%2895%25%29%20and%20designating%20community%20ART%20pick-up%20points%20%2844%25%29.%20While%20few%20sites%20%285%25%29%20reported%20stockouts%20of%20first-line%20ART%20regimens%2C%2010-11%25%20reported%20stockouts%20of%20second-%20and%20third-line%20regimens%2C%20respectively%2C%20primarily%20in%20high-prevalence%20and%20lower-income%20settings.%20Interruptions%20in%20HIV%20viral%20load%20%28VL%29%20testing%20included%20suspension%20of%20testing%20%2822%25%29%2C%20longer%20turnaround%20times%20%2841%25%29%20and%20supply%5C%2Freagent%20stockouts%20%2822%25%29%2C%20but%20did%20not%20differ%20across%20settings.%5CnCONCLUSIONS%3A%20While%20many%20sites%20in%20high%20HIV%20prevalence%20settings%20and%20lower-income%20countries%20reported%20introducing%20or%20expanding%20measures%20to%20support%20treatment%20adherence%20and%20continuity%20of%20care%2C%20the%20COVID-19%20pandemic%20resulted%20in%20disruptions%20to%20VL%20testing%20and%20ART%20supply%20chains%20that%20may%20negatively%20affect%20the%20quality%20of%20HIV%20care%20in%20these%20settings.%22%2C%22date%22%3A%222022-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26036%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A22%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22FD5QZYVM%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lotspeich%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELotspeich%20SC%2C%20Shepherd%20BE%2C%20Amorim%20GGC%2C%20Shaw%20PA%2C%20Tao%20R.%20Efficient%20odds%20ratio%20estimation%20under%20two-phase%20sampling%20using%20error-prone%20data%20from%20a%20multi-national%20HIV%20research%20cohort.%20Biometrics.%202022%20Dec%3B78%284%29%3A1674%26%23x2013%3B85.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DFD5QZYVM%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficient%20odds%20ratio%20estimation%20under%20two-phase%20sampling%20using%20error-prone%20data%20from%20a%20multi-national%20HIV%20research%20cohort%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lotspeich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20G.%20C.%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%22%2C%22lastName%22%3A%22Tao%22%7D%5D%2C%22abstractNote%22%3A%22Persons%20living%20with%20HIV%20engage%20in%20routine%20clinical%20care%2C%20generating%20large%20amounts%20of%20data%20in%20observational%20HIV%20cohorts.%20These%20data%20are%20often%20error-prone%2C%20and%20directly%20using%20them%20in%20biomedical%20research%20could%20bias%20estimation%20and%20give%20misleading%20results.%20A%20cost-effective%20solution%20is%20the%20two-phase%20design%2C%20under%20which%20the%20error-prone%20variables%20are%20observed%20for%20all%20patients%20during%20Phase%20I%2C%20and%20that%20information%20is%20used%20to%20select%20patients%20for%20data%20auditing%20during%20Phase%20II.%20For%20example%2C%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20selected%20a%20random%20sample%20from%20each%20site%20for%20data%20auditing.%20Herein%2C%20we%20consider%20efficient%20odds%20ratio%20estimation%20with%20partially%20audited%2C%20error-prone%20data.%20We%20propose%20a%20semiparametric%20approach%20that%20uses%20all%20information%20from%20both%20phases%20and%20accommodates%20a%20number%20of%20error%20mechanisms.%20We%20allow%20both%20the%20outcome%20and%20covariates%20to%20be%20error-prone%20and%20these%20errors%20to%20be%20correlated%2C%20and%20selection%20of%20the%20Phase%20II%20sample%20can%20depend%20on%20Phase%20I%20data%20in%20an%20arbitrary%20manner.%20We%20devise%20a%20computationally%20efficient%2C%20numerically%20stable%20EM%20algorithm%20to%20obtain%20estimators%20that%20are%20consistent%2C%20asymptotically%20normal%2C%20and%20asymptotically%20efficient.%20We%20demonstrate%20the%20advantages%20of%20the%20proposed%20methods%20over%20existing%20ones%20through%20extensive%20simulations.%20Finally%2C%20we%20provide%20applications%20to%20the%20CCASAnet%5Cu00a0cohort.%22%2C%22date%22%3A%222022-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fbiom.13512%22%2C%22ISSN%22%3A%221541-0420%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A17%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22L7N5GCQJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Girardi%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGirardi%20E%2C%20Caro-Vega%20Y%2C%20Cozzi-Lepri%20A%2C%20Musaazi%20J%2C%20Carriquiry%20G%2C%20Castelnuovo%20B%2C%20et%20al.%20The%20contribution%20of%20late%20HIV%20diagnosis%20on%20the%20occurrence%20of%20HIV-associated%20tuberculosis.%20AIDS.%202022%20Nov%2015%3B36%2814%29%3A2005%26%23x2013%3B13.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DL7N5GCQJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20contribution%20of%20late%20HIV%20diagnosis%20on%20the%20occurrence%20of%20HIV-associated%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enrico%22%2C%22lastName%22%3A%22Girardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandro%22%2C%22lastName%22%3A%22Cozzi-Lepri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Musaazi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Gori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yukari%20C.%22%2C%22lastName%22%3A%22Manabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonella%22%2C%22lastName%22%3A%22D%27arminio%20Monforte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Mussini%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20describe%20the%20timing%20of%20tuberculosis%20%28TB%29%20presentation%20in%20relation%20to%20diagnosis%20of%20HIV%20infection%20and%20antiretroviral%20therapy%20%28ART%29%20initiation%20and%20to%20evaluate%20whether%20the%20established%20impact%20from%20late%20presentation%20to%20care%20and%20late%20initiation%20of%20ART%20on%20the%20risk%20of%20TB%20is%20retained%20beyond%20the%20observation%20period%20of%20clinical%20trials.%5CnDESIGN%3A%20We%20used%20marginal%20structural%20models%20to%20emulate%20a%20clinical%20trial%20with%20up%20to%205%5Cu200ayears%20of%20follow-up%20to%20evaluate%20the%20impact%20of%20late%20initiation%20on%20TB%20risk.%5CnMETHODS%3A%20People%20with%20HIV%20%28PWH%29%20were%20enrolled%20from%202007%20to%202016%20in%20observational%20cohorts%20from%20Uganda%2C%20Peru%2C%20Mexico%20and%20Italy.%20The%20risk%20of%20TB%20was%20compared%20in%20LP%20%28accessing%20care%20with%20CD4%20%2B%20cell%20count%20%5Cu2264350%5Cu200acells%5C%2F%5Cu03bcl%29%20vs.%20nonlate%20presentation%20using%20survival%20curves%20and%20a%20weighted%20Cox%20regression.%20We%20emulated%20two%20strategies%3A%20initiating%20ART%20with%20CD4%20%2B%20cell%20count%20less%20than%20350%5Cu200acells%5C%2F%5Cu03bcl%20vs.%20CD4%20%2B%20cell%20count%20at%20least%20350%5Cu200acells%5C%2F%5Cu03bcl%20%28late%20initiation%29.%20We%20estimated%20TB%20attributable%20risk%20and%20population%20attributable%20fraction%20up%20to%205%5Cu200ayears%20from%20the%20emulated%20date%20of%20randomization.%5CnRESULTS%3A%20Twenty%20thousand%20one%20hundred%20and%20twelve%20patients%20and%201936%20TB%20cases%20were%20recorded.%20Over%2050%25%20of%20TB%20cases%20were%20diagnosed%20at%20presentation%20for%20HIV%20care.%20More%20than%2050%25%20of%20the%20incident%20cases%20of%20TB%20after%20ART%20initiation%20were%20attributable%20to%20late%20presentation%3B%20nearly%2070%25%20of%20TB%20cases%20during%20the%20first%20year%20of%20follow-up%20could%20be%20attributed%20to%20late%20presentation%20and%20more%20than%2050%25%2C%205%20years%20after%20first%20attending%20HIV%20care.%5CnCONCLUSION%3A%20Late%20presentation%20accounted%20for%20a%20large%20share%20of%20TB%20cases.%20Delaying%20ART%20initiation%20was%20detrimental%20for%20incident%20TB%20rates%2C%20and%20the%20impact%20of%20late%20presentation%20persisted%20up%20to%205%5Cu200ayears%20from%20HIV%20care%20entry.%22%2C%22date%22%3A%222022-11-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000003321%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A23%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22S266LR8R%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sobral%20et%20al.%22%2C%22parsedDate%22%3A%222022-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESobral%20L%2C%20Arriaga%20MB%2C%20Souza%20AB%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Barreto-Duarte%20B%2C%20Sales%20C%2C%20et%20al.%20Determinants%20of%20losses%20in%20the%20tuberculosis%20infection%20cascade%20of%20care%20among%20children%20and%20adolescent%20contacts%20of%20pulmonary%20tuberculosis%20cases%3A%20A%20Brazilian%20multi-centre%20longitudinal%20study.%20Lancet%20Reg%20Health%20Am.%202022%20Nov%3B15%3A100358.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DS266LR8R%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Determinants%20of%20losses%20in%20the%20tuberculosis%20infection%20cascade%20of%20care%20among%20children%20and%20adolescent%20contacts%20of%20pulmonary%20tuberculosis%20cases%3A%20A%20Brazilian%20multi-centre%20longitudinal%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luciana%22%2C%22lastName%22%3A%22Sobral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caio%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%22%2C%22lastName%22%3A%22Benjamin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamile%20G.%22%2C%22lastName%22%3A%22de%20Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Cristina%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Approximately%2010%25%20of%20the%20global%20tuberculosis%20%28TB%29%20burden%20is%20in%20children.%20Identification%2C%20diagnosis%2C%20and%20early%20treatment%20of%20Mycobacterium%20tuberculosis%20infection%20%28TBI%29%20is%20critical%20to%20prevent%20progression%20to%20TB%20in%20children.%20The%20risk%20of%20TB%2C%20including%20severe%20disease%2C%20is%20highest%20in%20children%20%3C5%20years%20old.%20We%20evaluated%20the%20cascade%20of%20TBI%20care%20among%20child%20and%20adolescent%20TB%20contacts%20to%20identify%20factors%20associated%20with%20losses%20in%20the%20cascade.%5CnMETHODS%3A%20Close%20contacts%20%5Cu2264%2018%20years%20old%20of%20pulmonary%20TB%20patients%20enrolled%20between%202015%20and%202019%20in%20a%20multi-centre%20Brazilian%20cohort%20were%20followed%20for%20up%20to%2024%20months%20and%20classified%20according%20to%20age%20groups%3A%20%3C5%20years%2C%205-9%20years%2C%2010-14%20years%20and%2015-18%20years.%20Data%20on%20clinical%20investigation%2C%20radiographic%20examination%2C%20IGRA%20testing%20at%20baseline%20and%206%20months%2C%20initiation%20and%20completion%20of%20TB%20preventive%20treatment%20%28TPT%29%20were%20collected.%20Multivariable%20regression%20analyses%20identified%20factors%20associated%20with%20TBI%20and%20losses%20in%20the%20cascade%20of%20care%20in%20children%20and%20adolescents.%5CnFINDINGS%3A%20Among%201795%20TB%20contacts%20initially%20identified%2C%20530%20%2829%5Cu00b75%25%29%20were%20%5Cu226418%20years%20old.%20Losses%20for%20all%20steps%20in%20the%20cascade%20were%20especially%20high%20in%20children%20%3C5%20years%20old%20%2888%25%29%20because%20at%20this%20age%20all%20contacts%20are%20recommended%20to%20initiate%20TPT.%20As%20a%20proportion%20of%20all%20children%2C%20completion%20of%20TPT%20was%20low%20%28between%2010%25%20and%2013%25%29%20in%20all%20age-groups.%20Furthermore%2C%20multivariable%20regression%20revealed%20that%20younger%20age%20of%20contacts%20and%20TB%20index%20cases%20who%20were%20female%2C%20had%20pulmonary%20cavities%2C%20and%20persistent%20cough%20were%20independently%20associated%20with%20losses%20in%20the%20cascade%20of%20care%20among%20persons%20%5Cu226418%20years%20old.%5CnINTERPRETATION%3A%20Losses%20in%20the%20TBI%20cascade%20were%20the%20highest%20among%20children%20%3C5%20years%2C%20which%20was%20the%20group%20at%20highest%20risk%20for%20TB%20among%20the%20four%20age%20groups.%20The%20findings%20highlight%20the%20need%20to%20improve%20screening%2C%20initiation%2C%20and%20completion%20of%20TPT%20of%20young%20children%20who%20are%20close%20contacts%20of%20people%20with%20TB%20in%20Brazil.%5CnFUNDING%3A%20National%20Institutes%20of%20Allergy%20and%20Infectious%20Diseases.%22%2C%22date%22%3A%222022-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2022.100358%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A22%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22FFW5IAYE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wada%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWada%20PY%2C%20Costa%20AG%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Barreto-Duarte%20B%2C%20Souza%20AB%2C%20Rocha%20MS%2C%20et%20al.%20Possible%20sex%20difference%20in%20latent%20tuberculosis%20infection%20risk%20among%20close%20tuberculosis%20contacts.%20Int%20J%20Infect%20Dis.%202022%20Sep%3B122%3A685%26%23x2013%3B92.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DFFW5IAYE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Possible%20sex%20difference%20in%20latent%20tuberculosis%20infection%20risk%20among%20close%20tuberculosis%20contacts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20Y.%22%2C%22lastName%22%3A%22Wada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allyson%20G.%22%2C%22lastName%22%3A%22Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29%20Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20More%20men%20than%20women%20develop%20and%20die%20of%20tuberculosis%20%28TB%29.%20Fewer%20data%20exist%20on%20sex%20differences%20in%20latent%20TB%20infection%20%28LTBI%29.%20We%20assessed%20for%20potential%20sex%20differences%20in%20LTBI%20acquisition%20among%20close%20TB%20contacts.%5CnMETHODS%3A%20Regional%20Prospective%20Observational%20Research%20for%20TB-Brazil%20is%20an%20observational%20multi-center%20cohort%20of%20individuals%20with%20culture-confirmed%20pulmonary%20TB%20and%20their%20close%20contacts.%20Participants%20were%20enrolled%20from%20five%20sites%20in%20Brazil%20from%20June%202015%20-%20June%202019.%20Close%20contacts%20were%20followed%20for%2024%20months%20after%20enrollment%2C%20with%20LTBI%20defined%20as%20a%20positive%20interferon-%5Cu03b3%20release%20assay%20%28IGRA%3B%20QuantiFERON%203rd%20or%204th%20generation%29%20at%20baseline%20or%206%20months.%20We%20performed%20univariate%2C%20bivariate%2C%20and%20multivariable%20logistic%20regression%20and%20propensity-score%20weighted%20models%20to%20assess%20odds%20ratios%20%28OR%29%20and%2095%25%20confidence%20intervals%20%28CI%29%20for%20LTBI%20acquisition%20by%20birth%20sex%20among%20close%20contacts.%5CnRESULTS%3A%20Of%201093%2C%20504%20%2846%25%29%20female%20close%20contacts%20were%20IGRA%20positive%20compared%20to%20295%20of%20745%20%2840%25%29%20men.%20The%20unadjusted%20OR%20for%20IGRA%20positivity%20among%20women%20vs%20men%20was%201.31%20%2895%25%20CI%3A%201.08-1.58%29.%20Bivariate%20adjustments%20yielded%20ORs%20in%20women%20vs%20men%20ranging%20from%201.19%20to%201.33%20%28P-value%20range%3A%20%3C0.01-0.07%29.%20Multivariable%20regression%20and%20weighted%20models%20yielded%20similar%20ORs%20in%20women%20vs%20men%2C%20of%201.14%20%2895%25%20CI%3A%200.92-1.41%29%20and%201.15%20%2895%25%20CI%3A%200.94-1.40%29%2C%20respectively.%5CnCONCLUSION%3A%20The%20point%20estimate%20for%20LTBI%20among%20close%20TB%20contacts%20in%20Brazil%20was%20higher%20in%20women%2C%20though%20less%20pronounced%20in%20multivariable%20models.%20If%20the%20sex%20difference%20in%20LTBI%20is%20confirmed%20in%20additional%20settings%2C%20studies%20of%20possible%20underlying%20differences%20in%20socio-behavioral%20factors%20or%20TB%20pathogenesis%20are%20warranted.%22%2C%22date%22%3A%222022-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2022.07.031%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A21%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22R2CLKZMG%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Edmonds%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EEdmonds%20A%2C%20Brazier%20E%2C%20Musick%20BS%2C%20Yotebieng%20M%2C%20Humphrey%20J%2C%20Abuogi%20LL%2C%20et%20al.%20Clinical%20and%20programmatic%20outcomes%20of%20HIV-exposed%20infants%20enrolled%20in%20care%20at%20geographically%20diverse%20clinics%2C%201997-2021%3A%20A%20cohort%20study.%20PLoS%20Med.%202022%20Sep%3B19%289%29%3Ae1004089.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DR2CLKZMG%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20and%20programmatic%20outcomes%20of%20HIV-exposed%20infants%20enrolled%20in%20care%20at%20geographically%20diverse%20clinics%2C%201997-2021%3A%20A%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20L.%22%2C%22lastName%22%3A%22Abuogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivia%22%2C%22lastName%22%3A%22Keiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malango%22%2C%22lastName%22%3A%22Msukwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelle%22%2C%22lastName%22%3A%22Maia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20A.%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Although%201%5Cu00b73%20million%20women%20with%20HIV%20give%20birth%20annually%2C%20care%20and%20outcomes%20for%20HIV-exposed%20infants%20remain%20incompletely%20understood.%20We%20analyzed%20programmatic%20and%20health%20indicators%20in%20a%20large%2C%20multidecade%20global%20dataset%20of%20linked%20mother-infant%20records%20from%20clinics%20and%20programs%20associated%20with%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%20AND%20FINDINGS%3A%20HIV-exposed%20infants%20were%20eligible%20for%20this%20retrospective%20cohort%20analysis%20if%20enrolled%20at%20%3C18%20months%20at%20198%20clinics%20in%2010%20countries%20across%205%20IeDEA%20regions%3A%20East%20Africa%20%28EA%29%2C%20Central%20Africa%20%28CA%29%2C%20West%20Africa%20%28WA%29%2C%20Southern%20Africa%20%28SA%29%2C%20and%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20%28CCASAnet%29.%20We%20estimated%20cumulative%20incidences%20of%20DNA%20PCR%20testing%2C%20loss%20to%20follow-up%20%28LTFU%29%2C%20HIV%20diagnosis%2C%20and%20death%20through%2024%20months%20of%20age%20using%20proportional%20subdistribution%20hazard%20models%20accounting%20for%20competing%20risks.%20Competing%20risks%20were%20transfer%2C%20care%20withdrawal%2C%20and%20confirmation%20of%20negative%20HIV%20status%2C%20along%20with%20LTFU%20and%20death%2C%20when%20not%20the%20outcome%20of%20interest.%20In%20CA%20and%20EA%2C%20we%20quantified%20associations%20between%20maternal%5C%2Finfant%20characteristics%20and%20each%20outcome.%20A%20total%20of%2082%2C067%20infants%20%2847%2C300%20EA%2C%2010%2C699%20CA%2C%206%2C503%20WA%2C%2015%2C770%20SA%2C%201%2C795%20CCASAnet%29%20born%20from%201997%20to%202021%20were%20included.%20Maternal%20antiretroviral%20therapy%20%28ART%29%20use%20during%20pregnancy%20ranged%20from%2065%5Cu00b76%25%20%28CCASAnet%29%20to%2089%5Cu00b75%25%20%28EA%29%2C%20with%20improvements%20in%20all%20regions%20over%20time.%20Twenty-four-month%20cumulative%20incidences%20varied%20widely%20across%20regions%2C%20ranging%20from%2012%5Cu00b73%25%20%2895%25%20confidence%20limit%20%5BCL%5D%2C%2011%5Cu00b72%25%2C13%5Cu00b75%25%29%20in%20WA%20to%2094%5Cu00b78%25%20%2895%25%20CL%2C%2094%5Cu00b76%25%2C95%5Cu00b71%25%29%20in%20EA%20for%20DNA%20PCR%20testing%3B%2056%5Cu00b72%25%20%2895%25%20CL%2C%2055%5Cu00b72%25%2C57%5Cu00b71%25%29%20in%20EA%20to%2098%5Cu00b75%25%20%2895%25%20CL%2C%2098%5Cu00b73%25%2C98%5Cu00b77%25%29%20in%20WA%20for%20LTFU%3B%201%5Cu00b79%25%20%2895%25%20CL%2C%201%5Cu00b76%25%2C2%5Cu00b73%25%29%20in%20WA%20to%2010%5Cu00b73%25%20%2895%25%20CL%2C%209%5Cu00b77%25%2C10%5Cu00b79%25%29%20in%20EA%20for%20HIV%20diagnosis%3B%20and%200%5Cu00b75%25%20%2895%25%20CL%2C%200%5Cu00b72%25%2C1%5Cu00b70%25%29%20in%20CCASAnet%20to%204%5Cu00b77%25%20%2895%25%20CL%2C%204%5Cu00b74%25%2C5%5Cu00b70%25%29%20in%20EA%20for%20death.%20Although%20infant%20retention%20did%20not%20improve%2C%20HIV%20diagnosis%20and%20death%20decreased%20over%20time%2C%20and%20in%20EA%2C%20the%20cumulative%20incidence%20of%20HIV%20diagnosis%20decreased%20substantially%2C%20declining%20to%202%5Cu00b79%25%20%2895%25%20CL%2C%201%5Cu00b75%25%2C5%5Cu00b74%25%29%20in%202020.%20Maternal%20ART%20was%20associated%20with%20decreased%20infant%20mortality%20%28subdistribution%20hazard%20ratio%20%5BsdHR%5D%2C%200%5Cu00b765%3B%2095%25%20CL%2C%200%5Cu00b747%2C0%5Cu00b791%20in%20EA%2C%20and%20sdHR%2C%200%5Cu00b751%3B%2095%25%20CL%2C%200%5Cu00b736%2C0%5Cu00b774%20in%20CA%29%20and%20HIV%20diagnosis%20%28sdHR%2C%200%5Cu00b740%3B%2095%25%20CL%2C%200%5Cu00b731%2C0%5Cu00b750%20in%20EA%2C%20and%20sdHR%2C%200%5Cu00b741%3B%2095%25%20CL%2C%200%5Cu00b731%2C0%5Cu00b754%20in%20CA%29.%20Study%20limitations%20include%20potential%20misclassification%20of%20outcomes%20in%20real-world%20service%20delivery%20data%20and%20possible%20nonrepresentativeness%20of%20IeDEA%20sites%20and%20the%20population%20of%20HIV-exposed%20infants%20they%20serve.%5CnCONCLUSIONS%3A%20While%20there%20was%20marked%20regional%20and%20temporal%20heterogeneity%20in%20clinical%20and%20programmatic%20outcomes%2C%20infant%20LTFU%20was%20high%20across%20all%20regions%20and%20time%20periods.%20Further%20efforts%20are%20needed%20to%20keep%20HIV-exposed%20infants%20in%20care%20to%20receive%20essential%20services%20to%20reduce%20HIV%20infection%20and%20mortality.%22%2C%22date%22%3A%222022-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1004089%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A21%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22IYFS3M3U%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wada%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWada%20PY%2C%20Kim%20A%2C%20Jayathilake%20K%2C%20Duda%20SN%2C%20Abo%20Y%2C%20Althoff%20KN%2C%20et%20al.%20Site-Level%20Comprehensiveness%20of%20Care%20Is%20Associated%20with%20Individual%20Clinical%20Retention%20Among%20Adults%20Living%20with%20HIV%20in%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%2C%20a%20Global%20HIV%20Cohort%20Collaboration%2C%202000-2016.%20AIDS%20Patient%20Care%20STDS.%202022%20Sep%3B36%289%29%3A343%26%23x2013%3B55.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIYFS3M3U%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Site-Level%20Comprehensiveness%20of%20Care%20Is%20Associated%20with%20Individual%20Clinical%20Retention%20Among%20Adults%20Living%20with%20HIV%20in%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%2C%20a%20Global%20HIV%20Cohort%20Collaboration%2C%202000-2016%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20Y.%22%2C%22lastName%22%3A%22Wada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yao%22%2C%22lastName%22%3A%22Abo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%20Jiun%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22Retention%20in%20care%20%28RIC%29%20reduces%20HIV%20transmission%20and%20associated%20morbidity%20and%20mortality.%20We%20examined%20whether%20delivery%20of%20comprehensive%20services%20influenced%20individual%20RIC%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20network.%20We%20collected%20site%20data%20through%20IeDEA%20assessments%201.0%20%282000-2009%29%20and%202.0%20%282010-2016%29.%20Each%20site%20received%20a%20comprehensiveness%20score%20for%20service%20availability%20%281%5Cu2009%3D%5Cu2009present%2C%200%5Cu2009%3D%5Cu2009absent%29%2C%20with%20tallies%20ranging%20from%200%20to%207.%20We%20obtained%20individual-level%20cohort%20data%20for%20adults%20with%20at%20least%20one%20visit%20from%202000%20to%202016%20at%20sites%20responding%20to%20either%20assessment.%20Person-time%20was%20recorded%20annually%2C%20with%20RIC%20defined%20as%20completing%20two%20visits%20at%20least%2090%20days%20apart%20in%20each%20calendar%20year.%20Multivariable%20modified%20Poisson%20regression%20clustered%20by%20site%20yielded%20risk%20ratios%20and%20predicted%20probabilities%20for%20individual%20RIC%20by%20comprehensiveness.%20Among%20347%2C060%20individuals%20in%20care%20at%20122%20sites%20with%201%2C619%2C558%20person-years%20of%20follow-up%2C%2069.8%25%20of%20person-time%20was%20retained%20in%20care%2C%20varying%20by%20region%20from%2053.8%25%20%28Asia-Pacific%29%20to%2082.7%25%20%28East%20Africa%29%3B%20RIC%20improved%20by%20about%202%25%20per%20year%20from%202000%20to%202016%20%28p%5Cu2009%3D%5Cu20090.012%29.%20Every%20site%20provided%20CD4%2B%20count%20testing%2C%20and%20%3E90%25%20of%20individuals%20received%20care%20at%20sites%20that%20provided%20combination%20antiretroviral%20therapy%20adherence%20measures%2C%20prevention%20of%20mother-to-child%20transmission%2C%20tuberculosis%20screening%2C%20HIV-related%20prevention%2C%20and%20community%20tracing%20services.%20In%20adjusted%20models%2C%20individuals%20at%20sites%20with%20more%20comprehensive%20services%20had%20higher%20probabilities%20of%20RIC%20%280.71%2C%200.74%2C%20and%200.83%20for%20scores%205%2C%206%2C%20and%207%2C%20respectively%3B%20p%5Cu2009%3D%5Cu20090.019%29.%20Within%20IeDEA%2C%20greater%20site-level%20comprehensiveness%20of%20services%20was%20associated%20with%20improved%20individual%20RIC.%20Much%20work%20remains%20in%20exploring%20this%20relationship%2C%20which%20may%20inform%20HIV%20clinical%20practice%20and%20health%20systems%20planning.%22%2C%22date%22%3A%222022-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2Fapc.2022.0042%22%2C%22ISSN%22%3A%221557-7449%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A21%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22BKWMNSHS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22N%5Cu00fa%5Cu00f1ez%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EN%26%23xFA%3B%26%23xF1%3Bez%20I%2C%20Crabtree-Ramirez%20B%2C%20Shepherd%20BE%2C%20Sterling%20TR%2C%20Cahn%20P%2C%20Veloso%20VG%2C%20et%20al.%20Late-onset%20opportunistic%20infections%20while%20receiving%20anti-retroviral%20therapy%20in%20Latin%20America%3A%20burden%20and%20risk%20factors.%20Int%20J%20Infect%20Dis.%202022%20Sep%3B122%3A469%26%23x2013%3B75.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DBKWMNSHS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Late-onset%20opportunistic%20infections%20while%20receiving%20anti-retroviral%20therapy%20in%20Latin%20America%3A%20burden%20and%20risk%20factors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%22%2C%22lastName%22%3A%22N%5Cu00fa%5Cu00f1ez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20The%20aim%20of%20this%20study%20was%20to%20describe%20the%20incidence%2C%20clinical%20characteristics%2C%20and%20risk%20factors%20of%20late-onset%20opportunistic%20infections%20%28LOI%29%20in%20people%20who%20live%20with%20HIV%20%28PWLHA%29%20within%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology.%5CnMETHODS%3A%20We%20performed%20a%20retrospective%20cohort%20study%20including%20treatment-naive%20PWLHA%20enrolled%20at%20seven%20sites%20%28Argentina%2C%20Brazil%2C%20Chile%2C%20Peru%2C%20Mexico%2C%20and%20two%20sites%20in%20Honduras%29.%20Follow-up%20began%20at%206%20months%20after%20treatment%20started.%20Outcomes%20were%20LOI%2C%20loss%20to%20follow-up%2C%20and%20death.%20We%20used%20a%20Cox%20proportional%20hazards%20model%20and%20a%20competing%20risks%20model%20to%20evaluate%20risk%20factors.%5CnRESULTS%3A%20A%20total%20of%2010%2C583%20patients%20were%20included.%20Median%20follow%20up%20was%20at%205.4%20years.%20LOI%20occurred%20in%20895%20%288.4%25%29%20patients.%20Median%20time%20to%20opportunistic%20infection%20was%202.1%20years.%20The%20most%20common%20infections%20were%20tuberculosis%20%2839%25%29%2C%20esophageal%20candidiasis%20%2810%25%29%2C%20and%20Pneumocystis%20jirovecii%20%28P.%20jirovecii%29%20pneumonia%20%2810%25%29.%20Death%20occurred%20in%20576%20%285.4%25%29%20patients%2C%20and%203021%20%2828.5%25%29%20patients%20were%20lost%20to%20follow-up.%20A%20protease%20inhibitor-based%20regimen%20%28hazard%20ratio%201.25%29%2C%20AIDS-defining%20events%20during%20the%20first%206%20months%20of%20antiretroviral-treatment%20%28hazard%20ratio%202.12%29%2C%20starting%20antiretroviral-treatment%20in%20earlier%20years%20%28hazard%20ratio%201.52%20for%202005%20vs%202010%29%2C%20and%20treatment%20switch%20%28hazard%20ratio%201.31%29%20were%20associated%20with%20a%20higher%20risk%20of%20LOI.%5CnCONCLUSION%3A%20LOI%20occurred%20in%20nearly%20one%20in%2010%20patients.%20People%20with%20risk%20factors%20could%20benefit%20from%20closer%20follow-up.%22%2C%22date%22%3A%222022-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2022.06.041%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A20%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22T6EA73R5%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Giraldo%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiraldo%20L%2C%20Fink%20V%2C%20Cahn%20F%2C%20Caceres%20B%2C%20Sued%20O%2C%20Duda%20S%2C%20et%20al.%20Redesigning%20an%20Electronic%20Health%20Record%20in%20Argentina%20to%20Improve%20Comprehensive%20Health%20Care%20and%20Clinical%20Research.%20Stud%20Health%20Technol%20Inform.%202022%20Jun%206%3B290%3A993%26%23x2013%3B4.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DT6EA73R5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Redesigning%20an%20Electronic%20Health%20Record%20in%20Argentina%20to%20Improve%20Comprehensive%20Health%20Care%20and%20Clinical%20Research%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliana%22%2C%22lastName%22%3A%22Giraldo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florencia%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betiana%22%2C%22lastName%22%3A%22Caceres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%5D%2C%22abstractNote%22%3A%22Updating%20electronic%20health%20record%20systems%20to%20meet%20new%20clinic%20needs%20and%20government%20regulations%20presents%20an%20ongoing%20challenge%20for%20health%20care%20organizations.%20To%20redesign%20an%20existing%20system%20for%20two%20HIV%20clinics%20in%20Argentina%2C%20we%20employed%20a%20three-phase%20approach%20of%20exploration%2C%20participatory%20design%2C%20and%20prototyping.%20The%20process%20and%20resulting%20architecture%20of%20the%20HIV-centered%20%5C%22RedClin%5C%22%20electronic%20health%20record%20may%20inform%20electronic%20health%20records%20at%20other%20clinics%20in%20Latin%20America%20and%20worldwide.%22%2C%22date%22%3A%222022-06-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3233%5C%2FSHTI220234%22%2C%22ISSN%22%3A%221879-8365%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A20%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22LZEERED7%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Giraldo%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiraldo%20L%2C%20Fink%20V%2C%20Cahn%20F%2C%20Aristegui%20I%2C%20Caceres%20B%2C%20Sued%20O%2C%20et%20al.%20Design%20and%20Development%20of%20an%20Electronic%20Health%20Record%20According%20to%20Argentine%20Gender%20Identity%20Law.%20Stud%20Health%20Technol%20Inform.%202022%20Jun%206%3B290%3A995%26%23x2013%3B6.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DLZEERED7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Design%20and%20Development%20of%20an%20Electronic%20Health%20Record%20According%20to%20Argentine%20Gender%20Identity%20Law%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliana%22%2C%22lastName%22%3A%22Giraldo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florencia%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22In%5Cu00e9s%22%2C%22lastName%22%3A%22Aristegui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betiana%22%2C%22lastName%22%3A%22Caceres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%5D%2C%22abstractNote%22%3A%22Health%20information%20systems%20face%20the%20challenge%20of%20collecting%20data%20on%20patients%27%20gender%20identity.%20The%20absence%20of%20this%20information%20may%20lead%20the%20patients%20to%20situations%20of%20vulnerability%20and%20discrimination.%20The%20objective%20of%20this%20study%20is%20to%20describe%20the%20process%20of%20designing%20and%20developing%20an%20Electronic%20Health%20Record%20according%20to%20the%20Argentine%20Gender%20Identity%20Law.%20This%20health%20record%20allows%20clinics%20to%20record%20legal%20names%20and%20surnames%2C%20other%20social%20names%2C%20gender%20identity%2C%20sex%20at%20birth%2C%20and%20legal%20sex.%22%2C%22date%22%3A%222022-06-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3233%5C%2FSHTI220235%22%2C%22ISSN%22%3A%221879-8365%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A19%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22CDVNLP47%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Eden%20et%20al.%22%2C%22parsedDate%22%3A%222022-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EEden%20SK%2C%20Li%20C%2C%20Shepherd%20BE.%20Nonparametric%20estimation%20of%20Spearman%26%23x2019%3Bs%20rank%20correlation%20with%20bivariate%20survival%20data.%20Biometrics.%202022%20Jun%3B78%282%29%3A421%26%23x2013%3B34.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DCDVNLP47%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nonparametric%20estimation%20of%20Spearman%27s%20rank%20correlation%20with%20bivariate%20survival%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svetlana%20K.%22%2C%22lastName%22%3A%22Eden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22We%20study%20rank-based%20approaches%20to%20estimate%20the%20correlation%20between%20two%20right-censored%20variables.%20With%20end-of-study%20censoring%2C%20it%20is%20often%20impossible%20to%20nonparametrically%20identify%20the%20complete%20bivariate%20survival%20distribution%2C%20and%20therefore%20it%20is%20impossible%20to%20nonparametrically%20compute%20Spearman%27s%20rank%20correlation.%20As%20a%20solution%2C%20we%20propose%20two%20measures%20that%20can%20be%20nonparametrically%20estimated.%20The%20first%20measure%20is%20Spearman%27s%20correlation%20in%20a%20restricted%20region.%20The%20second%20measure%20is%20Spearman%27s%20correlation%20for%20an%20altered%20but%20estimable%20joint%20distribution.%20We%20describe%20population%20parameters%20for%20these%20measures%20and%20illustrate%20how%20they%20are%20similar%20to%20and%20different%20from%20the%20overall%20Spearman%27s%20correlation.%20We%20propose%20consistent%20estimators%20of%20these%20measures%20and%20study%20their%20performance%20through%20simulations.%20We%20illustrate%20our%20methods%20with%20a%20study%20assessing%20the%20correlation%20between%20the%20time%20to%20viral%20failure%20and%20the%20time%20to%20regimen%20change%20among%20persons%20living%20with%20HIV%20in%20Latin%20America%20who%20start%20antiretroviral%20therapy.%22%2C%22date%22%3A%222022-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fbiom.13453%22%2C%22ISSN%22%3A%221541-0420%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A17%3A24Z%22%7D%7D%2C%7B%22key%22%3A%224D8B4PNE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Justice%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJustice%20AC%2C%20Goetz%20MB%2C%20Stewart%20CN%2C%20Hogan%20BC%2C%20Humes%20E%2C%20Luz%20PM%2C%20et%20al.%20Delayed%20presentation%20of%20HIV%20among%20older%20individuals%3A%20a%20growing%20problem.%20Lancet%20HIV.%202022%20Apr%3B9%284%29%3Ae269%26%23x2013%3B80.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D4D8B4PNE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Delayed%20presentation%20of%20HIV%20among%20older%20individuals%3A%20a%20growing%20problem%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20C.%22%2C%22lastName%22%3A%22Justice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20B.%22%2C%22lastName%22%3A%22Goetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20N.%22%2C%22lastName%22%3A%22Stewart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenna%20C.%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Humes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinei%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reena%22%2C%22lastName%22%3A%22Rajasuriar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%5D%2C%22abstractNote%22%3A%22Late%20presentation%20for%20care%20is%20a%20major%20impediment%20to%20the%20prevention%20and%20effective%20treatment%20of%20HIV%20infection.%20Older%20individuals%20are%20at%20increased%20risk%20of%20late%20presentation%2C%20represent%20a%20growing%20proportion%20of%20people%20with%20late%20presentation%2C%20and%20might%20require%20interventions%20tailored%20to%20their%20age%20group.%20We%20provide%20a%20summary%20of%20the%20literature%20published%20globally%20between%202016-21%20%28reporting%20data%20from%201984-2018%29%20and%20quantify%20the%20association%20of%20age%20with%20delayed%20presentation.%20Using%20the%20most%20common%20definitions%20of%20late%20presentation%20and%20older%20age%20from%20these%20earlier%20studies%2C%20we%20update%20this%20work%20with%20data%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%2C%20focusing%20on%20data%20from%202000-19%2C%20encompassing%20four%20continents.%20Finally%2C%20we%20consider%20how%20late%20presentation%20among%20older%20individuals%20might%20be%20more%20effectively%20addressed%20as%20electronic%20medical%20records%20become%20widely%20adopted.%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2822%2900003-0%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A19%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22I99FBBGX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Antimycobacterial%20Susceptibility%20Testing%20Group%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAntimycobacterial%20Susceptibility%20Testing%20Group.%20Updating%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-tuberculosis%20agents%3A%20implications%20for%20diagnosis%20and%20treatment.%20Eur%20Respir%20J.%202022%20Apr%3B59%284%29%3A2200166.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DI99FBBGX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Updating%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-tuberculosis%20agents%3A%20implications%20for%20diagnosis%20and%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Antimycobacterial%20Susceptibility%20Testing%20Group%22%7D%5D%2C%22abstractNote%22%3A%22Inappropriately%20high%20breakpoints%20have%20resulted%20in%20systematic%20false-susceptible%20AST%20results%20to%20anti-TB%20drugs.%20MIC%2C%20PK%5C%2FPD%20and%20clinical%20outcome%20data%20should%20be%20combined%20when%20setting%20breakpoints%20to%20minimise%20the%20emergence%20and%20spread%20of%20antimicrobial%20resistance.%20https%3A%5C%2F%5C%2Fbit.ly%5C%2F3i43wb6%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00166-2022%22%2C%22ISSN%22%3A%221399-3003%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A19%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22WG3D4A6V%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Caro-Vega%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECaro-Vega%20Y%2C%20Rebeiro%20PF%2C%20Shepherd%20BE%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Crabtree-Ramirez%20B%2C%20Cesar%20C%2C%20et%20al.%20Clinical%20effects%20of%20durability%20of%20immunosuppression%20in%20virologically%20suppressed%20ART-initiating%20persons%20with%20HIV%20in%20Latin%20America.%20A%20retrospective%20cohort%20study.%20Lancet%20Reg%20Health%20Am.%202022%20Apr%3B8%3A100175.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DWG3D4A6V%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20effects%20of%20durability%20of%20immunosuppression%20in%20virologically%20suppressed%20ART-initiating%20persons%20with%20HIV%20in%20Latin%20America.%20A%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20Mendes%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Clinical%20outcomes%20are%20rarely%20studied%20in%20virologically%20suppressed%20people%20living%20with%20HIV%20%28PWH%29%20and%20incomplete%20CD4%20recovery.%20To%20explore%20whether%20time%20living%20with%20severe%20immunosuppression%20predict%20clinical%20outcomes%20better%20than%20baseline%20or%20time%20updated%20CD4%2C%20we%20estimated%20the%20association%20between%20cumulative%20percentage%20of%20time%20with%20CD4%20%3C200%20cells%5C%2F%5Cu03bcL%20during%20viral%20suppression%20%28VS%29%20%28%25tCD4%3C200%29%2C%20and%20mortality%20and%20comorbidities%20during%202000-2019.%5CnMETHODS%3A%20In%20a%20retrospective%20cohort%20analysis%2C%20we%20followed%20PWH%20initiating%20ART%20in%20Latin%20America%20from%20first%20VS%20%28HIV-RNA%3C200%20copies%5C%2F%5Cu03bcL%29%20to%20death%2C%20virological%20failure%20or%20loss%20to%20follow-up.%20We%20fit%20Cox%20models%20to%20estimate%20risk%20of%20death%20and%5C%2For%20AIDS-defining%20and%20serious%20non-AIDS-defining%20events%20%28ADE%20and%20SNADE%20-cancer%2C%20cardiovascular%2C%20liver%2C%20and%20renal%20diseases%29%20by%20%25tCD4%3C200%20%28continuous%20variable%29.%20We%20predicted%20survival%20probabilities%20for%20each%20event%20and%20calculated%20risks%20of%20hypothetical%20cases%20of%20different%20%25tCD4%3C200.%5CnFINDINGS%3A%20In%208%2C369%20patients%20with%2034%5Cu00b79%20months%20of%20follow-up%20%28median%2C%20IQR%3A%2016%5Cu00b77%2C%2069%5Cu00b71%29%2C%204%2C274%20%2851%25%29%20started%20ART%20with%20CD4%3C200%20cells%5C%2F%5Cu03bcL.%20Median%20%25tCD4%3C200%20was%200%25%20%28IQR%3A%200%2C%2015%25%29.%20We%20identified%20195%20%282%5Cu00b73%25%29%20deaths%20and%20584%20%287%5Cu00b72%25%29%20patients%20with%20ADE%5C%2FSNADE.%20For%20an%20increased%20%25tCD4%3C200%20of%2015%25%20%28e.g.%2C%2015%25%20vs.%200%25%29%2C%20the%20adjusted%20relative%20hazard%20%28aHR%29%20of%20death%20was%201%5Cu00b727%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%201%5Cu00b719%20-%201%5Cu00b735%29%2C%20of%20ADE%5C%2FSNADE%20was%201%5Cu00b713%20%2895%25CI%3A%201%5Cu00b709%20-%201%5Cu00b717%29%2C%20of%20SNADE%20was%200%5Cu00b796%20%2895%25CI%3A%200%5Cu00b789%20-%201%5Cu00b702%29%20and%20of%20death%5C%2FADE%5C%2FSNADE%20was%201%5Cu00b711%20%2895%25CI%3A%201%5Cu00b707%20-%201%5Cu00b714%29.%20Estimates%20were%20similar%20after%20adjusting%20for%20time%20updated%20CD4%20count.%5CnINTERPRETATION%3A%20In%20virologically%20suppressed%20PWH%2C%20increased%20time%20living%20with%20severe%20immunosuppression%20had%20an%20increased%20risk%20of%20death%20and%20ADE%5C%2FSNADE%20in%20this%20Latin%20American%20cohort%2C%20independently%20of%20time%20updated%20CD4%20count.%5CnFUNDING%3A%20This%20work%20was%20supported%20by%20the%20NIH-funded%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%2C%20U01AI069923%29%2C%20a%20member%20cohort%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28leDEA%29.%20This%20award%20is%20funded%20by%20the%20following%20institutes%3A%20Eunice%20Kennedy%20Shriver%20National%20Institute%20Of%20Child%20Health%20%26%20Human%20Development%20%28NICHD%29%2C%20National%20Cancer%20Institute%20%28NCI%29%2C%20National%20Institute%20Of%20Allergy%20And%20Infectious%20Diseases%20%28NIAID%29%2C%20National%20Institute%20Of%20Mental%20Health%20%28NIMH%29%2C%20the%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute%20%28NHLBI%29%2C%20the%20National%20Institute%20on%20Alcohol%20Abuse%20and%20Alcoholism%20%28NIAAA%29%2C%20the%20National%20Institute%20of%20Diabetes%20and%20Digestive%20and%20Kidney%20Diseases%20%28NIDDK%29%2C%20and%20the%20Fogarty%20International%20Center%20%28FIC%29.%20Specific%20funding%20was%20provided%20from%20the%20Fogarty%20International%20Center%20%28FIC%29%20for%20lead%20author%2C%20Yanink%20Caro-Vega%2C%20for%20the%20Fogarty-IeDEA%20Mentorship%20Program%20%28FIMP%29.%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2021.100175%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A19%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22EEFGID3V%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoelho%20LE%2C%20Jenkins%20CA%2C%20Shepherd%20BE%2C%20Pape%20JW%2C%20Mejia%20Cordero%20F%2C%20Padgett%20D%2C%20et%20al.%20Weight%20gain%20post-ART%20in%20HIV%2B%20Latinos%5C%2Fas%20differs%20in%20the%20USA%2C%20Haiti%2C%20and%20Latin%20America.%20Lancet%20Reg%20Health%20Am.%202022%20Apr%3B8%3A100173.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DEEFGID3V%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Weight%20gain%20post-ART%20in%20HIV%2B%20Latinos%5C%2Fas%20differs%20in%20the%20USA%2C%20Haiti%2C%20and%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%20Cordero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree%20Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20R.%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20C.%22%2C%22lastName%22%3A%22Marconi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phyllis%20C.%22%2C%22lastName%22%3A%22Tien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20L.%22%2C%22lastName%22%3A%22Willig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Colasanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heidi%20M.%22%2C%22lastName%22%3A%22Crane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20John%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Horberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Mayor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Silverberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20An%20obesity%20epidemic%20has%20been%20documented%20among%20adult%20Latinos%5C%2Fas%20in%20Latin%20America%20and%20the%20United%20States%20%28US%29%3B%20however%2C%20little%20is%20known%20about%20obesity%20among%20Latinos%5C%2Fas%20with%20HIV%20%28PWH%29.%20Moreover%2C%20Latinos%5C%2Fas%20PWH%20in%20the%20US%20may%20have%20different%20weight%20trajectories%20than%20those%20in%20Latin%20America%20due%20to%20the%20cultural%20and%20environmental%20contexts.%20We%20assessed%20weight%20and%20body%20mass%20index%20%28BMI%29%20trajectories%20among%20PWH%20initiating%20antiretroviral%20therapy%20%28ART%29%20across%205%20countries%20in%20Latin%20America%20and%20the%20Caribbean%20and%20the%20US.%5CnMETHODS%3A%20ART-na%5Cu00ffve%20PWH%20%5Cu226518%20years%20old%2C%20enrolled%20in%20Brazil%2C%20Honduras%2C%20Mexico%2C%20Peru%2C%20and%20Haiti%20%28sites%20within%20CCA-SAnet%29%20and%20the%20US%20%28NA-ACCORD%29%20starting%20ART%20between%202000%20and%202017%2C%20with%20at%20least%20one%20weight%20measured%20after%20ART%20initiation%20were%20included.%20Participants%20were%20classified%20according%20to%20site%5C%2Fethnicity%20as%3A%20Latinos%5C%2Fas%20in%20US%2C%20non-Latinos%5C%2Fas%20in%20US%2C%20Haitians%2C%20and%20Latinos%5C%2Fas%20in%20Latin%20America.%20Generalized%20least%20squares%20models%20were%20used%20to%20assess%20trends%20in%20weight%20and%20BMI.%20Models%20estimating%20probabilities%20of%20becoming%20overweight%5C%2Fobese%20%28BMI%20%5Cu226525%20kg%5C%2Fm2%29%20and%20of%20becoming%20obese%20%28BMI%20%5Cu226530%20kg%5C%2Fm2%29%20post%20ART%20initiation%20for%20males%20and%20females%20were%20fit%20using%20generalized%20estimating%20equations%20with%20a%20logit%20link%20and%20an%20independence%20working%20correlation%20structure.%5CnFINDINGS%3A%20Among%2059%2C207%20PWH%2C%209%25%20were%20Latinos%5C%2Fas%20from%20Latin%20America%2C%209%25%20Latinos%5C%2Fas%20from%20the%20US%2C%2068%25%20non-Latinos%5C%2Fas%20from%20the%20US%20and%2014%25%20were%20Haitian.%20At%20ART%20initiation%2C%2029%25%20were%20overweight%20and%2014%25%20were%20obese.%20Post-ART%20weight%20and%20BMI%20increases%20were%20steeper%20for%20Latinos%5C%2Fas%20in%20Latin%20America%20compared%20with%20other%20sites%5C%2Fethnicities%3B%20however%2C%20BMI%20at%203-years%20post%20ART%20remained%20lower%20compared%20to%20Latinos%5C%2Fas%20and%20non-Latinos%5C%2Fas%20in%20the%20US.%20Among%20females%2C%20at%203-years%20post%20ART%20initiation%20the%20greatest%20adjusted%20probability%20of%20obesity%20was%20found%20among%20non-Latinas%20in%20the%20US%20%2815%5Cu00b72%25%29%20and%20lowest%20among%20Latinas%20in%20Latin%20America%20%288.6%25%29.%20Among%20males%2C%20while%20starting%20with%20a%20lower%20BMI%2C%20Latinos%20in%20Latin%20America%20had%20the%20greatest%20adjusted%20probability%20of%20becoming%20overweight%20or%20obese%203-years%20post-ART%20initiation.%5CnINTERPRETATION%3A%20In%20the%20Americas%2C%20PWH%20gain%20substantial%20weight%20after%20ART%20initiation.%20Despite%20environmental%20and%20cultural%20differences%2C%20PWH%20in%20Latin%20America%2C%20Haiti%20and%20Latinos%20and%20non-Latinos%20in%20the%20US%20share%20similar%20BMI%20trajectories%20on%20ART%20and%20high%20probabilities%20of%20becoming%20overweight%20and%20obese%20over%20time.%20Multicohort%20studies%20are%20needed%20to%20better%20understand%20the%20burden%20of%20other%20metabolic%20syndrome%20components%20in%20PWH%20across%20different%20countries.%22%2C%22date%22%3A%222022-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lana.2021.100173%22%2C%22ISSN%22%3A%222667-193X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A18%3A09Z%22%7D%7D%2C%7B%22key%22%3A%2252ERC49B%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Peetluk%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPeetluk%20LS%2C%20Rebeiro%20PF%2C%20Ridolfi%20FM%2C%20Andrade%20BB%2C%20Cordeiro-Santos%20M%2C%20Kritski%20A%2C%20et%20al.%20A%20Clinical%20Prediction%20Model%20for%20Unsuccessful%20Pulmonary%20Tuberculosis%20Treatment%20Outcomes.%20Clin%20Infect%20Dis.%202022%20Mar%2023%3B74%286%29%3A973%26%23x2013%3B82.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D52ERC49B%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Clinical%20Prediction%20Model%20for%20Unsuccessful%20Pulmonary%20Tuberculosis%20Treatment%20Outcomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20S.%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felipe%20M.%22%2C%22lastName%22%3A%22Ridolfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afranio%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Calvacante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20W.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dandan%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29-Brazil%20Network%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Despite%20widespread%20availability%20of%20curative%20therapy%2C%20tuberculosis%20%28TB%29%20treatment%20outcomes%20remain%20suboptimal.%20Clinical%20prediction%20models%20can%20inform%20treatment%20strategies%20to%20improve%20outcomes.%20Using%20baseline%20clinical%20data%2C%20we%20developed%20a%20prediction%20model%20for%20unsuccessful%20TB%20treatment%20outcome%20and%20evaluated%20the%20incremental%20value%20of%20human%20immunodeficiency%20virus%20%28HIV%29-related%20severity%20and%20isoniazid%20acetylator%20status.%5CnMETHODS%3A%20Data%20originated%20from%20the%20Regional%20Prospective%20Observational%20Research%20for%20Tuberculosis%20Brazil%20cohort%2C%20which%20enrolled%20newly%20diagnosed%20TB%20patients%20in%20Brazil%20from%202015%20through%202019.%20This%20analysis%20included%20participants%20with%20culture-confirmed%2C%20drug-susceptible%20pulmonary%20TB%20who%20started%20first-line%20anti-TB%20therapy%20and%20had%20%5Cu226512%20months%20of%20follow-up.%20The%20end%20point%20was%20unsuccessful%20TB%20treatment%3A%20composite%20of%20death%2C%20treatment%20failure%2C%20regimen%20switch%2C%20incomplete%20treatment%2C%20or%20not%20evaluated.%20Missing%20predictors%20were%20imputed.%20Predictors%20were%20chosen%20via%20bootstrapped%20backward%20selection.%20Discrimination%20and%20calibration%20were%20evaluated%20with%20c-statistics%20and%20calibration%20plots%2C%20respectively.%20Bootstrap%20internal%20validation%20estimated%20overfitting%2C%20and%20a%20shrinkage%20factor%20was%20applied%20to%20improve%20out-of-sample%20prediction.%20Incremental%20value%20was%20evaluated%20with%20likelihood%20ratio-based%20measures.%5CnRESULTS%3A%20Of%20944%20participants%2C%20191%20%2820%25%29%20had%20unsuccessful%20treatment%20outcomes.%20The%20final%20model%20included%207%20baseline%20predictors%3A%20hemoglobin%2C%20HIV%20infection%2C%20drug%20use%2C%20diabetes%2C%20age%2C%20education%2C%20and%20tobacco%20use.%20The%20model%20demonstrated%20good%20discrimination%20%28c-statistic%5Cu2005%3D%5Cu20050.77%3B%2095%25%20confidence%20interval%2C%20.73-.80%29%20and%20was%20well%20calibrated%20%28optimism-corrected%20intercept%20and%20slope%2C%20-0.12%20and%200.89%2C%20respectively%29.%20HIV-related%20factors%20and%20isoniazid%20acetylation%20status%20did%20not%20improve%20prediction%20of%20the%20final%20model.%5CnCONCLUSIONS%3A%20Using%20information%20readily%20available%20at%20treatment%20initiation%2C%20the%20prediction%20model%20performed%20well%20in%20this%20population.%20The%20findings%20may%20guide%20future%20work%20to%20allocate%20resources%20or%20inform%20targeted%20interventions%20for%20high-risk%20patients.%22%2C%22date%22%3A%222022-03-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciab598%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A16%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22A2V36D8V%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hovhannisyan%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHovhannisyan%20L%2C%20Coelho%20LE%2C%20Velasque%20L%2C%20De%20Boni%20RB%2C%20Clark%20J%2C%20Cardoso%20SW%2C%20et%20al.%20Multilevel%20Analysis%20of%20Individual%20and%20Neighborhood%20Characteristics%20Associated%20with%20Viral%20Suppression%20Among%20Adults%20with%20HIV%20in%20Rio%20de%20Janeiro%2C%20Brazil.%20AIDS%20Behav.%202022%20Mar%3B26%283%29%3A947%26%23x2013%3B62.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DA2V36D8V%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multilevel%20Analysis%20of%20Individual%20and%20Neighborhood%20Characteristics%20Associated%20with%20Viral%20Suppression%20Among%20Adults%20with%20HIV%20in%20Rio%20de%20Janeiro%2C%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyolya%22%2C%22lastName%22%3A%22Hovhannisyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luciane%22%2C%22lastName%22%3A%22Velasque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%20B.%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20W.%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22Understanding%20the%20impact%20of%20neighborhood%20context%20on%20viral%20suppression%20outcomes%20may%20help%20explain%20health%20disparities%20and%20identify%20future%20interventions.%20We%20assessed%20the%20relationship%20between%20individual%20characteristics%2C%20neighborhood%20socioeconomic%20context%2C%20and%20viral%20suppression%20using%20multilevel%20logistic%20regression%20models.%20Adults%20with%20HIV%20initiating%20antiretroviral%20therapy%20%28ART%29%20between%202000%20and%202017%2C%20who%20resided%20in%20Rio%20de%20Janeiro%20and%20had%20an%20HIV-1%20RNA%20level%20%28viral%20load%29%20measured%2090-270%20days%20after%20ART%20initiation%20were%20included.%20Overall%2C%2083.9%25%20achieved%20viral%20suppression.%20Participants%20who%20were%20older%2C%20had%20a%20higher%20level%20of%20education%2C%20and%20identified%20as%20heterosexual%20cisgender%20men%20and%20cisgender%20men-who-have-sex-with-men%20had%20increased%20odds%20of%20viral%20suppression.%20Later%20calendar%20year%20of%20ART%20initiation%20carried%20the%20strongest%20association%20with%20viral%20suppression%2C%20reflecting%20the%20increased%20effectiveness%20and%20tolerability%20of%20ART%20over%20time.%20Neighborhood%20socioeconomic%20indicators%20did%20not%20predict%20viral%20suppression%20in%20unadjusted%20or%20adjusted%20analyses%2C%20which%20may%20result%20from%20the%20integrated%20care%20provided%20in%20our%20health%20care%20facility%20together%20with%20Brazil%27s%20universal%20treatment.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10461-021-03450-2%22%2C%22ISSN%22%3A%221573-3254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A16%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22A232KDJD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EArriaga%20MB%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Barreto-Duarte%20B%2C%20Nogueira%20B%2C%20Freire%20MVCNS%2C%20Queiroz%20ATL%2C%20et%20al.%20The%20Effect%20of%20Diabetes%20and%20Prediabetes%20on%20Antituberculosis%20Treatment%20Outcomes%3A%20A%20Multicenter%20Prospective%20Cohort%20Study.%20J%20Infect%20Dis.%202022%20Feb%2015%3B225%284%29%3A617%26%23x2013%3B26.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DA232KDJD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Effect%20of%20Diabetes%20and%20Prediabetes%20on%20Antituberculosis%20Treatment%20Outcomes%3A%20A%20Multicenter%20Prospective%20Cohort%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Vit%5Cu00f3ria%20C.%20N.%20S.%22%2C%22lastName%22%3A%22Freire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%20S.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Cristina%20C.%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29%5Cu2013Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20It%20is%20unclear%20whether%20diabetes%20or%20prediabetes%20affects%20unfavorable%20treatment%20outcomes%20and%20death%20in%20people%20with%20tuberculosis%20%28PWTB%29.%5CnMETHODS%3A%20Culture-confirmed%2C%20drug-susceptible%20PWTB%2C%20enrolled%20in%20the%20Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29-Brazil%20cohort%20between%202015%20and%202019%20%28N%20%3D%20643%29%20were%20stratified%20based%20on%20glycemic%20status%20according%20to%20baseline%20glycated%20hemoglobin.%20Unfavorable%20tuberculosis%20%28TB%29%20outcome%20was%20defined%20as%20treatment%20failure%20or%20modification%2C%20recurrence%2C%20or%20death%3B%20favorable%20outcome%20was%20cure%20or%20treatment%20completion.%20We%20corroborated%20the%20findings%20using%20data%20from%20PWTB%20reported%20to%20the%20Brazilian%20National%20System%20of%20Diseases%20Notification%20%28SINAN%29%20during%202015-2019%20%28N%20%3D%2020%20989%29.%20Logistic%20regression%20models%20evaluated%20associations%20between%20glycemic%20status%20and%20outcomes.%5CnRESULTS%3A%20In%20both%20cohorts%2C%20in%20univariate%20analysis%2C%20unfavorable%20outcomes%20were%20more%20frequently%20associated%20with%20smoking%2C%20illicit%20drug%20use%2C%20and%20human%20immunodeficiency%20virus%20infection.%20Diabetes%2C%20but%20not%20prediabetes%2C%20was%20associated%20with%20unfavorable%20outcomes%20in%20the%20RePORT-Brazil%20%28adjusted%20relative%20risk%20%5BaRR%5D%2C%202.45%3B%20P%20%3C%20.001%29%20and%20SINAN%20%28aRR%2C%201.76%3B%20P%20%3C%20.001%29%20cohorts.%20Furthermore%2C%20diabetes%20was%20associated%20with%20high%20risk%20of%20death%20%28during%20TB%20treatment%29%20in%20both%20RePORT-Brazil%20%28aRR%2C%202.16%3B%20P%20%3D%20.040%29%20and%20SINAN%20%28aRR%2C%201.93%3B%20P%20%3D%20.001%29.%5CnCONCLUSIONS%3A%20Diabetes%20was%20associated%20with%20an%20increased%20risk%20of%20unfavorable%20outcomes%20and%20mortality%20in%20Brazilian%20PWTB.%20Interventions%20to%20improve%20TB%20treatment%20outcomes%20in%20persons%20with%20diabetes%20are%20needed.%22%2C%22date%22%3A%222022-02-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiab427%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A25%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22Q8LTF4R5%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Romo%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERomo%20ML%2C%20Patel%20RC%2C%20Edwards%20JK%2C%20Humphrey%20JM%2C%20Musick%20BS%2C%20Bernard%20C%2C%20et%20al.%20Disparities%20in%20Dolutegravir%20Uptake%20Affecting%20Females%20of%20Reproductive%20Age%20With%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%20After%20Initial%20Concerns%20About%20Teratogenicity%26%23x202F%3B%3A%20An%20Observational%20Study.%20Ann%20Intern%20Med.%202022%20Jan%3B175%281%29%3A84%26%23x2013%3B94.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DQ8LTF4R5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Disparities%20in%20Dolutegravir%20Uptake%20Affecting%20Females%20of%20Reproductive%20Age%20With%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%20After%20Initial%20Concerns%20About%20Teratogenicity%20%3A%20An%20Observational%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20L.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rena%20C.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessie%20K.%22%2C%22lastName%22%3A%22Edwards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mercy%20W.%22%2C%22lastName%22%3A%22Maina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Penner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Wyka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Penh%20Sun%22%2C%22lastName%22%3A%22Ly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radoslaw%22%2C%22lastName%22%3A%22Panczak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Kelvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20transition%20to%20dolutegravir-containing%20antiretroviral%20therapy%20%28ART%29%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%20was%20complicated%20by%20an%20initial%20safety%20signal%20in%20May%202018%20suggesting%20that%20exposure%20to%20dolutegravir%20at%20conception%20was%20possibly%20associated%20with%20infant%20neural%20tube%20defects.%20On%20the%20basis%20of%20additional%20evidence%2C%20in%20July%202019%2C%20the%20World%20Health%20Organization%20recommended%20dolutegravir%20for%20all%20adults%20and%20adolescents%20living%20with%20HIV.%5CnOBJECTIVE%3A%20To%20describe%20dolutegravir%20uptake%20and%20disparities%20by%20sex%20and%20age%20group%20in%20LMICs.%5CnDESIGN%3A%20Observational%20cohort%20study.%5CnSETTING%3A%2087%20sites%20that%20began%20using%20dolutegravir%20in%2011%20LMICs%20in%20the%20Asia-Pacific%3B%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%3B%20and%20sub-Saharan%20African%20regions%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnPATIENTS%3A%20134%5Cu00a0672%20patients%20aged%2016%20years%20or%20older%20who%20received%20HIV%20care%20from%20January%202017%20through%20March%202020.%5CnMEASUREMENTS%3A%20Sex%2C%20age%20group%2C%20and%20dolutegravir%20uptake%20%28that%20is%2C%20newly%20initiating%20ART%20with%20dolutegravir%20or%20switching%20to%20dolutegravir%20from%20another%20regimen%29.%5CnRESULTS%3A%20Differences%20in%20dolutegravir%20uptake%20among%20females%20of%20reproductive%20age%20%2816%20to%2049%20years%29%20emerged%20after%20the%20safety%20signal.%20By%20the%20end%20of%20follow-up%2C%20the%20cumulative%20incidence%20of%20dolutegravir%20uptake%20among%20females%2016%20to%2049%20years%20old%20was%2029.4%25%20%2895%25%20CI%2C%2029.0%25%20to%2029.7%25%29%20compared%20with%2057.7%25%20%28CI%2C%2057.2%25%20to%2058.3%25%29%20among%20males%2016%20to%2049%20years%20old.%20This%20disparity%20was%20greater%20in%20countries%20that%20began%20implementing%20dolutegravir%20before%20the%20safety%20signal%20and%20initially%20had%20highly%20restrictive%20policies%20versus%20countries%20with%20a%20later%20rollout.%20Dolutegravir%20uptake%20was%20similar%20among%20females%20and%20males%20aged%2050%20years%20or%20older.%5CnLIMITATION%3A%20Follow-up%20was%20limited%20to%206%20to%208%20months%20after%20international%20guidelines%20recommended%20expanding%20access%20to%20dolutegravir.%5CnCONCLUSION%3A%20Substantial%20disparities%20in%20dolutegravir%20uptake%20affecting%20females%20of%20reproductive%20age%20through%20early%202020%20are%20documented.%20Although%20this%20disparity%20was%20anticipated%20because%20of%20country-level%20restrictions%20on%20access%2C%20the%20results%20highlight%20its%20extent%20and%20initial%20persistence.%5CnPRIMARY%20FUNDING%20SOURCE%3A%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%222022-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7326%5C%2FM21-3037%22%2C%22ISSN%22%3A%221539-3704%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A17%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22888LDXIS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Villalva-Serra%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVillalva-Serra%20K%2C%20Barreto-Duarte%20B%2C%20Nunes%20VM%2C%20Menezes%20RC%2C%20Rodrigues%20MMS%2C%20Queiroz%20ATL%2C%20et%20al.%20Tuberculosis%20treatment%20outcomes%20of%20diabetic%20and%20non-diabetic%20TB%5C%2FHIV%20co-infected%20patients%3A%20A%20nationwide%20observational%20study%20in%20Brazil.%20Front%20Med%20%28Lausanne%29.%202022%3B9%3A972145.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D888LDXIS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20treatment%20outcomes%20of%20diabetic%20and%20non-diabetic%20TB%5C%2FHIV%20co-infected%20patients%3A%20A%20nationwide%20observational%20study%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klauss%22%2C%22lastName%22%3A%22Villalva-Serra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%20M.%22%2C%22lastName%22%3A%22Nunes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20C.%22%2C%22lastName%22%3A%22Menezes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%20S.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20is%20a%20worldwide%20public%20health%20problem%2C%20especially%20in%20countries%20that%20also%20report%20high%20numbers%20of%20people%20living%20with%20HIV%20%28PLWH%29%20and%5C%2For%20diabetes%20mellitus%20%28DM%29.%20However%2C%20the%20unique%20features%20of%20persons%20with%20TB-HIV-DM%20are%20incompletely%20understood.%20This%20study%20compared%20anti-TB%20treatment%20%28ATT%29%20outcomes%20of%20diabetic%20and%20non-diabetic%20TB%5C%2FHIV%20co-infected%20patients.%5CnMETHODS%3A%20A%20nationwide%20retrospective%20observational%20investigation%20was%20performed%20with%20data%20from%20the%20Brazilian%20Tuberculosis%20Database%20System%20among%20patients%20reported%20to%20have%20TB-HIV%20co-infection%20between%202014%20and%202019.%20This%20database%20includes%20all%20reported%20TB%20cases%20in%20Brazil.%20Exploratory%20and%20association%20analyses%20compared%20TB%20treatment%20outcomes%20in%20DM%20and%20non-DM%20patients.%20Unfavorable%20outcomes%20were%20defined%20as%20death%2C%20treatment%20failure%2C%20loss%20to%20follow-up%20or%20recurrence.%20Multivariable%20stepwise%20logistic%20regressions%20were%20used%20to%20identify%20the%20variables%20associated%20with%20unfavorable%20ATT%20outcomes%20in%20the%20TB-HIV%20population.%5CnRESULTS%3A%20Of%20the%2031%2C070%20TB-HIV%20patients%20analyzed%2C%20999%20%283.2%25%29%20reported%20having%20DM.%20However%2C%20in%20these%20TB-HIV%20patients%2C%20DM%20was%20not%20associated%20with%20any%20unfavorable%20treatment%20outcome%20%5Badjusted%20Odds%20Ratio%20%28aOR%29%3A%200.97%2C%2095%25%20CI%3A%200.83-1.12%2C%20p%20%3D%200.781%5D.%20Furthermore%2C%20DM%20was%20also%20not%20associated%20with%20any%20specific%20type%20of%20unfavorable%20outcome%20in%20this%20study.%20In%20both%20the%20TB-HIV%20group%20and%20the%20TB-HIV-DM%20subpopulation%2C%20use%20of%20alcohol%2C%20illicit%20drugs%20and%20tobacco%2C%20as%20well%20as%20non-white%20ethnicity%20and%20prior%20TB%20were%20all%20characteristics%20more%20frequently%20observed%20in%20persons%20who%20experienced%20an%20unfavorable%20ATT%20outcome.%5CnCONCLUSION%3A%20DM%20is%20not%20associated%20with%20unfavorable%20TB%20treatment%20outcomes%20in%20persons%20with%20TB-HIV%2C%20including%20death%2C%20treatment%20failure%2C%20recurrence%20and%20loss%20to%20follow%20up.%20However%2C%20consumption%20habits%2C%20non-white%20ethnicity%20and%20prior%20TB%20are%20all%20more%20frequently%20detected%20in%20those%20with%20unfavorable%20outcomes%20in%20both%20TB-HIV%20and%20TB-HIV-DM%20patients.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffmed.2022.972145%22%2C%22ISSN%22%3A%222296-858X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A22%3A51Z%22%7D%7D%2C%7B%22key%22%3A%226MSKCTJU%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Z%5Cu00fcrcher%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZ%26%23xFC%3Brcher%20K%2C%20Cox%20SR%2C%20Ballif%20M%2C%20Enane%20LA%2C%20Marcy%20O%2C%20Yotebieng%20M%2C%20et%20al.%20Integrating%20services%20for%20HIV%20and%20multidrug-resistant%20tuberculosis%3A%20A%20global%20cross-sectional%20survey%20among%20ART%20clinics%20in%20low-%20and%20middle-income%20countries.%20PLOS%20Glob%20Public%20Health.%202022%3B2%283%29%3Ae0000180.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D6MSKCTJU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integrating%20services%20for%20HIV%20and%20multidrug-resistant%20tuberculosis%3A%20A%20global%20cross-sectional%20survey%20among%20ART%20clinics%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Z%5Cu00fcrcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samyra%20R.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Reubenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Worarat%22%2C%22lastName%22%3A%22Imsanguan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larissa%22%2C%22lastName%22%3A%22Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nishi%22%2C%22lastName%22%3A%22Suryavanshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Tornheim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20the%20leading%20cause%20of%20death%20among%20PLHIV%20and%20multidrug-resistant-TB%20%28MDR-TB%29%20is%20associated%20with%20high%20mortality.%20We%20examined%20the%20management%20for%20adult%20PLHIV%20coinfected%20with%20MDR-TB%20at%20ART%20clinics%20in%20lower%20income%20countries.%20Between%202019%20and%202020%2C%20we%20conducted%20a%20cross-sectional%20survey%20at%2029%20ART%20clinics%20in%20high%20TB%20burden%20countries%20within%20the%20global%20IeDEA%20network.%20We%20used%20structured%20questionnaires%20to%20collect%20clinic-level%20data%20on%20the%20TB%20and%20HIV%20services%20and%20the%20availability%20of%20diagnostic%20tools%20and%20treatment%20for%20MDR-TB.%20Of%2029%20ART%20clinics%2C%2025%20%2886%25%29%20were%20in%20urban%20areas%20and%2019%20%2866%25%29%20were%20tertiary%20care%20clinics.%20Integrated%20HIV-TB%20services%20were%20reported%20at%2025%20%2886%25%29%20ART%20clinics%20for%20pan-susceptible%20TB%2C%20and%2014%20%2848%25%29%20clinics%20reported%20full%20MDR-TB%20services%20on-site%2C%20i.e.%20drug%20susceptibility%20testing%20%5BDST%5D%20and%20MDR-TB%20treatment.%20Some%20form%20of%20DST%20was%20available%20on-site%20at%2022%20%2876%25%29%20clinics%2C%20while%20the%20remainder%20referred%20testing%20off-site.%20On-site%20DST%20for%20second-line%20drugs%20was%20available%20at%209%20%2831%25%29%20clinics.%20MDR-TB%20treatment%20was%20delivered%20on-site%20at%2015%20%2852%25%29%20clinics%2C%20with%2010%20individualizing%20treatment%20based%20on%20DST%20results%20and%20five%20using%20standardized%20regimens%20alone.%20Bedaquiline%20was%20routinely%20available%20at%205%20%2817%25%29%20clinics%20and%20delamanid%20at%203%20%2810%25%29%20clinics.%20Although%20most%20ART%20clinics%20reported%20having%20integrated%20HIV%20and%20TB%20services%2C%20few%20had%20fully%20integrated%20MDR-TB%20services.%20There%20is%20a%20continued%20need%20for%20increased%20access%20to%20diagnostic%20and%20treatment%20options%20for%20MDR-TB%20patients%20and%20better%20integration%20of%20MDR-TB%20services%20into%20the%20HIV%20care%20continuum.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0000180%22%2C%22ISSN%22%3A%222767-3375%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A22%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22KIY34VYK%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EArriaga%20MB%2C%20Karim%20F%2C%20Queiroz%20ATL%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Barreto-Duarte%20B%2C%20Sales%20C%2C%20et%20al.%20Effect%20of%20Dysglycemia%20on%20Urinary%20Lipid%20Mediator%20Profiles%20in%20Persons%20With%20Pulmonary%20Tuberculosis.%20Front%20Immunol.%202022%3B13%3A919802.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DKIY34VYK%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20Dysglycemia%20on%20Urinary%20Lipid%20Mediator%20Profiles%20in%20Persons%20With%20Pulmonary%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farina%22%2C%22lastName%22%3A%22Karim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caio%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahomed-Yunus%20S.%22%2C%22lastName%22%3A%22Moosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matilda%22%2C%22lastName%22%3A%22Mazibuko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ginger%20L.%22%2C%22lastName%22%3A%22Milne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20Henrique%22%2C%22lastName%22%3A%22Serezani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20R.%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alasdair%22%2C%22lastName%22%3A%22Leslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Oxidized%20lipid%20mediators%20such%20as%20eicosanoids%20play%20a%20central%20role%20in%20the%20inflammatory%20response%20associated%20with%20tuberculosis%20%28TB%29%20pathogenesis.%20Diabetes%20mellitus%20%28DM%29%20leads%20to%20marked%20changes%20in%20lipid%20mediators%20in%20persons%20with%20TB.%20However%2C%20the%20associations%20between%20diabetes-related%20changes%20in%20lipid%20mediators%20and%20clearance%20of%20M.%20tuberculosis%20%28Mtb%29%20among%20persons%20on%20anti-TB%20treatment%20%28ATT%29%20are%20unknown.%20Quantification%20of%20urinary%20eicosanoid%20metabolites%20can%20provide%20insights%20into%20the%20circulating%20lipid%20mediators%20involved%20in%20Mtb%20immune%20responses.%5CnMETHODS%3A%20We%20conducted%20a%20multi-site%20prospective%20observational%20study%20among%20adults%20with%20drug-sensitive%20pulmonary%20TB%20and%20controls%20without%20active%20TB%3B%20both%20groups%20had%20sub-groups%20with%20or%20without%20dysglycemia%20at%20baseline.%20Participants%20were%20enrolled%20from%20RePORT-Brazil%20%28Salvador%20site%29%20and%20RePORT-South%20Africa%20%28Durban%20site%29%20and%20stratified%20according%20to%20TB%20status%20and%20baseline%20glycated%20hemoglobin%20levels%3A%20a%29%20TB-dysglycemia%20%28n%3D69%29%3B%20b%29%20TB-normoglycemia%20%28n%3D64%29%3B%20c%29%20non-TB%5C%2Fdysglycemia%20%28n%3D31%29%3B%20d%29%20non-TB%5C%2Fnon-dysglycemia%20%28n%3D29%29.%20We%20evaluated%20the%20following%20urinary%20eicosanoid%20metabolites%3A%2011%5Cu03b1-hydroxy-9%2C15-dioxo-2%2C3%2C4%2C5-tetranor-prostane-1%2C20-dioic%20acid%20%28major%20urinary%20metabolite%20of%20prostaglandin%20E2%2C%20PGE-M%29%2C%20tetranor-PGE1%20%28metabolite%20of%20PGE2%2C%20TN-E%29%2C%209%5Cu03b1-hydroxy-11%2C15-dioxo-2%2C3%2C4%2C5-tetranor-prostane-1%2C20-dioic%20acid%20%28metabolite%20of%20PGD2%2C%20PGD-M%29%2C%2011-dehydro-thromboxane%20B2%20%2811dTxB2%29%2C%202%2C3-dinor-6-keto-PGF1%5Cu03b1%20%28prostaglandin%20I%20metabolite%2C%20PGI-M%29%2C%20and%20leukotriene%20E4%20%28LTE4%29.%20Comparisons%20between%20the%20study%20groups%20were%20performed%20at%20three%20time%20points%3A%20before%20ATT%20and%202%20and%206%20months%20after%20initiating%20therapy.%5CnRESULTS%3A%20PGE-M%20and%20LTE4%20values%20were%20consistently%20higher%20at%20all%20three%20time-points%20in%20the%20TB-dysglycemia%20group%20compared%20to%20the%20other%20groups%20%28p%3C0.001%29.%20In%20addition%2C%20there%20was%20a%20significant%20decrease%20in%20PGI-M%20and%20LTE4%20levels%20from%20baseline%20to%20month%206%20in%20the%20TB-dysglycemia%20and%20TB-normoglycemia%20groups.%20Finally%2C%20TB-dysglycemia%20was%20independently%20associated%20with%20increased%20concentrations%20of%20PGD-M%2C%20PGI-M%2C%20and%20LTE4%20at%20baseline%20in%20a%20multivariable%20model%20adjusting%20for%20age%2C%20sex%2C%20BMI%2C%20and%20study%20site.%20These%20associations%20were%20not%20affected%20by%20HIV%20status.%5CnCONCLUSION%3A%20The%20urinary%20eicosanoid%20metabolite%20profile%20was%20associated%20with%20TB-dysglycemia%20before%20and%20during%20ATT.%20These%20observations%20can%20help%20identify%20the%20mechanisms%20involved%20in%20the%20pathogenesis%20of%20TB-dysglycemia%2C%20and%20potential%20biomarkers%20of%20TB%20treatment%20outcomes%2C%20including%20among%20persons%20with%20dysglycemia.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2022.919802%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A21%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22GIPKPZJL%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ara%5Cu00fajo-Pereira%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAra%26%23xFA%3Bjo-Pereira%20M%2C%20Barreto-Duarte%20B%2C%20Arriaga%20MB%2C%20Musselwhite%20LW%2C%20Vinhaes%20CL%2C%20Belaunzaran-Zamudio%20PF%2C%20et%20al.%20Relationship%20Between%20Anemia%20and%20Systemic%20Inflammation%20in%20People%20Living%20With%20HIV%20and%20Tuberculosis%3A%20A%20Sub-Analysis%20of%20the%20CADIRIS%20Clinical%20Trial.%20Front%20Immunol.%202022%3B13%3A916216.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DGIPKPZJL%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Relationship%20Between%20Anemia%20and%20Systemic%20Inflammation%20in%20People%20Living%20With%20HIV%20and%20Tuberculosis%3A%20A%20Sub-Analysis%20of%20the%20CADIRIS%20Clinical%20Trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20W.%22%2C%22lastName%22%3A%22Musselwhite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Rupert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luis%20J.%22%2C%22lastName%22%3A%22Montaner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20M.%22%2C%22lastName%22%3A%22Lederman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irini%22%2C%22lastName%22%3A%22Sereti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22People%20with%20HIV%20%28PWH%29%20are%20at%20increased%20risk%20of%20developing%20active%20tuberculosis%20%28TB%29%2C%20and%20anemia%20is%20a%20common%20complication%20in%20both%20conditions.%20Anemia%20in%20TB%20patients%20has%20been%20linked%20to%20immune%20activation%2C%20levels%20of%20inflammatory%20biomarkers%20in%20blood%2C%20and%20risk%20for%20HIV%20disease%20progression%20and%20death.%20In%20this%20study%20we%20show%20that%20anemia%20was%20associated%20with%20a%20more%20pronounced%20inflammatory%20profile%20in%20HIV-TB%20coinfected%20persons%20in%20a%20cohort%20of%20159%20individuals%20with%20advanced%20HIV%20disease%20%28CD4%20count%20%3C%20100%20cells%5C%2F%5Cu00b5L%29%20recruited%20as%20part%20of%20a%20randomized%20clinical%20trial%20%28NCT00988780%29.%20A%20panel%20of%20plasma%20biomarkers%20was%20assessed%20on%20plasma%20obtained%20prior%20to%20combination%20antiretroviral%20therapy%20%28cART%29%20initiation.%20We%20performed%20a%20series%20of%20multidimensional%20analyses%20including%20clinical%20variables%20and%20concentrations%20of%20inflammatory%20biomarkers%20to%20profile%20systemic%20inflammation%20of%20PWH%20with%20and%20without%20anemia.%20We%20observed%20that%20TB%20participants%20presented%20with%20moderately%20lower%20levels%20of%20hemoglobin%20than%20non-TB%20participants.%20These%20participants%20also%20presented%20a%20higher%20Degree%20of%20Inflammatory%20Perturbation%20%28DIP%29%20score%2C%20related%20to%20increased%20levels%20of%20IFN-%5Cu03b3%20and%20TNF.%20The%20DIP%20was%20associated%20with%20TB%20coinfection%20and%20anemia%20before%20cART%20initiation.%20Future%20mechanistic%20studies%20are%20warranted%20to%20assess%20the%20determinants%20of%20such%20associations%20and%20the%20implications%20on%20treatment%20outcomes.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2022.916216%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A21%3A05Z%22%7D%7D%5D%7D
1.
Brazier E, Ajeh R, Maruri F, Musick B, Freeman A, Wester CW, et al. Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc. 2022 Dec;25(12):e26036. Cite
1.
Lotspeich SC, Shepherd BE, Amorim GGC, Shaw PA, Tao R. Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort. Biometrics. 2022 Dec;78(4):1674–85. Cite
1.
Girardi E, Caro-Vega Y, Cozzi-Lepri A, Musaazi J, Carriquiry G, Castelnuovo B, et al. The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis. AIDS. 2022 Nov 15;36(14):2005–13. Cite
1.
Sobral L, Arriaga MB, Souza AB, Araújo-Pereira M, Barreto-Duarte B, Sales C, et al. Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study. Lancet Reg Health Am. 2022 Nov;15:100358. Cite
1.
Wada PY, Costa AG, Araújo-Pereira M, Barreto-Duarte B, Souza AB, Rocha MS, et al. Possible sex difference in latent tuberculosis infection risk among close tuberculosis contacts. Int J Infect Dis. 2022 Sep;122:685–92. Cite
1.
Edmonds A, Brazier E, Musick BS, Yotebieng M, Humphrey J, Abuogi LL, et al. Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med. 2022 Sep;19(9):e1004089. Cite
1.
Wada PY, Kim A, Jayathilake K, Duda SN, Abo Y, Althoff KN, et al. Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016. AIDS Patient Care STDS. 2022 Sep;36(9):343–55. Cite
1.
Núñez I, Crabtree-Ramirez B, Shepherd BE, Sterling TR, Cahn P, Veloso VG, et al. Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors. Int J Infect Dis. 2022 Sep;122:469–75. Cite
1.
Giraldo L, Fink V, Cahn F, Caceres B, Sued O, Duda S, et al. Redesigning an Electronic Health Record in Argentina to Improve Comprehensive Health Care and Clinical Research. Stud Health Technol Inform. 2022 Jun 6;290:993–4. Cite
1.
Giraldo L, Fink V, Cahn F, Aristegui I, Caceres B, Sued O, et al. Design and Development of an Electronic Health Record According to Argentine Gender Identity Law. Stud Health Technol Inform. 2022 Jun 6;290:995–6. Cite
1.
Eden SK, Li C, Shepherd BE. Nonparametric estimation of Spearman’s rank correlation with bivariate survival data. Biometrics. 2022 Jun;78(2):421–34. Cite
1.
Justice AC, Goetz MB, Stewart CN, Hogan BC, Humes E, Luz PM, et al. Delayed presentation of HIV among older individuals: a growing problem. Lancet HIV. 2022 Apr;9(4):e269–80. Cite
1.
Antimycobacterial Susceptibility Testing Group. Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment. Eur Respir J. 2022 Apr;59(4):2200166. Cite
1.
Caro-Vega Y, Rebeiro PF, Shepherd BE, Belaunzarán-Zamudio PF, Crabtree-Ramirez B, Cesar C, et al. Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study. Lancet Reg Health Am. 2022 Apr;8:100175. Cite
1.
Coelho LE, Jenkins CA, Shepherd BE, Pape JW, Mejia Cordero F, Padgett D, et al. Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America. Lancet Reg Health Am. 2022 Apr;8:100173. Cite
1.
Peetluk LS, Rebeiro PF, Ridolfi FM, Andrade BB, Cordeiro-Santos M, Kritski A, et al. A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes. Clin Infect Dis. 2022 Mar 23;74(6):973–82. Cite
1.
Hovhannisyan L, Coelho LE, Velasque L, De Boni RB, Clark J, Cardoso SW, et al. Multilevel Analysis of Individual and Neighborhood Characteristics Associated with Viral Suppression Among Adults with HIV in Rio de Janeiro, Brazil. AIDS Behav. 2022 Mar;26(3):947–62. Cite
1.
Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, Nogueira B, Freire MVCNS, Queiroz ATL, et al. The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study. J Infect Dis. 2022 Feb 15;225(4):617–26. Cite
1.
Romo ML, Patel RC, Edwards JK, Humphrey JM, Musick BS, Bernard C, et al. Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study. Ann Intern Med. 2022 Jan;175(1):84–94. Cite
1.
Villalva-Serra K, Barreto-Duarte B, Nunes VM, Menezes RC, Rodrigues MMS, Queiroz ATL, et al. Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil. Front Med (Lausanne). 2022;9:972145. Cite
1.
Zürcher K, Cox SR, Ballif M, Enane LA, Marcy O, Yotebieng M, et al. Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries. PLOS Glob Public Health. 2022;2(3):e0000180. Cite
1.
Arriaga MB, Karim F, Queiroz ATL, Araújo-Pereira M, Barreto-Duarte B, Sales C, et al. Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis. Front Immunol. 2022;13:919802. Cite
1.
Araújo-Pereira M, Barreto-Duarte B, Arriaga MB, Musselwhite LW, Vinhaes CL, Belaunzaran-Zamudio PF, et al. Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial. Front Immunol. 2022;13:916216. Cite
2021
76770
IP6F4TRX
2021
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-d31de161b56e3883f0dc38ed10906815%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22R7IPF6I8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Costa%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-22%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECosta%20AG%2C%20Carvalho%20BKS%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Ibiapina%20HNS%2C%20Spener-Gomes%20R%2C%20Souza%20AB%2C%20et%20al.%20Lessons%20Learned%20from%20Implementation%20of%20an%20Interferon%20Gamma%20Release%20Assay%20to%20Screen%20for%20Latent%20Tuberculosis%20Infection%20in%20a%20Large%20Multicenter%20Observational%20Cohort%20Study%20in%20Brazil.%20Microbiol%20Spectr.%202021%20Dec%2022%3B9%283%29%3Ae0116321.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DR7IPF6I8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lessons%20Learned%20from%20Implementation%20of%20an%20Interferon%20Gamma%20Release%20Assay%20to%20Screen%20for%20Latent%20Tuberculosis%20Infection%20in%20a%20Large%20Multicenter%20Observational%20Cohort%20Study%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allyson%20G.%22%2C%22lastName%22%3A%22Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20K.%20S.%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiochelson%20N.%20S.%22%2C%22lastName%22%3A%22Ibiapina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriano%22%2C%22lastName%22%3A%22Gomes-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20M.%20S.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisangela%20C.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%22%2C%22lastName%22%3A%22Benjamin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamile%20G.%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afranio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT-Brazil%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22The%20interferon%20gamma%20release%20assay%20%28IGRA%29%20has%20emerged%20as%20a%20useful%20tool%20for%20identifying%20latent%20tuberculosis%20infection%20%28LTBI%29.%20This%20assay%20can%20be%20performed%20through%20testing%20platforms%20such%20as%20the%20QuantiFERON-TB%20Gold%20Plus%20%28QFT-Plus%29%20assay.%20This%20in%20vitro%20test%20has%20been%20incorporated%20into%20several%20guidelines%20worldwide%20and%20has%20recently%20been%20considered%20by%20the%20World%20Health%20Organization%20%28WHO%29%20for%20the%20diagnosis%20of%20LTBI.%20The%20possibility%20of%20systematically%20implementing%20IGRAs%20such%20as%20the%20QFT-Plus%20assay%20in%20centers%20that%20perform%20LTBI%20screening%20has%20been%20accelerated%20by%20the%20decreased%20availability%20of%20the%20tuberculin%20skin%20test%20%28TST%29%20in%20several%20countries.%20Nevertheless%2C%20the%20process%20to%20implement%20IGRA%20testing%20in%20routine%20clinical%20care%20has%20many%20gaps.%20The%20study%20utilized%20the%20expertise%20acquired%20by%20the%20laboratory%20teams%20of%20the%20Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29-Brazil%20consortium%20during%20study%20protocol%20implementation%20of%20LTBI%20screening%20of%20tuberculosis%20%28TB%29%20close%20contacts.%20RePORT-Brazil%20includes%20clinical%20research%20sites%20from%20Brazilian%20cities%20and%20is%20the%20largest%20multicenter%20cohort%20of%20TB%20close%20contacts%20in%20the%20country%20to%20date.%20Operational%20and%20logistical%20challenges%20faced%20during%20IGRA%20implementation%20in%20all%20study%20laboratories%20are%20described%2C%20as%20well%20as%20the%20solutions%20that%20were%20developed%20and%20led%20to%20the%20successful%20establishment%20of%20IGRA%20testing%20in%20RePORT-Brazil.%20The%20descriptions%20of%20the%20problems%20identified%20and%20resolved%20in%20this%20study%20can%20assist%20laboratories%20implementing%20IGRAs%2C%20in%20addition%20to%20manufacturers%20of%20IGRAs%20providing%20effective%20technical%20support.%20This%20will%20facilitate%20the%20implementation%20of%20IGRA%20testing%20in%20countries%20with%20large%20TB%20burdens%2C%20such%20as%20Brazil.%20IMPORTANCE%20The%20IGRA%20has%20emerged%20as%20a%20useful%20tool%20for%20identifying%20persons%20with%20LTBI.%20Although%20the%20implementation%20of%20IGRAs%20is%20of%20utmost%20importance%2C%20to%20our%20knowledge%20there%20is%20scarce%20information%20on%20the%20identification%20of%20logistical%20and%20technical%20challenges%20for%20systematic%20screening%20for%20LTBI%20on%20a%20large%20scale.%20Thus%2C%20the%20descriptions%20of%20the%20problems%20identified%20and%20resolved%20in%20this%20study%20can%20assist%20laboratories%20implementing%20IGRAs%2C%20in%20addition%20to%20manufacturers%20of%20IGRAs%20providing%20effective%20technical%20support.%20This%20will%20facilitate%20the%20implementation%20of%20IGRA%20testing%20in%20countries%20with%20large%20TB%20burdens%2C%20such%20as%20Brazil.%22%2C%22date%22%3A%222021-12-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1128%5C%2FSpectrum.01163-21%22%2C%22ISSN%22%3A%222165-0497%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A16%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22A6TA7TWC%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222021-12-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EArriaga%20MB%2C%20Rocha%20MS%2C%20Nogueira%20BMF%2C%20Nascimento%20V%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Souza%20AB%2C%20et%20al.%20The%20Effect%20of%20Diabetes%20and%20Prediabetes%20on%20Mycobacterium%20tuberculosis%20Transmission%20to%20Close%20Contacts.%20J%20Infect%20Dis.%202021%20Dec%2015%3B224%2812%29%3A2064%26%23x2013%3B72.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DA6TA7TWC%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Effect%20of%20Diabetes%20and%20Prediabetes%20on%20Mycobacterium%20tuberculosis%20Transmission%20to%20Close%20Contacts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Nascimento%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20M.%20S.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alysson%20G.%22%2C%22lastName%22%3A%22Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriano%22%2C%22lastName%22%3A%22Gomes-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisangela%20C.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20It%20is%20unknown%20whether%20dysglycemia%20is%20associated%20with%20Mycobacterium%20tuberculosis%20transmission.%5CnMETHODS%3A%20We%20assessed%20epidemiological%20and%20clinical%20characteristics%20of%20patients%20with%20culture-confirmed%20pulmonary%20tuberculosis%20and%20their%20close%20contacts%2C%20enrolled%20in%20a%20multicenter%20prospective%20cohort%20in%20Brazil.%20Contacts%20were%20investigated%20at%20baseline%20and%206%20months%20after%20enrollment.%20QuantiFERON%20positivity%20at%20baseline%20and%20conversion%20%28from%20negative%20to%20positive%20at%20month%206%29%20were%20compared%20between%20subgroups%20of%20contacts%20according%20to%20glycemic%20status%20of%20persons%20with%20tuberculosis%20%28PWTB%29%20as%20diabetes%20mellitus%20%28DM%29%20or%20prediabetes.%20Multivariable%20mixed-effects%20logistic%20regression%20models%20were%20performed%20to%20test%20independent%20associations%20with%20baseline%20QuantiFERON%20positive%20and%20QuantiFERON%20conversion.%5CnRESULTS%3A%20There%20were%20592%20PWTB%20%28153%20DM%2C%20141%20prediabetes%2C%20211%20normoglycemic%29%20and%201784%20contacts%2C%20of%20whom%20658%20were%20QuantiFERON-positive%20at%20baseline%20and%20106%20converters.%20Multivariable%20analyses%20demonstrated%20that%20tuberculosis-prediabetes%20cases%2C%20acid-fast%20bacilli-positive%2C%20pulmonary%20cavities%2C%20and%20living%20with%20someone%20who%20smoked%20were%20independently%20associated%20with%20QuantiFERON%20positive%20in%20contacts%20at%20baseline.%20DM%2C%20persistent%20cough%2C%20acid-fast%20bacilli-positive%2C%20and%20pulmonary%20cavities%20in%20tuberculosis%20source%20cases%20were%20associated%20with%20QuantiFERON%20conversion.%5CnCONCLUSIONS%3A%20Contacts%20of%20persons%20with%20pulmonary%20tuberculosis%20and%20dysglycemia%20were%20at%20increased%20risk%20of%20being%20QuantiFERON%20positive%20at%20baseline%20or%20month%206.%20Increased%20focus%20on%20such%20close%20contacts%20could%20improve%20tuberculosis%20control.%22%2C%22date%22%3A%222021-12-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiab264%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A16%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22N2AYU9YE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Han%20et%20al.%22%2C%22parsedDate%22%3A%222021-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHan%20WM%2C%20Law%20MG%2C%20Egger%20M%2C%20Wools-Kaloustian%20K%2C%20Moore%20R%2C%20McGowan%20C%2C%20et%20al.%20Global%20estimates%20of%20viral%20suppression%20in%20children%20and%20adolescents%20and%20adults%20on%20antiretroviral%20therapy%20adjusted%20for%20missing%20viral%20load%20measurements%3A%20a%20multiregional%2C%20retrospective%20cohort%20study%20in%2031%20countries.%20Lancet%20HIV.%202021%20Dec%3B8%2812%29%3Ae766%26%23x2013%3B75.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DN2AYU9YE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20estimates%20of%20viral%20suppression%20in%20children%20and%20adolescents%20and%20adults%20on%20antiretroviral%20therapy%20adjusted%20for%20missing%20viral%20load%20measurements%3A%20a%20multiregional%2C%20retrospective%20cohort%20study%20in%2031%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Win%20Min%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingesawaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thahira%20Jamal%22%2C%22lastName%22%3A%22Mohamed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Salters%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20Esteves%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K.%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20collaboration%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20As%20countries%20move%20towards%20the%20UNAIDS%27s%2095-95-95%20targets%20and%20with%20strong%20evidence%20that%20undetectable%20equals%20untransmittable%2C%20it%20is%20increasingly%20important%20to%20assess%20whether%20those%20with%20HIV%20who%20are%20receiving%20antiretroviral%20therapy%20%28ART%29%20achieve%20viral%20suppression.%20We%20estimated%20the%20proportions%20of%20children%20and%20adolescents%20and%20adults%20with%20viral%20suppression%20at%201%2C%202%2C%20and%203%20years%20after%20initiating%20ART.%5CnMETHODS%3A%20In%20this%20retrospective%20cohort%20study%2C%20seven%20regional%20cohorts%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20contributed%20data%20from%20individuals%20initiating%20ART%20between%20Jan%201%2C%202010%2C%20and%20Dec%2031%2C%202019%2C%20at%20148%20sites%20in%2031%20countries%20with%20annual%20viral%20load%20monitoring.%20Only%20people%20with%20HIV%20who%20started%20ART%20after%20the%20time%20a%20site%20started%20routine%20viral%20load%20monitoring%20were%20included.%20Data%20up%20to%20March%2031%2C%202020%2C%20were%20analysed.%20We%20estimated%20the%20proportions%20of%20children%20and%20adolescents%20%28aged%20%3C18%20years%20at%20ART%20initiation%29%20and%20adults%20%28aged%20%5Cu226518%20years%20at%20ART%20initiation%29%20with%20viral%20suppression%20%28viral%20load%20%3C1000%20copies%20per%20mL%29%20at%201%2C%202%2C%20and%203%20years%20after%20ART%20initiation%20using%20an%20intention-to-treat%20approach%20and%20an%20adjusted%20approach%20that%20accounted%20for%20missing%20viral%20load%20measurements.%5CnFINDINGS%3A%2021%5Cu2008594%20children%20and%20adolescents%20%2811%5Cu2008812%20%5B55%25%5D%20female%2C%209782%20%5B45%25%5D%20male%29%20from%20106%20sites%20in%2022%20countries%20and%20255%5Cu2008662%20adults%20%28163%5Cu2008831%20%5B64%25%5D%20female%2C%2091%5Cu2008831%20%5B36%25%5D%20male%29%20from%20143%20sites%20in%2030%20countries%20were%20included.%20Using%20the%20intention-to-treat%20approach%2C%20the%20proportion%20of%20children%20and%20adolescents%20with%20viral%20suppression%20was%207303%20%2836%25%29%20of%2020%5Cu2008478%20at%201%20year%2C%205709%20%2830%25%29%20of%2019%5Cu2008135%20at%202%20years%2C%20and%204287%20%2824%25%29%20of%2017%5Cu2008589%20at%203%20years%20after%20ART%20initiation%3B%20the%20proportion%20of%20adults%20with%20viral%20suppression%20was%20106%5Cu2008541%20%2844%25%29%20of%20240%5Cu2008600%20at%201%20year%2C%2079%5Cu2008141%20%2836%25%29%20of%20220%5Cu2008925%20at%202%20years%2C%20and%2057%5Cu2008970%20%2829%25%29%20of%20201%5Cu2008124%20at%203%20years%20after%20ART%20initiation.%20After%20adjusting%20for%20missing%20viral%20load%20measurements%20among%20those%20who%20transferred%2C%20were%20lost%20to%20follow-up%2C%20or%20who%20were%20in%20follow-up%20without%20viral%20load%20testing%2C%20the%20proportion%20of%20children%20and%20adolescents%20with%20viral%20suppression%20was%2012%5Cu2008048%20%2864%25%20%5Bplausible%20range%2043-81%5D%29%20of%2018%5Cu2008835%20at%201%20year%2C%2010%5Cu2008796%20%2862%25%20%5B41-77%5D%29%20of%2017%5Cu2008553%20at%202%20years%2C%20and%209177%20%2859%25%20%5B38-91%5D%29%20of%2015%5Cu2008667%20at%203%20years%20after%20ART%20initiation%3B%20the%20proportion%20of%20adults%20with%20viral%20suppression%20was%20176%5Cu2008964%20%2879%25%20%5B53-80%5D%29%20of%20225%5Cu2008418%20at%201%20year%2C%20145%5Cu2008552%20%2872%25%20%5B48-79%5D%29%20of%20201%5Cu2008238%20at%202%20years%2C%20and%20115%5Cu2008260%20%2865%25%20%5B43-69%5D%29%20of%20178%5Cu2008458%20at%203%20years%20after%20ART%20initiation.%5CnINTERPRETATION%3A%20Although%20adults%20with%20HIV%20are%20approaching%20the%20global%20target%20of%2095%25%20viral%20suppression%2C%20progress%20among%20children%20and%20adolescents%20is%20much%20slower.%20Substantial%20efforts%20are%20still%20needed%20to%20reach%20the%20viral%20suppression%20target%20for%20children%20and%20adolescents.%5CnFUNDING%3A%20US%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%222021-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2821%2900265-4%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A15%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22X6FH6GUQ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22McMahon%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMcMahon%20DE%2C%20Semeere%20A%2C%20Laker-Oketta%20M%2C%20Byakwaga%20H%2C%20Mugglin%20C%2C%20Duda%20SN%2C%20et%20al.%20Global%20Disparities%20in%20Skin%20Cancer%20Services%20at%20HIV%20Treatment%20Centers%20across%2029%20Countries.%20J%20Invest%20Dermatol.%202021%20Oct%3B141%2810%29%3A2533-2536.e2.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DX6FH6GUQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20Disparities%20in%20Skin%20Cancer%20Services%20at%20HIV%20Treatment%20Centers%20across%2029%20Countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devon%20E.%22%2C%22lastName%22%3A%22McMahon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aggrey%22%2C%22lastName%22%3A%22Semeere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Laker-Oketta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catrina%22%2C%22lastName%22%3A%22Mugglin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iskandar%22%2C%22lastName%22%3A%22Azwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%20E.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jid.2021.02.758%22%2C%22ISSN%22%3A%221523-1747%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A10%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22IQTJMWZJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrazier%20E%2C%20Tymejczyk%20O%2C%20Zaniewski%20E%2C%20Egger%20M%2C%20Wools-Kaloustian%20K%2C%20Yiannoutsos%20CT%2C%20et%20al.%20Effects%20of%20National%20Adoption%20of%20Treat-All%20Guidelines%20on%20Pre-Antiretroviral%20Therapy%20%28ART%29%20CD4%20Testing%20and%20Viral%20Load%20Monitoring%20After%20ART%20initiation%3A%20A%20Regression%20Discontinuity%20Analysis.%20Clin%20Infect%20Dis.%202021%20Sep%2015%3B73%286%29%3Ae1273%26%23x2013%3B81.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIQTJMWZJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effects%20of%20National%20Adoption%20of%20Treat-All%20Guidelines%20on%20Pre-Antiretroviral%20Therapy%20%28ART%29%20CD4%20Testing%20and%20Viral%20Load%20Monitoring%20After%20ART%20initiation%3A%20A%20Regression%20Discontinuity%20Analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20S.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junko%22%2C%22lastName%22%3A%22Tanuma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Th%5Cu00e9odore%22%2C%22lastName%22%3A%22Niyongabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20World%20Health%20Organization%27s%20Treat-All%20guidance%20recommends%20CD4%20testing%20before%20initiating%20antiretroviral%20therapy%20%28ART%29%2C%20and%20routine%20viral%20load%20%28VL%29%20monitoring%20%28over%20CD4%20monitoring%29%20for%20patients%20on%20ART.%5CnMETHODS%3A%20We%20used%20regression%20discontinuity%20analyses%20to%20estimate%20changes%20in%20CD4%20testing%20and%20VL%20monitoring%20among%20547%20837%20ART-naive%20patients%20enrolling%20in%20human%20immunodeficiency%20virus%20%28HIV%29%20care%20during%202006-2018%20at%20225%20clinics%20in%2026%20countries%20where%20Treat-All%20policies%20were%20adopted.%20We%20examined%20CD4%20testing%20within%2012%20months%20before%20and%20VL%20monitoring%206%20months%20after%20ART%20initiation%20among%20adults%20%28%5Cu226520%20years%29%2C%20adolescents%20%2810-19%20years%29%2C%20and%20children%20%280-9%20years%29%20in%20low%5C%2Flower-middle-income%20countries%20%28L%5C%2FLMICs%29%20and%20high%5C%2Fupper-middle-income%20countries%20%28H%5C%2FUMICs%29.%5CnRESULTS%3A%20Treat-All%20adoption%20led%20to%20an%20immediate%20decrease%20in%20pre-ART%20CD4%20testing%20among%20adults%20in%20L%5C%2FLMICs%2C%20from%2057.0%25%20to%2048.1%25%20%28-8.9%20percentage%20points%20%5Bpp%5D%3B%2095%25%20CI%3A%20-11.0%2C%20-6.8%29%2C%20and%20a%20small%20increase%20in%20H%5C%2FUMICs%2C%20from%2090.1%25%20to%2091.7%25%20%28%2B1.6pp%3B%2095%25%20CI%3A%200.2%2C%203.0%29%2C%20with%20no%20changes%20among%20adolescents%20or%20children%3B%20decreases%20in%20pre-ART%20CD4%20testing%20accelerated%20after%20Treat-All%20adoption%20in%20L%5C%2FLMICs.%20In%20L%5C%2FLMICs%2C%20VL%20monitoring%20after%20ART%20initiation%20was%20low%20among%20all%20patients%20in%20L%5C%2FLMICs%20before%20Treat-All%3B%20while%20there%20was%20no%20immediate%20change%20at%20Treat-All%20adoption%2C%20VL%20monitoring%20trends%20significantly%20increased%20afterwards.%20VL%20monitoring%20increased%20among%20adults%20immediately%20after%20Treat-All%20adoption%2C%20from%2058.2%25%20to%2061.1%25%20%28%2B2.9pp%3B%2095%25%20CI%3A%200.5%2C%205.4%29%2C%20with%20no%20significant%20changes%20among%20adolescents%5C%2Fchildren.%5CnCONCLUSIONS%3A%20While%20on-ART%20VL%20monitoring%20has%20improved%20in%20L%5C%2FLMICs%2C%20Treat-All%20adoption%20has%20accelerated%20and%20disparately%20worsened%20suboptimal%20pre-ART%20CD4%20monitoring%2C%20which%20may%20compromise%20care%20outcomes%20for%20individuals%20with%20advanced%20HIV.%22%2C%22date%22%3A%222021-09-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciab222%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A12%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22QEPFHCUN%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Souza%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESouza%20AB%2C%20Arriaga%20MB%2C%20Amorim%20G%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Nogueira%20BMF%2C%20Queiroz%20ATL%2C%20et%20al.%20Determinants%20of%20losses%20in%20the%20latent%20tuberculosis%20infection%20cascade%20of%20care%20in%20Brazil.%20BMJ%20Glob%20Health.%202021%20Sep%3B6%289%29%3Ae005969.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DQEPFHCUN%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Determinants%20of%20losses%20in%20the%20latent%20tuberculosis%20infection%20cascade%20of%20care%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20Brito%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%22%2C%22lastName%22%3A%22Benjamin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamile%20G.%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa%20E%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Factors%20associated%20with%20losses%20in%20the%20latent%20tuberculosis%20infection%20%28LTBI%29%20cascade%20of%20care%20in%20contacts%20of%20patients%20with%20tuberculosis%20%28TB%29%20were%20investigated%20in%20a%20multicentre%20prospective%20cohort%20from%20highly%20endemic%20regions%20in%20Brazil.%5CnMETHODS%3A%20Close%20contacts%20of%201187%20patients%20with%20culture-confirmed%20pulmonary%20TB%20were%20prospectively%20studied%20between%202015%20and%202019%2C%20with%20follow-up%20of%206-24%20months.%20Data%20on%20TB%20screening%20by%20clinical%20investigation%2C%20radiographic%20examination%20and%20interferon-gamma%20release%20assay%20%28IGRA%29%20were%20collected.%20Multivariable%20regressions%20were%20used%20to%20identify%20determinants%20of%20losses%20in%20the%20LTBI%20cascade.%5CnRESULTS%3A%20Among%204145%20TB%20contacts%20initially%20identified%2C%201901%20were%20examined%20%2854%25%20loss%29.%20Among%20those%20examined%2C%20933%20were%20people%20living%20with%20HIV%2C%20%5Cu22645%20years%20old%20and%5C%2For%20had%20positive%20IGRA%20results%2C%20and%20therefore%20had%20a%20recommendation%20to%20start%20TB%20preventive%20treatment%20%28TPT%29.%20Of%20those%2C%20454%20%2823%25%29%20initiated%20treatment%2C%20and%20247%20%2854%25%20of%20those%20initiating%3B%2026%25%20of%20those%20in%20whom%20treatment%20was%20recommended%29%20completed%20TPT.%20Multivariable%20regression%20analysis%20revealed%20that%20living%20with%20HIV%2C%20illiteracy%20and%20black%5C%2Fpardo%20%28brown%29%20race%20were%20independently%20associated%20with%20losses%20in%20the%20cascade.%5CnCONCLUSION%3A%20There%20were%20losses%20at%20all%20LTBI%20cascade%20stages%2C%20but%20particularly%20at%20the%20initial%20screening%20and%20examination%20steps.%20Close%20contacts%20of%20low%20socioeconomic%20status%20and%20living%20with%20HIV%20were%20at%20heightened%20risk%20of%20not%20completing%20the%20LTBI%20cascade%20of%20care%20in%20Brazil.%22%2C%22date%22%3A%222021-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2021-005969%22%2C%22ISSN%22%3A%222059-7908%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A12%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22PFHLVF3T%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Johnson%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJohnson%20LF%2C%20Kariminia%20A%2C%20Trickey%20A%2C%20Yiannoutsos%20CT%2C%20Ekouevi%20DK%2C%20Minga%20AK%2C%20et%20al.%20Achieving%20consistency%20in%20measures%20of%20HIV-1%20viral%20suppression%20across%20countries%3A%20derivation%20of%20an%20adjustment%20based%20on%20international%20antiretroviral%20treatment%20cohort%20data.%20J%20Int%20AIDS%20Soc.%202021%20Sep%3B24%20Suppl%205%28Suppl%205%29%3Ae25776.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPFHLVF3T%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Achieving%20consistency%20in%20measures%20of%20HIV-1%20viral%20suppression%20across%20countries%3A%20derivation%20of%20an%20adjustment%20based%20on%20international%20antiretroviral%20treatment%20cohort%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Trickey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K.%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%20K.%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Roberta%20Pati%22%2C%22lastName%22%3A%22Pascom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Win%20Min%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lei%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nei-Yuan%22%2C%22lastName%22%3A%22Hsiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Marsh%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20The%20third%20of%20the%20Joint%20United%20Nations%20Programme%20on%20HIV%5C%2FAIDS%20%28UNAIDS%29%2090-90-90%20targets%20is%20to%20achieve%20a%2090%25%20rate%20of%20viral%20suppression%20%28HIV%20viral%20load%20%3C1000%20HIV-1%20RNA%20copies%5C%2Fml%29%20in%20patients%20on%20antiretroviral%20treatment%20%28ART%29%20by%202020.%20However%2C%20some%20countries%20use%20different%20thresholds%20when%20reporting%20viral%20suppression%2C%20and%20there%20is%20thus%20a%20need%20for%20an%20adjustment%20to%20standardize%20estimates%20to%20the%20%3C1000%20threshold.%20We%20aim%20to%20propose%20such%20an%20adjustment%2C%20to%20support%20consistent%20monitoring%20of%20progress%20towards%20the%20%5C%22third%2090%5C%22%20target.%5CnMETHODS%3A%20We%20considered%20three%20possible%20distributions%20for%20viral%20loads%20in%20ART%20patients%3A%20Weibull%2C%20Pareto%20and%20reverse%20Weibull%20%28imposing%20an%20upper%20limit%20but%20no%20lower%20limit%20on%20the%20log%20scale%29.%20The%20models%20were%20fitted%20to%20data%20on%20viral%20load%20distributions%20in%20ART%20patients%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20collaboration%20%28representing%20seven%20global%20regions%29%20and%20the%20ART%20Cohort%20Collaboration%20%28representing%20Europe%29%2C%20using%20separate%20random%20effects%20models%20for%20adults%20and%20children.%20The%20models%20were%20validated%20using%20data%20from%20the%20World%20Health%20Organization%20%28WHO%29%20HIV%20drug%20resistance%20report%20and%20the%20Brazilian%20national%20ART%20programme.%5CnRESULTS%3A%20Models%20were%20calibrated%20using%20921%2C157%20adult%20and%2037%2C431%20paediatric%20viral%20load%20measurements%2C%20over%202010-2019.%20The%20Pareto%20and%20reverse%20Weibull%20models%20provided%20the%20best%20fits%20to%20the%20data%2C%20but%20for%20all%20models%2C%20the%20%5C%22shape%5C%22%20parameters%20for%20the%20viral%20load%20distributions%20differed%20significantly%20between%20regions.%20The%20Weibull%20model%20performed%20best%20in%20the%20validation%20against%20the%20WHO%20drug%20resistance%20survey%20data%2C%20while%20the%20Pareto%20model%20produced%20uncertainty%20ranges%20that%20were%20too%20narrow%2C%20relative%20to%20the%20validation%20data.%20Based%20on%20these%20analyses%2C%20we%20recommend%20using%20the%20reverse%20Weibull%20model.%20For%20example%2C%20if%20a%20country%20reports%20an%2080%25%20rate%20of%20viral%20suppression%20at%20%3C200%20copies%5C%2Fml%2C%20this%20model%20estimates%20the%20proportion%20virally%20suppressed%20at%20%3C1000%20copies%5C%2Fml%20is%2088.3%25%20%280.800.56%20%29%2C%20with%20uncertainty%20range%2085.5-90.6%25%20%280.800.70%20-0.800.44%20%29.%5CnCONCLUSIONS%3A%20Estimates%20of%20viral%20suppression%20can%20change%20substantially%20depending%20on%20the%20threshold%20used%20in%20defining%20viral%20suppression.%20It%20is%2C%20therefore%2C%20important%20that%20viral%20suppression%20rates%20are%20standardized%20to%20the%20same%20threshold%20for%20the%20purpose%20of%20assessing%20progress%20towards%20UNAIDS%20targets.%20We%20have%20proposed%20a%20simple%20adjustment%20that%20allows%20this%2C%20and%20this%20has%20been%20incorporated%20into%20UNAIDS%20modelling%20software.%22%2C%22date%22%3A%222021-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25776%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A12%3A08Z%22%7D%7D%2C%7B%22key%22%3A%224VXFUYEV%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kassanjee%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKassanjee%20R%2C%20Johnson%20LF%2C%20Zaniewski%20E%2C%20Ballif%20M%2C%20Christ%20B%2C%20Yiannoutsos%20CT%2C%20et%20al.%20Global%20HIV%20mortality%20trends%20among%20children%20on%20antiretroviral%20treatment%20corrected%20for%20under-reported%20deaths%3A%20an%20updated%20analysis%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20collaboration.%20J%20Int%20AIDS%20Soc.%202021%20Sep%3B24%20Suppl%205%28Suppl%205%29%3Ae25780.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D4VXFUYEV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20HIV%20mortality%20trends%20among%20children%20on%20antiretroviral%20treatment%20corrected%20for%20under-reported%20deaths%3A%20an%20updated%20analysis%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedikt%22%2C%22lastName%22%3A%22Christ%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patience%22%2C%22lastName%22%3A%22Nyakato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tavitiya%22%2C%22lastName%22%3A%22Sudjaritruk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%5Cu00e9sir%5Cu00e9%20Lucien%22%2C%22lastName%22%3A%22Dahourou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christelle%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Kasozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20The%20Joint%20United%20Nations%20Programme%20on%20HIV%5C%2FAIDS%20%28UNAIDS%29%20projections%20of%20paediatric%20HIV%20prevalence%20and%20deaths%20rely%20on%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20for%20mortality%20estimates%20among%20children%20living%20with%20HIV%20%28CHIV%29%20receiving%20antiretroviral%20therapy%20%28ART%29.%20Previous%20estimates%2C%20based%20on%20data%20through%202014%2C%20may%20no%20longer%20be%20accurate%20due%20to%20expanded%20paediatric%20HIV%20care%20and%20treatment%20eligibility%2C%20and%20the%20possibility%20of%20unreported%20deaths%20in%20CHIV%20considered%20lost%20to%20follow-up%20%28LTFU%29.%20We%20therefore%20estimated%20all-cause%20mortality%20and%20its%20trends%20in%20CHIV%20%28%3C15%5Cu00a0years%20old%29%20on%20ART%20using%20extended%20and%20new%20IeDEA%20data.%5CnMETHODS%3A%20We%20analysed%20%28i%29%20IeDEA%20observational%20data%20from%20CHIV%20in%20routine%20care%20globally%2C%20and%20%28ii%29%20novel%20data%20from%20an%20IeDEA%20tracing%20study%20that%20determined%20outcomes%20in%20a%20sample%20of%20CHIV%20after%20being%20LTFU%20in%20southern%20Africa.%20We%20included%2045%2C711%20CHIV%20on%20ART%20during%202004%20to%202017%20at%2072%20programmes%20in%20Africa%2C%20Asia-Pacific%20and%20Latin%20America.%20We%20used%20mixed%20effects%20Poisson%20regression%20to%20estimate%20mortality%20by%20age%2C%20sex%2C%20CD4%20at%20ART%20start%2C%20time%20on%20ART%2C%20region%20and%20calendar%20year.%20For%20Africa%2C%20in%20an%20adjusted%20analysis%20that%20accounts%20for%20unreported%20deaths%20among%20those%20LTFU%2C%20we%20first%20modified%20the%20routine%20data%20by%20simulating%20mortality%20outcomes%20within%20six%20months%20after%20LTFU%2C%20based%20on%20a%20Gompertz%20survival%20model%20fitted%20to%20the%20tracing%20data%20%28n%20%3D%20221%29.%5CnRESULTS%3A%20Observed%20mortality%20rates%20were%201.8%20%2895%25%20CI%3A%201.7%20to%201.9%29%20and%209.4%20%286.3%20to%2013.4%29%20deaths%20per%20100%5Cu00a0person-years%20in%20the%20routine%20and%20tracing%20data%2C%20respectively.%20We%20found%20strong%20evidence%20of%20higher%20mortality%20at%20shorter%20ART%20durations%2C%20lower%20CD4%20values%2C%20and%20in%20infancy.%20Averaging%20over%20covariate%20patterns%2C%20the%20adjusted%20mortality%20rate%20was%2054%25%20higher%20than%20the%20unadjusted%20rate.%20In%20unadjusted%20analyses%2C%20mortality%20reduced%20by%20an%20average%2060%25%20and%2073%25%20from%202005%20to%202017%2C%20within%20and%20outside%20of%20Africa%2C%20respectively.%20In%20the%20adjusted%20analysis%20for%20Africa%2C%20this%20temporal%20reduction%20was%2042%25.%5CnCONCLUSIONS%3A%20Mortality%20rates%20among%20CHIV%20have%20decreased%20substantially%20over%20time.%20However%2C%20when%20accounting%20for%20worse%20outcomes%20among%20those%20LTFU%2C%20mortality%20estimates%20increased%20and%20temporal%20improvements%20were%20slightly%20reduced%2C%20suggesting%20caution%20in%20interpreting%20analyses%20based%20only%20on%20programme%20data.%20The%20improved%20and%20updated%20IeDEA%20estimates%20on%20mortality%20among%20CHIV%20on%20ART%20support%20UNAIDS%20efforts%20to%20accurately%20model%20global%20HIV%20statistics.%22%2C%22date%22%3A%222021-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25780%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A11%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22UP8RQPXJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Somerville%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESomerville%20K%2C%20Jenkins%20CA%2C%20Carlucci%20JG%2C%20Person%20AK%2C%20Machado%20DM%2C%20Luque%20MT%2C%20et%20al.%20Outcomes%20After%20Second-Line%20Antiretroviral%20Therapy%20in%20Children%20Living%20With%20HIV%20in%20Latin%20America.%20J%20Acquir%20Immune%20Defic%20Syndr.%202021%20Jul%201%3B87%283%29%3A993%26%23x2013%3B1001.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DUP8RQPXJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20After%20Second-Line%20Antiretroviral%20Therapy%20in%20Children%20Living%20With%20HIV%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kayla%22%2C%22lastName%22%3A%22Somerville%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20M.%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20T.%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20A.%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%20K.%22%2C%22lastName%22%3A%22Friedman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Little%20is%20known%20about%20the%20long-term%20outcomes%20of%20children%20living%20with%20HIV%20in%20Latin%20America.%20Few%20studies%20have%20examined%20antiretroviral%20therapy%20%28ART%29%20regimen%20switches%20in%20the%20years%20after%20the%20introduction%20of%20ART%20in%20this%20population.%20This%20study%20aimed%20to%20assess%20clinical%20outcomes%20among%20children%20who%20started%20second-line%20ART%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology.%5CnMETHODS%3A%20Children%20%28%3C18%20years%20old%29%20with%20HIV%20who%20switched%20to%20second-line%20ART%20at%20sites%20within%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20were%20included.%20The%20cumulative%20incidence%20and%20relative%20hazards%20of%20virologic%20failure%20while%20on%20second-line%20ART%2C%20loss%20to%20follow-up%2C%20additional%20major%20ART%20regimen%20changes%2C%20and%20all-cause%20mortality%20were%20evaluated%20using%20competing%20risks%20methods%20and%20Cox%20models.%5CnRESULTS%3A%20A%20total%20of%20672%20children%20starting%20second-line%20ART%20were%20included.%20Three%20years%20after%20starting%20second-line%20ART%2C%20the%20cumulative%20incidence%20of%20death%20was%200.10%20%5B95%25%20confidence%20interval%20%28CI%29%200.08%20to%200.13%5D%2C%20loss%20to%20follow-up%20was%200.14%20%2895%25%20CI%3A%200.11%20to%200.17%29%2C%20and%20major%20regimen%20change%20was%200.19%20%2895%25%20CI%3A%200.15%20to%200.22%29.%20Of%20those%20changing%20regimens%2C%2035%25%20were%20due%20to%20failure%20and%2011%25%20due%20to%20toxicities%5C%2Fside%20effects.%20Among%20the%20312%20children%20with%20viral%20load%20data%2C%20the%20cumulative%20incidence%20of%20virologic%20failure%20at%203%20years%20was%200.62%20%2895%25%20CI%3A%200.56%20to%200.68%29%3B%20time%20to%20virologic%20failure%20and%20regimen%20change%20were%20uncorrelated%20%28rank%20correlation%20-0.001%3B%2095%25%20CI%20-0.18%20to%200.17%29.%5CnCONCLUSIONS%3A%20Poor%20outcomes%20after%20starting%20second-line%20ART%20in%20Latin%20America%20were%20common.%20The%20high%20incidence%20of%20virologic%20failure%20and%20its%20poor%20correlation%20with%20changing%20regimens%20was%20particularly%20worrisome.%20Additional%20efforts%20are%20needed%20to%20ensure%20children%20receive%20optimal%20ART%20regimens.%22%2C%22date%22%3A%222021-07-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000002678%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A11%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22CNW2CY6C%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Z%5Cu00fcrcher%20et%20al.%22%2C%22parsedDate%22%3A%222021-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZ%26%23xFC%3Brcher%20K%2C%20Reichmuth%20ML%2C%20Ballif%20M%2C%20Loiseau%20C%2C%20Borrell%20S%2C%20Reinhard%20M%2C%20et%20al.%20Mortality%20from%20drug-resistant%20tuberculosis%20in%20high-burden%20countries%20comparing%20routine%20drug%20susceptibility%20testing%20with%20whole-genome%20sequencing%3A%20a%20multicentre%20cohort%20study.%20Lancet%20Microbe.%202021%20Jul%3B2%287%29%3Ae320%26%23x2013%3B30.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DCNW2CY6C%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20from%20drug-resistant%20tuberculosis%20in%20high-burden%20countries%20comparing%20routine%20drug%20susceptibility%20testing%20with%20whole-genome%20sequencing%3A%20a%20multicentre%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Z%5Cu00fcrcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20L.%22%2C%22lastName%22%3A%22Reichmuth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Loiseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Borrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Reinhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronika%22%2C%22lastName%22%3A%22Skrivankova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rico%22%2C%22lastName%22%3A%22H%5Cu00f6mke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alash%27le%20G.%22%2C%22lastName%22%3A%22Abimiku%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Collantes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jane%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Wilkinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Huebner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Drug%20resistance%20threatens%20global%20tuberculosis%20control.%20We%20aimed%20to%20examine%20mortality%20in%20patients%20with%20tuberculosis%20from%20high-burden%20countries%2C%20according%20to%20concordance%20or%20discordance%20of%20results%20from%20drug%20susceptibility%20testing%20done%20locally%20and%20whole-genome%20sequencing%20%28WGS%29.%5CnMETHODS%3A%20In%20this%20multicentre%20cohort%20study%2C%20we%20collected%20pulmonary%20Mycobacterium%20tuberculosis%20isolates%20and%20clinical%20data%20from%20individuals%20with%20tuberculosis%20from%20antiretroviral%20therapy%20programmes%20and%20tuberculosis%20clinics%20in%20C%5Cu00f4te%20d%27Ivoire%2C%20Democratic%20Republic%20of%20the%20Congo%2C%20Kenya%2C%20Nigeria%2C%20Peru%2C%20South%20Africa%2C%20and%20Thailand%2C%20stratified%20by%20HIV%20status%20and%20drug%20resistance.%20Sites%20tested%20drug%20susceptibility%20using%20routinely%20available%20methods.%20WGS%20was%20done%20on%20Illumina%20HiSeq%202500%20in%20the%20USA%20and%20Switzerland%2C%20and%20TBprofiler%20was%20used%20to%20analyse%20the%20genomes.%20We%20included%20individuals%20aged%2016%20years%20or%20older%20with%20pulmonary%20tuberculosis%20%28bacteriologically%20confirmed%20or%20clinically%20diagnosed%29.%20We%20analysed%20mortality%20in%20multivariable%20logistic%20regression%20models%20adjusted%20for%20sex%2C%20age%2C%20HIV%20status%2C%20history%20of%20tuberculosis%2C%20and%20sputum%20positivity.%5CnFINDINGS%3A%20Between%20Sept%201%2C%202014%2C%20and%20July%204%2C%202016%2C%20of%20634%20patients%20included%20in%20our%20previous%20analysis%2C%20we%20included%20582%20patients%20with%20tuberculosis%20%28median%20age%2033%20years%20%5BIQR%2027-43%5D%2C%20225%20%5B39%25%5D%20women%2C%20and%20247%20%5B42%25%5D%20HIV-positive%29.%20Based%20on%20WGS%2C%20339%20%2858%25%29%20isolates%20were%20pan-susceptible%2C%2035%20%286%25%29%20monoresistant%2C%20146%20%2825%25%29%20multidrug-resistant%2C%20and%2024%20%284%25%29%20pre-extensively%20drug-resistant%20%28pre-XDR%29%20or%20XDR.%20The%20analysis%20of%20mortality%20was%20based%20on%20530%20patients%3B%2063%20%2812%25%29%20died%20and%2077%20%2815%25%29%20patients%20received%20inappropriate%20treatment.%20Mortality%20ranged%20from%206%25%20%2818%20of%20310%29%20in%20patients%20with%20pan-susceptible%20tuberculosis%20to%2039%25%20%28nine%20of%2023%29%20in%20patients%20with%20pre-XDR%20or%20XDR%20tuberculosis.%20The%20adjusted%20odds%20ratio%20for%20mortality%20was%204%5Cu00b792%20%2895%25%20CI%202%5Cu00b747-9%5Cu00b778%29%20among%20undertreated%20patients%2C%20compared%20with%20appropriately%20treated%20patients.%5CnINTERPRETATION%3A%20In%20seven%20countries%20with%20a%20high%20burden%20of%20tuberculosis%2C%20we%20observed%20discrepancies%20between%20drug%20resistance%20patterns%20obtained%20locally%20and%20WGS.%20The%20underdiagnosis%20of%20drug%20resistance%20resulted%20in%20inappropriate%20treatment%20and%20higher%20mortality.%20WGS%20can%20provide%20accurate%20and%20detailed%20drug%20resistance%20information%20required%20to%20improve%20the%20outcomes%20of%20drug-resistant%20tuberculosis%20in%20high-burden%20settings.%20Our%20results%20support%20WHO%27s%20call%20for%20point-of-care%20tests%20based%20on%20WGS.%5CnFUNDING%3A%20National%20Institutes%20of%20Allergy%20and%20Infectious%20Diseases%2C%20Swiss%20National%20Science%20Foundation%2C%20and%20Swiss%20National%20Center%20for%20Mycobacteria.%22%2C%22date%22%3A%222021-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2666-5247%2821%2900044-6%22%2C%22ISSN%22%3A%222666-5247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A16%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22L98KN9ML%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Joseph%20et%20al.%22%2C%22parsedDate%22%3A%222021-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJoseph%20Y%2C%20Yao%20Z%2C%20Dua%20A%2C%20Severe%20P%2C%20Collins%20SE%2C%20Bang%20H%2C%20et%20al.%20Long-term%20mortality%20after%20tuberculosis%20treatment%20among%20persons%20living%20with%20HIV%20in%20Haiti.%20J%20Int%20AIDS%20Soc.%202021%20Jul%3B24%287%29%3Ae25721.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DL98KN9ML%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20mortality%20after%20tuberculosis%20treatment%20among%20persons%20living%20with%20HIV%20in%20Haiti%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvetot%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiwen%22%2C%22lastName%22%3A%22Yao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akanksha%22%2C%22lastName%22%3A%22Dua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrice%22%2C%22lastName%22%3A%22Severe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20E.%22%2C%22lastName%22%3A%22Collins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heejung%22%2C%22lastName%22%3A%22Bang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Antoine%20Jean-Juste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oksana%22%2C%22lastName%22%3A%22Ocheretina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Apollon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%20L.%22%2C%22lastName%22%3A%22McNairy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Dupnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%22%2C%22lastName%22%3A%22Cremieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Byrne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%20P.%22%2C%22lastName%22%3A%22Koenig%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Long-term%20mortality%20among%20TB%20survivors%20appears%20to%20be%20higher%20than%20control%20populations%20without%20TB%20in%20many%20settings.%20However%2C%20data%20are%20limited%20among%20persons%20with%20HIV%20%28PWH%29.%20We%20assessed%20the%20association%20between%20cured%20TB%20and%20long-term%20mortality%20among%20persons%20with%20PWH%20in%20Haiti.%5CnMETHODS%3A%20A%20prospective%20cohort%20of%20PWH%20from%20the%20CIPRA%20HT-001%20trial%20was%20followed%20from%20study%20enrolment%20%28August%202005%20to%20July%202008%29%20to%20study%20closure%20%28December%202018%29%20to%20compare%20mortality%20between%20participants%20with%20and%20without%20TB.%20The%20index%20date%20for%20the%20survival%20analysis%20was%20defined%20as%20240%5Cu00a0days%20after%20TB%20diagnosis%20or%20randomization%20date.%20Time%20to%20death%20was%20described%20using%20Kaplan-Meier%20curves%2C%20and%20log-rank%20tests%20were%20used%20to%20compare%20time%20to%20death%20between%20the%20TB%20and%20no-TB%20cohorts.%20The%20association%20between%20TB%20and%20long-term%20mortality%20was%20estimated%20with%20multivariable%20Cox%20models.%5CnRESULTS%3A%20Of%20the%20816%20participants%20in%20the%20CIPRA%20HT-001%20trial%2C%2077%20were%20excluded%20for%20a%20history%20of%20TB%20prior%20to%20study%20enrolment%20and%2031%20were%20excluded%20due%20to%20death%20or%20attrition%20prior%20to%20the%20index%20date%2C%20leaving%20574%20in%20the%20no-TB%20and%20134%20in%20the%20TB%20cohort.%20Twenty-four%20%2817.9%25%29%20participants%20in%20the%20TB%20and%2048%20%288.4%25%29%20in%20the%20no-TB%20cohort%20died%20during%20follow-up.%20Five%20and%2010-year%20mortality%20rates%20were%2014.2%25%20and%2017.9%25%20respectively%2C%20in%20the%20TB%20cohort%2C%20and%206.1%25%20and%208.4%25%20in%20the%20no-TB%20cohort.%20In%20Kaplan-Meier%20analysis%2C%20participants%20in%20the%20TB%20cohort%20had%20a%20significantly%20shorter%20time%20to%20death%20%28log-rank%20p%5Cu00a0%3C%5Cu00a00.001%29.%20In%20multivariable%20analysis%2C%20TB%20treatment%20was%20the%20only%20predictor%20of%20mortality%20%28HR%3A%202.78%3B%2095%25%20CI%3A%201.61%2C%204.79%29.%20Sensitivity%20analyses%2C%20which%20included%20only%20baseline%20TB%20cases%2C%20an%20index%20date%20of%20two%20years%20after%20TB%20diagnosis%2C%20and%20study%20enrolment%20and%20case-control%20matching%20yielded%20results%20that%20were%20consistent%20with%20primary%20analyses.%5CnCONCLUSIONS%3A%20PWH%20who%20are%20successfully%20treated%20for%20TB%20have%20higher%20long-term%20mortality%20than%20those%20who%20are%20never%20diagnosed%20with%20TB%2C%20even%20after%20accounting%20for%20acute%20TB-related%20mortality.%20A%20better%20understanding%20of%20the%20underlying%20mechanisms%20associated%20with%20TB%20sequelae%20is%20critically%20needed%20to%20guide%20specific%20interventions.%20Until%20then%2C%20more%20aggressive%20measures%20for%20health%20promotion%20and%20disease%20prevention%20are%20essential%20to%20improve%20long-term%20survival%20for%20PWH%20after%20TB%20treatment.%22%2C%22date%22%3A%222021-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25721%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A11%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22ZP39EHCR%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Oh%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOh%20EJ%2C%20Shepherd%20BE%2C%20Lumley%20T%2C%20Shaw%20PA.%20Improved%20generalized%20raking%20estimators%20to%20address%20dependent%20covariate%20and%20failure-time%20outcome%20error.%20Biom%20J.%202021%20Jun%3B63%285%29%3A1006%26%23x2013%3B27.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DZP39EHCR%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improved%20generalized%20raking%20estimators%20to%20address%20dependent%20covariate%20and%20failure-time%20outcome%20error%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Lumley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%5D%2C%22abstractNote%22%3A%22Biomedical%20studies%20that%20use%20electronic%20health%20records%20%28EHR%29%20data%20for%20inference%20are%20often%20subject%20to%20bias%20due%20to%20measurement%20error.%20The%20measurement%20error%20present%20in%20EHR%20data%20is%20typically%20complex%2C%20consisting%20of%20errors%20of%20unknown%20functional%20form%20in%20covariates%20and%20the%20outcome%2C%20which%20can%20be%20dependent.%20To%20address%20the%20bias%20resulting%20from%20such%20errors%2C%20generalized%20raking%20has%20recently%20been%20proposed%20as%20a%20robust%20method%20that%20yields%20consistent%20estimates%20without%20the%20need%20to%20model%20the%20error%20structure.%20We%20provide%20rationale%20for%20why%20these%20previously%20proposed%20raking%20estimators%20can%20be%20expected%20to%20be%20inefficient%20in%20failure-time%20outcome%20settings%20involving%20misclassification%20of%20the%20event%20indicator.%20We%20propose%20raking%20estimators%20that%20utilize%20multiple%20imputation%2C%20to%20impute%20either%20the%20target%20variables%20or%20auxiliary%20variables%2C%20to%20improve%20the%20efficiency.%20We%20also%20consider%20outcome-dependent%20sampling%20designs%20and%20investigate%20their%20impact%20on%20the%20efficiency%20of%20the%20raking%20estimators%2C%20either%20with%20or%20without%20multiple%20imputation.%20We%20present%20an%20extensive%20numerical%20study%20to%20examine%20the%20performance%20of%20the%20proposed%20estimators%20across%20various%20measurement%20error%20settings.%20We%20then%20apply%20the%20proposed%20methods%20to%20our%20motivating%20setting%2C%20in%20which%20we%20seek%20to%20analyze%20HIV%20outcomes%20in%20an%20observational%20cohort%20with%20EHR%20data%20from%20the%20Vanderbilt%20Comprehensive%20Care%5Cu00a0Clinic.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fbimj.202000187%22%2C%22ISSN%22%3A%221521-4036%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A10%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22IASSXK9M%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chiao%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChiao%20EY%2C%20Coghill%20A%2C%20Kizub%20D%2C%20Fink%20V%2C%20Ndlovu%20N%2C%20Mazul%20A%2C%20et%20al.%20The%20effect%20of%20non-AIDS-defining%20cancers%20on%20people%20living%20with%20HIV.%20Lancet%20Oncol.%202021%20Jun%3B22%286%29%3Ae240%26%23x2013%3B53.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIASSXK9M%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effect%20of%20non-AIDS-defining%20cancers%20on%20people%20living%20with%20HIV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20Y.%22%2C%22lastName%22%3A%22Chiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Coghill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darya%22%2C%22lastName%22%3A%22Kizub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ntokozo%22%2C%22lastName%22%3A%22Ndlovu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Mazul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%22%2C%22lastName%22%3A%22Sigel%22%7D%5D%2C%22abstractNote%22%3A%22Non-AIDS-defining%20cancers%20are%20a%20growing%20source%20of%20morbidity%20for%20people%20with%20HIV%20globally.%20Although%20people%20living%20with%20HIV%20have%20a%20disproportionately%20increased%20risk%20of%20developing%20virally%20mediated%20cancers%2C%20cancer%20burden%20for%20common%20non-AIDS-defining%20cancers%20that%20are%20not%20virally%20associated%20and%20are%20linked%20to%20ageing%2C%20such%20as%20prostate%20cancer%2C%20is%20becoming%20higher%20than%20for%20virally%20mediated%20cancers.%20Ageing%2C%20behavioural%2C%20and%20HIV-specific%20factors%20drive%20the%20incidence%20and%20affect%20the%20outcomes%20of%20non-AIDS-defining%20cancers%2C%20presenting%20different%20challenges%20for%20addressing%20global%20morbidity%20and%20mortality%20from%20non-AIDS-defining%20cancer.%20Although%20large%20population-based%20studies%20have%20shown%20that%20people%20living%20with%20HIV%20with%20non-AIDS-defining%20cancers%20have%20poorer%20cancer%20outcomes%20than%20do%20people%20without%20HIV%2C%20current%20guidelines%20emphasise%20that%20people%20living%20with%20HIV%20with%20non-AIDS-defining%20cancers%20should%20receive%20standard%2C%20guideline-based%20treatment%2C%20and%20infectious%20disease%20and%20oncology%20providers%20should%20work%20closely%20to%20address%20potential%20drug%20interactions%20between%20antiretroviral%20therapy%20and%20antineoplastic%20treatment.%20Most%20trials%20target%20preventive%20measures%20focusing%20on%20non-AIDS-defining%20cancers.%20However%2C%20treatment%20trials%20for%20the%20optimal%20management%20of%20people%20living%20with%20HIV%20and%20non-AIDS-defining%20cancer%2C%20including%20interventions%20such%20as%20immunotherapies%2C%20are%20needed%20to%20improve%20non-AIDS-defining%20cancer%20outcomes.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS1470-2045%2821%2900137-6%22%2C%22ISSN%22%3A%221474-5488%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A10%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22HUWU5LPS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tsondai%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETsondai%20PR%2C%20Davies%20MA%2C%20Singtoroj%20T%2C%20Maxwell%20N%2C%20McGowan%20CC%2C%20Songtaweesin%20WN%2C%20et%20al.%20Improving%20Methods%20to%20Classify%20Perinatal%20versus%20Nonperinatal%20HIV%20Acquisition%20in%20Young%20Adolescents%2010-14%20Years%20of%20Age.%20Pediatr%20Infect%20Dis%20J.%202021%20May%201%3B40%285%29%3A453%26%23x2013%3B6.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DHUWU5LPS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improving%20Methods%20to%20Classify%20Perinatal%20versus%20Nonperinatal%20HIV%20Acquisition%20in%20Young%20Adolescents%2010-14%20Years%20of%20Age%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20Ruvimbo%22%2C%22lastName%22%3A%22Tsondai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thida%22%2C%22lastName%22%3A%22Singtoroj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wipaporn%20N.%22%2C%22lastName%22%3A%22Songtaweesin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karl-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Technau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%20C.%20M.%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22Mode%20of%20HIV%20acquisition%20for%20adolescents%20with%20HIV%20is%20often%20not%20recorded%20within%20routine%20healthcare%20databases.%20Hence%2C%20age%20at%20enrollment%20in%20HIV%20care%20is%20often%20used%20as%20a%20proxy%20for%20perinatal%20versus%20nonperinatal%20infection.%20Using%20routine%20cohort%20data%20from%20adolescents%20presenting%20for%20HIV%20care%2010-14%20years%20of%20age%2C%20we%20developed%20logistic%20regression%20models%20to%20predict%20likely%20mode%20of%20infection.%22%2C%22date%22%3A%222021-05-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FINF.0000000000003059%22%2C%22ISSN%22%3A%221532-0987%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A06%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22C56JT5TS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yohannes%20et%20al.%22%2C%22parsedDate%22%3A%222021-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYohannes%20NT%2C%20Jenkins%20CA%2C%20Clouse%20K%2C%20Cort%26%23xE9%3Bs%20CP%2C%20Mej%26%23xED%3Ba%20Cordero%20F%2C%20Padgett%20D%2C%20et%20al.%20Timing%20of%20HIV%20diagnosis%20relative%20to%20pregnancy%20and%20postpartum%20HIV%20care%20continuum%20outcomes%20among%20Latin%20American%20women%2C%202000%20to%202017.%20J%20Int%20AIDS%20Soc.%202021%20May%3B24%285%29%3Ae25740.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DC56JT5TS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Timing%20of%20HIV%20diagnosis%20relative%20to%20pregnancy%20and%20postpartum%20HIV%20care%20continuum%20outcomes%20among%20Latin%20American%20women%2C%202000%20to%202017%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathaniel%20T.%22%2C%22lastName%22%3A%22Yohannes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Clouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%20Cordero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%20K.%22%2C%22lastName%22%3A%22Friedman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20HIV%20incidence%20among%20women%20of%20reproductive%20age%20and%20vertical%20HIV%20transmission%20rates%20remain%20high%20in%20Latin%20America.%20We%2C%20therefore%2C%20quantified%20HIV%20care%20continuum%20barriers%20and%20outcomes%20among%20pregnant%20women%20living%20with%20HIV%20%28WLWH%29%20in%20Latin%20America.%5CnMETHODS%3A%20WLWH%20%28aged%20%5Cu226516%5Cu00a0years%29%20enrolling%20at%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20sites%20from%202000%20to%202017%20who%20had%20HIV%20diagnosis%2C%20pregnancy%20and%20delivery%20dates%20contributed.%20Logistic%20regression%20produced%20adjusted%20odds%20ratios%20%28aOR%29%20and%2095%25%20confidence%20intervals%20%28CI%29%20for%20retention%20in%20care%20%28%5Cu22652%20visits%20%5Cu22653%5Cu00a0months%20apart%29%20and%20virological%20suppression%20%28viral%20load%20%3C200%20copies%5C%2FmL%29%2012%5Cu00a0months%20after%20pregnancy%20outcome.%20Cumulative%20incidences%20of%20loss%20to%20follow-up%20%28LTFU%29%20postpartum%20were%20estimated%20using%20Cox%20regression.%20Evidence%20of%20HIV%20status%20at%20pregnancy%20confirmation%20was%20the%20exposure.%20Covariates%20included%20pregnancy%20outcome%20%28born%20alive%20vs.%20others%29%3B%20AIDS%20diagnosis%20prior%20to%20delivery%3B%20CD4%2C%20age%2C%20HIV-1%20RNA%20and%20cART%20regimen%20at%20first%20delivery%20and%20CCASAnet%20country.%5CnRESULTS%3A%20Among%20579%20WLWH%2C%20median%20postpartum%20follow-up%20was%204.34%5Cu00a0years%20%28IQR%201.91%2C%207.35%29%3B%20459%20%2879%25%29%20were%20HIV-diagnosed%20before%20pregnancy%20confirmation%2C%20445%20%2877%25%29%20retained%20in%20care%20and%20259%20%2845%25%29%20virologically%20suppressed%20at%2012%5Cu00a0months%20of%20postpartum.%20Cumulative%20incidence%20of%20LTFU%20was%2021%25%20by%2012%5Cu00a0months%20and%2040%25%20by%20five%20years%20postpartum.%20Those%20HIV-diagnosed%20during%20pregnancy%20had%20lower%20odds%20of%20retention%20%28aOR%5Cu00a0%3D%5Cu00a00.58%2C%2095%25%20CI%3A%200.35%20to%200.97%29%20and%20virological%20suppression%20%28aOR%5Cu00a0%3D%5Cu00a00.50%2C%2095%25%20CI%3A%200.31%20to%200.82%29%20versus%20those%20HIV-diagnosed%20before.%5CnCONCLUSION%3A%20HIV%20diagnosis%20during%20pregnancy%20was%20associated%20with%20poorer%2012-month%20retention%20and%20virological%20suppression.%20Young%20women%20should%20be%20tested%20and%20linked%20to%20HIV%20care%20earlier%20to%20narrow%20these%20disparities.%22%2C%22date%22%3A%222021-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25740%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A10%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22FBH28KWD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Smiley%20et%20al.%22%2C%22parsedDate%22%3A%222021-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESmiley%20CL%2C%20Rebeiro%20PF%2C%20Cesar%20C%2C%20Belaunzaran-Zamudio%20PF%2C%20Crabtree-Ramirez%20B%2C%20Padgett%20D%2C%20et%20al.%20Estimated%20life%20expectancy%20gains%20with%20antiretroviral%20therapy%20among%20adults%20with%20HIV%20in%20Latin%20America%20and%20the%20Caribbean%3A%20a%20multisite%20retrospective%20cohort%20study.%20Lancet%20HIV.%202021%20May%3B8%285%29%3Ae266%26%23x2013%3B73.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DFBH28KWD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimated%20life%20expectancy%20gains%20with%20antiretroviral%20therapy%20among%20adults%20with%20HIV%20in%20Latin%20America%20and%20the%20Caribbean%3A%20a%20multisite%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Casey%20L.%22%2C%22lastName%22%3A%22Smiley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20There%20are%20few%20data%20on%20life%20expectancy%20gains%20among%20people%20living%20with%20HIV%20in%20low-income%20and%20middle-income%20settings%20where%20antiretroviral%20therapy%20%28ART%29%20is%20increasingly%20available.%20We%20aimed%20to%20analyse%20life%20expectancy%20trends%20from%202003%20to%202017%20among%20people%20with%20HIV%20beginning%20treatment%20with%20ART%20within%20the%20Caribbean%2C%20central%20America%2C%20and%20South%20America.%5CnMETHODS%3A%20We%20did%20a%20multisite%20retrospective%20cohort%20study%20and%20included%20people%20with%20HIV%20who%20had%20started%20treatment%20with%20ART%20and%20were%20aged%2016%20years%20or%20older%20between%20Jan%201%2C%202003%2C%20and%20Dec%2031%2C%202017%2C%20from%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20sites%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%2C%20and%20Peru%2C%20who%20contributed%20person-time%20data%20from%20the%20age%20of%2020%20years%20until%20date%20of%20death%2C%20last%20contact%2C%20database%20closure%2C%20or%20Dec%2031%2C%202017.%20We%20used%20the%20Chiang%20method%20of%20abridged%20life%20tables%20to%20estimate%20life%20expectancy%20at%20age%2020%20years%20for%20three%20eras%20%282003-08%2C%202009-12%2C%20and%202013-17%29%20overall%20and%20by%20demographic%20and%20clinical%20characteristics%20at%20ART%20initiation.%20We%20used%20Poisson%20regression%20models%20to%20weight%20mortality%20rates%20to%20account%20for%20informative%20censoring.%5CnFINDINGS%3A%2030%5Cu2009688%20people%20with%20HIV%20were%20included%20in%20the%20study%3B%2017%5Cu2009491%20%2857%5Cu00b70%25%29%20were%20from%20the%20Haiti%20site%20and%2013%5Cu2009197%20%2843%5Cu00b70%25%29%20were%20from%20all%20other%20sites.%20There%20were%202637%20deaths%20during%20the%20study%20period%3A%201470%20in%20Haiti%20and%201167%20in%20other%20sites.%20Crude%20and%20weighted%20mortality%20rates%20decreased%20among%20all%20age%20groups%20over%20calendar%20eras.%20From%202003-08%20to%202013-17%2C%20overall%20life%20expectancy%20for%20people%20with%20HIV%20at%20age%2020%20years%20increased%20from%2013%5Cu00b79%20years%20%2895%25%20CI%2012%5Cu00b75-15%5Cu00b72%29%20to%2061%5Cu00b72%20years%20%2859%5Cu00b70-63%5Cu00b74%29%20in%20Haiti%20and%20from%2031%5Cu00b70%20years%20%2829%5Cu00b73-32%5Cu00b78%29%20to%2069%5Cu00b75%20years%20%2867%5Cu00b72-71%5Cu00b78%29%20in%20other%20sites.%20Life%20expectancies%20at%20the%20end%20of%20the%20study%20period%20were%20within%2010%20years%20of%20those%20of%20the%20general%20population%20%2869%5Cu00b79%20years%20in%20Haiti%20and%2078%5Cu00b70%20years%20in%20all%20other%20sites%20in%202018%29.%20Disparities%20in%20life%20expectancy%20among%20people%20with%20HIV%20by%20sex%20or%20HIV%20transmission%20risk%20factor%2C%20CD4%20cell%20count%2C%20level%20of%20education%2C%20and%20history%20of%20tuberculosis%20at%20or%20before%20ART%20initiation%20persisted%20across%20calendar%20eras.%5CnINTERPRETATION%3A%20Life%20expectancy%20among%20people%20with%20HIV%20receiving%20ART%20has%20significantly%20improved%20in%20Latin%20America%20and%20the%20Caribbean.%20Persistent%20disparities%20in%20life%20expectancy%20among%20people%20with%20HIV%20by%20demographic%20and%20clinical%20factors%20at%20ART%20initiation%20highlight%20vulnerable%20populations%20in%20the%20region.%5CnFUNDING%3A%20National%20Institutes%20of%20Health.%5CnTRANSLATION%3A%20For%20the%20Spanish%20translation%20of%20the%20abstract%20see%20Supplementary%20Materials%20section.%22%2C%22date%22%3A%222021-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2820%2930358-1%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A09%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22E5T9PBLV%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nascimento-Carvalho%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENascimento-Carvalho%20GC%2C%20Nascimento-Carvalho%20EC%2C%20Ramos%20CL%2C%20Vilas-Boas%20AL%2C%20Moreno-Carvalho%20OA%2C%20Vinhaes%20CL%2C%20et%20al.%20Zika-exposed%20microcephalic%20neonates%20exhibit%20higher%20degree%20of%20inflammatory%20imbalance%20in%20cerebrospinal%20fluid.%20Sci%20Rep.%202021%20Apr%2019%3B11%281%29%3A8474.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DE5T9PBLV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Zika-exposed%20microcephalic%20neonates%20exhibit%20higher%20degree%20of%20inflammatory%20imbalance%20in%20cerebrospinal%20fluid%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20C.%22%2C%22lastName%22%3A%22Nascimento-Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20C.%22%2C%22lastName%22%3A%22Nascimento-Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%20L.%22%2C%22lastName%22%3A%22Ramos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana-Luisa%22%2C%22lastName%22%3A%22Vilas-Boas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ot%5Cu00e1vio%20A.%22%2C%22lastName%22%3A%22Moreno-Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristiana%20M.%22%2C%22lastName%22%3A%22Nascimento-Carvalho%22%7D%5D%2C%22abstractNote%22%3A%22Not%20every%20neonate%20with%20congenital%20Zika%20virus%20%28ZIKV%29%20infection%20%28CZI%29%20is%20born%20with%20microcephaly.%20We%20compared%20inflammation%20mediators%20in%20CSF%20%28cerebrospinal%20fluid%20obtained%20from%20lumbar%20puncture%29%20between%20ZIKV-exposed%20neonates%20with%5C%2Fwithout%20microcephaly%20%28cases%29%20and%20controls.%20In%20Brazil%2C%20in%20the%20same%20laboratory%2C%20we%20identified%2014%20ZIKV-exposed%20neonates%20during%20the%20ZIKV%20epidemic%20%282015-2016%29%2C%207%2850%25%29%20with%20and%207%2850%25%29%20without%20microcephaly%2C%20without%20any%20other%20congenital%20infection%2C%20and%2014%20neonates%20%282017-2018%29%20eligible%20to%20be%20controls%20and%20to%20match%20cases.%2029%20inflammation%20mediators%20were%20measured%20using%20Luminex%20immunoassay%20and%20multidimensional%20analyses%20were%20employed.%20Neonates%20with%20ZIKV-associated%20microcephaly%20presented%20substantially%20higher%20degree%20of%20inflammatory%20perturbation%2C%20associated%20with%20uncoupled%20inflammatory%20response%20and%20decreased%20correlations%20between%20concentrations%20of%20inflammatory%20biomarkers.%20The%20groups%20of%20microcephalic%20and%20non-microcephalic%20ZIKV-exposed%20neonates%20were%20distinguished%20from%20the%20control%20group%20%28area%20under%20curve%20%5BAUC%5D%5Cu2009%3D%5Cu20091%3B%20P%5Cu2009%3C%5Cu20090.0001%29.%20Between%20controls%20and%20those%20non-microcephalic%20exposed%20to%20ZIKV%2C%20IL-1%5Cu03b2%2C%20IL-3%2C%20IL-4%2C%20IL-7%20and%20EOTAXIN%20were%20the%20top%20CSF%20markers.%20By%20comparing%20the%20microcephalic%20cases%20with%20controls%2C%20the%20top%20discriminant%20scores%20were%20for%20IL-1%5Cu03b2%2C%20IL-3%2C%20EOTAXIN%20and%20IL-12p70.%20The%20degree%20of%20inflammatory%20imbalance%20may%20be%20associated%20with%20microcephaly%20in%20CZI%20and%20it%20may%20aid%20additional%20investigations%20in%20experimental%20pre-clinical%20models%20testing%20immune%20modulators%20in%20preventing%20extensive%20damage%20of%20the%20Central%20Nervous%20System.%22%2C%22date%22%3A%222021-04-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-87895-4%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A09%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22VGW9BUYP%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Spener-Gomes%20et%20al.%22%2C%22parsedDate%22%3A%222021-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESpener-Gomes%20R%2C%20Costa%20AG%2C%20Melo%20HF%20de%2C%20Souza%20AB%20de%2C%20Beraldi-Magalh%26%23xE3%3Bes%20F%2C%20Jesus%20JS%2C%20et%20al.%20Examination%20of%20respiratory%20specimens%20improves%20microbiological%20diagnosis%20of%20patients%20with%20presumptive%20extrapulmonary%20tuberculosis.%20Int%20J%20Infect%20Dis.%202021%20Apr%3B105%3A743%26%23x2013%3B5.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DVGW9BUYP%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Examination%20of%20respiratory%20specimens%20improves%20microbiological%20diagnosis%20of%20patients%20with%20presumptive%20extrapulmonary%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allyson%20Guimar%5Cu00e3es%22%2C%22lastName%22%3A%22Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hilda%20Ferreira%20de%22%2C%22lastName%22%3A%22Melo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20Brito%20de%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Beraldi-Magalh%5Cu00e3es%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaquelane%20Silva%22%2C%22lastName%22%3A%22Jesus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Izabella%22%2C%22lastName%22%3A%22Safe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anete%22%2C%22lastName%22%3A%22Trajman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Bacteriological%20confirmation%20of%20extrapulmonary%20tuberculosis%20%28EPTB%29%20is%20challenging%20for%20several%20reasons%3A%20the%20paucibacillary%20nature%20of%20the%20sample%3B%20scarce%20resources%2C%20mainly%20in%20middle%20and%20low-income%20countries%3B%20the%20need%20for%20hospitalization%3B%20and%20unfavorable%20outcomes.%20We%20evaluated%20the%20diagnostic%20role%20of%20respiratory%20specimen%20examination%20prospectively%20in%20a%20cohort%20of%20patients%20with%20presumptive%20EPTB.%5CnMETHODS%3A%20From%20July%202018%20to%20January%202019%2C%20in%20a%20tuberculosis%20%28TB%29%5C%2FHIV%20reference%20hospital%2C%20a%20cohort%20of%20157%20patients%20with%20presumed%20EPTB%20was%20evaluated.%20Xpert%5Cu00ae%20MTB%5C%2FRIF%20Ultra%20or%20a%20culture-positive%20result%20was%20considered%20for%20bacteriologically%20confirmed%20TB.%5CnRESULTS%3A%20Out%20of%20157%20patients%20with%20presumptive%20EPTB%2C%2097%20%2862%25%29%20provided%20extrapulmonary%20and%20respiratory%20specimens%20and%2060%20%2838%25%29%20extrapulmonary%20specimens%20only.%20Of%20the%2060%20patients%20with%20extrapulmonary%20samples%2C%205%20%288%25%29%20were%20positive.%20Of%20those%20with%20respiratory%20and%20extrapulmonary%20samples%2C%2027%20%2828%25%29%20were%20positive%3A%2010%20in%20both%20the%20respiratory%20and%20extrapulmonary%20samples%2C%206%20in%20the%20extrapulmonary%20sample%20only%2C%20and%2011%20in%20the%20respiratory%20sample%20only.%20A%20respiratory%20specimen%20examination%20increased%20by%206-fold%20the%20chance%20of%20bacteriological%20confirmation%20of%20TB%20%28odds%20ratio%20%3D%205.97%20%5B1.11-47.17%5D%29.%5CnCONCLUSION%3A%20We%20conclude%20that%20respiratory%20samples%20should%20be%20examined%20in%20patients%20with%20presumptive%20EPTB.%22%2C%22date%22%3A%222021-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2021.03.022%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A09%3A35Z%22%7D%7D%2C%7B%22key%22%3A%227S6QCLVA%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Peetluk%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPeetluk%20LS%2C%20Ridolfi%20FM%2C%20Rebeiro%20PF%2C%20Liu%20D%2C%20Rolla%20VC%2C%20Sterling%20TR.%20Systematic%20review%20of%20prediction%20models%20for%20pulmonary%20tuberculosis%20treatment%20outcomes%20in%20adults.%20BMJ%20Open.%202021%20Mar%202%3B11%283%29%3Ae044687.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7S6QCLVA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Systematic%20review%20of%20prediction%20models%20for%20pulmonary%20tuberculosis%20treatment%20outcomes%20in%20adults%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20S.%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felipe%20M.%22%2C%22lastName%22%3A%22Ridolfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dandan%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20systematically%20review%20and%20critically%20evaluate%20prediction%20models%20developed%20to%20predict%20tuberculosis%20%28TB%29%20treatment%20outcomes%20among%20adults%20with%20pulmonary%20TB.%5CnDESIGN%3A%20Systematic%20review.%5CnDATA%20SOURCES%3A%20PubMed%2C%20Embase%2C%20Web%20of%20Science%20and%20Google%20Scholar%20were%20searched%20for%20studies%20published%20from%201%20January%201995%20to%209%20January%202020.%5CnSTUDY%20SELECTION%20AND%20DATA%20EXTRACTION%3A%20Studies%20that%20developed%20a%20model%20to%20predict%20pulmonary%20TB%20treatment%20outcomes%20were%20included.%20Study%20screening%2C%20data%20extraction%20and%20quality%20assessment%20were%20conducted%20independently%20by%20two%20reviewers.%20Study%20quality%20was%20evaluated%20using%20the%20Prediction%20model%20Risk%20Of%20Bias%20Assessment%20Tool.%20Data%20were%20synthesised%20with%20narrative%20review%20and%20in%20tables%20and%20figures.%5CnRESULTS%3A%2014%5Cu2009739%20articles%20were%20identified%2C%20536%20underwent%20full-text%20review%20and%2033%20studies%20presenting%2037%20prediction%20models%20were%20included.%20Model%20outcomes%20included%20death%20%28n%3D16%2C%2043%25%29%2C%20treatment%20failure%20%28n%3D6%2C%2016%25%29%2C%20default%20%28n%3D6%2C%2016%25%29%20or%20a%20composite%20outcome%20%28n%3D9%2C%2025%25%29.%20Most%20models%20%28n%3D30%2C%2081%25%29%20measured%20discrimination%20%28median%20c-statistic%3D0.75%3B%20IQR%3A%200.68-0.84%29%2C%20and%2017%20%2846%25%29%20reported%20calibration%2C%20often%20the%20Hosmer-Lemeshow%20test%20%28n%3D13%29.%20Nineteen%20%2851%25%29%20models%20were%20internally%20validated%2C%20and%20six%20%2816%25%29%20were%20externally%20validated.%20Eighteen%20%2854%25%29%20studies%20mentioned%20missing%20data%2C%20and%20of%20those%2C%20half%20%28n%3D9%29%20used%20complete%20case%20analysis.%20The%20most%20common%20predictors%20included%20age%2C%20sex%2C%20extrapulmonary%20TB%2C%20body%20mass%20index%2C%20chest%20X-ray%20results%2C%20previous%20TB%20and%20HIV.%20Risk%20of%20bias%20varied%20across%20studies%2C%20but%20all%20studies%20had%20high%20risk%20of%20bias%20in%20their%20analysis.%5CnCONCLUSIONS%3A%20TB%20outcome%20prediction%20models%20are%20heterogeneous%20with%20disparate%20outcome%20definitions%2C%20predictors%20and%20methodology.%20We%20do%20not%20recommend%20applying%20any%20in%20clinical%20settings%20without%20external%20validation%2C%20and%20encourage%20future%20researchers%20adhere%20to%20guidelines%20for%20developing%20and%20reporting%20of%20prediction%20models.%5CnTRIAL%20REGISTRATION%3A%20The%20study%20was%20registered%20on%20the%20international%20prospective%20register%20of%20systematic%20reviews%20PROSPERO%20%28CRD42020155782%29.%22%2C%22date%22%3A%222021-03-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2020-044687%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A08%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22BVWWK3WC%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rodrigues%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERodrigues%20A%2C%20Struchiner%20CJ%2C%20Coelho%20LE%2C%20Veloso%20VG%2C%20Grinsztejn%20B%2C%20Luz%20PM.%20Late%20initiation%20of%20antiretroviral%20therapy%3A%20inequalities%20by%20educational%20level%20despite%20universal%20access%20to%20care%20and%20treatment.%20BMC%20Public%20Health.%202021%20Feb%2019%3B21%281%29%3A389.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DBVWWK3WC%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Late%20initiation%20of%20antiretroviral%20therapy%3A%20inequalities%20by%20educational%20level%20despite%20universal%20access%20to%20care%20and%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudio%20J.%22%2C%22lastName%22%3A%22Struchiner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Late%20antiretroviral%20treatment%20initiation%20for%20HIV%20disease%20worsens%20health%20outcomes%20and%20contributes%20to%20ongoing%20transmission.%20We%20investigated%20whether%20socioeconomic%20inequalities%20exist%20in%20access%20to%20treatment%20in%20a%20setting%20with%20universal%20access%20to%20care%20and%20treatment.%5CnMETHODS%3A%20This%20study%20investigated%20the%20association%20of%20educational%20level%2C%20used%20as%20a%20proxy%20for%20socioeconomic%20status%2C%20with%20late%20treatment%20initiation%20and%20treatment%20initiation%20with%20advanced%20disease.%20Study%20participants%20included%20adults%20%28%5Cu226525%5Cu2009years%29%20who%20started%20treatment%20from%202005%20to%202018%20at%20Instituto%20Nacional%20de%20Infectologia%20Evandro%20Chagas%20of%20Funda%5Cu00e7%5Cu00e3o%20Oswaldo%20Cruz%20%28INI%5C%2FFIOCRUZ%29%2C%20Rio%20de%20Janeiro%2C%20Brazil.%20Educational%20level%20was%20categorized%20following%20UNESCO%27s%20International%20Standard%20Classification%20of%20Education%3A%20incomplete%20basic%20education%2C%20basic%20education%2C%20secondary%20level%2C%20and%20tertiary%20level.%20We%20defined%20late%20treatment%20initiation%20as%20those%20initiating%20treatment%20with%20a%20CD4%5Cu2009%3C%5Cu2009350%20cells%5C%2FmL%20or%20an%20AIDS-defining%20event%2C%20and%20treatment%20initiation%20with%20advanced%20disease%20as%20those%20initiating%20treatment%20with%20a%20CD4%5Cu2009%3C%5Cu2009200%20cells%5C%2FmL%20or%20an%20AIDS-defining%20event.%20A%20directed%20acyclic%20graph%20%28DAG%29%20was%20constructed%20to%20represent%20the%20theoretical-operational%20model%20and%20to%20understand%20the%20involvement%20of%20covariates.%20Logistic%20regression%20models%20were%20used%20to%20estimate%20the%20adjusted%20odds%20ratios%20%28aOR%29%20and%2095%25%20confidence%20intervals%20%2895%25CI%29.%20Multiple%20imputation%20using%20a%20chained%20equations%20approach%20was%20used%20to%20treat%20missing%20values%20and%20non-linear%20terms%20for%20continuous%20variables%20were%20tested.%5CnRESULTS%3A%20In%20total%2C%203226%20individuals%20composed%20the%20study%20population%3A%20876%20%2827.4%25%29%20had%20incomplete%20basic%20education%2C%20540%20%2816.9%25%29%20basic%2C%201251%20%2839.2%25%29%20secondary%20level%2C%20and%20525%20%2816.4%25%29%20tertiary%20level.%20Late%20treatment%20initiation%20was%20observed%20for%202076%20%2864.4%25%29%20while%20treatment%20initiation%20with%20advanced%20disease%20was%20observed%20for%201423%20%2844.1%25%29.%20Compared%20to%20tertiary%20level%20of%20education%2C%20incomplete%20basic%2C%20basic%20and%20secondary%20level%20increased%20the%20odds%20of%20late%20treatment%20initiation%20by%2089%25%20%28aOR%3A1.89%2095%25CI%3A1.47-2.43%29%2C%2061%25%20%28aOR%3A1.61%2095%25CI%3A1.23-2.10%29%2C%20and%2035%25%20%28aOR%3A1.35%2095%25CI%3A1.09-1.67%29.%20Likewise%2C%20the%20odds%20of%20treatment%20initiation%20with%20advanced%20disease%20was%202.5-fold%20%28aOR%3A2.53%2095%25CI%3A1.97-3.26%29%2C%202-fold%20%28aOR%3A2.07%2095%25CI%3A1.59-2.71%29%2C%201.5-fold%20%28aOR%3A1.51%2095%25CI%3A1.21-1.88%29%20higher%20for%20those%20with%20incomplete%20basic%2C%20basic%20and%20secondary%20level%20education%20compared%20to%20tertiary%20level.%5CnCONCLUSION%3A%20Despite%20universal%20access%20to%20HIV%20care%20and%20antiretroviral%20treatment%2C%20late%20treatment%20initiation%20and%20social%20inequalities%20persist.%20Lower%20educational%20level%20significantly%20increased%20the%20odds%20of%20both%20outcomes%2C%20reinforcing%20the%20existence%20of%20barriers%20to%20%5C%22universal%5C%22%20antiretroviral%20treatment.%22%2C%22date%22%3A%222021-02-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-021-10421-8%22%2C%22ISSN%22%3A%221471-2458%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A08%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22AMDG3GK4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Oh%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOh%20EJ%2C%20Shepherd%20BE%2C%20Lumley%20T%2C%20Shaw%20PA.%20Raking%20and%20regression%20calibration%3A%20Methods%20to%20address%20bias%20from%20correlated%20covariate%20and%20time-to-event%20error.%20Stat%20Med.%202021%20Feb%2010%3B40%283%29%3A631%26%23x2013%3B49.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DAMDG3GK4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Raking%20and%20regression%20calibration%3A%20Methods%20to%20address%20bias%20from%20correlated%20covariate%20and%20time-to-event%20error%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Lumley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%5D%2C%22abstractNote%22%3A%22Medical%20studies%20that%20depend%20on%20electronic%20health%20records%20%28EHR%29%20data%20are%20often%20subject%20to%20measurement%20error%2C%20as%20the%20data%20are%20not%20collected%20to%20support%20research%20questions%20under%20study.%20These%20data%20errors%2C%20if%20not%20accounted%20for%20in%20study%20analyses%2C%20can%20obscure%20or%20cause%20spurious%20associations%20between%20patient%20exposures%20and%20disease%20risk.%20Methodology%20to%20address%20covariate%20measurement%20error%20has%20been%20well%20developed%3B%20however%2C%20time-to-event%20error%20has%20also%20been%20shown%20to%20cause%20significant%20bias%2C%20but%20methods%20to%20address%20it%20are%20relatively%20underdeveloped.%20More%20generally%2C%20it%20is%20possible%20to%20observe%20errors%20in%20both%20the%20covariate%20and%20the%20time-to-event%20outcome%20that%20are%20correlated.%20We%20propose%20regression%20calibration%20%28RC%29%20estimators%20to%20simultaneously%20address%20correlated%20error%20in%20the%20covariates%20and%20the%20censored%20event%20time.%20Although%20RC%20can%20perform%20well%20in%20many%20settings%20with%20covariate%20measurement%20error%2C%20it%20is%20biased%20for%20nonlinear%20regression%20models%2C%20such%20as%20the%20Cox%20model.%20Thus%2C%20we%20additionally%20propose%20raking%20estimators%20which%20are%20consistent%20estimators%20of%20the%20parameter%20defined%20by%20the%20population%20estimating%20equation.%20Raking%20can%20improve%20upon%20RC%20in%20certain%20settings%20with%20failure-time%20data%2C%20require%20no%20explicit%20modeling%20of%20the%20error%20structure%2C%20and%20can%20be%20utilized%20under%20outcome-dependent%20sampling%20designs.%20We%20discuss%20features%20of%20the%20underlying%20estimation%20problem%20that%20affect%20the%20degree%20of%20improvement%20the%20raking%20estimator%20has%20over%20the%20RC%20approach.%20Detailed%20simulation%20studies%20are%20presented%20to%20examine%20the%20performance%20of%20the%20proposed%20estimators%20under%20varying%20levels%20of%20signal%2C%20error%2C%20and%20censoring.%20The%20methodology%20is%20illustrated%20on%20observational%20EHR%20data%20on%20HIV%20outcomes%20from%20the%20Vanderbilt%20Comprehensive%20Care%20Clinic.%22%2C%22date%22%3A%222021-02-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fsim.8793%22%2C%22ISSN%22%3A%221097-0258%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A05%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22N3AA3HUL%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tao%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETao%20R%2C%20Lotspeich%20SC%2C%20Amorim%20G%2C%20Shaw%20PA%2C%20Shepherd%20BE.%20Efficient%20semiparametric%20inference%20for%20two-phase%20studies%20with%20outcome%20and%20covariate%20measurement%20errors.%20Stat%20Med.%202021%20Feb%2010%3B40%283%29%3A725%26%23x2013%3B38.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DN3AA3HUL%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficient%20semiparametric%20inference%20for%20two-phase%20studies%20with%20outcome%20and%20covariate%20measurement%20errors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%22%2C%22lastName%22%3A%22Tao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lotspeich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22In%20modern%20observational%20studies%20using%20electronic%20health%20records%20or%20other%20routinely%20collected%20data%2C%20both%20the%20outcome%20and%20covariates%20of%20interest%20can%20be%20error-prone%20and%20their%20errors%20often%20correlated.%20A%20cost-effective%20solution%20is%20the%20two-phase%20design%2C%20under%20which%20the%20error-prone%20outcome%20and%20covariates%20are%20observed%20for%20all%20subjects%20during%20the%20first%20phase%20and%20that%20information%20is%20used%20to%20select%20a%20validation%20subsample%20for%20accurate%20measurements%20of%20these%20variables%20in%20the%20second%20phase.%20Previous%20research%20on%20two-phase%20measurement%20error%20problems%20largely%20focused%20on%20scenarios%20where%20there%20are%20errors%20in%20covariates%20only%20or%20the%20validation%20sample%20is%20a%20simple%20random%20sample%20of%20study%20subjects.%20Herein%2C%20we%20propose%20a%20semiparametric%20approach%20to%20general%20two-phase%20measurement%20error%20problems%20with%20a%20quantitative%20outcome%2C%20allowing%20for%20correlated%20errors%20in%20the%20outcome%20and%20covariates%20and%20arbitrary%20second-phase%20selection.%20We%20devise%20a%20computationally%20efficient%20and%20numerically%20stable%20expectation-maximization%20algorithm%20to%20maximize%20the%20nonparametric%20likelihood%20function.%20The%20resulting%20estimators%20possess%20desired%20statistical%20properties.%20We%20demonstrate%20the%20superiority%20of%20the%20proposed%20methods%20over%20existing%20approaches%20through%20extensive%20simulation%20studies%2C%20and%20we%20illustrate%20their%20use%20in%20an%20observational%20HIV%20study.%22%2C%22date%22%3A%222021-02-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fsim.8799%22%2C%22ISSN%22%3A%221097-0258%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A05%3A34Z%22%7D%7D%2C%7B%22key%22%3A%225SIFTFW2%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222021-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EArriaga%20MB%2C%20Amorim%20G%2C%20Queiroz%20ATL%2C%20Rodrigues%20MMS%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Nogueira%20BMF%2C%20et%20al.%20Novel%20stepwise%20approach%20to%20assess%20representativeness%20of%20a%20large%20multicenter%20observational%20cohort%20of%20tuberculosis%20patients%3A%20The%20example%20of%20RePORT%20Brazil.%20Int%20J%20Infect%20Dis.%202021%20Feb%3B103%3A110%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D5SIFTFW2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Novel%20stepwise%20approach%20to%20assess%20representativeness%20of%20a%20large%20multicenter%20observational%20cohort%20of%20tuberculosis%20patients%3A%20The%20example%20of%20RePORT%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%20S.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betania%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20Brito%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%22%2C%22lastName%22%3A%22Benjamin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamile%20G.%22%2C%22lastName%22%3A%22de%20Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kleydson%22%2C%22lastName%22%3A%22Alves%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20A%20major%20goal%20of%20tuberculosis%20%28TB%29%20epidemiological%20studies%20is%20to%20obtain%20results%20that%20can%20be%20generalized%20to%20the%20larger%20population%20with%20TB.%20The%20ability%20to%20extrapolate%20findings%20on%20the%20determinants%20of%20TB%20treatment%20outcomes%20is%20also%20important.%5CnMETHODS%3A%20We%20compared%20baseline%20clinical%20and%20demographic%20characteristics%20and%20determinants%20of%20anti-TB%20treatment%20outcomes%20between%20persons%20enrolled%20in%20the%20Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29-Brazil%20cohort%20between%20June%202015%20and%20June%202019%2C%20and%20the%20registry%20of%20TB%20cases%20reported%20to%20the%20Brazilian%20National%20TB%20Program%20%28Information%20System%20for%20Notifiable%20Diseases%20%5BSINAN%5D%29%20during%20the%20same%20time%20period.%20Multivariable%20regression%20models%20adjusted%20for%20the%20study%20site%20were%20performed%20using%20second-generation%20p-values%2C%20a%20novel%20statistical%20approach.%20Associations%20with%20unfavorable%20treatment%20outcomes%20were%20tested%20for%20both%20RePORT-Brazil%20and%20SINAN%20cohorts.%5CnFINDINGS%3A%20A%20total%20of%201%2C060%20culture-confirmed%20TB%20patients%20were%20enrolled%20in%20RePORT-Brazil%20and%20455%2C873%20TB%20cases%20were%20reported%20to%20SINAN.%20Second-generation%20p-value%20analyses%20revealed%20that%20the%20cohorts%20were%20strikingly%20similar%20with%20regard%20to%20sex%2C%20age%2C%20use%20of%20antiretroviral%20therapy%20and%20positive%20initial%20smear%20sputum%20microscopy.%20However%2C%20diabetes%2C%20HIV%20infection%2C%20and%20smoking%20were%20more%20frequently%20documented%20in%20RePORT-Brazil.%20Illicit%20drug%20use%2C%20the%20presence%20of%20diabetes%2C%20and%20history%20of%20prior%20TB%20were%20associated%20with%20unfavorable%20TB%20treatment%20outcomes%3B%20illicit%20drug%20use%20was%20associated%20with%20such%20outcomes%20in%20both%20cohorts.%5CnCONCLUSIONS%3A%20There%20were%20important%20similarities%20in%20demographic%20characteristics%20and%20determinants%20of%20clinical%20outcomes%20between%20the%20RePORT-Brazil%20cohort%20and%20the%20Brazilian%20National%20registry%20of%20TB%20cases.%22%2C%22date%22%3A%222021-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2020.11.140%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A06%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22XGZKIDL8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castilho%20et%20al.%22%2C%22parsedDate%22%3A%222021-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECastilho%20JL%2C%20Kim%20A%2C%20Jenkins%20CA%2C%20Grinsztejn%20B%2C%20Gotuzzo%20E%2C%20Fink%20V%2C%20et%20al.%20Antiretroviral%20therapy%20and%20Kaposi%26%23x2019%3Bs%20sarcoma%20trends%20and%20outcomes%20among%20adults%20with%20HIV%20in%20Latin%20America.%20J%20Int%20AIDS%20Soc.%202021%20Jan%3B24%281%29%3Ae25658.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DXGZKIDL8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antiretroviral%20therapy%20and%20Kaposi%27s%20sarcoma%20trends%20and%20outcomes%20among%20adults%20with%20HIV%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Mercedes%22%2C%22lastName%22%3A%22Escuder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%20Alencar%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%20B.%22%2C%22lastName%22%3A%22Tenore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sidnei%20R.%22%2C%22lastName%22%3A%22Pimentel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Let%5Cu00edcia%20Rodrigues%22%2C%22lastName%22%3A%22Ikeda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulo%20R.%22%2C%22lastName%22%3A%22de%20Alencastro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Unai%22%2C%22lastName%22%3A%22Tupinanbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Brites%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estela%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliana%22%2C%22lastName%22%3A%22Netto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Grangeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%2C%20South%20America%20network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Kaposi%27s%20sarcoma%20%28KS%29%20remains%20the%20most%20frequent%20malignancy%20in%20persons%20living%20with%20HIV%20%28PWH%29%20in%20Latin%20America.%20We%20examined%20KS%20trends%20and%20outcomes%20from%20Latin%20American%20clinical%20sites%20in%20the%20era%20of%20increased%20access%20to%20antiretroviral%20therapy%20%28ART%29.%5CnMETHODS%3A%20Cohorts%20in%20Brazil%2C%20Peru%2C%20Mexico%2C%20Honduras%2C%20Argentina%20and%20Chile%20contributed%20clinical%20data%20of%20PWH%20%5Cu226516%5Cu00a0years%20old%20from%202000%20to%202017%2C%20excluding%20patients%20with%20KS%20diagnosed%20before%20clinic%20enrolment.%20We%20compared%20KS%20incidence%20over%20time%20using%20multivariable%20incidence%20rate%20ratios.%20Predictors%20of%20KS%20before%5C%2Fat%20or%20after%20ART%20initiation%20and%20of%20mortality%20after%20KS%20were%20examined%20using%20Cox%20regression.%5CnRESULTS%3A%20Of%2025%5Cu00a0981%20PWH%2C%20481%20had%20incident%20KS%2C%20including%20200%20ART-na%5Cu00efve%20and%20281%20ART-treated%20patients.%20From%202000%20to%202017%2C%20the%20incidence%20of%20KS%20decreased%20from%2055.1%20to%203.0%20per%201000%20person-years.%20In%20models%20adjusting%20for%20CD4%20and%20other%20factors%2C%20the%20relative%20risk%20for%20KS%20decreased%20from%202000%20to%202008.%20Since%202010%2C%20the%20adjusted%20risk%20of%20KS%20increased%20in%20the%20periods%20before%20and%20%5Cu226490%5Cu00a0days%20after%20ART%20initiation%20but%20decreased%20%3E90%5Cu00a0days%20after%20ART.%20In%20addition%20to%20low%20CD4%20and%20male-to-male%20sex%2C%20KS%20risk%20after%20ART%20was%20associated%20with%20age%20and%20history%20of%20other%20AIDS-defining%20illnesses.%20Mortality%20after%20KS%20%28approximately%2025%25%20after%20five%20years%29%20was%20not%20associated%20with%20either%20year%20of%20KS%20diagnosis%20nor%20timing%20of%20diagnosis%20relative%20to%20ART%20initiation.%5CnCONCLUSIONS%3A%20KS%20incidence%20in%20Latin%20America%20has%20remained%20stable%20in%20recent%20years%20and%20risk%20is%20highest%20before%20and%20shortly%20after%20ART%20initiation.%20Early%20diagnosis%20of%20HIV%20and%20ART%20initiation%20remain%20critical%20priorities%20in%20the%20region.%22%2C%22date%22%3A%222021-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25658%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A06%3A16Z%22%7D%7D%2C%7B%22key%22%3A%223EGF6982%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pereira%20et%20al.%22%2C%22parsedDate%22%3A%222021-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPereira%20GFM%2C%20Kim%20A%2C%20Jalil%20EM%2C%20Fernandes%20Fonseca%20F%2C%20Shepherd%20BE%2C%20Veloso%20VG%2C%20et%20al.%20Dolutegravir%20and%20pregnancy%20outcomes%20in%20women%20on%20antiretroviral%20therapy%20in%20Brazil%3A%20a%20retrospective%20national%20cohort%20study.%20Lancet%20HIV.%202021%20Jan%3B8%281%29%3Ae33%26%23x2013%3B41.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D3EGF6982%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dolutegravir%20and%20pregnancy%20outcomes%20in%20women%20on%20antiretroviral%20therapy%20in%20Brazil%3A%20a%20retrospective%20national%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerson%20Fernando%20Mendes%22%2C%22lastName%22%3A%22Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%20M.%22%2C%22lastName%22%3A%22Jalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Fernandes%20Fonseca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Rick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Cristina%22%2C%22lastName%22%3A%22Pimenta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Beber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renato%20Girade%22%2C%22lastName%22%3A%22Corr%5Cu00eaa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renato%22%2C%22lastName%22%3A%22Lima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adele%22%2C%22lastName%22%3A%22Schwartz%20Benzaken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22National%20Cohort%20Study%20of%20Dolutegravir%20and%20Pregnancy%20Outcomes%20in%20Brazil%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Dolutegravir%20has%20been%20widely%20available%20in%20Brazil%20since%202017.%20Following%20the%20signal%20that%20infants%20born%20to%20women%20with%20dolutegravir%20exposure%20at%20conception%20in%20Botswana%20had%20a%20higher%20risk%20of%20neural%20tube%20defects%20%28NTDs%29%2C%20public%20health%20leaders%20initiated%20a%20national%20investigation%20to%20evaluate%20periconception%20dolutegravir%20exposure%20among%20all%20pregnant%20Brazilian%20women%20with%20HIV%20and%20its%20potential%20association%20with%20risk%20of%20NTDs%2C%20stillbirth%2C%20or%20miscarriage%20before%2022%20weeks%20%28also%20called%20spontaneous%20abortion%29.%5CnMETHODS%3A%20In%20this%20retrospective%2C%20observational%2C%20national%2C%20cohort%20study%2C%20we%20identified%20all%20women%20with%20pregnancies%20and%20possible%20dolutegravir%20exposure%20within%208%20weeks%20of%20estimated%20date%20of%20conception%20between%20Jan%201%2C%202017%2C%20and%20May%2031%2C%202018%2C%20and%20approximately%203%3A1%20matched%20pregnant%20women%20exposed%20to%20efavirenz%20between%20Jan%201%2C%202015%2C%20and%20May%2031%2C%202018%2C%20using%20the%20Brazilian%20antiretroviral%20therapy%20database.%20We%20did%20detailed%20chart%20reviews%20for%20identified%20women.%20The%20primary%20outcomes%20were%20NTD%20and%20a%20composite%20measure%20of%20NTD%2C%20stillbirth%2C%20or%20miscarriage.%20NTD%20incidences%20were%20calculated%20with%2095%25%20CI.%20The%20composite%20outcome%20was%20examined%20with%20logistic%20regression%20using%20propensity%20score%20matching%20weights%20to%20balance%20confounders.%5CnFINDINGS%3A%20Of%201427%20included%20women%2C%20382%20were%20exposed%20to%20dolutegravir%20within%208%20weeks%20of%20estimated%20date%20of%20conception.%20During%20pregnancy%2C%20183%20%2848%25%29%20of%20382%20dolutegravir-exposed%20and%20465%20%2844%25%29%20of%201045%20efavirenz-exposed%20women%20received%20folic%20acid%20supplementation.%20There%20were%201452%20birth%20outcomes.%20There%20were%20no%20NTDs%20in%20either%20dolutegravir-exposed%20%280%2C%2095%25%20CI%200-0%5Cu00b70010%29%20or%20efavirenz-exposed%20groups%20%280%2C%2095%25%20CI%200-0%5Cu00b70036%29.%20There%20were%2023%20%286%25%29%20stillbirths%20or%20miscarriages%20in%20384%20dolutegravir-exposed%20fetuses%20and%2028%20%283%25%29%20in%20the%201068%20efavirenz-exposed%20fetuses%20%28p%3D0%5Cu00b70037%29.%20Logistic%20regression%20models%20did%20not%20consistently%20indicate%20an%20association%20between%20dolutegravir%20exposure%20and%20risk%20of%20stillbirths%20or%20miscarriages.%20After%20study%20closure%2C%20two%20confirmed%20NTD%20outcomes%20in%20fetuses%20with%20periconception%20dolutegravir%20exposure%20were%20reported%20to%20public%20health%20officials.%20An%20updated%20estimate%20of%20NTD%20incidence%20incorporating%20these%20cases%20and%20the%20estimated%20number%20of%20additional%20dolutegravir-exposed%20pregnancies%20between%20Jan%201%2C%202015%20and%20Feb%2028%2C%202019%2C%20is%200%5Cu00b70018%20%2895%25%20CI%200%5Cu00b70005-0%5Cu00b70067%29.%5CnINTERPRETATION%3A%20Neither%20dolutegravir%20nor%20efavirenz%20exposure%20was%20associated%20with%20NTDs%20in%20our%20national%20cohort%3B%20incidence%20of%20NTDs%20is%20probably%20well%20under%201%25%20in%20dolutegravir-exposed%20HIV-positive%20women%20but%20still%20slightly%20above%20HIV-uninfected%20women%20%280%5Cu00b706%25%29%20in%20Brazil.%5CnFUNDING%3A%20The%20Brazilian%20Ministry%20of%20Health%20and%20the%20United%20States%27%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%222021-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2820%2930268-X%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A05%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22HK5SS97G%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriaga%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EArriaga%20MB%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Barreto-Duarte%20B%2C%20Sales%20C%2C%20Miguez-Pinto%20JP%2C%20Nogueira%20EB%2C%20et%20al.%20Prevalence%20and%20Clinical%20Profiling%20of%20Dysglycemia%20and%20HIV%20Infection%20in%20Persons%20With%20Pulmonary%20Tuberculosis%20in%20Brazil.%20Front%20Med%20%28Lausanne%29.%202021%3B8%3A804173.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DHK5SS97G%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevalence%20and%20Clinical%20Profiling%20of%20Dysglycemia%20and%20HIV%20Infection%20in%20Persons%20With%20Pulmonary%20Tuberculosis%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caio%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00e3o%20Pedro%22%2C%22lastName%22%3A%22Miguez-Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evelyn%20B.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bet%5Cu00e2nia%20M.%20F.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aline%22%2C%22lastName%22%3A%22Benjamin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamile%20G.%22%2C%22lastName%22%3A%22de%20Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moreno%20M.%20S.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kristki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT-Brazil%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20There%20are%20scarce%20data%20on%20the%20prevalence%20and%20disease%20presentation%20of%20HIV%20in%20patients%20with%20tuberculosis%20%28TB%29%20and%20dysglycemia%20%28diabetes%20%5BDM%5D%20and%20prediabetes%20%5BPDM%5D%29%2C%20especially%20in%20TB-endemic%20countries.%5CnMETHODS%3A%20We%20assessed%20the%20baseline%20epidemiological%20and%20clinical%20characteristics%20of%20patients%20with%20culture-confirmed%20pulmonary%20TB%2C%20enrolled%20in%20a%20multicenter%20prospective%20cohort%20in%20Brazil%20%28RePORT-Brazil%29%20during%202015-2019.%20Dysglycemia%20was%20defined%20by%20elevated%20glycated%20hemoglobin%20and%20stratified%20as%20PDM%20or%20DM.%20Additionally%2C%20we%20used%20data%20from%20TB%20cases%20obtained%20through%20the%20Brazilian%20National%20Notifiable%20Diseases%20Information%20System%20%28SINAN%29%2C%20during%202015-2019.%20In%20SINAN%2C%20diagnosis%20of%20diabetes%20was%20based%20on%20self-report.%20Logistic%20regression%20models%20were%20performed%20to%20test%20independent%20associations%20between%20HIV%2C%20dysglycemia%20status%2C%20and%20other%20baseline%20characteristics%20in%20both%20cohorts.%5CnRESULTS%3A%20In%20the%20RePORT-Brazil%20cohort%2C%20the%20prevalence%20of%20DM%20and%20of%20PDM%20was%2023.7%20and%2037.8%25%2C%20respectively.%20Furthermore%2C%20the%20prevalence%20of%20HIV%20was%2021.4%25%20in%20the%20group%20of%20persons%20with%20TB-dysglycemia%20and%2020.5%25%20in%20that%20of%20patients%20with%20TBDM.%20In%20the%20SINAN%20cohort%2C%20the%20prevalence%20of%20DM%20was%209.2%25%2C%20and%20among%20the%20TBDM%20group%20the%20prevalence%20of%20HIV%20was%204.1%25.%20Logistic%20regressions%20demonstrated%20that%20aging%20was%20independently%20associated%20with%20PDM%20or%20DM%20in%20both%20the%20RePORT-Brazil%20and%20SINAN%20cohorts.%20In%20RePORT-Brazil%2C%20illicit%20drug%20use%20was%20associated%20with%20PDM%2C%20whereas%20a%20higher%20body%20mass%20index%20%28BMI%29%20was%20associated%20with%20DM%20occurrence.%20Of%20note%2C%20HIV%20was%20not%20associated%20with%20an%20increased%20risk%20of%20PDM%20or%20DM%20in%20patients%20with%20pulmonary%20TB%20in%20both%20cohorts.%20Moreover%2C%20in%20both%20cohorts%2C%20the%20TBDM-HIV%20group%20presented%20with%20a%20lower%20proportion%20of%20positive%20sputum%20smear%20and%20a%20higher%20frequency%20of%20tobacco%20and%20alcohol%20users.%5CnCONCLUSION%3A%20There%20is%20a%20high%20prevalence%20of%20dysglycemia%20in%20patients%20with%20pulmonary%20TB%20in%20Brazil%2C%20regardless%20of%20the%20HIV%20status.%20This%20reinforces%20the%20idea%20that%20DM%20should%20be%20systematically%20screened%20in%20persons%20with%20TB.%20Presence%20of%20HIV%20does%20not%20substantially%20impact%20clinical%20presentation%20in%20persons%20with%20TBDM%2C%20although%20it%20is%20associated%20with%20more%20frequent%20use%20of%20recreational%20drugs%20and%20smear%20negative%20sputum%20samples%20during%20TB%20screening.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffmed.2021.804173%22%2C%22ISSN%22%3A%222296-858X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A17%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22QTJUW8B4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carvalho%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECarvalho%20ACC%2C%20Amorim%20G%2C%20Melo%20MGM%2C%20Silveira%20AKA%2C%20Vargas%20PHL%2C%20Moreira%20ASR%2C%20et%20al.%20Pre-Treatment%20Neutrophil%20Count%20as%20a%20Predictor%20of%20Antituberculosis%20Therapy%20Outcomes%3A%20A%20Multicenter%20Prospective%20Cohort%20Study.%20Front%20Immunol.%202021%3B12%3A661934.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DQTJUW8B4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pre-Treatment%20Neutrophil%20Count%20as%20a%20Predictor%20of%20Antituberculosis%20Therapy%20Outcomes%3A%20A%20Multicenter%20Prospective%20Cohort%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Cristina%20C.%22%2C%22lastName%22%3A%22Carvalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%22%2C%22lastName%22%3A%22Amorim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayla%20G.%20M.%22%2C%22lastName%22%3A%22Melo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Karla%20A.%22%2C%22lastName%22%3A%22Silveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%20H.%20L.%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Rocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20R.%22%2C%22lastName%22%3A%22Lapa-E-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisangela%20C.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Neutrophils%20have%20been%20associated%20with%20lung%20tissue%20damage%20in%20many%20diseases%2C%20including%20tuberculosis%20%28TB%29.%20Whether%20neutrophil%20count%20can%20serve%20as%20a%20predictor%20of%20adverse%20treatment%20outcomes%20is%20unknown.%5CnMETHODS%3A%20We%20prospectively%20assessed%20936%20patients%20%28172%20HIV-seropositive%29%20with%20culture-confirmed%20pulmonary%20TB%2C%20enrolled%20in%20a%20multicenter%20prospective%20cohort%20study%20from%20different%20regions%20in%20Brazil%2C%20from%20June%202015%20to%20June%202019%2C%20and%20were%20followed%20up%20to%20two%20years.%20TB%20patients%20had%20a%20baseline%20visit%20before%20treatment%20%28month%200%29%20and%20visits%20at%20month%202%20and%206%20%28or%20at%20the%20end%20of%20TB%20treatment%29.%20Smear%20microscopy%2C%20and%20culture%20for%20Mycobacterium%20tuberculosis%20%28MTB%29%20were%20performed%20at%20TB%20diagnosis%20and%20during%20follow-up.%20Complete%20blood%20counts%20were%20measured%20at%20baseline.%20Treatment%20outcome%20was%20defined%20as%20either%20unfavorable%20%28death%2C%20treatment%20failure%20or%20TB%20recurrence%29%20or%20favorable%20%28cure%20or%20treatment%20completion%29.%20We%20performed%20multivariable%20logistic%20regression%2C%20with%20propensity%20score%20regression%20adjustment%2C%20to%20estimate%20the%20association%20between%20neutrophil%20count%20with%20MTB%20culture%20result%20at%20month%202%20and%20unfavorable%20treatment%20outcome.%20We%20used%20a%20propensity%20score%20adjustment%20instead%20of%20a%20fully%20adjusted%20regression%20model%20due%20to%20the%20relatively%20low%20number%20of%20outcomes.%5CnRESULTS%3A%20Among%20682%20patients%20who%20had%20MTB%20culture%20results%20at%20month%202%2C%2040%20%285.9%25%29%20had%20a%20positive%20result.%20After%20regression%20with%20propensity%20score%20adjustment%2C%20no%20significant%20association%20between%20baseline%20neutrophil%20count%20%28103%5C%2Fmm3%29%20and%20positive%20MTB%20culture%20at%20month%202%20was%20found%20among%20either%20HIV-seronegative%20%28OR%20%3D%201.06%2C%2095%25%20CI%20%3D%20%5B0.95%3B1.19%5D%20or%20HIV-seropositive%20patients%20%28OR%20%3D%200.77%2C%2095%25%20CI%20%3D%20%5B0.51%3B%201.20%5D%29.%20Of%20691%20TB%20patients%20followed%20up%20for%20at%20least%2018%20months%20and%20up%20to%2024%20months%2C%20635%20%2891.9%25%29%20were%20either%20cured%20or%20completed%20treatment%2C%20and%2056%20%288.1%25%29%20had%20an%20unfavorable%20treatment%20outcome.%20A%20multivariable%20regression%20with%20propensity%20score%20adjustment%20found%20an%20association%20between%20higher%20neutrophil%20count%20%28103%5C%2Fmm3%29%20at%20baseline%20and%20unfavorable%20outcome%20among%20HIV-seronegative%20patients%20%5BOR%3D%201.17%20%2895%25%20CI%3D%20%5B1.06%3B1.30%5D%29.%20In%20addition%2C%20adjusted%20Cox%20regression%20found%20that%20higher%20baseline%20neutrophil%20count%20%28103%5C%2Fmm3%29%20was%20associated%20with%20unfavorable%20treatment%20outcomes%20overall%20and%20among%20HIV-seronegative%20patients%20%28HR%3D%201.16%20%2895%25%20CI%20%3D%20%5B1.05%3B1.27%5D%29.%5CnCONCLUSION%3A%20Increased%20neutrophil%20count%20prior%20to%20anti-TB%20treatment%20initiation%20was%20associated%20with%20unfavorable%20treatment%20outcomes%2C%20particularly%20among%20HIV-seronegative%20patients.%20Further%20prospective%20studies%20evaluating%20neutrophil%20count%20in%20response%20to%20drug%20treatment%20and%20association%20with%20TB%20treatment%20outcomes%20are%20warranted.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2021.661934%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A11%3A40Z%22%7D%7D%5D%7D
1.
Costa AG, Carvalho BKS, Araújo-Pereira M, Ibiapina HNS, Spener-Gomes R, Souza AB, et al. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. Microbiol Spectr. 2021 Dec 22;9(3):e0116321. Cite
1.
Arriaga MB, Rocha MS, Nogueira BMF, Nascimento V, Araújo-Pereira M, Souza AB, et al. The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts. J Infect Dis. 2021 Dec 15;224(12):2064–72. Cite
1.
Han WM, Law MG, Egger M, Wools-Kaloustian K, Moore R, McGowan C, et al. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. Lancet HIV. 2021 Dec;8(12):e766–75. Cite
1.
McMahon DE, Semeere A, Laker-Oketta M, Byakwaga H, Mugglin C, Duda SN, et al. Global Disparities in Skin Cancer Services at HIV Treatment Centers across 29 Countries. J Invest Dermatol. 2021 Oct;141(10):2533-2536.e2. Cite
1.
Brazier E, Tymejczyk O, Zaniewski E, Egger M, Wools-Kaloustian K, Yiannoutsos CT, et al. Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis. Clin Infect Dis. 2021 Sep 15;73(6):e1273–81. Cite
1.
Souza AB, Arriaga MB, Amorim G, Araújo-Pereira M, Nogueira BMF, Queiroz ATL, et al. Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. BMJ Glob Health. 2021 Sep;6(9):e005969. Cite
1.
Johnson LF, Kariminia A, Trickey A, Yiannoutsos CT, Ekouevi DK, Minga AK, et al. Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. J Int AIDS Soc. 2021 Sep;24 Suppl 5(Suppl 5):e25776. Cite
1.
Kassanjee R, Johnson LF, Zaniewski E, Ballif M, Christ B, Yiannoutsos CT, et al. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. J Int AIDS Soc. 2021 Sep;24 Suppl 5(Suppl 5):e25780. Cite
1.
Somerville K, Jenkins CA, Carlucci JG, Person AK, Machado DM, Luque MT, et al. Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America. J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):993–1001. Cite
1.
Zürcher K, Reichmuth ML, Ballif M, Loiseau C, Borrell S, Reinhard M, et al. Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe. 2021 Jul;2(7):e320–30. Cite
1.
Joseph Y, Yao Z, Dua A, Severe P, Collins SE, Bang H, et al. Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti. J Int AIDS Soc. 2021 Jul;24(7):e25721. Cite
1.
Oh EJ, Shepherd BE, Lumley T, Shaw PA. Improved generalized raking estimators to address dependent covariate and failure-time outcome error. Biom J. 2021 Jun;63(5):1006–27. Cite
1.
Chiao EY, Coghill A, Kizub D, Fink V, Ndlovu N, Mazul A, et al. The effect of non-AIDS-defining cancers on people living with HIV. Lancet Oncol. 2021 Jun;22(6):e240–53. Cite
1.
Tsondai PR, Davies MA, Singtoroj T, Maxwell N, McGowan CC, Songtaweesin WN, et al. Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. Pediatr Infect Dis J. 2021 May 1;40(5):453–6. Cite
1.
Yohannes NT, Jenkins CA, Clouse K, Cortés CP, Mejía Cordero F, Padgett D, et al. Timing of HIV diagnosis relative to pregnancy and postpartum HIV care continuum outcomes among Latin American women, 2000 to 2017. J Int AIDS Soc. 2021 May;24(5):e25740. Cite
1.
Smiley CL, Rebeiro PF, Cesar C, Belaunzaran-Zamudio PF, Crabtree-Ramirez B, Padgett D, et al. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study. Lancet HIV. 2021 May;8(5):e266–73. Cite
1.
Nascimento-Carvalho GC, Nascimento-Carvalho EC, Ramos CL, Vilas-Boas AL, Moreno-Carvalho OA, Vinhaes CL, et al. Zika-exposed microcephalic neonates exhibit higher degree of inflammatory imbalance in cerebrospinal fluid. Sci Rep. 2021 Apr 19;11(1):8474. Cite
1.
Spener-Gomes R, Costa AG, Melo HF de, Souza AB de, Beraldi-Magalhães F, Jesus JS, et al. Examination of respiratory specimens improves microbiological diagnosis of patients with presumptive extrapulmonary tuberculosis. Int J Infect Dis. 2021 Apr;105:743–5. Cite
1.
Peetluk LS, Ridolfi FM, Rebeiro PF, Liu D, Rolla VC, Sterling TR. Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults. BMJ Open. 2021 Mar 2;11(3):e044687. Cite
1.
Rodrigues A, Struchiner CJ, Coelho LE, Veloso VG, Grinsztejn B, Luz PM. Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment. BMC Public Health. 2021 Feb 19;21(1):389. Cite
1.
Oh EJ, Shepherd BE, Lumley T, Shaw PA. Raking and regression calibration: Methods to address bias from correlated covariate and time-to-event error. Stat Med. 2021 Feb 10;40(3):631–49. Cite
1.
Tao R, Lotspeich SC, Amorim G, Shaw PA, Shepherd BE. Efficient semiparametric inference for two-phase studies with outcome and covariate measurement errors. Stat Med. 2021 Feb 10;40(3):725–38. Cite
1.
Arriaga MB, Amorim G, Queiroz ATL, Rodrigues MMS, Araújo-Pereira M, Nogueira BMF, et al. Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil. Int J Infect Dis. 2021 Feb;103:110–8. Cite
1.
Castilho JL, Kim A, Jenkins CA, Grinsztejn B, Gotuzzo E, Fink V, et al. Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America. J Int AIDS Soc. 2021 Jan;24(1):e25658. Cite
1.
Pereira GFM, Kim A, Jalil EM, Fernandes Fonseca F, Shepherd BE, Veloso VG, et al. Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study. Lancet HIV. 2021 Jan;8(1):e33–41. Cite
1.
Arriaga MB, Araújo-Pereira M, Barreto-Duarte B, Sales C, Miguez-Pinto JP, Nogueira EB, et al. Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in Brazil. Front Med (Lausanne). 2021;8:804173. Cite
1.
Carvalho ACC, Amorim G, Melo MGM, Silveira AKA, Vargas PHL, Moreira ASR, et al. Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. Front Immunol. 2021;12:661934. Cite
2020
76770
IP6F4TRX
2020
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-f12699acc3942de2ccd93090e3ff3f27%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%224UMMEW8L%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Giganti%20and%20Shepherd%22%2C%22parsedDate%22%3A%222020-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiganti%20MJ%2C%20Shepherd%20BE.%20Multiple-Imputation%20Variance%20Estimation%20in%20Studies%20With%20Missing%20or%20Misclassified%20Inclusion%20Criteria.%20Am%20J%20Epidemiol.%202020%20Dec%201%3B189%2812%29%3A1628%26%23x2013%3B32.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D4UMMEW8L%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiple-Imputation%20Variance%20Estimation%20in%20Studies%20With%20Missing%20or%20Misclassified%20Inclusion%20Criteria%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22In%20observational%20studies%20using%20routinely%20collected%20data%2C%20a%20variable%20with%20a%20high%20level%20of%20missingness%20or%20misclassification%20may%20determine%20whether%20an%20observation%20is%20included%20in%20the%20analysis.%20In%20settings%20where%20inclusion%20criteria%20are%20assessed%20after%20imputation%2C%20the%20popular%20multiple-imputation%20variance%20estimator%20proposed%20by%20Rubin%20%28%5C%22Rubin%27s%20rules%5C%22%20%28RR%29%29%20is%20biased%20due%20to%20incompatibility%20between%20imputation%20and%20analysis%20models.%20While%20alternative%20approaches%20exist%2C%20most%20analysts%20are%20not%20familiar%20with%20them.%20Using%20partially%20validated%20data%20from%20a%20human%20immunodeficiency%20virus%20cohort%2C%20we%20illustrate%20the%20calculation%20of%20an%20imputation%20variance%20estimator%20proposed%20by%20Robins%20and%20Wang%20%28RW%29%20in%20a%20scenario%20where%20the%20study%20exclusion%20criteria%20are%20based%20on%20a%20variable%20that%20must%20be%20imputed.%20In%20this%20motivating%20example%2C%20the%20corresponding%20imputation%20variance%20estimate%20for%20the%20log%20odds%20was%2029%25%20smaller%20using%20the%20RW%20estimator%20than%20using%20the%20RR%20estimator.%20We%20further%20compared%20these%202%20variance%20estimators%20with%20a%20simulation%20study%20which%20showed%20that%20coverage%20probabilities%20of%2095%25%20confidence%20intervals%20based%20on%20the%20RR%20estimator%20were%20too%20high%20and%20became%20worse%20as%20more%20observations%20were%20imputed%20and%20more%20subjects%20were%20excluded%20from%20the%20analysis.%20The%20RW%20imputation%20variance%20estimator%20performed%20much%20better%20and%20should%20be%20employed%20when%20there%20is%20incompatibility%20between%20imputation%20and%20analysis%20models.%20We%20provide%20analysis%20code%20to%20aid%20future%20analysts%20in%20implementing%20this%20method.%22%2C%22date%22%3A%222020-12-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Faje%5C%2Fkwaa153%22%2C%22ISSN%22%3A%221476-6256%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A04%3A41Z%22%7D%7D%2C%7B%22key%22%3A%223MI446PI%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reichmuth%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EReichmuth%20ML%2C%20H%26%23xF6%3Bmke%20R%2C%20Z%26%23xFC%3Brcher%20K%2C%20Sander%20P%2C%20Avihingsanon%20A%2C%20Collantes%20J%2C%20et%20al.%20Natural%20Polymorphisms%20in%20Mycobacterium%20tuberculosis%20Conferring%20Resistance%20to%20Delamanid%20in%20Drug-Naive%20Patients.%20Antimicrob%20Agents%20Chemother.%202020%20Oct%2020%3B64%2811%29%3Ae00513-20.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D3MI446PI%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Natural%20Polymorphisms%20in%20Mycobacterium%20tuberculosis%20Conferring%20Resistance%20to%20Delamanid%20in%20Drug-Naive%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%20L.%22%2C%22lastName%22%3A%22Reichmuth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rico%22%2C%22lastName%22%3A%22H%5Cu00f6mke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Z%5Cu00fcrcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Collantes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Loiseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Borrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Reinhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Wilkinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20M.%22%2C%22lastName%22%3A%22Keller%22%7D%5D%2C%22abstractNote%22%3A%22Mutations%20in%20the%20genes%20of%20the%20F420%20signaling%20pathway%20of%20Mycobacterium%20tuberculosis%20complex%2C%20including%20dnn%2C%20fgd1%2C%20fbiA%2C%20fbiB%2C%20fbiC%2C%20and%20fbiD%2C%20can%20lead%20to%20delamanid%20resistance.%20We%20searched%20for%20such%20mutations%20among%20129%20M.%20tuberculosis%20strains%20from%20Asia%2C%20South%20America%2C%20and%20Africa%20using%20whole-genome%20sequencing%3B%2070%20%2854%25%29%20strains%20had%20at%20least%20one%20mutation%20in%20one%20of%20the%20genes.%20For%2010%20strains%20with%20mutations%2C%20we%20determined%20the%20MIC%20of%20delamanid.%20We%20found%20one%20strain%20from%20a%20delamanid-naive%20patient%20carrying%20the%20natural%20polymorphism%20Tyr29del%20%28ddn%29%20that%20was%20associated%20with%20a%20critical%20delamanid%20MIC.%22%2C%22date%22%3A%222020-10-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00513-20%22%2C%22ISSN%22%3A%221098-6596%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A04%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22FFXWGDNJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rebeiro%20et%20al.%22%2C%22parsedDate%22%3A%222020-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERebeiro%20PF%2C%20Duda%20SN%2C%20Wools-Kaloustian%20KK%2C%20Nash%20D%2C%20Althoff%20KN%2C%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%20Implications%20of%20COVID-19%20for%20HIV%20Research%3A%20data%20sources%2C%20indicators%20and%20longitudinal%20analyses.%20J%20Int%20AIDS%20Soc.%202020%20Oct%3B23%2810%29%3Ae25627.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DFFXWGDNJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Implications%20of%20COVID-19%20for%20HIV%20Research%3A%20data%20sources%2C%20indicators%20and%20longitudinal%20analyses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25627%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A04%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22DCF4JDC5%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Desmonde%20et%20al.%22%2C%22parsedDate%22%3A%222020-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDesmonde%20S%2C%20Neilan%20AM%2C%20Musick%20B%2C%20Patten%20G%2C%20Chokephaibulkit%20K%2C%20Edmonds%20A%2C%20et%20al.%20Time-varying%20age-%20and%20CD4-stratified%20rates%20of%20mortality%20and%20WHO%20stage%203%20and%20stage%204%20events%20in%20children%2C%20adolescents%20and%20youth%200%20to%2024%20years%20living%20with%20perinatally%20acquired%20HIV%2C%20before%20and%20after%20antiretroviral%20therapy%20initiation%20in%20the%20paediatric%20IeDEA%20Global%20Cohort%20Consortium.%20J%20Int%20AIDS%20Soc.%202020%20Oct%3B23%2810%29%3Ae25617.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DDCF4JDC5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Time-varying%20age-%20and%20CD4-stratified%20rates%20of%20mortality%20and%20WHO%20stage%203%20and%20stage%204%20events%20in%20children%2C%20adolescents%20and%20youth%200%20to%2024%20years%20living%20with%20perinatally%20acquired%20HIV%2C%20before%20and%20after%20antiretroviral%20therapy%20initiation%20in%20the%20paediatric%20IeDEA%20Global%20Cohort%20Consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20M.%22%2C%22lastName%22%3A%22Neilan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Patten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kulkanya%22%2C%22lastName%22%3A%22Chokephaibulkit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20L.%22%2C%22lastName%22%3A%22Ciaranello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Evaluating%20outcomes%20of%20paediatric%20patients%20with%20HIV%20provides%20crucial%20data%20for%20clinicians%20and%20policymakers.%20We%20analysed%20mortality%20and%20clinical%20events%20rates%20among%20children%2C%20adolescents%2C%20and%20youth%20with%20perinatally%20acquired%20HIV%20%28PHIV%29%20aged%200%20to%2024%5Cu00a0years%20stratified%20by%20time-varying%20age%20and%20CD4%2C%20before%20and%20after%20antiretroviral%20therapy%20%28ART%29%2C%20in%20the%20paediatric%20IeDEA%20multiregional%20collaboration%20%28East%2C%20West%2C%20Central%20and%20Southern%20Africa%2C%20Asia-Pacific%2C%20and%20Central%5C%2FSouth%20America%20and%20the%20Caribbean%29.%5CnMETHODS%3A%20ART-na%5Cu00efve%20children%20with%20HIV%20enrolled%20before%20age%2010%20%28proxy%20for%20perinatal%20infection%29%20at%20IeDEA%20sites%20between%202004%20and%202016%2C%20with%20%5Cu22651%20CD4%20measurement%20during%20follow-up%20were%20included.%20We%20estimated%20incidence%20rates%20%28IR%29%20and%2095%25%20confidence%20intervals%20%2895%25%20CI%29%20of%20mortality%20and%20first%20occurrence%20of%20WHO-4%20and%20WHO-3%20events%2C%20excluding%20tuberculosis%2C%20during%20person-years%20%28PY%29%20spent%20within%20different%20age%20%28%3C2%2C%202%20to%204%2C%205%20to%209%2C%2010%20to%2014%2C%2015%20to%2019%2C%2020%20to%2024%29%20and%20CD4%20%28percent%20when%20%3C5%5Cu00a0years%20%5B%3C15%25%2C%2015%25%20to%2024%25%2C%20%5Cu226525%25%5D%3B%20count%20when%20%5Cu22655%5Cu00a0years%20%5B%3C200%2C%20200%20to%20499%2C%20%5Cu2265500%5Cu00a0cells%5C%2F%5Cu00b5L%5D%29%20strata.%20We%20used%20linear%20mixed%20models%20to%20predict%20CD4%20evolution%2C%20with%20trends%20modelled%20by%20region.%5CnRESULTS%3A%20In%20the%20pre-ART%20period%2C%2049%5Cu00a0137%20participants%20contributed%2051%5Cu00a0966%5Cu00a0PY%20of%20follow-up%20%28median%20enrolment%20age%3A%203.9%5Cu00a0years%29.%20The%20overall%20pre-ART%20IRs%20were%202.8%5C%2F100%5Cu00a0PY%20%2895%25%20CI%3A%202.7%20to%202.9%29%20for%20mortality%2C%203.3%5C%2F100%5Cu00a0PY%20%2895%25%20CI%3A%203.0%20to%203.5%29%20for%20first%20occurrence%20of%20a%20WHO-4%20event%2C%20and%207.0%5C%2F100%5Cu00a0PY%20%2895%25%20CI%3A%206.7%20to%207.4%29%20for%20first%20occurrence%20of%20a%20WHO-3%20event.%20Lower%20CD4%20and%20younger%20age%20strata%20were%20associated%20with%20increased%20rates%20of%20both%20mortality%20and%20first%20occurrence%20of%20a%20clinical%20event.%20In%20the%20post-ART%20period%2C%2052%5Cu00a0147%20PHIVY%20contributed%20207%5Cu00a0945%20PY%20%28ART%20initiation%20median%20age%3A%204.5%5Cu00a0years%29.%20Overall%20mortality%20IR%20was%201.4%5C%2F100%5Cu00a0PY%20%2895%25%20CI%3A%201.4%20to%201.5%29%20and%20higher%20in%20low%20CD4%20strata%3B%20patients%20at%20each%20end%20of%20the%20age%20spectrum%20%28%3C2%20and%20%3E19%29%20had%20increased%20mortality%20post-ART.%20IRs%20for%20first%20occurrence%20of%20WHO-4%20and%20WHO-3%20events%20were%201.3%5C%2F100%5Cu00a0PY%20%2895%25%20CI%3A%201.2%20to%201.4%29%20and%202.1%5C%2F100%5Cu00a0PY%20%2895%25%20CI%3A%202.0%20to%202.2%29%20respectively.%20These%20were%20also%20associated%20with%20lower%20CD4%20and%20younger%20age%20strata.%5CnCONCLUSIONS%3A%20Mortality%20and%20incidence%20of%20clinical%20events%20were%20highest%20in%20both%20younger%20%28%3C2%5Cu00a0years%29%20and%20older%20%28%3E19%5Cu00a0years%29%20youth%20with%20PHIV.%20Scaling-up%20services%20for%20%3C2%5Cu00a0years%20%28early%20access%20to%20HIV%20diagnosis%20and%20care%29%20and%20%3E19%5Cu00a0years%20%28adolescent-%20and%20youth-focused%20health%20services%29%20is%20critical%20to%20improve%20outcomes%20among%20PHIVY.%22%2C%22date%22%3A%222020-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25617%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A01%3A08Z%22%7D%7D%2C%7B%22key%22%3A%228935IIPV%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Loiseau%20et%20al.%22%2C%22parsedDate%22%3A%222020-09-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELoiseau%20C%2C%20Brites%20D%2C%20Reinhard%20M%2C%20Z%26%23xFC%3Brcher%20K%2C%20Borrell%20S%2C%20Ballif%20M%2C%20et%20al.%20HIV%20Coinfection%20Is%20Associated%20with%20Low-Fitness%20rpoB%20Variants%20in%20Rifampicin-Resistant%20Mycobacterium%20tuberculosis.%20Antimicrob%20Agents%20Chemother.%202020%20Sep%2021%3B64%2810%29%3Ae00782-20.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D8935IIPV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20Coinfection%20Is%20Associated%20with%20Low-Fitness%20rpoB%20Variants%20in%20Rifampicin-Resistant%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Loiseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Brites%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Reinhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Z%5Cu00fcrcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Borrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliana%20K.%22%2C%22lastName%22%3A%22Rutaihwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Wilkinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jane%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alash%27le%22%2C%22lastName%22%3A%22Abimiku%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Zetola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basra%22%2C%22lastName%22%3A%22Doulla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%5D%2C%22abstractNote%22%3A%22We%20analyzed%20312%20drug-resistant%20genomes%20of%20Mycobacterium%20tuberculosis%20isolates%20collected%20from%20HIV-coinfected%20and%20HIV-negative%20TB%20patients%20from%20nine%20countries%20with%20a%20high%20tuberculosis%20burden.%20We%20found%20that%20rifampicin-resistant%20M.%20tuberculosis%20strains%20isolated%20from%20HIV-coinfected%20patients%20carried%20disproportionally%20more%20resistance-conferring%20mutations%20in%20rpoB%20that%20are%20associated%20with%20a%20low%20fitness%20in%20the%20absence%20of%20the%20drug%2C%20suggesting%20these%20low-fitness%20rpoB%20variants%20can%20thrive%20in%20the%20context%20of%20reduced%20host%20immunity.%22%2C%22date%22%3A%222020-09-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00782-20%22%2C%22ISSN%22%3A%221098-6596%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A03%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22LF3CD2MW%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shepherd%20and%20Shaw%22%2C%22parsedDate%22%3A%222020-09-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShepherd%20BE%2C%20Shaw%20PA.%20Errors%20in%20multiple%20variables%20in%20human%20immunodeficiency%20virus%20%28HIV%29%20cohort%20and%20electronic%20health%20record%20data%3A%20statistical%20challenges%20and%20opportunities.%20Stat%20Commun%20Infect%20Dis.%202020%20Sep%201%3B12%28Suppl1%29%3A20190015.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DLF3CD2MW%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Errors%20in%20multiple%20variables%20in%20human%20immunodeficiency%20virus%20%28HIV%29%20cohort%20and%20electronic%20health%20record%20data%3A%20statistical%20challenges%20and%20opportunities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%3A%20Observational%20data%20derived%20from%20patient%20electronic%20health%20records%20%28EHR%29%20data%20are%20increasingly%20used%20for%20human%20immunodeficiency%20virus%5C%2Facquired%20immunodeficiency%20syndrome%20%28HIV%5C%2FAIDS%29%20research.%20There%20are%20challenges%20to%20using%20these%20data%2C%20in%20particular%20with%20regards%20to%20data%20quality%3B%20some%20are%20recognized%2C%20some%20unrecognized%2C%20and%20some%20recognized%20but%20ignored.%20There%20are%20great%20opportunities%20for%20the%20statistical%20community%20to%20improve%20inference%20by%20incorporating%20validation%20subsampling%20into%20analyses%20of%20EHR%20data.Methods%3A%20Methods%20to%20address%20measurement%20error%2C%20misclassification%2C%20and%20missing%20data%20are%20relevant%2C%20as%20are%20sampling%20designs%20such%20as%20two-phase%20sampling.%20However%2C%20many%20of%20the%20existing%20statistical%20methods%20for%20measurement%20error%2C%20for%20example%2C%20only%20address%20relatively%20simple%20settings%2C%20whereas%20the%20errors%20seen%20in%20these%20datasets%20span%20multiple%20variables%20%28both%20predictors%20and%20outcomes%29%2C%20are%20correlated%2C%20and%20even%20affect%20who%20is%20included%20in%20the%20study.Results%5C%2FConclusion%3A%20We%20will%20discuss%20some%20preliminary%20methods%20in%20this%20area%20with%20a%20particular%20focus%20on%20time-to-event%20outcomes%20and%20outline%20areas%20of%20future%20research.%22%2C%22date%22%3A%222020-09-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1515%5C%2Fscid-2019-0015%22%2C%22ISSN%22%3A%222194-6310%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A05%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22TSFYJ5TX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-25%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20SN%2C%20Musick%20BS%2C%20Davies%20MA%2C%20Sohn%20AH%2C%20Ledergerber%20B%2C%20Wools-Kaloustian%20K%2C%20et%20al.%20The%20IeDEA%20Data%20Exchange%20Standard%3A%20a%20common%20data%20model%20for%20global%20HIV%20cohort%20collaboration%20%5BInternet%5D.%20medRxiv%3B%202020%20%5Bcited%202023%20Jun%2016%5D.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.medrxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2020.07.22.20159921v1%27%3Ehttps%3A%5C%2F%5C%2Fwww.medrxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2020.07.22.20159921v1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DTSFYJ5TX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22The%20IeDEA%20Data%20Exchange%20Standard%3A%20a%20common%20data%20model%20for%20global%20HIV%20cohort%20collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Ledergerber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%20J.%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cam%20Ha%20Dao%22%2C%22lastName%22%3A%22Ostinelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenna%20C.%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiuhu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%20L.%22%2C%22lastName%22%3A%22Goodall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%20Karsten%22%2C%22lastName%22%3A%22Kristensen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20V.%22%2C%22lastName%22%3A%22Hansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%20F.%20M.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%20T.%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%5D%2C%22abstractNote%22%3A%22Objective%20To%20describe%20content%20domains%20and%20applications%20of%20the%20IeDEA%20Data%20Exchange%20Standard%2C%20its%20development%20history%2C%20governance%20structure%2C%20and%20relationships%20to%20other%20established%20data%20models%2C%20as%20well%20as%20to%20share%20open%20source%2C%20reusable%2C%20scalable%2C%20and%20adaptable%20implementation%20tools%20with%20the%20informatics%20community.%5CnMethods%20In%202012%2C%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20collaboration%20began%20development%20of%20a%20data%20exchange%20standard%2C%20the%20IeDEA%20DES%2C%20to%20support%20collaborative%20global%20HIV%20epidemiology%20research.%20With%20the%20HIV%20Cohorts%20Data%20Exchange%20Protocol%20as%20a%20template%2C%20a%20global%20group%20of%20data%20managers%2C%20statisticians%2C%20clinicians%2C%20informaticians%2C%20and%20epidemiologists%20reviewed%20existing%20data%20schemas%20and%20clinic%20data%20procedures%20to%20develop%20the%20HIV%20data%20exchange%20model.%20The%20model%20received%20a%20substantial%20update%20in%202017%2C%20with%20annual%20updates%20thereafter.%5CnFindings%20The%20resulting%20IeDEA%20DES%20is%20a%20patient-centric%20common%20data%20model%20designed%20for%20HIV%20research%20that%20has%20been%20informed%20by%20established%20data%20models%20from%20US-based%20electronic%20health%20records%2C%20broad%20experience%20in%20data%20collection%20in%20resource-limited%20settings%2C%20and%20informatics%20best%20practices.%20The%20IeDEA%20DES%20is%20inherently%20flexible%20and%20continues%20to%20grow%20based%20on%20the%20ongoing%20stewardship%20of%20the%20IeDEA%20Data%20Harmonization%20Working%20Group%20with%20input%20from%20external%20collaborators.%20Use%20of%20the%20IeDEA%20DES%20has%20improved%20multiregional%20collaboration%20within%20and%20beyond%20IeDEA%2C%20expediting%20over%2095%20multiregional%20research%20projects%20using%20data%20from%20more%20than%20400%20HIV%20care%20and%20treatment%20sites%20across%20seven%20global%20regions.%20A%20detailed%20data%20model%20specification%20and%20REDCap%20data%20entry%20templates%20that%20implement%20the%20IeDEA%20DES%20are%20publicly%20available%20on%20GitHub.%5CnConclusions%20The%20IeDEA%20common%20data%20model%20and%20related%20resources%20are%20powerful%20tools%20to%20foster%20collaboration%20and%20accelerate%20science%20across%20research%20networks.%20While%20currently%20directed%20towards%20observational%20HIV%20research%20and%20data%20from%20resource-limited%20settings%2C%20this%20model%20is%20flexible%20and%20extendable%20to%20other%20areas%20of%20health%20research.%5CnHighlightsThe%20IeDEA%20Data%20Exchange%20Standard%20is%20a%20data%20model%20for%20HIV%20epidemiology%20research.The%20model%20has%20expedited%2095%20projects%20using%20data%20from%20%3E400%20HIV%20clinics%20worldwide.A%20browsable%20and%20adaptable%20version%20and%20data%20collection%20templates%20are%20available%20online.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222020-07-25%22%2C%22DOI%22%3A%2210.1101%5C%2F2020.07.22.20159921%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medrxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2020.07.22.20159921v1%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A01%3A49Z%22%7D%7D%2C%7B%22key%22%3A%226R8AQ3EA%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Oliveira-de-Souza%20et%20al.%22%2C%22parsedDate%22%3A%222020-07-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOliveira-de-Souza%20D%2C%20Vinhaes%20CL%2C%20Arriaga%20MB%2C%20Kumar%20NP%2C%20Queiroz%20ATL%2C%20Fukutani%20KF%2C%20et%20al.%20Aging%20increases%20the%20systemic%20molecular%20degree%20of%20inflammatory%20perturbation%20in%20patients%20with%20tuberculosis.%20Sci%20Rep.%202020%20Jul%209%3B10%281%29%3A11358.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D6R8AQ3EA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Aging%20increases%20the%20systemic%20molecular%20degree%20of%20inflammatory%20perturbation%20in%20patients%20with%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deivide%22%2C%22lastName%22%3A%22Oliveira-de-Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathella%20Pavan%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artur%20T.%20L.%22%2C%22lastName%22%3A%22Queiroz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subash%22%2C%22lastName%22%3A%22Babu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20a%20chronic%20infection%20that%20can%20affect%20individuals%20of%20all%20ages.%20The%20description%20of%20determinants%20of%20immunopathogenesis%20in%20TB%20is%20of%20tremendous%20interest%20due%20to%20the%20perspective%20of%20finding%20a%20reliable%20host-directed%20therapy%20to%20reduce%20disease%20burden.%20The%20association%20between%20specific%20biomarker%20profiles%20related%20to%20inflammation%20and%20the%20diverse%20clinical%20disease%20presentations%20in%20TB%20has%20been%20extensively%20studied%20in%20adults.%20However%2C%20relatively%20scarce%20data%20on%20profiling%20the%20inflammatory%20responses%20in%20pediatric%20TB%20are%20available.%20Here%2C%20we%20employed%20the%20molecular%20degree%20of%20perturbation%20%28MDP%29%20score%20adapted%20to%20plasma%20biomarkers%20in%20two%20distinct%20databanks%20from%20studies%20that%20examined%20either%20adults%20or%20children%20presenting%20with%20pulmonary%20or%20extrapulmonary%20disease.%20We%20used%20multidimensional%20statistical%20analyses%20to%20characterize%20the%20impact%20of%20age%20on%20the%20overall%20changes%20in%20the%20systemic%20inflammation%20profiles%20in%20subpopulation%20of%20TB%20patients.%20Our%20findings%20indicate%20that%20TB%20results%20in%20significant%20increases%20in%20molecular%20perturbation%2C%20with%20the%20highest%20values%20being%20detected%20in%20adult%20patients.%20Furthermore%2C%20there%20were%20unique%20differences%20in%20the%20biomarker%20perturbation%20patterns%20and%20the%20overall%20degree%20of%20inflammation%20according%20to%20disease%20site%20and%20age.%20Importantly%2C%20the%20molecular%20degree%20of%20perturbation%20was%20not%20influenced%20by%20sex.%20Our%20results%20revealed%20that%20aging%20is%20an%20important%20determinant%20of%20the%20differences%20in%20quality%20and%20magnitude%20of%20systemic%20inflammatory%20perturbation%20in%20distinct%20clinical%20forms%20of%20TB.%22%2C%22date%22%3A%222020-07-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-020-68255-0%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A02%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22RF3KDUC5%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Boettiger%20et%20al.%22%2C%22parsedDate%22%3A%222020-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBoettiger%20DC%2C%20Escuder%20MM%2C%20Law%20MG%2C%20Veloso%20V%2C%20Souza%20RA%2C%20Ikeda%20MLR%2C%20et%20al.%20Cardiovascular%20disease%20among%20people%20living%20with%20HIV%20in%20Brazil.%20Trop%20Med%20Int%20Health.%202020%20Jul%3B25%287%29%3A886%26%23x2013%3B96.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DRF3KDUC5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiovascular%20disease%20among%20people%20living%20with%20HIV%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C.%22%2C%22lastName%22%3A%22Boettiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Mercedes%22%2C%22lastName%22%3A%22Escuder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%20A.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20L.%20R.%22%2C%22lastName%22%3A%22Ikeda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulo%20R.%22%2C%22lastName%22%3A%22de%20Alencastro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Unai%22%2C%22lastName%22%3A%22Tupinamb%5Cu00e1s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Brites%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jackeline%20O.%22%2C%22lastName%22%3A%22Ggomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayonara%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Grangeiro%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20There%20is%20a%20paucity%20of%20data%20on%20cardiovascular%20disease%20%28CVD%29%20among%20people%20living%20with%20HIV%20%28PLHIV%29%20in%20resource-limited%20countries.%20We%20assessed%20factors%20associated%20with%20CVD%20and%20the%20impact%20of%20prevalent%20CVD%20on%20all-cause%20mortality%20in%20PLHIV%20on%20antiretroviral%20therapy%20in%20Brazil.%5CnMETHODS%3A%20Competing%20risk%20regression%20to%20assess%20factors%20associated%20with%20CVD%20and%20all-cause%20mortality%20in%20the%20HIV-Brazil%20Cohort%20Study%20between%202003%20and%202014.%5CnRESULTS%3A%20Among%205614%20patients%2C%20the%20rate%20of%20CVD%20was%203.5%20%2895%25%20confidence%20interval%20%5B95%25%20CI%5D%202.9-4.3%29%20per%201000%20person-years.%20CVD%20was%20associated%20with%20older%20age%20%28adjusted%20hazard%20ratio%20%5BaHR%5D%206.4%20for%20%5Cu226555%5Cu00a0years%20vs.%20%3C35%5Cu00a0years%2C%2095%25%20CI%3A%202.5-16.3%2C%20P%5Cu00a0%3C%5Cu00a00.01%29%2C%20black%20race%20%28aHR%201.8%20vs.%20white%20race%2C%2095%25%20CI%3A%201.0-3.1%2C%20P%5Cu00a0%3D%5Cu00a00.04%29%2C%20past%20CVD%20%28aHR%203.0%20vs.%20no%20past%20CVD%2C%2095%25%20CI%3A%201.4-6.2%2C%20P%5Cu00a0%3C%5Cu00a00.01%29%2C%20hypertension%20%28aHR%201.8%20vs.%20no%20hypertension%2C%2095%25%20CI%3A%201.0-3.1%2C%20P%5Cu00a0%3D%5Cu00a00.04%29%2C%20high-grade%20dyslipidemia%20%28aHR%209.3%20vs.%20no%20high-grade%20dyslipidemia%2C%2095%25%20CI%3A%206.0-14.6%2C%20P%5Cu00a0%3C%5Cu00a00.01%29%2C%20ever%20smoking%20%28aHR%202.4%20vs.%20never%2C%2095%25%20CI%3A%201.2-5.0%2C%20P%5Cu00a0%3D%5Cu00a00.02%29%20and%20low%20nadir%20CD4%20cell%20count%20%28aHR%201.8%20for%20100-250%5Cu00a0cells%5C%2Fmm3%20vs.%20%3E250%5Cu00a0cells%5C%2Fmm3%20%2C%2095%25%20CI%3A%201.0-3.2%2C%20P%5Cu00a0%3D%5Cu00a00.05%29.%20The%20rate%20of%20death%20was%2016.6%20%2895%25%20CI%3A%2015.1-18.3%29%20per%201000%20person-years.%20Death%20was%20strongly%20associated%20with%20having%20had%20a%20past%20CVD%20event%20%28aHR%201.7%20vs.%20no%20past%20CVD%20event%2C%2095%25%20CI%3A%201.1-2.7%2C%20P%5Cu00a0%3D%5Cu00a00.01%29.%5CnCONCLUSIONS%3A%20Traditional%20and%20HIV-specific%20factors%20associated%20with%20CVD%20among%20PLHIV%20in%20Brazil%20are%20similar%20to%20those%20identified%20among%20PLHIV%20in%20high-income%20countries.%20PLHIV%20in%20Brazil%20with%20a%20history%20of%20CVD%20have%20a%20high%20risk%20of%20death.%20CVD%20care%20and%20treatment%20remain%20priorities%20for%20PLHIV%20in%20Brazil%20as%20this%20population%20ages%20and%20antiretroviral%20therapy%20use%20expands.%22%2C%22date%22%3A%22Jul%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Ftmi.13405%22%2C%22ISSN%22%3A%221365-3156%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A11%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22N7VW7429%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Patten%20et%20al.%22%2C%22parsedDate%22%3A%222020-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPatten%20G%2C%20Puthanakit%20T%2C%20McGowan%20CC%2C%20Wools-Kaloustian%20K%2C%20Hazra%20R%2C%20Pinto%20JA%2C%20et%20al.%20Raltegravir%20use%20and%20outcomes%20among%20children%20and%20adolescents%20living%20with%20HIV%20in%20the%20IeDEA%20global%20consortium.%20J%20Int%20AIDS%20Soc.%202020%20Jul%3B23%287%29%3Ae25580.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DN7VW7429%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Raltegravir%20use%20and%20outcomes%20among%20children%20and%20adolescents%20living%20with%20HIV%20in%20the%20IeDEA%20global%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Patten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanyawee%22%2C%22lastName%22%3A%22Puthanakit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%22%2C%22lastName%22%3A%22Hazra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%20A.%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%22%2C%22lastName%22%3A%22Rabie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20As%20integrase%20inhibitors%20become%20available%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%2C%20they%20offer%20the%20potential%20to%20expand%20extremely%20limited%20treatment%20options%20available%20to%20children%20and%20adolescents.%20In%20LMICs%2C%20only%20small%20numbers%20have%20used%20raltegravir%2C%20primarily%20as%20part%20of%20third-line%20regimens.%20Using%20data%20from%20the%20IeDEA%20global%20consortium%2C%20we%20aimed%20to%20describe%20the%20characteristics%20of%20children%20on%20raltegravir-containing%20regimens%20and%20their%20outcomes.%5CnMETHODS%3A%20We%20included%20data%20from%201994%20to%202017%20from%20children%20%28age%20%3C18%5Cu00a0years%29%2C%20from%20East%20and%20Southern%20Africa%2C%20Asia%20and%20South%20America%2C%20who%20received%20cART%20regimens%20containing%20raltegravir%20for%20%5Cu226590%5Cu00a0days.%20We%20describe%20their%20characteristics%20at%20raltegravir%20start%2C%20and%20their%20immunological%20and%20virological%20outcomes.%5CnRESULTS%20AND%20DISCUSSION%3A%20In%20total%2C%2062%20children%20were%20included%2C%20with%20median%20age%20at%20raltegravir%20initiation%20of%2014.3%5Cu00a0years%20%28IQR%2011.2%20to%2015.8%29%20and%20median%20CD4%20count%20of%20276%5Cu00a0cells%5C%2F%5Cu00b5L%20%28IQR%2068%20to%20494%29.%20Among%2040%20%2865%25%29%20with%20drug%20resistance%20testing%20prior%20to%20raltegravir%2C%2071%25%20were%20resistant%20to%20at%20least%20one%20protease%20inhibitor%20%28PI%29%2C%20and%2032%25%20had%20high-level%20resistance%20to%20at%20least%20one%20drug%20class.%20Most%20%28n%5Cu00a0%3D%5Cu00a050%3B%2081%25%29%20received%20raltegravir%20as%20part%20of%20third-line%20cART%20following%20PI-based%20regimens%2C%20and%20were%20on%20regimens%20containing%20four%20or%20more%20drugs%20%28n%5Cu00a0%3D%5Cu00a047%2C%2076%25%29.%20By%20database%20closure%2C%20median%20duration%20on%20raltegravir%20was%202.0%5Cu00a0years%20%28IQR%200.8%20to%203.0%29%2C%201%20%281.6%25%29%20patient%20had%20died%2C%206%20%289.7%25%29%20were%20lost%20to%20follow-up%20and%2021%20%2834%25%29%20had%20discontinued%20raltegravir.%20Among%2015%20patients%20reporting%20reasons%20for%20stopping%20raltegravir%2C%20six%20discontinued%20because%20it%20was%20no%20longer%20available.%20Within%20one%20year%20of%20starting%20raltegravir%2C%20among%2053%20patients%20with%20VL%20measures%2C%2040%20%2875%25%29%20had%20VL%5Cu00a0%3C%5Cu00a01000%5Cu00a0copies%5C%2FmL%2C%20and%20among%2054%20with%20a%20reported%20CD4%20count%2C%2045%20%2883%25%29%20and%2036%20%2867%25%29%20were%20%5Cu2265350%20and%20%5Cu2265500%5Cu00a0cells%5C%2F%5Cu00b5L%2C%20respectively%2C%20with%20median%20CD4%20count%20increasing%20to%20517.5%5Cu00a0cells%5C%2F%5Cu00b5L%20%28IQR%20288%20to%20810%29.%5CnCONCLUSIONS%3A%20Among%20children%20in%20LMICs%2C%20the%20initial%20use%20of%20raltegravir%20has%20been%20primarily%20for%20post%20PI-based%20cART.%20We%20found%20good%20virological%20and%20immunological%20outcomes%20despite%20frequent%20prior%20triple-class%20failure%20and%20high%20levels%20of%20drug%20resistance.%20Both%20access%20to%20raltegravir%20and%20long-term%20adherence%20to%20regimens%20with%20large%20pill-burdens%20remain%20challenging.%20Policies%20which%20promote%20earlier%20access%20to%20new%20drugs%20and%20simplify%20daily%20regimens%20for%20children%20and%20adolescents%20in%20LMICs%20are%20needed.%22%2C%22date%22%3A%22Jul%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25580%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A12%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22HPP832HE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Koenig%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKoenig%20SP%2C%20Kim%20A%2C%20Shepherd%20BE%2C%20Cesar%20C%2C%20Veloso%20V%2C%20Cortes%20CP%2C%20et%20al.%20Increased%20Mortality%20After%20Tuberculosis%20Treatment%20Completion%20in%20Persons%20Living%20With%20Human%20Immunodeficiency%20Virus%20in%20Latin%20America.%20Clin%20Infect%20Dis.%202020%20Jun%2024%3B71%281%29%3A215%26%23x2013%3B7.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DHPP832HE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20Mortality%20After%20Tuberculosis%20Treatment%20Completion%20in%20Persons%20Living%20With%20Human%20Immunodeficiency%20Virus%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%20P.%22%2C%22lastName%22%3A%22Koenig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahra%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%5D%2C%22abstractNote%22%3A%22We%20assessed%20the%20association%20between%20cured%20tuberculosis%20%28TB%29%20and%20mortality%20among%20persons%20living%20with%20human%20immunodeficiency%20virus%20%28HIV%29%20in%20Latin%20America.%20We%20compared%20survival%20among%20persons%20with%20and%20without%20TB%20at%20enrollment%20in%20HIV%20care%2C%20starting%209%20months%20after%20clinic%20enrollment.%20In%20multivariable%20analysis%2C%20TB%20was%20associated%20with%20higher%20long-term%20mortality%20%28hazard%20ratio%2C%201.57%3B%2095%25%20confidence%20interval%2C%201.25-1.99%29.%22%2C%22date%22%3A%22Jun%2024%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciz1032%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A08%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22XGGCU9VH%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rebeiro%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERebeiro%20PF%2C%20Cohen%20MJ%2C%20Ewing%20HM%2C%20Figueiredo%20MC%2C%20Peetluk%20LS%2C%20Andrade%20KB%2C%20et%20al.%20Knowledge%20and%20stigma%20of%20latent%20tuberculosis%20infection%20in%20Brazil%3A%20implications%20for%20tuberculosis%20prevention%20strategies.%20BMC%20Public%20Health.%202020%20Jun%209%3B20%281%29%3A897.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DXGGCU9VH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Knowledge%20and%20stigma%20of%20latent%20tuberculosis%20infection%20in%20Brazil%3A%20implications%20for%20tuberculosis%20prevention%20strategies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mollie%20J.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20M.%22%2C%22lastName%22%3A%22Ewing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20Cruvinel%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20Saag%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kleydson%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marshall%22%2C%22lastName%22%3A%22Eakin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20J.%22%2C%22lastName%22%3A%22Zechmeister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20elimination%20requires%20treatment%20of%20millions%20of%20persons%20with%20latent%20M.%20tuberculosis%20infection%20%28LTBI%29.%20LTBI%20treatment%20acceptance%20depends%20on%20population-wide%20TB%20knowledge%20and%20low%20stigma%2C%20but%20limited%20data%20are%20available%20on%20the%20relationship%20between%20stigma%20and%20knowledge.%20We%20assessed%20knowledge%20of%20TB%20disease%20and%20LTBI%20throughout%20Brazil%20and%20examined%20their%20association%20with%20TB%20stigma%20and%20incidence.%5CnMETHODS%3A%20We%20performed%20a%20nationwide%20survey%20with%20multi-stage%20probability%20design%20through%20AmericasBarometer%20from%20April-May%202017%3B%20the%20sample%20was%20representative%20of%20Brazil%20at%20regional%20and%20national%20levels.%20Knowledge%20of%20and%20stigma%20toward%20TB%20were%20assessed%20by%20validated%20survey%20questions.%5CnRESULTS%3A%20Survey-weighted%20responses%20of%201532%20individuals%20suggest%20that%2057%25%20of%20the%20population%20knew%20LTBI%20can%20occur%2C%20and%2090%25%20would%20seek%20treatment%20for%20it.%20Regarding%20active%20TB%2C%2085%25%20knew%20TB%20symptoms%2C%2070%25%20reported%20they%20should%20avoid%20contact%20with%20someone%20with%20active%20TB%2C%20and%2024%25%20had%20stigma%20toward%20persons%20with%20TB%20%28i.e.%2C%20thought%20persons%20with%20tuberculosis%20should%20feel%20ashamed%2C%20or%20deserved%20their%20illness%29.%20In%20regression%20models%20adjusting%20for%20clinical%20and%20demographic%20variables%2C%20knowledge%20of%20LTBI%20was%20associated%20with%20increased%20stigma%20toward%20persons%20with%20TB%20%28adjusted%20odds%20ratio%20%5BOR%5D%5Cu2009%3D%5Cu20092.13%2C%2095%25%20confidence%20interval%20%5BCI%5D%3A%201%5Cu00b725-3.63%2C%20for%20%5C%22should%20feel%20ashamed%5C%22%3B%20OR%5Cu2009%3D%5Cu20091%5Cu00b782%2C%2095%25%20CI%3A%201%5Cu00b715-2%5Cu00b789%2C%20for%20%5C%22deserve%20illness%5C%22%29.%20Adjusting%20for%20regional%20TB%20incidence%20did%20not%20affect%20this%20association.%5CnCONCLUSIONS%3A%20High%20proportions%20of%20this%20representative%20Brazilian%20population%20had%20knowledge%20of%20LTBI%20and%20were%20willing%20to%20seek%20treatment%20for%20it.%20However%2C%20such%20knowledge%20was%20associated%20with%20TB-specific%20stigma.%20Strategies%20to%20educate%20and%20implement%20treatment%20of%20latent%20tuberculosis%20must%20include%20efforts%20to%20decrease%20TB%20stigma.%22%2C%22date%22%3A%22Jun%2009%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-020-09053-1%22%2C%22ISSN%22%3A%221471-2458%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A12%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22C283XGQT%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Belaunzar%5Cu00e1n-Zamudio%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBelaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Caro-Vega%20YN%2C%20Shepherd%20BE%2C%20Rebeiro%20PF%2C%20Crabtree-Ram%26%23xED%3Brez%20BE%2C%20Cortes%20CP%2C%20et%20al.%20The%20Population%20Impact%20of%20Late%20Presentation%20With%20Advanced%20HIV%20Disease%20and%20Delayed%20Antiretroviral%20Therapy%20in%20Adults%20Receiving%20HIV%20Care%20in%20Latin%20America.%20Am%20J%20Epidemiol.%202020%20Jun%201%3B189%286%29%3A564%26%23x2013%3B72.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DC283XGQT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Population%20Impact%20of%20Late%20Presentation%20With%20Advanced%20HIV%20Disease%20and%20Delayed%20Antiretroviral%20Therapy%20in%20Adults%20Receiving%20HIV%20Care%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%20N.%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20Wagner%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%22%7D%5D%2C%22abstractNote%22%3A%22Late%20presentation%20to%20care%20and%20antiretroviral%20therapy%20%28ART%29%20initiation%20with%20advanced%20human%20immunodeficiency%20virus%20%28HIV%29%20disease%20are%20common%20in%20Latin%20America.%20We%20estimated%20the%20impact%20of%20these%20conditions%20on%20mortality%20in%20the%20region.%20We%20included%20adults%20enrolled%20during%202001-2014%20at%20HIV%20care%20clinics.%20We%20estimated%20the%20adjusted%20attributable%20risk%20%28AR%29%20and%20population%20attributable%20fraction%20%28PAF%29%20for%20all-cause%20mortality%20of%20presentation%20to%20care%20with%20advanced%20HIV%20disease%20%28advanced%20LP%29%2C%20ART%20initiation%20with%20advanced%20HIV%20disease%2C%20and%20not%20initiating%20ART.%20Advanced%20HIV%20disease%20was%20defined%20as%20CD4%5Cu00a0of%20%3C200%20cells%5C%2F%5Cu03bcL%20or%20acquired%20immune%20deficiency%20syndrome.%20AR%20and%20PAF%20were%20derived%20using%20marginal%20structural%20models.%20Of%209%2C229%20patients%2C%2056%25%20presented%20with%20advanced%20HIV%20disease.%20ARs%20of%20death%20for%20advanced%20LP%20were%2086%25%2C%2071%25%2C%20and%2058%25%2C%20and%20PAFs%20were%2078%25%2C%2058%25%2C%20and%2043%25%20at%201%2C%205%2C%20and%2010%20years%20after%20enrollment.%20Among%20people%20without%20advanced%20LP%2C%20ARs%20of%20death%20for%20delaying%20ART%20were%2039%25%2C%2032%25%2C%20and%2037%25%20at%201%2C%205%2C%20and%2010%20years%20post-enrollment%20and%20PAFs%20were%2020%25%2C%2014%25%2C%20and%2015%25.%20Among%20people%20with%20advanced%20LP%2C%20ART%20decreased%20the%20hazard%20of%20death%20by%2063%25%20in%20the%20first%20year%20after%20enrollment%2C%20but%2093%25%20of%20these%20started%20ART%3B%20thus%20universal%20ART%20among%20them%20would%20reduce%20mortality%20by%20only%2010%25.%20Earlier%20presentation%20to%20care%20and%20earlier%20ART%20initiation%20would%20prevent%20most%20HIV%20deaths%20in%20Latin%20America.%22%2C%22date%22%3A%22Jun%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Faje%5C%2Fkwz252%22%2C%22ISSN%22%3A%221476-6256%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A08%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22W4Z9IKZJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Penn-Nicholson%20et%20al.%22%2C%22parsedDate%22%3A%222020-05-25%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPenn-Nicholson%20A%2C%20Mbandi%20SK%2C%20Thompson%20E%2C%20Mendelsohn%20SC%2C%20Suliman%20S%2C%20Chegou%20NN%2C%20et%20al.%20RISK6%2C%20a%206-gene%20transcriptomic%20signature%20of%20TB%20disease%20risk%2C%20diagnosis%20and%20treatment%20response.%20Sci%20Rep.%202020%20May%2025%3B10%281%29%3A8629.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DW4Z9IKZJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22RISK6%2C%20a%206-gene%20transcriptomic%20signature%20of%20TB%20disease%20risk%2C%20diagnosis%20and%20treatment%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Penn-Nicholson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanley%20Kimbung%22%2C%22lastName%22%3A%22Mbandi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20C.%22%2C%22lastName%22%3A%22Mendelsohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Suliman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Novel%20N.%22%2C%22lastName%22%3A%22Chegou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanus%20T.%22%2C%22lastName%22%3A%22Malherbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatoumatta%22%2C%22lastName%22%3A%22Darboe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mzwandile%22%2C%22lastName%22%3A%22Erasmus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Willem%20A.%22%2C%22lastName%22%3A%22Hanekom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Bilek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%20H.%20E.%22%2C%22lastName%22%3A%22Kaufmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%22%2C%22lastName%22%3A%22Winter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carl%22%2C%22lastName%22%3A%22Morrow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ildiko%22%2C%22lastName%22%3A%22Van%20Rhijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Branch%22%2C%22lastName%22%3A%22Moody%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Murray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%22%2C%22lastName%22%3A%22Sutherland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kogieleum%22%2C%22lastName%22%3A%22Naidoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nesri%22%2C%22lastName%22%3A%22Padayatchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerhard%22%2C%22lastName%22%3A%22Walzl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Hatherill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Zak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Scriba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Adolescent%20Cohort%20Study%20team%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22GC6-74%20Consortium%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22SATVI%20Clinical%20and%20Laboratory%20Team%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22ScreenTB%20Consortium%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22AE-TBC%20Consortium%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22RePORT%20Brazil%20Team%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Peruvian%20Household%20Contacts%20Cohort%20Team%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CAPRISA%20IMPRESS%20team%22%7D%5D%2C%22abstractNote%22%3A%22Improved%20tuberculosis%20diagnostics%20and%20tools%20for%20monitoring%20treatment%20response%20are%20urgently%20needed.%20We%20developed%20a%20robust%20and%20simple%2C%20PCR-based%20host-blood%20transcriptomic%20signature%2C%20RISK6%2C%20for%20multiple%20applications%3A%20identifying%20individuals%20at%20risk%20of%20incident%20disease%2C%20as%20a%20screening%20test%20for%20subclinical%20or%20clinical%20tuberculosis%2C%20and%20for%20monitoring%20tuberculosis%20treatment.%20RISK6%20utility%20was%20validated%20by%20blind%20prediction%20using%20quantitative%20real-time%20%28qRT%29%20PCR%20in%20seven%20independent%20cohorts.%20Prognostic%20performance%20significantly%20exceeded%20that%20of%20previous%20signatures%20discovered%20in%20the%20same%20cohort.%20Performance%20for%20diagnosing%20subclinical%20and%20clinical%20disease%20in%20HIV-uninfected%20and%20HIV-infected%20persons%2C%20assessed%20by%20area%20under%20the%20receiver-operating%20characteristic%20curve%2C%20exceeded%2085%25.%20As%20a%20screening%20test%20for%20tuberculosis%2C%20the%20sensitivity%20at%2090%25%20specificity%20met%20or%20approached%20the%20benchmarks%20set%20out%20in%20World%20Health%20Organization%20target%20product%20profiles%20for%20non-sputum-based%20tests.%20RISK6%20scores%20correlated%20with%20lung%20immunopathology%20activity%2C%20measured%20by%20positron%20emission%20tomography%2C%20and%20tracked%20treatment%20response%2C%20demonstrating%20utility%20as%20treatment%20response%20biomarker%2C%20while%20predicting%20treatment%20failure%20prior%20to%20treatment%20initiation.%20Performance%20of%20the%20test%20in%20capillary%20blood%20samples%20collected%20by%20finger-prick%20was%20noninferior%20to%20venous%20blood%20collected%20in%20PAXgene%20tubes.%20These%20results%20support%20incorporation%20of%20RISK6%20into%20rapid%2C%20capillary%20blood-based%20point-of-care%20PCR%20devices%20for%20prospective%20assessment%20in%20field%20studies.%22%2C%22date%22%3A%22May%2025%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-020-65043-8%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A11%3A29Z%22%7D%7D%2C%7B%22key%22%3A%227UK9LY25%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jesson%20et%20al.%22%2C%22parsedDate%22%3A%222020-05-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJesson%20J%2C%20Desmonde%20S%2C%20Yiannoutsos%20CT%2C%20Patten%20G%2C%20Malateste%20K%2C%20Duda%20SN%2C%20et%20al.%20Weight-for-age%20distributions%20among%20children%20with%20HIV%20on%20antiretroviral%20therapy%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20multiregional%20consortium.%20BMC%20Res%20Notes.%202020%20May%2024%3B13%281%29%3A249.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7UK9LY25%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Weight-for-age%20distributions%20among%20children%20with%20HIV%20on%20antiretroviral%20therapy%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20multiregional%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Jesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Patten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeriane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Ciaranello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Pediatric%20antiretroviral%20therapy%20%28ART%29%20for%20children%20with%20HIV%20%28CHIV%29%20must%20be%20dosed%20appropriately%20for%20children%27s%20changing%20weights%20as%20they%20grow.%20To%20inform%20accurate%20estimates%20of%20ART%20formulations%20and%20doses%20needed%2C%20we%20described%20weight-for-age%20distributions%20among%20CHIV%20on%20ART%20in%20the%20IeDEA%20global%20pediatric%20collaboration%20between%202004%20and%202016%2C%20using%20data%20from%20six%20regions%20%28East%2C%20West%2C%20Central%2C%20and%20Southern%20Africa%2C%20Asia-Pacific%2C%20and%20Central%5C%2FSouth%20America%20and%20the%20Caribbean%29.%5CnRESULTS%3A%20Overall%2C%2059%2C862%20children%20contributed%20to%20the%20analysis.%20Age%20and%20weight%20data%20were%20available%20from%20530%2C080%20clinical%20encounters%20for%20girls%20and%20537%2C894%20for%20boys.%20For%20each%20one-year%20age%20stratum%20from%200%20to%2015%5Cu00a0years%2C%20we%20calculated%20the%20proportion%20of%20children%20in%20each%20of%20the%20weight%20bands%20designated%20by%20the%20World%20Health%20Organization%20as%20relevant%20to%20pediatric%20ART%20formulations%3A%200%20to%20%5Cu2009%3C%5Cu20093%5Cu00a0kg%2C%203%20to%20%5Cu2009%3C%5Cu20096%5Cu00a0kg%2C%206%20to%20%5Cu2009%3C%5Cu200910%5Cu00a0kg%2C%2010%20to%20%5Cu2009%3C%5Cu200914%5Cu00a0kg%2C%2014%20to%20%5Cu2009%3C%5Cu200920%5Cu00a0kg%2C%2020%20to%20%5Cu2009%3C%5Cu200925%5Cu00a0kg%2C%2025%20to%20%5Cu2009%3C%5Cu200930%5Cu00a0kg%2C%2030%20to%20%5Cu2009%3C%5Cu200935%5Cu00a0kg%2C%2035%20to%20%5Cu2009%3C%5Cu200940%5Cu00a0kg%2C%2040%20to%20%5Cu2009%3C%5Cu200945%5Cu00a0kg%2C%2045%20to%20%5Cu2009%3C%5Cu200950%5Cu00a0kg%2C%2050%20to%20%5Cu2009%3C%5Cu200955%5Cu00a0kg%2C%2055%20to%20%5Cu2009%3C%5Cu200960%5Cu00a0kg%2C%20and%5Cu2009%5Cu2265%5Cu200960%5Cu00a0kg.%20Data%20are%20reported%20for%20the%20entire%20cohort%2C%20as%20well%20as%20stratified%20by%20sex%20and%20IeDEA%20region%2C%20calendar%20year%20of%20ART%20use%2C%20and%20duration%20on%20ART%20at%20time%20of%20assessment%20%28%3C%5Cu200912%20or%5Cu2009%5Cu2265%5Cu200912%5Cu00a0months%29%2C%20provided%20in%20data%20tables.%20These%20data%20are%20critical%20to%20improve%20the%20accuracy%20of%20forecasting%20and%20procurement%20of%20pediatric%20ART%20formulations%20as%20the%20pediatric%20HIV%20epidemic%20and%20pediatric%20HIV%20treatment%20strategies%20evolve.%22%2C%22date%22%3A%222020-05-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13104-020-05081-7%22%2C%22ISSN%22%3A%221756-0500%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A02%3A38Z%22%7D%7D%2C%7B%22key%22%3A%227SUA9UKZ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Peetluk%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPeetluk%20LS%2C%20Rebeiro%20PF%2C%20Cordeiro-Santos%20M%2C%20Kritski%20A%2C%20Andrade%20BB%2C%20Durovni%20B%2C%20et%20al.%20Lack%20of%20Weight%20Gain%20During%20the%20First%202%20Months%20of%20Treatment%20and%20Human%20Immunodeficiency%20Virus%20Independently%20Predict%20Unsuccessful%20Treatment%20Outcomes%20in%20Tuberculosis.%20J%20Infect%20Dis.%202020%20Apr%207%3B221%289%29%3A1416%26%23x2013%3B24.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7SUA9UKZ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lack%20of%20Weight%20Gain%20During%20the%20First%202%20Months%20of%20Treatment%20and%20Human%20Immunodeficiency%20Virus%20Independently%20Predict%20Unsuccessful%20Treatment%20Outcomes%20in%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20S.%22%2C%22lastName%22%3A%22Peetluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afranio%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%22%2C%22lastName%22%3A%22Calvacante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Weight%20change%20may%20inform%20tuberculosis%20treatment%20response%2C%20but%20its%20predictive%20power%20may%20be%20confounded%20by%20human%20immunodeficiency%20virus%20%28HIV%29.%5CnMETHODS%3A%20We%20prospectively%20followed%20up%20adults%20with%20culture-confirmed%2C%20drug-susceptible%2C%20pulmonary%20tuberculosis%20receiving%20standard%204-drug%20therapy%20%28isoniazid%2C%20rifampin%2C%20pyrazinamide%2C%20and%20ethambutol%29%20in%20Brazil.%20We%20examined%20median%20weight%20change%202%20months%20after%20treatment%20initiation%20by%20HIV%20status%2C%20using%20quantile%20regression%2C%20and%20unsuccessful%20tuberculosis%20treatment%20outcome%20%28treatment%20failure%2C%20tuberculosis%20recurrence%2C%20or%20death%29%20by%20HIV%20and%20weight%20change%20status%2C%20using%20Cox%20regression.%5CnRESULTS%3A%20Among%20547%20participants%2C%20102%20%2819%25%29%20were%20HIV%20positive%2C%20and%2035%20%286%25%29%20had%20an%20unsuccessful%20outcome.%20After%20adjustment%20for%20confounders%2C%20persons%20living%20with%20HIV%20%28PLWH%29%20gained%20a%20median%20of%201.3%20kg%20%2895%25%20confidence%20interval%20%5BCI%5D%2C%20-2.8%20to%20.1%29%20less%20than%20HIV-negative%20individuals%20during%20the%20first%202%20months%20of%20tuberculosis%20treatment.%20PLWH%20were%20at%20increased%20risk%20of%20an%20unsuccessful%20outcome%20%28adjusted%20hazard%20ratio%2C%204.8%3B%2095%25%20CI%2C%202.1-10.9%29.%20Weight%20change%20was%20independently%20associated%20with%20outcome%2C%20with%20risk%20of%20unsuccessful%20outcome%20decreasing%20by%2012%25%20%2895%25%20CI%2C%20.81%25-.95%25%29%20per%201-kg%20increase.%5CnCONCLUSIONS%3A%20PLWH%20gained%20less%20weight%20during%20the%20first%202%20months%20of%20tuberculosis%20treatment%2C%20and%20lack%20of%20weight%20gain%20and%20HIV%20independently%20predicted%20unsuccessful%20tuberculosis%20treatment%20outcomes.%20Weight%2C%20an%20easily%20collected%20biomarker%2C%20may%20identify%20patients%20who%20would%20benefit%20from%20alternative%20treatment%20strategies.%22%2C%22date%22%3A%22Apr%2007%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjiz595%22%2C%22ISSN%22%3A%221537-6613%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A09%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22PXM7B56Z%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%22%2C%22parsedDate%22%3A%222020-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECollaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration.%20Outcomes%20of%20second-line%20antiretroviral%20therapy%20among%20children%20living%20with%20HIV%3A%20a%20global%20cohort%20analysis.%20J%20Int%20AIDS%20Soc.%202020%20Apr%3B23%284%29%3Ae25477.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPXM7B56Z%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20of%20second-line%20antiretroviral%20therapy%20among%20children%20living%20with%20HIV%3A%20a%20global%20cohort%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Limited%20data%20describe%20outcomes%20on%20second-line%20antiretroviral%20therapy%20%28ART%29%20among%20children%20globally.%20Our%20objective%20was%20to%20contribute%20data%20on%20outcomes%20among%20children%20living%20with%20HIV%20after%20initiation%20of%20second-line%20ART%20in%20the%20context%20of%20routine%20care%20within%20a%20large%20global%20cohort%20collaboration.%5CnMETHODS%3A%20Patient-level%20data%20from%201993%20through%202015%20from%2011%20paediatric%20HIV%20cohorts%20were%20pooled.%20Characteristics%20at%20switch%20and%20through%20two%20years%20of%20follow-up%20were%20summarized%20for%20children%20who%20switched%20to%20second-line%20ART%20after%20starting%20a%20standard%20first-line%20regimen%20in%20North%20America%2C%20Latin%20America%2C%20Europe%2C%20Asia%2C%20Southern%20Africa%20%28South%20Africa%20%26%20Botswana%29%20and%20the%20rest%20of%20sub-Saharan%20Africa%20%28SSA%29.%20Cumulative%20incidences%20of%20mortality%20and%20loss%20to%20follow-up%20%28LTFU%29%20were%20estimated%20using%20a%20competing%20risks%20framework.%5CnRESULTS%3A%20Of%20the%2085%2C389%20children%20on%20first-line%20ART%2C%203%2C555%20%284%25%29%20switched%20to%20second-line%20after%20a%20median%20of%202.8%5Cu00a0years%20on%20ART%20%28IQR%3A%201.6%2C%204.7%29%3B%2069%25%20were%20from%20Southern%20Africa%20or%20SSA%20and%2086%25%20of%20second-line%20regimens%20were%20protease%20inhibitor-based.%20At%20switch%2C%20median%20age%20was%208.4%5Cu00a0years%20and%2050%25%20had%20a%20prior%20AIDS%20diagnosis.%20Median%20follow-up%20after%20switch%20to%20second-line%20ranged%20from%201.8%5Cu00a0years%20in%20SSA%20to%205.3%5Cu00a0years%20in%20North%20America.%20Median%20CD4%20counts%20at%20switch%20to%20second-line%20ranged%20from%20235%5Cu00a0cells%5C%2Fmm3%20in%20SSA%20to%20828%5Cu00a0cells%5C%2Fmm3%20in%20North%20America.%20Improvements%20in%20CD4%20counts%20were%20observed%20over%20two%20years%20of%20follow-up%2C%20particularly%20in%20regions%20with%20lower%20CD4%20counts%20at%20second-line%20switch.%20Improvements%20in%20weight-for-age%20z-scores%20were%20not%20observed%20during%20follow-up.%20Cumulative%20incidence%20of%20LTFU%20at%20two%20years%20was%20%3C5%25%20in%20all%20regions%20except%20SSA%20%287.1%25%29%20and%20Southern%20Africa%20%287.4%25%29.%20Risk%20of%20mortality%20was%20%3C3%25%20at%20two%20years%20of%20follow-up%20in%20all%20regions%2C%20except%20Latin%20America%20%284.9%25%29%20and%20SSA%20%285.5%25%29.%5CnCONCLUSIONS%3A%20Children%20switched%20to%20second-line%20ART%20experience%20CD4%20count%20increases%20as%20well%20as%20low%20to%20moderate%20rates%20of%20LTFU%20and%20mortality%20within%20two%20years%20after%20switch.%20Severe%20immune%20deficiency%20at%20time%20of%20switch%20in%20some%20settings%20suggests%20need%20for%20improved%20recognition%20and%20management%20of%20treatment%20failure%20in%20children.%22%2C%22date%22%3A%22Apr%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25477%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A11%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22J8RKRBUT%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lotspeich%20et%20al.%22%2C%22parsedDate%22%3A%222020-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELotspeich%20SC%2C%20Giganti%20MJ%2C%20Maia%20M%2C%20Vieira%20R%2C%20Machado%20DM%2C%20Succi%20RC%2C%20et%20al.%20Self-audits%20as%20alternatives%20to%20travel-audits%20for%20improving%20data%20quality%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology.%20J%20Clin%20Transl%20Sci.%202020%20Apr%3B4%282%29%3A125%26%23x2013%3B32.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DJ8RKRBUT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Self-audits%20as%20alternatives%20to%20travel-audits%20for%20improving%20data%20quality%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lotspeich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelle%22%2C%22lastName%22%3A%22Maia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renalice%22%2C%22lastName%22%3A%22Vieira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%20C%5Cu00e9lia%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayonara%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20Sergio%22%2C%22lastName%22%3A%22Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Fernanda%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaetane%22%2C%22lastName%22%3A%22Julmiste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%20Tulio%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Audits%20play%20a%20critical%20role%20in%20maintaining%20the%20integrity%20of%20observational%20cohort%20data.%20While%20previous%20work%20has%20validated%20the%20audit%20process%2C%20sending%20trained%20auditors%20to%20sites%20%28%5C%22travel-audits%5C%22%29%20can%20be%20costly.%20We%20investigate%20the%20efficacy%20of%20training%20sites%20to%20conduct%20%5C%22self-audits.%5C%22%5CnMethods%3A%20In%202017%2C%20eight%20research%20groups%20in%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20for%20HIV%20Epidemiology%20each%20audited%20a%20subset%20of%20their%20patient%20records%20randomly%20selected%20by%20the%20data%20coordinating%20center%20at%20Vanderbilt.%20Designated%20investigators%20at%20each%20site%20compared%20abstracted%20research%20data%20to%20the%20original%20clinical%20source%20documents%20and%20captured%20audit%20findings%20electronically.%20Additionally%2C%20two%20Vanderbilt%20investigators%20performed%20on-site%20travel-audits%20at%20three%20randomly%20selected%20sites%20%28one%20adult%20and%20two%20pediatric%29%20in%20late%20summer%202017.%5CnResults%3A%20Self-%20and%20travel-auditors%2C%20respectively%2C%20reported%20that%2093%25%20and%2092%25%20of%208919%20data%20entries%2C%20captured%20across%2028%20unique%20clinical%20variables%20on%2065%20patients%2C%20were%20entered%20correctly.%20Across%20all%20entries%2C%208409%20%2894%25%29%20received%20the%20same%20assessment%20from%20self-%20and%20travel-auditors%20%287988%20correct%20and%20421%20incorrect%29.%20Of%20421%20entries%20mutually%20assessed%20as%20%5C%22incorrect%2C%5C%22%20304%20%2882%25%29%20were%20corrected%20by%20both%20self-%20and%20travel-auditors%20and%20250%20of%20these%20%2872%25%29%20received%20the%20same%20corrections.%20Reason%20for%20changing%20antiretroviral%20therapy%20%28ART%29%20regimen%2C%20ART%20end%20date%2C%20viral%20load%20value%2C%20CD4%25%2C%20and%20HIV%20diagnosis%20date%20had%20the%20most%20mismatched%20corrections.%5CnConclusions%3A%20With%20similar%20overall%20error%20rates%2C%20findings%20suggest%20that%20data%20audits%20conducted%20by%20trained%20local%20investigators%20could%20provide%20an%20alternative%20to%20on-site%20audits%20by%20external%20auditors%20to%20ensure%20continued%20data%20quality.%20However%2C%20discrepancies%20observed%20between%20corrections%20illustrate%20challenges%20in%20determining%20correct%20values%20even%20with%20audits.%22%2C%22date%22%3A%22Apr%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1017%5C%2Fcts.2019.442%22%2C%22ISSN%22%3A%222059-8661%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A10%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22Z8393DEX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cubillos-Angulo%20et%20al.%22%2C%22parsedDate%22%3A%222020-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECubillos-Angulo%20JM%2C%20Arriaga%20MB%2C%20Melo%20MGM%2C%20Silva%20EC%2C%20Alvarado-Arnez%20LE%2C%20de%20Almeida%20AS%2C%20et%20al.%20Polymorphisms%20in%20interferon%20pathway%20genes%20and%20risk%20of%20Mycobacterium%20tuberculosis%20infection%20in%20contacts%20of%20tuberculosis%20cases%20in%20Brazil.%20Int%20J%20Infect%20Dis.%202020%20Mar%3B92%3A21%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DZ8393DEX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Polymorphisms%20in%20interferon%20pathway%20genes%20and%20risk%20of%20Mycobacterium%20tuberculosis%20infection%20in%20contacts%20of%20tuberculosis%20cases%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Manuel%22%2C%22lastName%22%3A%22Cubillos-Angulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayla%20G.%20M.%22%2C%22lastName%22%3A%22Melo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisangela%20C.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucia%20Elena%22%2C%22lastName%22%3A%22Alvarado-Arnez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%20S.%22%2C%22lastName%22%3A%22de%20Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milton%20O.%22%2C%22lastName%22%3A%22Moraes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20R.%22%2C%22lastName%22%3A%22Lapa%20E%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20R.%22%2C%22lastName%22%3A%22Hawn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%20M.%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Host%20genetic%20polymorphisms%20may%20be%20important%20in%20determining%20susceptibility%20to%20Mycobacterium%20tuberculosis%20%28Mtb%29%20infection%2C%20but%20their%20role%20is%20not%20fully%20understood.%20Detection%20of%20microbial%20DNA%20and%20activation%20of%20type%20I%20interferon%20%28IFN%29%20pathways%20regulate%20macrophage%20responses%20to%20Mtb%20infection.%5CnMETHODS%3A%20We%20examined%20whether%20seven%20candidate%20gene%20SNPs%20were%20associated%20with%20tuberculin%20skin%20test%20%28TST%29%20positivity%20in%20close%20contacts%20of%20microbiologically%20confirmed%20pulmonary%20TB%20patients%20in%20Brazil.%20Independent%20associations%20with%20TST%20positivity%20were%20tested%20using%20multivariable%20logistic%20regression%20%28using%20genotypes%20and%20clinical%20variables%29%20and%20genetic%20models.%5CnRESULTS%3A%20Among%20482%20contacts%20of%20145%20TB%20index%20cases%2C%20296%20contacts%20were%20TST%20positive.%20Multivariable%20regression%20analysis%20adjusted%20for%20population%20admixture%2C%20age%2C%20family%20relatedness%2C%20sex%20and%20clinical%20variables%20related%20to%20increased%20TB%20risk%20demonstrated%20that%20SNPs%20in%20PYHIN1-IFI16-AIM2%20rs1101998%20%28adjusted%20OR%20%5BaOR%5D%3A%203.72%3B%2095%25CI%3D1.15-12.0%3B%20p%3D0.028%29%20and%20in%20PYHIN1-IFI16-AIM2%20rs1633256%20%28aOR%3D24.84%3B%2095%25CI%3D2.26-272.95%3B%20p%3D0.009%29%20were%20associated%20with%20TST%20positivity%20in%20a%20recessive%20model.%20Furthermore%2C%20an%20IRF7%20polymorphism%20%28rs11246213%29%20was%20associated%20with%20reduced%20odds%20of%20TST%20positivity%20in%20a%20dominant%20model%20%28aOR%3A%200.50%2C%2095%25CI%3A%200.26-0.93%3B%20p%3D0.029%29.%5CnCONCLUSIONS%3A%20Polymorphisms%20in%20PYHIN1-IFI16-AIM2%20rs1633256%2C%20rs1101998%20and%20in%20IRF7%20rs11246213%20were%20associated%20with%20altered%20susceptibility%20to%20Mtb%20infection%20in%20this%20Brazilian%20cohort.%22%2C%22date%22%3A%222020-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2019.12.013%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-14T20%3A16%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22TVFE865Y%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cubillos-Angulo%20et%20al.%22%2C%22parsedDate%22%3A%222020-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECubillos-Angulo%20JM%2C%20Arriaga%20MB%2C%20Melo%20MGM%2C%20Silva%20EC%2C%20Alvarado-Arnez%20LE%2C%20de%20Almeida%20AS%2C%20et%20al.%20Polymorphisms%20in%20interferon%20pathway%20genes%20and%20risk%20of%20Mycobacterium%20tuberculosis%20infection%20in%20contacts%20of%20tuberculosis%20cases%20in%20Brazil.%20Int%20J%20Infect%20Dis.%202020%20Mar%3B92%3A21%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DTVFE865Y%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Polymorphisms%20in%20interferon%20pathway%20genes%20and%20risk%20of%20Mycobacterium%20tuberculosis%20infection%20in%20contacts%20of%20tuberculosis%20cases%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Manuel%22%2C%22lastName%22%3A%22Cubillos-Angulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayla%20G.%20M.%22%2C%22lastName%22%3A%22Melo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisangela%20C.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucia%20Elena%22%2C%22lastName%22%3A%22Alvarado-Arnez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%20S.%22%2C%22lastName%22%3A%22de%20Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milton%20O.%22%2C%22lastName%22%3A%22Moraes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20R.%22%2C%22lastName%22%3A%22Lapa%20E%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20R.%22%2C%22lastName%22%3A%22Hawn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%20M.%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Host%20genetic%20polymorphisms%20may%20be%20important%20in%20determining%20susceptibility%20to%20Mycobacterium%20tuberculosis%20%28Mtb%29%20infection%2C%20but%20their%20role%20is%20not%20fully%20understood.%20Detection%20of%20microbial%20DNA%20and%20activation%20of%20type%20I%20interferon%20%28IFN%29%20pathways%20regulate%20macrophage%20responses%20to%20Mtb%20infection.%5CnMETHODS%3A%20We%20examined%20whether%20seven%20candidate%20gene%20SNPs%20were%20associated%20with%20tuberculin%20skin%20test%20%28TST%29%20positivity%20in%20close%20contacts%20of%20microbiologically%20confirmed%20pulmonary%20TB%20patients%20in%20Brazil.%20Independent%20associations%20with%20TST%20positivity%20were%20tested%20using%20multivariable%20logistic%20regression%20%28using%20genotypes%20and%20clinical%20variables%29%20and%20genetic%20models.%5CnRESULTS%3A%20Among%20482%20contacts%20of%20145%20TB%20index%20cases%2C%20296%20contacts%20were%20TST%20positive.%20Multivariable%20regression%20analysis%20adjusted%20for%20population%20admixture%2C%20age%2C%20family%20relatedness%2C%20sex%20and%20clinical%20variables%20related%20to%20increased%20TB%20risk%20demonstrated%20that%20SNPs%20in%20PYHIN1-IFI16-AIM2%20rs1101998%20%28adjusted%20OR%20%5BaOR%5D%3A%203.72%3B%2095%25CI%3D1.15-12.0%3B%20p%3D0.028%29%20and%20in%20PYHIN1-IFI16-AIM2%20rs1633256%20%28aOR%3D24.84%3B%2095%25CI%3D2.26-272.95%3B%20p%3D0.009%29%20were%20associated%20with%20TST%20positivity%20in%20a%20recessive%20model.%20Furthermore%2C%20an%20IRF7%20polymorphism%20%28rs11246213%29%20was%20associated%20with%20reduced%20odds%20of%20TST%20positivity%20in%20a%20dominant%20model%20%28aOR%3A%200.50%2C%2095%25CI%3A%200.26-0.93%3B%20p%3D0.029%29.%5CnCONCLUSIONS%3A%20Polymorphisms%20in%20PYHIN1-IFI16-AIM2%20rs1633256%2C%20rs1101998%20and%20in%20IRF7%20rs11246213%20were%20associated%20with%20altered%20susceptibility%20to%20Mtb%20infection%20in%20this%20Brazilian%20cohort.%22%2C%22date%22%3A%222020-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2019.12.013%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-07T21%3A25%3A50Z%22%7D%7D%2C%7B%22key%22%3A%223W3RIAX6%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Humphrey%20et%20al.%22%2C%22parsedDate%22%3A%222020-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHumphrey%20JM%2C%20Mpofu%20P%2C%20Pettit%20AC%2C%20Musick%20B%2C%20Carter%20EJ%2C%20Messou%20E%2C%20et%20al.%20Mortality%20Among%20People%20With%20HIV%20Treated%20for%20Tuberculosis%20Based%20on%20Positive%2C%20Negative%2C%20or%20No%20Bacteriologic%20Test%20Results%20for%20Tuberculosis%3A%20The%20IeDEA%20Consortium.%20Open%20Forum%20Infect%20Dis.%202020%20Jan%3B7%281%29%3Aofaa006.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D3W3RIAX6%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20Among%20People%20With%20HIV%20Treated%20for%20Tuberculosis%20Based%20on%20Positive%2C%20Negative%2C%20or%20No%20Bacteriologic%20Test%20Results%20for%20Tuberculosis%3A%20The%20IeDEA%20Consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philani%22%2C%22lastName%22%3A%22Mpofu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20C.%22%2C%22lastName%22%3A%22Pettit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jane%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20In%20resource-constrained%20settings%2C%20many%20people%20with%20HIV%20%28PWH%29%20are%20treated%20for%20tuberculosis%20%28TB%29%20without%20bacteriologic%20testing.%20Their%20mortality%20compared%20with%20those%20with%20bacteriologic%20testing%20is%20uncertain.%5CnMethods%3A%20We%20conducted%20an%20observational%20cohort%20study%20among%20PWH%5Cu2005%5Cu226515%20years%20of%20age%20initiating%20TB%20treatment%20at%20sites%20affiliated%20with%204%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20regions%20from%202012%20to%202014%3A%20Caribbean%2C%20Central%20and%20South%20America%2C%20and%20Central%2C%20East%2C%20and%20West%20Africa.%20The%20exposure%20of%20interest%20was%20the%20TB%20bacteriologic%20test%20status%20at%20TB%20treatment%20initiation%3A%20positive%2C%20negative%2C%20or%20no%20test%20result.%20The%20hazard%20of%20death%20in%20the%2012%20months%20after%20TB%20treatment%20initiation%20was%20estimated%20using%20a%20Cox%20proportional%20hazard%20model.%20Missing%20covariate%20values%20were%20multiply%20imputed.%5CnResults%3A%20In%202091%20PWH%2C%20median%20age%2036%20years%2C%2053%25%20had%20CD4%20counts%5Cu2005%5Cu2264200%20cells%5C%2Fmm3%2C%20and%2052%25%20were%20on%20antiretroviral%20therapy%20%28ART%29%20at%20TB%20treatment%20initiation.%20The%20adjusted%20hazard%20of%20death%20was%20higher%20in%20patients%20with%20no%20test%20compared%20with%20those%20with%20positive%20test%20results%20%28hazard%20ratio%20%5BHR%5D%2C%201.56%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%201.08-2.26%29.%20The%20hazard%20of%20death%20was%20also%20higher%20among%20those%20with%20negative%20compared%20with%20positive%20tests%20but%20was%20not%20statistically%20significant%20%28HR%2C%201.28%3B%2095%25%20CI%2C%200.91-1.81%29.%20Being%20on%20ART%2C%20having%20a%20higher%20CD4%20count%2C%20and%20tertiary%20facility%20level%20were%20associated%20with%20a%20lower%20hazard%20for%20death.%5CnConclusions%3A%20There%20was%20some%20evidence%20that%20PWH%20treated%20for%20TB%20with%20no%20bacteriologic%20test%20results%20were%20at%20higher%20risk%20of%20death%20than%20those%20with%20positive%20tests.%20Research%20is%20needed%20to%20understand%20the%20causes%20of%20death%20in%20PWH%20treated%20for%20TB%20without%20bacteriologic%20testing.%22%2C%22date%22%3A%22Jan%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofaa006%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A11%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22VG84HGCJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Giganti%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiganti%20MJ%2C%20Shaw%20PA%2C%20Chen%20G%2C%20Bebawy%20SS%2C%20Turner%20MM%2C%20Sterling%20TR%2C%20et%20al.%20Accounting%20for%20dependent%20errors%20in%20predictors%20and%20time-to-event%20outcomes%20using%20electronic%20health%20records%2C%20validation%20samples%20and%20multiple%20imputation.%20Ann%20Appl%20Stat%20%5BInternet%5D.%202020%20%5Bcited%202020%20Sep%2015%5D%3B14%282%29%3A1045%26%23x2013%3B61.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fprojecteuclid.org%5C%2Feuclid.aoas%5C%2F1593449337%27%3Ehttps%3A%5C%2F%5C%2Fprojecteuclid.org%5C%2Feuclid.aoas%5C%2F1593449337%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DVG84HGCJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accounting%20for%20dependent%20errors%20in%20predictors%20and%20time-to-event%20outcomes%20using%20electronic%20health%20records%2C%20validation%20samples%20and%20multiple%20imputation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guanhua%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sally%20S.%22%2C%22lastName%22%3A%22Bebawy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%20M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2206%5C%2F2020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1214%5C%2F20-AOAS1343%22%2C%22ISSN%22%3A%221932-6157%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fprojecteuclid.org%5C%2Feuclid.aoas%5C%2F1593449337%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A16%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22UFWDNVZP%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rohner%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERohner%20E%2C%20B%26%23xFC%3Btikofer%20L%2C%20Schmidlin%20K%2C%20Sengayi%20M%2C%20Maskew%20M%2C%20Giddy%20J%2C%20et%20al.%20Cervical%20cancer%20risk%20in%20women%20living%20with%20HIV%20across%20four%20continents%3A%20A%20multicohort%20study.%20Int%20J%20Cancer.%202020%2001%3B146%283%29%3A601%26%23x2013%3B9.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DUFWDNVZP%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cervical%20cancer%20risk%20in%20women%20living%20with%20HIV%20across%20four%20continents%3A%20A%20multicohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22B%5Cu00fctikofer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kurt%22%2C%22lastName%22%3A%22Schmidlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazvita%22%2C%22lastName%22%3A%22Sengayi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mhairi%22%2C%22lastName%22%3A%22Maskew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janet%22%2C%22lastName%22%3A%22Giddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katayoun%22%2C%22lastName%22%3A%22Taghavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Goedert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20John%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Silverberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gypsyamber%22%2C%22lastName%22%3A%22D%27Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pragna%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firouze%22%2C%22lastName%22%3A%22Bani-Sadr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ninon%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vassilios%22%2C%22lastName%22%3A%22Paparizos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrice%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annelies%22%2C%22lastName%22%3A%22Verbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00f6rg%20Janne%22%2C%22lastName%22%3A%22Vehreschild%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%20A.%22%2C%22lastName%22%3A%22Post%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Sabin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Mocroft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Dronda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niels%22%2C%22lastName%22%3A%22Obel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Grabar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincenzo%22%2C%22lastName%22%3A%22Spagnuolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugenia%22%2C%22lastName%22%3A%22Quiros-Roldan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Mussini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20M.%22%2C%22lastName%22%3A%22Miro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Hasse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Konopnicki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernardino%22%2C%22lastName%22%3A%22Roca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Barger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20M.%22%2C%22lastName%22%3A%22Clifford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvia%22%2C%22lastName%22%3A%22Franceschi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Bohlius%22%7D%5D%2C%22abstractNote%22%3A%22We%20compared%20invasive%20cervical%20cancer%20%28ICC%29%20incidence%20rates%20in%20Europe%2C%20South%20Africa%2C%20Latin%20and%20North%20America%20among%20women%20living%20with%20HIV%20who%20initiated%20antiretroviral%20therapy%20%28ART%29%20between%201996%20and%202014.%20We%20analyzed%20cohort%20data%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20and%20the%20Collaboration%20of%20Observational%20HIV%20Epidemiological%20Research%20in%20Europe%20%28COHERE%29%20in%20EuroCoord.%20We%20used%20flexible%20parametric%20survival%20models%20to%20determine%20regional%20ICC%20rates%20and%20risk%20factors%20for%20incident%20ICC.%20We%20included%2064%2C231%20women%20from%2045%20countries.%20During%20320%2C141%20person-years%20%28pys%29%2C%20356%20incident%20ICC%20cases%20were%20diagnosed%20%28Europe%20164%2C%20South%20Africa%20156%2C%20North%20America%2019%20and%20Latin%20America%2017%29.%20Raw%20ICC%20incidence%20rates%20per%20100%2C000%20pys%20were%20447%20in%20South%20Africa%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%20382-523%29%2C%20136%20in%20Latin%20America%20%2895%25%20CI%3A%2085-219%29%2C%2076%20in%20North%20America%20%2895%25%20CI%3A%2048-119%29%20and%2066%20in%20Europe%20%2895%25%20CI%3A%2057-77%29.%20Compared%20to%20European%20women%20ICC%20rates%20at%205%20years%20after%20ART%20initiation%20were%20more%20than%20double%20in%20Latin%20America%20%28adjusted%20hazard%20ratio%20%5BaHR%5D%3A%202.43%2C%2095%25%20CI%3A%201.27-4.68%29%20and%2011%20times%20higher%20in%20South%20Africa%20%28aHR%3A%2010.66%2C%2095%25%20CI%3A%206.73-16.88%29%2C%20but%20similar%20in%20North%20America%20%28aHR%3A%200.79%2C%2095%25%20CI%3A%200.37-1.71%29.%20Overall%2C%20ICC%20rates%20increased%20with%20age%20%28%3E50%5Cu2009years%20vs.%2016-30%5Cu2009years%2C%20aHR%3A%201.57%2C%2095%25%20CI%3A%201.03-2.40%29%20and%20lower%20CD4%20cell%20counts%20at%20ART%20initiation%20%28per%20100%20cell%5C%2F%5Cu03bcl%20decrease%2C%20aHR%3A%201.25%2C%2095%25%20CI%3A%201.15-1.36%29.%20Improving%20access%20to%20early%20ART%20initiation%20and%20effective%20cervical%20cancer%20screening%20in%20women%20living%20with%20HIV%20should%20be%20key%20parts%20of%20global%20efforts%20to%20reduce%20cancer-related%20health%20inequities.%22%2C%22date%22%3A%2202%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fijc.32260%22%2C%22ISSN%22%3A%221097-0215%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A07%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22TQP3QRJX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22IeDEA%20and%20COHERE%20in%20EuroCoord%20Cohort%20Collaboration%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIeDEA%20and%20COHERE%20in%20EuroCoord%20Cohort%20Collaboration.%20All-cause%20mortality%20after%20antiretroviral%20therapy%20initiation%20in%20HIV-positive%20women%20from%20Europe%2C%20Sub-Saharan%20Africa%20and%20the%20Americas.%20AIDS.%202020%2001%3B34%282%29%3A277%26%23x2013%3B89.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DTQP3QRJX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22All-cause%20mortality%20after%20antiretroviral%20therapy%20initiation%20in%20HIV-positive%20women%20from%20Europe%2C%20Sub-Saharan%20Africa%20and%20the%20Americas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20and%20COHERE%20in%20EuroCoord%20Cohort%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Women%20account%20for%20over%20half%20of%20persons%20living%20with%20HIV%5C%2FAIDS%20globally.%20We%20examined%20geographic%20variation%20in%20all-cause%20mortality%20after%20antiretroviral%20therapy%20%28ART%29%20for%20women%20living%20with%20HIV%20%28WLWH%29%20worldwide.%5CnMETHODS%3A%20We%20pooled%20data%20from%20WLWH%20at%20least%2018%20years%20initiating%20ART%202000-2014%20within%20COHERE%20%28Europe%29%20and%20IeDEA%20regions%20%28East%20Africa%2C%20West%20Africa%2C%20South%20Africa%2C%20North%20America%2C%20Latin%20America%5C%2FCaribbean%29.%20Mortality%20rates%20were%20calculated%20at%200-3%2C%203-6%2C%206-12%2C%2012-24%20and%2024-48%20months%20after%20ART%2C%20and%20mortality%20rate%20ratios%20were%20compared%20with%20European%20rates%20with%20piecewise%20exponential%20parametric%20survival%20models%20based%20on%20Poisson%20regression.%5CnFINDINGS%3A%20One%20hundred%20ninety%20thousand%2C%20one%20hundred%20and%20seventy-five%20WLWH%20%2816%25%20Europe%2C%2047%25%20East%20Africa%2C%2013%25%20West%20Africa%2C%2019%25%20South%20Africa%2C%201%25%20South%20America%2C%203%25%20North%20America%20and%202%25%20Central%20America%5C%2FCaribbean%29%20were%20included.%20The%20highest%20death%20rates%20occurred%200-3%20months%20after%20ART%20%5B1.51%20%2895%25%20CI%201.25-1.82%29%20per%20100%20person-years%20in%20Europe%2C%2012.45%20%2811.30-13.73%29%2C%2014.03%20%2813.12-15.02%29%20and%209.44%20%288.80-10.11%29%20in%20East%2C%20West%20and%20South%20Africa%2C%20and%201.53%20%280.97-2.43%29%2C%207.83%20%285.44-11.27%29%20and%2017.02%20%2814.62-19.81%29%20in%20North%2C%20South%20America%20and%20Central%20America%5C%2FCaribbean%2C%20respectively%5D%20and%20declined%20thereafter.%20Mortality%20in%20Europe%20was%20the%20lowest%2C%20with%20regional%20differences%20greatest%20in%20the%20first%203%20months%20and%20smaller%20at%20longer%20ART%20durations%20%5Badjusted%20rate%20ratios%2024-48%20months%20after%20ART%3A%203.63%20%2895%25%20CI%203.04-4.33%29%2C%205.61%20%284.84-6.51%29%20and%203.47%20%282.97-4.06%29%20for%20East%2C%20West%20and%20South%20Africa%3B%202.86%20%282.26-3.62%29%2C%202.42%20%281.65-3.55%29%20and%202.50%20%281.92-3.26%29%20for%20North%2C%20South%20America%20and%20Central%20America%5C%2FCaribbean%2C%20respectively%5D.%5CnCONCLUSION%3A%20Global%20variations%20in%20short-term%20and%20long-term%20mortality%20among%20WLWH%20initiating%20ART%20may%20inform%20context-specific%20interventions.%22%2C%22date%22%3A%2202%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000002399%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A14%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22CQQJNR7W%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Safe%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESafe%20IP%2C%20Amaral%20EP%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Lacerda%20MVG%2C%20Printes%20VS%2C%20Souza%20AB%2C%20et%20al.%20Adjunct%20N-Acetylcysteine%20Treatment%20in%20Hospitalized%20Patients%20With%20HIV-Associated%20Tuberculosis%20Dampens%20the%20Oxidative%20Stress%20in%20Peripheral%20Blood%3A%20Results%20From%20the%20RIPENACTB%20Study%20Trial.%20Front%20Immunol.%202020%3B11%3A602589.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DCQQJNR7W%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjunct%20N-Acetylcysteine%20Treatment%20in%20Hospitalized%20Patients%20With%20HIV-Associated%20Tuberculosis%20Dampens%20the%20Oxidative%20Stress%20in%20Peripheral%20Blood%3A%20Results%20From%20the%20RIPENACTB%20Study%20Trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Izabella%20P.%22%2C%22lastName%22%3A%22Safe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20P.%22%2C%22lastName%22%3A%22Amaral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcus%20V.%20G.%22%2C%22lastName%22%3A%22Lacerda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vitoria%20S.%22%2C%22lastName%22%3A%22Printes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20B.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Beraldi-Magalh%5Cu00e3es%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wuelton%20M.%22%2C%22lastName%22%3A%22Monteiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanderson%20S.%22%2C%22lastName%22%3A%22Sampaio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%20M.%20S.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%22%2C%22lastName%22%3A%22Spener-Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allyson%20Guimar%5Cu00e3es%22%2C%22lastName%22%3A%22Costa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Cordeiro-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20still%20causes%20significant%20morbidity%20and%20mortality%20worldwide%2C%20especially%20in%20persons%20living%20with%20human%20immunodeficiency%20virus%20%28HIV%29.%20This%20disease%20is%20hallmarked%20by%20persistent%20oxidative%20stress%20and%20systemic%20inflammation.%20N-acetylcysteine%20%28NAC%29%2C%20a%20glutathione%20%28GSH%29%20precursor%2C%20has%20been%20shown%20in%20experimental%20models%20to%20limit%20Mycobacterium%20tuberculosis%20infection%20and%20disease%20both%20by%20suppression%20of%20the%20host%20oxidative%20response%20and%20through%20direct%20antimicrobial%20activity.%20In%20a%20recent%20phase%20II%20randomized%20clinical%20trial%20%28RIPENACTB%20study%29%2C%20use%20of%20NAC%20as%20adjunct%20therapy%20during%20the%20first%20two%20months%20of%20anti-TB%20treatment%20was%20safe.%20Whether%20adjunct%20NAC%20therapy%20of%20patients%20with%20TB-HIV%20coinfection%20in%20the%20context%20of%20anti-TB%20treatment%20could%20directly%20affect%20pro-oxidation%20and%20systemic%20inflammation%20has%20not%20been%20yet%20formally%20demonstrated.%20To%20test%20this%20hypothesis%2C%20we%20leveraged%20existing%20data%20and%20biospecimens%20from%20the%20RIPENACTB%20trial%20to%20measure%20a%20number%20of%20surrogate%20markers%20of%20oxidative%20stress%20and%20of%20immune%20activation%20in%20peripheral%20blood%20of%20the%20participants%20at%20pre-treatment%20and%20at%20the%20day%2060%20of%20anti-TB%20treatment.%20Upon%20initiation%20of%20therapy%2C%20we%20found%20that%20the%20group%20of%20patients%20undertaking%20NAC%20exhibited%20significant%20increase%20in%20GSH%20levels%20and%20in%20total%20antioxidant%20status%20while%20displaying%20substantial%20reduction%20in%20lipid%20peroxidation%20compared%20to%20the%20control%20group.%20Only%20small%20changes%20in%20plasma%20concentrations%20of%20cytokines%20were%20noted.%20Pharmacological%20improvement%20of%20the%20host%20antioxidant%20status%20appears%20to%20be%20a%20reasonable%20strategy%20to%20reduce%20TB-associated%20immunopathology.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.602589%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A07%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22IQH4U8Q8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barreto-Duarte%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBarreto-Duarte%20B%2C%20Sterling%20TR%2C%20Fiske%20CT%2C%20Almeida%20A%2C%20Nochowicz%20CH%2C%20Smith%20RM%2C%20et%20al.%20Increased%20Frequency%20of%20Memory%20CD4%2B%20T-Cell%20Responses%20in%20Individuals%20With%20Previously%20Treated%20Extrapulmonary%20Tuberculosis.%20Front%20Immunol.%202020%3B11%3A605338.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIQH4U8Q8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20Frequency%20of%20Memory%20CD4%2B%20T-Cell%20Responses%20in%20Individuals%20With%20Previously%20Treated%20Extrapulmonary%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%20T.%22%2C%22lastName%22%3A%22Fiske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20H.%22%2C%22lastName%22%3A%22Nochowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%20M.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louise%22%2C%22lastName%22%3A%22Barnett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Warren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amondrea%22%2C%22lastName%22%3A%22Blackman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20Roberto%22%2C%22lastName%22%3A%22Lapa%20E%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Spyros%20A.%22%2C%22lastName%22%3A%22Kalams%22%7D%5D%2C%22abstractNote%22%3A%22Extrapulmonary%20TB%20%28EPTB%29%20occurs%20with%20increased%20frequency%20in%20persons%20with%20underlying%20immunodeficiency.%20Even%20after%20recovery%20from%20acute%20illness%2C%20differences%20in%20immune%20phenotype%20and%20activation%20persist.%20Studies%20defining%20characteristics%20of%20immune%20responses%20after%20recovery%20from%20extrapulmonary%20TB%20may%20provide%20insights%20into%20factors%20that%20increase%20TB%20risk.%20We%20performed%20two%20case-control%20studies%20%28in%20the%20United%20States%20and%20Brazil%29%20among%20HIV-seronegative%20adults%20with%20previous%20EPTB%20%28n%20%3D%209%3B%2025%29%2C%20previous%20pulmonary%20TB%20%28n%20%3D%207%3B%2025%29%2C%20latent%20M.%20tuberculosis%20%28Mtb%29%20infection%20%28n%20%3D%2011%3B%2025%29%2C%20and%20uninfected%20TB%20contacts%20%28n%20%3D%2010%3B%2025%29.%20We%20assessed%20the%20frequency%20of%20dual%20CD4%2B%20interferon-%5Cu03b3%20and%20tumor%20necrosis%20factor-%5Cu03b1%20responses%20after%20stimulation%20with%20overlapping%20Mtb%20peptides%20from%20ESAT-6%20or%20CFP-10%2C%20or%20gamma-irradiated%20Mtb%20H37Rv%2C%20proliferative%20responses%20to%20Mtb%20antigens%2C%20T-regulatory%20cell%20%28Treg%29%20frequency%20and%20phenotype.%20In%20both%20study%20populations%2C%20individuals%20with%20prior%20EPTB%20had%20the%20highest%20frequency%20of%20intracellular%20cytokine-producing%20cells%20in%20response%20to%20Mtb%20antigens%20%28p%20%3C%200.05%3B%20p%20%3C.0001%29.%20Persons%20with%20prior%20EPTB%20in%20Brazil%20had%20the%20highest%20levels%20of%20CD4%20proliferation%20to%20Mtb%20antigens%20%28p%20%3C%200.0001%29%2C%20and%20the%20highest%20expression%20of%20CD39%20on%20Tregs%20%28p%20%3C%200.0001%29.%20Individuals%20with%20treated%20EPTB%20maintained%20high%20frequencies%20of%20Mtb-specific%20memory%20responses%20and%20active%20Treg%20cells%2C%20suggesting%20that%20susceptibility%20to%20EPTB%20occurs%20despite%20the%20ability%20to%20develop%20and%20maintain%20enhanced%20adaptive%20immune%20responses.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.605338%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A05%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22AKVZ9WPF%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barreto-Duarte%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBarreto-Duarte%20B%2C%20Sterling%20TR%2C%20Fiske%20CT%2C%20Almeida%20A%2C%20Nochowicz%20CH%2C%20Smith%20RM%2C%20et%20al.%20Increased%20Frequency%20of%20Memory%20CD4%2B%20T-Cell%20Responses%20in%20Individuals%20With%20Previously%20Treated%20Extrapulmonary%20Tuberculosis.%20Front%20Immunol.%202020%3B11%3A605338.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DAKVZ9WPF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20Frequency%20of%20Memory%20CD4%2B%20T-Cell%20Responses%20in%20Individuals%20With%20Previously%20Treated%20Extrapulmonary%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%20T.%22%2C%22lastName%22%3A%22Fiske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20H.%22%2C%22lastName%22%3A%22Nochowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%20M.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louise%22%2C%22lastName%22%3A%22Barnett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Warren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amondrea%22%2C%22lastName%22%3A%22Blackman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20Roberto%22%2C%22lastName%22%3A%22Lapa%20E%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Spyros%20A.%22%2C%22lastName%22%3A%22Kalams%22%7D%5D%2C%22abstractNote%22%3A%22Extrapulmonary%20TB%20%28EPTB%29%20occurs%20with%20increased%20frequency%20in%20persons%20with%20underlying%20immunodeficiency.%20Even%20after%20recovery%20from%20acute%20illness%2C%20differences%20in%20immune%20phenotype%20and%20activation%20persist.%20Studies%20defining%20characteristics%20of%20immune%20responses%20after%20recovery%20from%20extrapulmonary%20TB%20may%20provide%20insights%20into%20factors%20that%20increase%20TB%20risk.%20We%20performed%20two%20case-control%20studies%20%28in%20the%20United%20States%20and%20Brazil%29%20among%20HIV-seronegative%20adults%20with%20previous%20EPTB%20%28n%20%3D%209%3B%2025%29%2C%20previous%20pulmonary%20TB%20%28n%20%3D%207%3B%2025%29%2C%20latent%20M.%20tuberculosis%20%28Mtb%29%20infection%20%28n%20%3D%2011%3B%2025%29%2C%20and%20uninfected%20TB%20contacts%20%28n%20%3D%2010%3B%2025%29.%20We%20assessed%20the%20frequency%20of%20dual%20CD4%2B%20interferon-%5Cu03b3%20and%20tumor%20necrosis%20factor-%5Cu03b1%20responses%20after%20stimulation%20with%20overlapping%20Mtb%20peptides%20from%20ESAT-6%20or%20CFP-10%2C%20or%20gamma-irradiated%20Mtb%20H37Rv%2C%20proliferative%20responses%20to%20Mtb%20antigens%2C%20T-regulatory%20cell%20%28Treg%29%20frequency%20and%20phenotype.%20In%20both%20study%20populations%2C%20individuals%20with%20prior%20EPTB%20had%20the%20highest%20frequency%20of%20intracellular%20cytokine-producing%20cells%20in%20response%20to%20Mtb%20antigens%20%28p%20%3C%200.05%3B%20p%20%3C.0001%29.%20Persons%20with%20prior%20EPTB%20in%20Brazil%20had%20the%20highest%20levels%20of%20CD4%20proliferation%20to%20Mtb%20antigens%20%28p%20%3C%200.0001%29%2C%20and%20the%20highest%20expression%20of%20CD39%20on%20Tregs%20%28p%20%3C%200.0001%29.%20Individuals%20with%20treated%20EPTB%20maintained%20high%20frequencies%20of%20Mtb-specific%20memory%20responses%20and%20active%20Treg%20cells%2C%20suggesting%20that%20susceptibility%20to%20EPTB%20occurs%20despite%20the%20ability%20to%20develop%20and%20maintain%20enhanced%20adaptive%20immune%20responses.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.605338%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A04%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22CV4Z4X6M%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Demitto%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDemitto%20FO%2C%20Ara%26%23xFA%3Bjo-Pereira%20M%2C%20Schmaltz%20CA%2C%20Sant%26%23x2019%3BAnna%20FM%2C%20Arriaga%20MB%2C%20Andrade%20BB%2C%20et%20al.%20Impact%20of%20Persistent%20Anemia%20on%20Systemic%20Inflammation%20and%20Tuberculosis%20Outcomes%20in%20Persons%20Living%20With%20HIV.%20Front%20Immunol.%202020%3B11%3A588405.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DCV4Z4X6M%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20Persistent%20Anemia%20on%20Systemic%20Inflammation%20and%20Tuberculosis%20Outcomes%20in%20Persons%20Living%20With%20HIV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%20O.%22%2C%22lastName%22%3A%22Demitto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Ara%5Cu00fajo-Pereira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolina%20A.%22%2C%22lastName%22%3A%22Schmaltz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fl%5Cu00e1via%20M.%22%2C%22lastName%22%3A%22Sant%27Anna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20C.%22%2C%22lastName%22%3A%22Rolla%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20associated%20with%20systemic%20inflammation%20and%20anemia%2C%20which%20are%20aggravated%20in%20persons%20living%20with%20HIV%20%28PLWH%29.%20Here%2C%20we%20characterized%20the%20dynamics%20of%20hemoglobin%20levels%20in%20PLWH%20coinfected%20with%20TB%20undergoing%20antitubercular%20therapy%20%28ATT%29.%20We%20also%20examined%20the%20relationships%20between%20anemia%20and%20systemic%20inflammatory%20disturbance%20as%20well%20as%20the%20association%20between%20persistent%20anemia%20and%20unfavorable%20clinical%20outcomes.%20Data%20on%20several%20blood%20biochemical%20parameters%20and%20on%20blood%20cell%20counts%20were%20retrospectively%20analyzed%20in%20a%20cohort%20of%20256%20TB%5C%2FHIV%20patients%20from%20Brazil%20during%20180%20days%20of%20ATT.%20Multidimensional%20statistical%20analyses%20were%20employed%20to%20profile%20systemic%20inflammation%20of%20patients%20stratified%20by%20anemia%20status%20%28hemoglobin%20levels%20%3C12%20g%5C%2FdL%20for%20female%20and%20%3C13.5%20g%5C%2FdL%20for%20male%20individuals%29%20prior%20to%20treatment%20and%20to%20perform%20prediction%20of%20unfavorable%20outcomes%2C%20such%20as%20treatment%20failure%2C%20loss%20to%20follow%20up%20and%20death.%20We%20found%20that%20101%20%2863.63%25%29%20of%20patients%20with%20anemia%20at%20pre-ATT%20persisted%20with%20such%20condition%20until%20day%20180.%20Such%20individuals%20exhibited%20heightened%20degree%20of%20inflammatory%20perturbation%20%28DIP%29%2C%20which%20in%20turn%20was%20inversely%20correlated%20with%20hemoglobin%20levels.%20Recovery%20from%20anemia%20was%20associated%20with%20increased%20pre-ATT%20albumin%20levels%20whereas%20persistent%20anemia%20was%20related%20to%20higher%20total%20protein%20levels%20in%20serum.%20Multivariable%20regression%20analysis%20revealed%20that%20lower%20baseline%20hemoglobin%20levels%20was%20the%20major%20determinant%20of%20the%20unfavorable%20outcomes.%20Our%20findings%20demonstrate%20that%20persistent%20anemia%20in%20PLWH%20during%20the%20course%20of%20ATT%20is%20closely%20related%20with%20chronic%20inflammatory%20perturbation.%20Early%20intervention%20to%20promote%20recovery%20from%20anemia%20may%20improve%20ATT%20outcomes.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.588405%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A03%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22YY72BJV9%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Musay%5Cu00f3n-Oblitas%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMusay%26%23xF3%3Bn-Oblitas%20FY%2C%20C%26%23xE1%3Brcamo%20CP%2C%20Gimbel%20S%2C%20Zarate%20JIE%2C%20Espinoza%20ABG.%20Validation%20of%20a%20counseling%20guide%20for%20adherence%20to%20antiretroviral%20therapy%20using%20implementation%20science.%20Rev%20Lat%20Am%20Enfermagem.%202020%3B28%3Ae3228.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DYY72BJV9%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Validation%20of%20a%20counseling%20guide%20for%20adherence%20to%20antiretroviral%20therapy%20using%20implementation%20science%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Flor%20Yesenia%22%2C%22lastName%22%3A%22Musay%5Cu00f3n-Oblitas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cesar%20Paul%22%2C%22lastName%22%3A%22C%5Cu00e1rcamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Gimbel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Ignacio%20Echevarria%22%2C%22lastName%22%3A%22Zarate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Beatriz%20Gra%5Cu00f1a%22%2C%22lastName%22%3A%22Espinoza%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20to%20determine%20the%20contents%20that%20must%20be%20included%20in%20the%20usual%20counseling%20to%20improve%20the%20adherence%20to%20antiretroviral%20therapy%20%28ART%29%20of%20HIV%20patients%2C%20according%20to%20their%20different%20levels%20of%20alcohol%20consumption%2C%20and%20to%20determine%20the%20validity%20of%20the%20Counseling%20Guide%20in%20improving%20the%20adherence%20to%20ART%20in%20patients%20who%20consume%20alcohol%20using%20Implementation%20Science.%5CnMETHOD%3A%20this%20is%20an%20observational%20study%20with%20formative%20and%20validation%20phases.%20The%20formative%20phase%20defined%20the%20content%2C%20approach%20and%20structure%20of%20the%20counseling.%20Validation%20included%20focus%20groups%20with%20patients%20and%20nurses%2C%20trial%20process%20by%20an%20expert%20and%20a%20pilot%20test.%20The%20criteria%20evaluated%20based%20on%20Implementation%20Science%20were%3A%20intervention%20source%2C%20evidence%20strength%20and%20quality%2C%20relative%20advantage%2C%20and%20complexity.%20The%20following%20criteria%20were%20also%20evaluated%3A%20usefulness%2C%20practicality%2C%20acceptability%2C%20sustainability%2C%20effectiveness%3B%20content%20consistency%20and%20congruence%3B%20procedural%20compliance%20and%20difficulties%2C%20and%20time%20spent%20in%20counseling.%5CnRESULTS%3A%20the%20strength%20of%20evidence%20of%20the%20counseling%20is%20High-IIA%2C%20with%20strong%20level%20of%20recommendation%20and%20presenting%20usefulness%2C%20practicality%2C%20acceptability%2C%20sustainability%20and%20effectiveness.%20Eight%20in%2011%20experts%20argued%20that%20the%20Guide%20is%20clear%2C%20consistent%20and%20congruent.%20Initial%20counseling%20takes%20around%2024%20minutes%3B%20and%20follow-up%20counseling%2C%2021.%20The%20instruments%20of%20the%20Guide%20present%20reliability%20levels%20between%20good%20and%20high%20%280.65%20%5Cu2265%20alpha%20%5Cu2264%200.92%29.%5CnCONCLUSION%3A%20the%20Counseling%20Guide%20is%20valid%20to%20improve%20the%20adherence%20to%20antiretroviral%20therapy%20in%20patients%20who%20consume%20alcohol.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%2C%20por%2C%20spa%22%2C%22DOI%22%3A%2210.1590%5C%2F1518-8345.3117.3228%22%2C%22ISSN%22%3A%221518-8345%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222023-06-16T16%3A02%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22X8FUEHA2%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EParcesepe%20AM%2C%20Lancaster%20K%2C%20Edelman%20EJ%2C%20DeBoni%20R%2C%20Ross%20J%2C%20Atwoli%20L%2C%20et%20al.%20Substance%20use%20service%20availability%20in%20HIV%20treatment%20programs%3A%20Data%20from%20the%20global%20IeDEA%20consortium%2C%202014-2015%20and%202017.%20PLoS%20ONE.%202020%3B15%288%29%3Ae0237772.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DX8FUEHA2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Substance%20use%20service%20availability%20in%20HIV%20treatment%20programs%3A%20Data%20from%20the%20global%20IeDEA%20consortium%2C%202014-2015%20and%202017%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Jennifer%22%2C%22lastName%22%3A%22Edelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22DeBoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukoye%22%2C%22lastName%22%3A%22Atwoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judica%5Cu00ebl%22%2C%22lastName%22%3A%22Tine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Substance%20use%20is%20common%20among%20people%20living%20with%20HIV%20and%20has%20been%20associated%20with%20suboptimal%20HIV%20treatment%20outcomes.%20Integrating%20substance%20use%20services%20into%20HIV%20care%20is%20a%20promising%20strategy%20to%20improve%20patient%20outcomes.%5CnMETHODS%3A%20We%20report%20on%20substance%20use%20education%2C%20screening%2C%20and%20referral%20practices%20from%20two%20surveys%20of%20HIV%20care%20and%20treatment%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20HIV%20care%20and%20treatment%20sites%20participating%20in%20IeDEA%20are%20primarily%20public-sector%20health%20facilities%20and%20include%20both%20academic%20and%20community-based%20hospitals%20and%20health%20facilities.%20A%20total%20of%20286%20sites%20in%2045%20countries%20participated%20in%20the%202014-2015%20survey%20and%20237%20sites%20in%2044%20countries%20participated%20in%20the%202017%20survey.%20We%20compared%20changes%20over%20time%20for%20147%20sites%20that%20participated%20in%20both%20surveys.%5CnRESULTS%3A%20In%202014-2015%2C%20most%20sites%20%2875%25%29%20reported%20providing%20substance%20use-related%20education%20on-site%20%28i.e.%2C%20at%20the%20HIV%20clinic%20or%20the%20same%20health%20facility%29.%20Approximately%20half%20reported%20on-site%20screening%20for%20substance%20use%20%2852%25%29%20or%20referrals%20for%20substance%20use%20treatment%20%2851%25%29.%20In%202017%2C%20the%20proportion%20of%20sites%20providing%20on-site%20substance%20use-related%20education%2C%20screening%2C%20or%20referrals%20increased%20by%209%25%2C%2016%25%2C%20and%208%25%2C%20respectively.%20In%202017%2C%20on-site%20substance%20use%20screening%20and%20referral%20were%20most%20commonly%20reported%20at%20sites%20serving%20only%20adults%20%28compared%20to%20only%20children%5C%2Fadolescents%20or%20adults%20and%20children%5C%2Fadolescents%3B%20screening%3A%2086%25%2C%2037%25%2C%20and%2059%25%2C%20respectively%3B%20referral%3A%2076%25%2C%2047%25%2C%20and%2046%25%2C%20respectively%29%20and%20at%20sites%20in%20high-income%20countries%20%28compared%20to%20upper%20middle%20income%2C%20lower%20middle%20income%20or%20low-income%20countries%3B%20screening%3A%2089%25%2C%2076%25%2C%2068%25%2C%20and%2045%25%2C%20respectively%3B%20referral%3A%2082%25%2C%2071%25%2C%2057%25%2C%20and%2034%25%2C%20respectively%29.%5CnCONCLUSION%3A%20Although%20there%20have%20been%20increases%20in%20the%20proportion%20of%20sites%20reporting%20substance%20use%20education%2C%20screening%2C%20and%20referral%20services%20across%20IeDEA%20sites%2C%20gaps%20persist%20in%20the%20integration%20of%20substance%20use%20services%20into%20HIV%20care%2C%20particularly%20in%20relation%20to%20screening%20and%20referral%20practices%2C%20with%20reduced%20availability%20for%20children%5C%2Fadolescents%20and%20those%20receiving%20care%20within%20resource-constrained%20settings.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0237772%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A12%3A55Z%22%7D%7D%2C%7B%22key%22%3A%2276J2KQJJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Belaunzaran-Zamudio%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBelaunzaran-Zamudio%20PF%2C%20Caro-Vega%20Y%2C%20Giganti%20MJ%2C%20Castilho%20JL%2C%20Crabtree-Ramirez%20BE%2C%20Shepherd%20BE%2C%20et%20al.%20Frequency%20of%20non-communicable%20diseases%20in%20people%2050%20years%20of%20age%20and%20older%20receiving%20HIV%20care%20in%20Latin%20America.%20PLoS%20ONE.%202020%3B15%286%29%3Ae0233965.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D76J2KQJJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Frequency%20of%20non-communicable%20diseases%20in%20people%2050%20years%20of%20age%20and%20older%20receiving%20HIV%20care%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20C.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20American%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20A%20growing%20population%20of%20older%20adults%20with%20HIV%20will%20increase%20demands%20on%20HIV-related%20healthcare.%20Nearly%20a%20quarter%20of%20people%20receiving%20care%20for%20HIV%20in%20Latin%20America%20are%20currently%2050%20years%20or%20older%2C%20yet%20little%20is%20known%20about%20the%20frequency%20of%20comorbidities%20in%20this%20population.%20We%20estimated%20the%20prevalence%20and%20incidence%20of%20non-communicable%20diseases%20%28NCDs%29%20among%20people%2050%20years%20of%20age%20or%20older%20%28%5Cu226550yo%29%20receiving%20HIV%20care%20during%202000-2015%20in%20six%20centers%20affiliated%20with%20the%20Caribbean%2C%20Central%20and%20South%20American%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29.%5CnMETHODS%3A%20We%20estimated%20the%20annual%20prevalence%2C%20and%20overall%20prevalence%20and%20incidence%20of%20cardiovascular%20diseases%2C%20diabetes%2C%20hypertension%2C%20dyslipidemia%2C%20psychiatric%20disorders%2C%20chronic%20liver%20and%20renal%20diseases%2C%20and%20non-AIDS-defining%20cancers%2C%20and%20multimorbidity%20%28more%20than%20one%20NCD%29%20of%20people%20%5Cu226550yo%20receiving%20care%20for%20HIV.%20Analyses%20were%20performed%20according%20to%20age%20at%20enrollment%20into%20HIV%20care%20%28%3C50yo%20and%20%5Cu226550yo%29.%5CnRESULTS%3A%20We%20included%203%2C415%20patients%20%5Cu226550yo%2C%20of%20whom%201%2C487%2843%25%29%20were%20enrolled%20at%20age%20%5Cu226550%20years.%20The%20annual%20prevalence%20of%20NCDs%20increased%20from%2032%25%20to%2068%25%20and%20multimorbidity%20from%2030%25%20to%2040%25%20during%202000-2015.%20At%20the%20last%20registered%20visit%2C%2053%25%20of%20patients%20enrolled%20%3C50yo%20and%2050%25%20of%20those%20enrolled%20%5Cu226550yo%20had%20at%20least%20one%20NCD.%20Most%20common%20NCDs%20at%20the%20last%20visit%20in%20each%20age-group%20at%20enrollment%20were%20dyslipidemia%20%2836%25%20in%20%3C50yo%20and%2028%25%20in%20%5Cu226550yo%29%2C%20hypertension%20%2817%25%20and%2018%25%29%2C%20psychiatric%20disorders%20%2815%25%20and%2010%25%29%2C%20and%20diabetes%20%2811%25%20and%2012%25%29.%5CnCONCLUSIONS%3A%20The%20prevalence%20of%20NCDs%20and%20multimorbidity%20in%20people%20%5Cu226550%20years%20receiving%20care%20for%20HIV%20in%20CCASAnet%20centers%20in%20Latin%20America%20increased%20substantially%20in%20the%20last%2015%20years.%20Our%20results%20make%20evident%20the%20need%20of%20planning%20for%20provision%20of%20complex%2C%20primary%20care%20for%20aging%20adults%20living%20with%20HIV.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0233965%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A12%3A08Z%22%7D%7D%5D%7D
1.
Giganti MJ, Shepherd BE. Multiple-Imputation Variance Estimation in Studies With Missing or Misclassified Inclusion Criteria. Am J Epidemiol. 2020 Dec 1;189(12):1628–32. Cite
1.
Reichmuth ML, Hömke R, Zürcher K, Sander P, Avihingsanon A, Collantes J, et al. Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e00513-20. Cite
1.
Rebeiro PF, Duda SN, Wools-Kaloustian KK, Nash D, Althoff KN, International epidemiology Databases to Evaluate AIDS (IeDEA). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. J Int AIDS Soc. 2020 Oct;23(10):e25627. Cite
1.
Desmonde S, Neilan AM, Musick B, Patten G, Chokephaibulkit K, Edmonds A, et al. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. J Int AIDS Soc. 2020 Oct;23(10):e25617. Cite
1.
Loiseau C, Brites D, Reinhard M, Zürcher K, Borrell S, Ballif M, et al. HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00782-20. Cite
1.
Shepherd BE, Shaw PA. Errors in multiple variables in human immunodeficiency virus (HIV) cohort and electronic health record data: statistical challenges and opportunities. Stat Commun Infect Dis. 2020 Sep 1;12(Suppl1):20190015. Cite
1.
Duda SN, Musick BS, Davies MA, Sohn AH, Ledergerber B, Wools-Kaloustian K, et al. The IeDEA Data Exchange Standard: a common data model for global HIV cohort collaboration [Internet]. medRxiv; 2020 [cited 2023 Jun 16]. Available from: https://www.medrxiv.org/content/10.1101/2020.07.22.20159921v1 Cite
1.
Oliveira-de-Souza D, Vinhaes CL, Arriaga MB, Kumar NP, Queiroz ATL, Fukutani KF, et al. Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis. Sci Rep. 2020 Jul 9;10(1):11358. Cite
1.
Boettiger DC, Escuder MM, Law MG, Veloso V, Souza RA, Ikeda MLR, et al. Cardiovascular disease among people living with HIV in Brazil. Trop Med Int Health. 2020 Jul;25(7):886–96. Cite
1.
Patten G, Puthanakit T, McGowan CC, Wools-Kaloustian K, Hazra R, Pinto JA, et al. Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. J Int AIDS Soc. 2020 Jul;23(7):e25580. Cite
1.
Koenig SP, Kim A, Shepherd BE, Cesar C, Veloso V, Cortes CP, et al. Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America. Clin Infect Dis. 2020 Jun 24;71(1):215–7. Cite
1.
Rebeiro PF, Cohen MJ, Ewing HM, Figueiredo MC, Peetluk LS, Andrade KB, et al. Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health. 2020 Jun 9;20(1):897. Cite
1.
Belaunzarán-Zamudio PF, Caro-Vega YN, Shepherd BE, Rebeiro PF, Crabtree-Ramírez BE, Cortes CP, et al. The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America. Am J Epidemiol. 2020 Jun 1;189(6):564–72. Cite
1.
Penn-Nicholson A, Mbandi SK, Thompson E, Mendelsohn SC, Suliman S, Chegou NN, et al. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Sci Rep. 2020 May 25;10(1):8629. Cite
1.
Jesson J, Desmonde S, Yiannoutsos CT, Patten G, Malateste K, Duda SN, et al. Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Res Notes. 2020 May 24;13(1):249. Cite
1.
Peetluk LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, Andrade BB, Durovni B, et al. Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. J Infect Dis. 2020 Apr 7;221(9):1416–24. Cite
1.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration. Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. J Int AIDS Soc. 2020 Apr;23(4):e25477. Cite
1.
Lotspeich SC, Giganti MJ, Maia M, Vieira R, Machado DM, Succi RC, et al. Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology. J Clin Transl Sci. 2020 Apr;4(2):125–32. Cite
1.
Cubillos-Angulo JM, Arriaga MB, Melo MGM, Silva EC, Alvarado-Arnez LE, de Almeida AS, et al. Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil. Int J Infect Dis. 2020 Mar;92:21–8. Cite
1.
Cubillos-Angulo JM, Arriaga MB, Melo MGM, Silva EC, Alvarado-Arnez LE, de Almeida AS, et al. Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil. Int J Infect Dis. 2020 Mar;92:21–8. Cite
1.
Humphrey JM, Mpofu P, Pettit AC, Musick B, Carter EJ, Messou E, et al. Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infect Dis. 2020 Jan;7(1):ofaa006. Cite
1.
Giganti MJ, Shaw PA, Chen G, Bebawy SS, Turner MM, Sterling TR, et al. Accounting for dependent errors in predictors and time-to-event outcomes using electronic health records, validation samples and multiple imputation. Ann Appl Stat [Internet]. 2020 [cited 2020 Sep 15];14(2):1045–61. Available from: https://projecteuclid.org/euclid.aoas/1593449337 Cite
1.
Rohner E, Bütikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, et al. Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer. 2020 01;146(3):601–9. Cite
1.
IeDEA and COHERE in EuroCoord Cohort Collaboration. All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas. AIDS. 2020 01;34(2):277–89. Cite
1.
Safe IP, Amaral EP, Araújo-Pereira M, Lacerda MVG, Printes VS, Souza AB, et al. Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial. Front Immunol. 2020;11:602589. Cite
1.
Barreto-Duarte B, Sterling TR, Fiske CT, Almeida A, Nochowicz CH, Smith RM, et al. Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Front Immunol. 2020;11:605338. Cite
1.
Barreto-Duarte B, Sterling TR, Fiske CT, Almeida A, Nochowicz CH, Smith RM, et al. Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Front Immunol. 2020;11:605338. Cite
1.
Demitto FO, Araújo-Pereira M, Schmaltz CA, Sant’Anna FM, Arriaga MB, Andrade BB, et al. Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Front Immunol. 2020;11:588405. Cite
1.
Musayón-Oblitas FY, Cárcamo CP, Gimbel S, Zarate JIE, Espinoza ABG. Validation of a counseling guide for adherence to antiretroviral therapy using implementation science. Rev Lat Am Enfermagem. 2020;28:e3228. Cite
1.
Parcesepe AM, Lancaster K, Edelman EJ, DeBoni R, Ross J, Atwoli L, et al. Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE. 2020;15(8):e0237772. Cite
1.
Belaunzaran-Zamudio PF, Caro-Vega Y, Giganti MJ, Castilho JL, Crabtree-Ramirez BE, Shepherd BE, et al. Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America. PLoS ONE. 2020;15(6):e0233965. Cite
2019
76770
IP6F4TRX
2019
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-bf8678be45549bf5619a95c22ea79e01%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22E5J4VXQT%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Giganti%20et%20al.%22%2C%22parsedDate%22%3A%222019-12-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiganti%20MJ%2C%20Shepherd%20BE%2C%20Caro-Vega%20Y%2C%20Luz%20PM%2C%20Rebeiro%20PF%2C%20Maia%20M%2C%20et%20al.%20The%20impact%20of%20data%20quality%20and%20source%20data%20verification%20on%20epidemiologic%20inference%3A%20a%20practical%20application%20using%20HIV%20observational%20data.%20BMC%20Public%20Health.%202019%20Dec%2030%3B19%281%29%3A1748.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DE5J4VXQT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20impact%20of%20data%20quality%20and%20source%20data%20verification%20on%20epidemiologic%20inference%3A%20a%20practical%20application%20using%20HIV%20observational%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelle%22%2C%22lastName%22%3A%22Maia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaetane%22%2C%22lastName%22%3A%22Julmiste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Data%20audits%20are%20often%20evaluated%20soon%20after%20completion%2C%20even%20though%20the%20identification%20of%20systematic%20issues%20may%20lead%20to%20additional%20data%20quality%20improvements%20in%20the%20future.%20In%20this%20study%2C%20we%20assess%20the%20impact%20of%20the%20entire%20data%20audit%20process%20on%20subsequent%20statistical%20analyses.%5CnMETHODS%3A%20We%20conducted%20on-site%20audits%20of%20datasets%20from%20nine%20international%20HIV%20care%20sites.%20Error%20rates%20were%20quantified%20for%20key%20demographic%20and%20clinical%20variables%20among%20a%20subset%20of%20records%20randomly%20selected%20for%20auditing.%20Based%20on%20audit%20results%2C%20some%20sites%20were%20tasked%20with%20targeted%20validation%20of%20high-error-rate%20variables%20resulting%20in%20a%20post-audit%20dataset.%20We%20estimated%20the%20times%20from%20antiretroviral%20therapy%20initiation%20until%20death%20and%20first%20AIDS-defining%20event%20using%20the%20pre-audit%20data%2C%20the%20audit%20data%2C%20and%20the%20post-audit%20data.%5CnRESULTS%3A%20The%20overall%20discrepancy%20rate%20between%20pre-audit%20and%20audit%20data%20%28n%5Cu2009%3D%5Cu2009250%29%20across%20all%20audited%20variables%20was%2017.1%25.%20The%20estimated%20probability%20of%20mortality%20and%20an%20AIDS-defining%20event%20over%20time%20was%20higher%20in%20the%20audited%20data%20relative%20to%20the%20pre-audit%20data.%20Among%20patients%20represented%20in%20both%20the%20post-audit%20and%20pre-audit%20cohorts%20%28n%5Cu2009%3D%5Cu200918%2C999%29%2C%20AIDS%20and%20mortality%20estimates%20also%20were%20higher%20in%20the%20post-audit%20data.%5CnCONCLUSION%3A%20Though%20some%20changes%20may%20have%20occurred%20independently%2C%20our%20findings%20suggest%20that%20improved%20data%20quality%20following%20the%20audit%20may%20impact%20epidemiological%20inferences.%22%2C%22date%22%3A%22Dec%2030%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-019-8105-2%22%2C%22ISSN%22%3A%221471-2458%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A10%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22NRNNS2GX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Silveira-Mattos%20et%20al.%22%2C%22parsedDate%22%3A%222019-10-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESilveira-Mattos%20PS%2C%20Barreto-Duarte%20B%2C%20Vasconcelos%20B%2C%20Fukutani%20KF%2C%20Vinhaes%20CL%2C%20Oliveira-de-Souza%20D%2C%20et%20al.%20Differential%20expression%20of%20activation%20markers%20by%20Mycobacterium%20tuberculosis-specific%20CD4%2B%20T-cell%20distinguishes%20extrapulmonary%20from%20pulmonary%20tuberculosis%20and%20latent%20infection.%20Clin%20Infect%20Dis.%202019%20Oct%2030%3B%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DNRNNS2GX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Differential%20expression%20of%20activation%20markers%20by%20Mycobacterium%20tuberculosis-specific%20CD4%2B%20T-cell%20distinguishes%20extrapulmonary%20from%20pulmonary%20tuberculosis%20and%20latent%20infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulo%20S.%22%2C%22lastName%22%3A%22Silveira-Mattos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Barreto-Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Vasconcelos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deivide%22%2C%22lastName%22%3A%22Oliveira-de-Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20C.%22%2C%22lastName%22%3A%22Ibegbu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20C.%22%2C%22lastName%22%3A%22Figueiredo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jyothi%22%2C%22lastName%22%3A%22Rengarajan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Diagnosis%20of%20active%20tuberculosis%20%28ATB%29%20currently%20relies%20on%20detection%20of%20M.%20tuberculosis%20%28Mtb%29.%20Identifying%20patients%20with%20extrapulmonary%20TB%20%28EPTB%29%20remains%20challenging%20because%20microbiological%20confirmation%20is%20often%20not%20possible.%20Highly%20accurate%20blood-based%20tests%20could%20improve%20diagnosis%20of%20both%20EPTB%20and%20pulmonary%20TB%20%28PTB%29%2C%20and%20timely%20initiation%20of%20anti-TB%20therapy.%5CnMETHODS%3A%20A%20case-control%20study%20was%20performed%20using%20discriminant%20analyses%20to%20validate%20an%20approach%20using%20Mtb-specific%20CD4%2BT-cell%20activation%20markers%20in%20blood%20to%20discriminate%20PTB%20and%20EPTB%20from%20latent%20TB%20infection%20%28LTBI%29%20as%20well%20as%20EPTB%20from%20PTB%20in%20270%20Brazilian%20individuals.%20We%20further%20tested%20the%20effect%20of%20HIV%20co-infection%20on%20diagnostic%20performance.%20Frequencies%20of%20IFN%5Cu03b3%2BCD4%2BT-cells%20expressing%20CD38%2C%20HLADR%2C%20and%5C%2For%20Ki67%20were%20assessed%20by%20flow%20cytometry.%5CnRESULTS%3A%20EPTB%20and%20PTB%20were%20associated%20with%20higher%20frequencies%20of%20CD4%2BT-cells%20expressing%20CD38%2C%20HLADR%20or%20Ki67%20compared%20to%20LTBI%20%28all%20p-values%20%3C%20.001%29.%20Moreover%2C%20frequencies%20of%20HLADR%2B%20%28p%3D%20.03%29%20or%20Ki67%2B%20%28p%3C%20.001%29%20cells%20accurately%20distinguished%20EPTB%20from%20PTB.%20HIV%20infection%20did%20not%20affect%20the%20capacity%20of%20these%20markers%20to%20distinguish%20ATB%20from%20LTBI%20or%20EPTB%20from%20PTB.%5CnCONCLUSION%3A%20Cell%20activation%20markers%20in%20Mtb-specific%20CD4%2BT-cells%20distinguished%20ATB%20from%20LTBI%2C%20and%20EPTB%20from%20PTB%2C%20regardless%20of%20HIV%20infection%20status.%20These%20parameters%20provide%20an%20attractive%20approach%20for%20developing%20blood-based%20diagnostic%20tests%20for%20both%20active%20and%20latent%20TB.%22%2C%22date%22%3A%22Oct%2030%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciz1070%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A08%3A26Z%22%7D%7D%2C%7B%22key%22%3A%2272GR3VZF%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%22%2C%22parsedDate%22%3A%222019-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECollaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration.%20Incidence%20of%20switching%20to%20second-line%20antiretroviral%20therapy%20and%20associated%20factors%20in%20children%20with%20HIV%3A%20an%20international%20cohort%20collaboration.%20Lancet%20HIV.%202019%20Feb%3B6%282%29%3Ae105%26%23x2013%3B15.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D72GR3VZF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Incidence%20of%20switching%20to%20second-line%20antiretroviral%20therapy%20and%20associated%20factors%20in%20children%20with%20HIV%3A%20an%20international%20cohort%20collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Estimates%20of%20incidence%20of%20switching%20to%20second-line%20antiretroviral%20therapy%20%28ART%29%20among%20children%20with%20HIV%20are%20necessary%20to%20inform%20the%20need%20for%20paediatric%20second-line%20formulations.%20We%20aimed%20to%20quantify%20the%20cumulative%20incidence%20of%20switching%20to%20second-line%20ART%20among%20children%20in%20an%20international%20cohort%20collaboration.%5CnMETHODS%3A%20In%20this%20international%20cohort%20collaboration%20study%2C%20we%20pooled%20individual%20patient-level%20data%20for%20children%20younger%20than%2018%20years%20who%20initiated%20ART%20%28two%20or%20more%20nucleoside%20reverse-transcriptase%20inhibitors%20%5BNRTI%5D%20plus%20a%20non-NRTI%20%5BNNRTI%5D%20or%20boosted%20protease%20inhibitor%29%20between%201993%20and%202015%20from%2012%20observational%20cohort%20networks%20in%20the%20Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration.%20Patients%20who%20were%20reported%20to%20be%20horizontally%20infected%20with%20HIV%20and%20those%20who%20were%20enrolled%20in%20trials%20of%20treatment%20monitoring%2C%20switching%2C%20or%20interruption%20strategies%20were%20excluded.%20Switch%20to%20second-line%20ART%20was%20defined%20as%20change%20of%20one%20or%20more%20NRTI%20plus%20either%20change%20in%20drug%20class%20%28NNRTI%20to%20protease%20inhibitor%20or%20vice%20versa%29%20or%20protease%20inhibitor%20change%2C%20change%20from%20single%20to%20dual%20protease%20inhibitor%2C%20or%20addition%20of%20a%20new%20drug%20class.%20We%20used%20cumulative%20incidence%20curves%20to%20assess%20time%20to%20switching%2C%20and%20multivariable%20proportional%20hazards%20models%20to%20explore%20patient-level%20and%20cohort-level%20factors%20associated%20with%20switching%2C%20with%20death%20and%20loss%20to%20follow-up%20as%20competing%20risks.%5CnFINDINGS%3A%20At%20the%20data%20cutoff%20of%20Sept%2016%2C%202015%2C%20182%5Cu2008747%20children%20with%20HIV%20were%20included%20in%20the%20CIPHER%20dataset%2C%20of%20whom%2093%5Cu2008351%20were%20eligible%2C%20with%2083%5Cu2008984%20%2890%5Cu00b70%25%29%20from%20sub-Saharan%20Africa.%20At%20ART%20initiation%2C%20the%20median%20patient%20age%20was%203%5Cu00b79%20years%20%28IQR%201%5Cu00b76-6%5Cu00b79%29%20and%2082%5Cu2008885%20%2888%5Cu00b78%25%29%20patients%20initiated%20NNRTI-based%20and%2010%20466%20%2811%5Cu00b72%25%29%20initiated%20protease%20inhibitor-based%20regimens.%20Median%20duration%20of%20follow-up%20after%20ART%20initiation%20was%2026%20months%20%28IQR%209-52%29.%203883%20%284%5Cu00b72%25%29%20patients%20switched%20to%20second-line%20ART%20after%20a%20median%20of%2035%20months%20%28IQR%2020-57%29%20of%20ART.%20The%20cumulative%20incidence%20of%20switching%20at%203%20years%20was%203%5Cu00b71%25%20%2895%25%20CI%203%5Cu00b70-3%5Cu00b72%29%2C%20but%20this%20estimate%20varied%20widely%20depending%20on%20the%20cohort%20monitoring%20strategy%2C%20from%206%5Cu00b78%25%20%286%5Cu00b75-7%5Cu00b72%29%20in%20settings%20with%20routine%20monitoring%20of%20CD4%20%28CD4%25%20or%20CD4%20count%29%20and%20viral%20load%20to%200%5Cu00b78%25%20%280%5Cu00b76-1%5Cu00b70%29%20in%20settings%20with%20clinical%20only%20monitoring.%20In%20multivariable%20analyses%2C%20patient-level%20factors%20associated%20with%20an%20increased%20likelihood%20of%20switching%20were%20male%20sex%2C%20older%20age%20at%20ART%20initiation%2C%20and%20initial%20NNRTI-based%20regimen%20%28p%3C0%5Cu00b70001%29.%20Cohort-level%20factors%20that%20increased%20the%20likelihood%20of%20switching%20were%20higher-income%20country%20%28p%3D0%5Cu00b70017%29%20and%20routine%20or%20targeted%20monitoring%20of%20CD4%20and%20viral%20load%20%28p%3C0%5Cu00b70001%29%2C%20which%20was%20associated%20with%20a%20166%25%20increase%20in%20likelihood%20of%20switching%20compared%20with%20CD4%20only%20monitoring%20%28subdistributional%20hazard%20ratio%202%5Cu00b766%2C%2095%25%20CI%202%5Cu00b722-3%5Cu00b719%29.%5CnINTERPRETATION%3A%20Our%20global%20paediatric%20analysis%20found%20wide%20variations%20in%20the%20incidence%20of%20switching%20to%20second-line%20ART%20across%20monitoring%20strategies.%20These%20findings%20suggest%20the%20scale-up%20of%20viral%20load%20monitoring%20would%20probably%20increase%20demand%20for%20paediatric%20second-line%20ART%20formulations.%5CnFUNDING%3A%20International%20AIDS%20Society-CIPHER.%22%2C%22date%22%3A%22Feb%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2818%2930319-9%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A05%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22EPAK82BX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Pettit%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPettit%20AC%2C%20Jenkins%20CA%2C%20Blevins%20Peratikos%20M%2C%20Yotebieng%20M%2C%20Diero%20L%2C%20Do%20CD%2C%20et%20al.%20Directly%20observed%20therapy%20and%20risk%20of%20unfavourable%20tuberculosis%20treatment%20outcomes%20among%20an%20international%20cohort%20of%20people%20living%20with%20HIV%20in%20low-%20and%20middle-income%20countries.%20J%20Int%20AIDS%20Soc.%202019%3B22%2812%29%3Ae25423.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DEPAK82BX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Directly%20observed%20therapy%20and%20risk%20of%20unfavourable%20tuberculosis%20treatment%20outcomes%20among%20an%20international%20cohort%20of%20people%20living%20with%20HIV%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20C.%22%2C%22lastName%22%3A%22Pettit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meridith%22%2C%22lastName%22%3A%22Blevins%20Peratikos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cuong%20D.%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Hawerlander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Identification%20of%20persons%20living%20with%20human%20immunodeficiency%20virus%20%28HIV%29-associated%20tuberculosis%20%28TB%29%20at%20increased%20risk%20for%20unfavourable%20TB%20outcomes%20would%20inform%20efforts%20to%20improve%20such%20outcomes.%20We%20sought%20to%20identify%20factors%20associated%20with%20a%20decreased%20risk%20of%20unfavourable%20TB%20treatment%20outcomes%20among%20people%20living%20with%20HIV-infection%20%28PLHIV%29%20in%20low-%20and%20middle-income%20countries%20%28LMIC%29%2C%20with%20a%20specific%20focus%20on%20directly%20observed%20therapy%20%28DOT%29%20compared%20with%20self-administered%20therapy%20%28SAT%29%20during%20the%20continuation%20phase%20of%20anti-TB%20therapy.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20cohort%20study%20among%20adults%20diagnosed%20with%20HIV-associated%20TB%20in%20Africa%2C%20Asia%20and%20the%20Americas%20from%202012%20to%202013%3B%20data%20were%20collected%20from%202012%20to%202016.%20Unfavourable%20TB%20treatment%20outcomes%20%28death%20during%20TB%20treatment%2C%20and%20TB%20treatment%20failure%20or%20recurrence%29%20were%20defined%20according%20to%20World%20Health%20Organization%20criteria.%20Receipt%20of%20DOT%20was%20obtained%20at%20the%20site%20level%20and%20defined%20as%20%5Cu22655%5Cu00a0days%20of%20DOT%20per%20week.%20The%20person%20administering%20DOT%20and%20treatment%20location%20varied%20by%20site.%20Lack%20of%20receipt%20of%20DOT%20was%20defined%20as%20SAT.%20Multivariable%20logistic%20regression%20estimated%20the%20adjusted%20odds%20of%20unfavourable%20TB%20treatment%20outcomes.%5CnRESULTS%3A%20Among%201862%20adults%20with%20HIV-associated%20TB%20included%2C%20252%20%2813.5%25%29%20had%20unfavourable%20TB%20outcomes%20%28226%20deaths%2C%2026%20recurrences%5C%2Ffailures%29.%20Overall%2C%201825%20%2898%25%29%20received%20DOT%20in%20the%20intensive%20phase%20and%201617%20%2887%25%29%20received%20DOT%20in%20the%20continuation%20phase.%20DOT%20in%20the%20continuation%20phase%20was%20not%20significantly%20associated%20with%20unfavourable%20TB%20outcomes%20%28aOR%201.43%2C%2095%25%20CI%200.86%20to%202.38%29%20compared%20to%20SAT.%20Body%20mass%20index%20%28BMI%29%20change%20during%20anti-TB%20treatment%20%28per%202%20units%20increase%2C%20aOR%200.74%2C%2095%25%20CI%200.68%20to%200.82%29%20and%20CD4%2B%20count%20at%20TB%20diagnosis%20%28200%20vs.%2050%20%5Cu00a0cells%5C%2F%5Cu00b5L%2C%20aOR%200.54%2C%2095%25%20CI%200.39%20to%200.73%29%20were%20both%20independently%20associated%20with%20decreased%20odds%20of%20unfavourable%20TB%20treatment%20outcomes.%5CnCONCLUSIONS%3A%20In%20this%20large%2C%20international%20cohort%20of%20people%20living%20with%20HIV-associated%20TB%20in%20LMIC%20who%20received%20intensive%20phase%20DOT%2C%20DOT%20during%20the%20continuation%20phase%20of%20anti-TB%20therapy%20was%20not%20associated%20with%20a%20decreased%20odds%20of%20unfavourable%20TB%20treatment%20outcomes%20compared%20to%20SAT.%20Randomized%20trials%20evaluating%20the%20effect%20of%20continuation-phase%20DOT%20on%20TB%20outcomes%20among%20PLHIV%20are%20needed.%22%2C%22date%22%3A%2212%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25423%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A10%3A05Z%22%7D%7D%2C%7B%22key%22%3A%228DCVCGJD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Crabtree-Ram%5Cu00edrez%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree-Ram%26%23xED%3Brez%20BE%2C%20Caro-Vega%20Y%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Shepherd%20BE%2C%20Rebeiro%20PF%2C%20Veloso%20V%2C%20et%20al.%20Temporal%20changes%20in%20ART%20initiation%20in%20adults%20with%20high%20CD4%20counts%20in%20Latin%20America%3A%20a%20cohort%20study.%20J%20Int%20AIDS%20Soc.%202019%3B22%2812%29%3Ae25413.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D8DCVCGJD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20changes%20in%20ART%20initiation%20in%20adults%20with%20high%20CD4%20counts%20in%20Latin%20America%3A%20a%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%2C%20South%20America%20Network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%202013%2C%20the%20World%20Health%20Organization%20%28WHO%29%20recommended%20initiating%20combination%20ART%20%28cART%29%20in%20all%20adults%20with%20HIV%20and%20CD4%2B%20lymphocyte%20counts%20%28CD4%29%20%3C500%5Cu00a0cells%5C%2Fmm3%20.%20In%202015%2C%20this%20was%20updated%20to%20recommend%20cART%20initiation%20in%20all%20patients%20with%20HIV%2C%20regardless%20of%20CD4%20count.%20Implementation%20of%20these%20guidelines%20in%20real-world%20settings%20has%20not%20been%20evaluated%20in%20Latin%20America.%20To%20assess%20changes%20in%20time%20to%20cART%20initiation%20during%20routine%20care%2C%20we%20estimated%20trends%20in%20time%20from%20enrolment%20in%20care%20to%20cART%20initiation%20in%20HIV-positive%20adults%20with%20high%20CD4%20counts%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%20during%202003%20to%202017.%5CnMETHODS%3A%20All%20cART-naive%20individuals%20%5Cu226518%5Cu00a0years%20of%20age%20from%202003%20to%202017%20with%20CD4%20%5Cu2265350%5Cu00a0cells%5C%2Fmm3%20and%20without%20AIDS%20at%20enrolment%20at%20five%20CCASAnet%20sites%20%28Brazil%2C%20Chile%2C%20Honduras%2C%20Mexico%20and%20Peru%29%20were%20included.%20Patients%20without%20information%20regarding%20AIDS-defining%20events%20were%20excluded.%20We%20estimated%20unadjusted%20median%20time%20from%20enrolment%20to%20cART%20initiation%20by%20calendar%20year%20using%20Kaplan-Meier%20methods%20and%20calculated%20adjusted%20hazard%20ratios%20%28HR%29%20and%2095%25%20confidence%20intervals%20%2895%25%20CI%29%20for%20trends%20in%20cART%20initiation%20using%20Cox%20models%20and%20restricted%20cubic%20splines%20for%20continuous%20variables%2C%20accounting%20for%20age%2C%20sex%2C%20CD4%20at%20enrolment%2C%20route%20of%20HIV%20transmission%20and%20clinic%20site.%5CnRESULTS%3A%20Of%20the%203171%20patients%20included%2C%201%2C650%20%2852%25%29%20had%20CD4%20%5Cu2265500%5Cu00a0cells%5C%2Fmm3%20at%20enrolment.%20Median%20time%20to%20cART%20initiation%20after%202013%20was%206.21%5Cu00a0weeks%20%28interquartile%20range%20%28IQR%29%3A%201.89%2C%2023.21%29%2C%20and%204.71%5Cu00a0weeks%20%28IQR%3A%201.43%2C%209.57%29%20after%202015.%20Among%20763%20%2824%25%29%20patients%20who%20never%20initiated%20cART%2C%2033%20%284.3%25%29%20were%20reported%20as%20deceased%2C%20481%20%2863%25%29%20were%20lost%20to%20follow-up%2C%20and%20249%20%2833%25%29%20were%20administratively%20censored%20before%20initiation.%20Adjusted%20probability%20of%20cART%20initiation%20greatly%20increased%20in%20recent%20years%2C%20in%20particular%20after%202013%20and%202015%20%282013%20vs.%202003%3A%20HR%5Cu00a0%3D%5Cu00a07.14%3B%2095%25%20CI%3A%205.84%20to%208.73%2C%20and%202015%20vs.%202003%3A%20HR%5Cu00a0%3D%5Cu00a012.60%3B%2095%25%20CI%3A%2010.37%20to%2015.32%29.%5CnCONCLUSIONS%3A%20Time%20to%20cART%20initiation%20decreased%20substantially%2C%20roughly%20following%20changes%20in%20WHO%20guidelines%20in%20this%20real-world%20setting%20in%20Latin%20America.%20However%2C%20a%20very%20high%20proportion%20of%20patients%20never%20started%20cART%2C%20compromising%20retention%20in%20care%20and%20survival%2C%20as%20shown%20by%20their%20higher%20proportion%20of%20LTFU%20and%20death%2C%20which%20reinforce%20the%20notion%20that%20earlier%20treatment%20implementation%20strategies%20are%20needed.%22%2C%22date%22%3A%2212%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25413%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A15%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22KBWACZVE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Stover%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EStover%20J%2C%20Glaubius%20R%2C%20Mofenson%20L%2C%20Dugdale%20CM%2C%20Davies%20MA%2C%20Patten%20G%2C%20et%20al.%20Updates%20to%20the%20Spectrum%5C%2FAIM%20model%20for%20estimating%20key%20HIV%20indicators%20at%20national%20and%20subnational%20levels.%20AIDS.%202019%2015%3B33%20Suppl%203%3AS227%26%23x2013%3B34.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DKBWACZVE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Updates%20to%20the%20Spectrum%5C%2FAIM%20model%20for%20estimating%20key%20HIV%20indicators%20at%20national%20and%20subnational%20levels%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Stover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Glaubius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynne%22%2C%22lastName%22%3A%22Mofenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20M.%22%2C%22lastName%22%3A%22Dugdale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Patten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20Spectrum%5C%2FAIM%20model%20is%20used%20by%20national%20programs%20and%20UNAIDS%20to%20prepare%20annual%20estimates%20of%20the%20status%20of%20the%20HIV%20epidemic%20in%20170%20countries.%20The%20model%20and%20assumptions%20are%20updated%20regularly%20under%20the%20guidance%20of%20the%20UNAIDS%20Reference%20Group%20on%20Estimates%2C%20Modelling%20and%20Projections%20in%20response%20to%20new%20data%2C%20studies%20and%20program%20needs.%20This%20article%20describes%20the%20most%20recent%20updates%20for%20the%202018%20round%20of%20estimates.%5CnMETHODS%3A%20New%20data%20on%20AIDS-related%20mortality%20from%20Europe%20and%20Brazil%20have%20been%20used%20to%20update%20mortality%20rates%20of%20those%20not%20on%20antiretroviral%20therapy%20%28ART%29.%20Household%20survey%20data%20and%20new%20studies%20of%20pregnant%20women%2C%20mothers%2C%20and%20children%20have%20been%20used%20to%20improve%20estimates%20of%20the%20number%20of%20HIV-positive%20pregnant%20and%20breastfeeding%20women%20and%20pediatric%20ART%20initiation.%20New%20tools%20to%20estimate%20geographic%20variation%20in%20HIV%20prevalence%20have%20been%20used%20to%20prepare%20district%20estimates%20of%20key%20indicators.%5CnRESULTS%3A%20The%202018%20version%20of%20Spectrum%20includes%3A%20new%20estimates%20of%20non-ART%20AIDS-related%20mortality%20by%20CD4%20count%20that%20depend%20on%20ART%20coverage%3B%20a%20procedure%20to%20estimate%20country-specific%20patterns%20of%20HIV%20incidence%20by%20age%20by%20fitting%20to%20prevalence%20by%20age%20from%20household%20surveys%3B%20an%20updated%20estimate%20of%20postpartum%20transmission%20with%20ART%20started%20before%20pregnancy%20of%200.023%25%20per%20month%3B%20an%20updated%20estimate%20of%20retention%20on%20treatment%20at%20delivery%20of%2080%25%20for%20all%20women%20on%20ART%3B%20a%20somewhat%20older%20pattern%20of%20ART%20initiation%20by%20age%20that%20has%2026%25%20of%20new%20pediatric%20patients%20initiating%20ART%20at%2010-14%20years%20of%20age%2C%2018%25%20at%202-4%20years%20of%20age%2C%20and%2026%25%20at%205-9%20years%20of%20age%3B%20and%20a%20new%20tool%20for%20estimating%20key%20HIV%20indicators%20at%20the%20district%20level.%5CnCONCLUSION%3A%20The%20new%20methods%20and%20data%20implemented%20in%20the%202018%20version%20of%20Spectrum%20allow%20national%20programs%20more%20flexibility%20in%20describing%20their%20programs%20and%20are%20intended%20to%20improve%20the%20estimates%20of%20adult%20mortality%20and%20pediatric%20HIV%20indicators.%22%2C%22date%22%3A%2212%2015%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000002357%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A10%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22964ATDZ6%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Johnson%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJohnson%20LF%2C%20Anderegg%20N%2C%20Zaniewski%20E%2C%20Eaton%20JW%2C%20Rebeiro%20PF%2C%20Carriquiry%20G%2C%20et%20al.%20Global%20variations%20in%20mortality%20in%20adults%20after%20initiating%20antiretroviral%20treatment%3A%20an%20updated%20analysis%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20cohort%20collaboration.%20AIDS.%202019%2015%3B33%20Suppl%203%3AS283%26%23x2013%3B94.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D964ATDZ6%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20variations%20in%20mortality%20in%20adults%20after%20initiating%20antiretroviral%20treatment%3A%20an%20updated%20analysis%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20cohort%20collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20W.%22%2C%22lastName%22%3A%22Eaton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K.%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20B.%22%2C%22lastName%22%3A%22Holmes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Y.%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgos%22%2C%22lastName%22%3A%22Bakoyannis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20UNAIDS%20models%20use%20data%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20collaboration%20in%20setting%20assumptions%20about%20mortality%20rates%20after%20antiretroviral%20treatment%20%28ART%29%20initiation.%20This%20study%20aims%20to%20update%20these%20assumptions%20with%20new%20data%2C%20to%20quantify%20the%20extent%20of%20regional%20variation%20in%20ART%20mortality%20and%20to%20assess%20trends%20in%20ART%20mortality.%5CnMETHODS%3A%20Adult%20ART%20patients%20from%20Africa%2C%20Asia%20and%20the%20Americas%20were%20included%20if%20they%20had%20a%20known%20date%20of%20ART%20initiation%20during%202001-2017%20and%20a%20baseline%20CD4%20cell%20count.%20In%20cohorts%20that%20relied%20only%20on%20passive%20follow-up%20%28no%20patient%20tracing%20or%20linkage%20to%20vital%20registration%20systems%29%2C%20mortality%20outcomes%20were%20imputed%20in%20patients%20lost%20to%20follow-up%20based%20on%20a%20meta-analysis%20of%20tracing%20study%20data.%20Poisson%20regression%20models%20were%20fitted%20to%20the%20mortality%20data.%5CnRESULTS%3A%20464%20048%20ART%20patients%20were%20included.%20In%20multivariable%20analysis%2C%20mortality%20rates%20were%20lowest%20in%20Asia%20and%20highest%20in%20Africa%2C%20with%20no%20significant%20differences%20between%20African%20regions.%20Adjusted%20mortality%20rates%20varied%20significantly%20between%20programmes%20within%20regions.%20Mortality%20rates%20in%20the%20first%2012%20months%20after%20ART%20initiation%20were%20significantly%20higher%20during%202001-2006%20than%20during%202010-2014%2C%20although%20the%20difference%20was%20more%20substantial%20in%20Asia%20and%20the%20Americas%20%5Badjusted%20incidence%20rate%20ratio%20%28aIRR%29%201.43%2C%2095%25%20CI%3A%201.22-1.66%5D%20than%20in%20Africa%20%28aIRR%201.07%2C%2095%25%20CI%3A%201.04-1.11%29.%5CnCONCLUSION%3A%20There%20is%20substantial%20variation%20in%20ART%20mortality%20between%20and%20within%20regions%2C%20even%20after%20controlling%20for%20differences%20in%20mortality%20by%20age%2C%20sex%2C%20baseline%20CD4%20category%20and%20calendar%20period.%20ART%20mortality%20rates%20have%20declined%20substantially%20over%20time%2C%20although%20declines%20have%20been%20slower%20in%20Africa.%22%2C%22date%22%3A%2212%2015%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000002358%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A10%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22XNGPMT99%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Jesson%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJesson%20J%2C%20Schomaker%20M%2C%20Malasteste%20K%2C%20Wati%20DK%2C%20Kariminia%20A%2C%20Sylla%20M%2C%20et%20al.%20Stunting%20and%20growth%20velocity%20of%20adolescents%20with%20perinatally%20acquired%20HIV%3A%20differential%20evolution%20for%20males%20and%20females.%20A%20multiregional%20analysis%20from%20the%20IeDEA%20global%20paediatric%20collaboration.%20J%20Int%20AIDS%20Soc.%202019%3B22%2811%29%3Ae25412.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DXNGPMT99%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Stunting%20and%20growth%20velocity%20of%20adolescents%20with%20perinatally%20acquired%20HIV%3A%20differential%20evolution%20for%20males%20and%20females.%20A%20multiregional%20analysis%20from%20the%20IeDEA%20global%20paediatric%20collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Jesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Schomaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malasteste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dewi%20K.%22%2C%22lastName%22%3A%22Wati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariam%22%2C%22lastName%22%3A%22Sylla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouakou%22%2C%22lastName%22%3A%22Kouadio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shobna%22%2C%22lastName%22%3A%22Sawry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mwangelwa%22%2C%22lastName%22%3A%22Mubiana-Mbewe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Ayaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20global%20cohort%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Stunting%20is%20a%20key%20issue%20for%20adolescents%20with%20perinatally%20acquired%20HIV%20%28APH%29%20that%20needs%20to%20be%20better%20understood.%20As%20part%20of%20the%20IeDEA%20multiregional%20consortium%2C%20we%20described%20growth%20evolution%20during%20adolescence%20for%20APH%20on%20antiretroviral%20therapy%20%28ART%29.%5CnMETHODS%3A%20We%20included%20data%20from%20sub-Saharan%20Africa%2C%20the%20Asia-Pacific%2C%20and%20the%20Caribbean%2C%20Central%20and%20South%20America%20regions%20collected%20between%202003%20and%202016.%20Adolescents%20on%20ART%2C%20reporting%20perinatally%20acquired%20infection%20or%20entering%20HIV%20care%20before%2010%5Cu00a0years%20of%20age%2C%20with%20at%20least%20one%20height%20measurement%20between%2010%20and%2016%5Cu00a0years%20of%20age%2C%20and%20followed%20in%20care%20until%20at%20least%2014%5Cu00a0years%20of%20age%20were%20included.%20Characteristics%20at%20ART%20initiation%20and%20at%2010%5Cu00a0years%20of%20age%20were%20compared%20by%20sex.%20Correlates%20of%20growth%20defined%20by%20height-for-age%20z-scores%20%28HAZ%29%20between%20ages%2010%20and%2019%5Cu00a0years%20were%20studied%20separately%20for%20males%20and%20females%2C%20using%20linear%20mixed%20models.%5CnRESULTS%3A%20Overall%2C%208737%20APH%20were%20included%2C%20with%2046%25%20from%20Southern%20Africa.%20Median%20age%20at%20ART%20initiation%20was%208.1%5Cu00a0years%20%28interquartile%20range%20%28IQR%29%206.1%20to%209.6%29%2C%2050%25%20were%20females%2C%20and%2041%25%20were%20stunted%20%28HAZ%3C-2%5Cu00a0SD%29%20at%20ART%20initiation.%20Males%20and%20females%20did%20not%20differ%20by%20age%20and%20stunting%20at%20ART%20initiation%2C%20CD4%20count%20over%20time%20or%20retention%20in%20care.%20At%2010%5Cu00a0years%20of%20age%2C%2034%25%20of%20males%20were%20stunted%20versus%2039%25%20of%20females%20%28p%5Cu00a0%3C%5Cu00a00.001%29.%20Females%20had%20better%20subsequent%20growth%2C%20resulting%20in%20a%20higher%20prevalence%20of%20stunting%20for%20males%20compared%20to%20females%20by%20age%2015%20%2848%25%20vs.%2025%25%29%20and%2018%5Cu00a0years%20%2831%25%20vs.%2015%25%29.%20In%20linear%20mixed%20models%2C%20older%20age%20at%20ART%20initiation%20and%20low%20CD4%20count%20were%20associated%20with%20poor%20growth%20over%20time%20%28p%5Cu00a0%3C%5Cu00a00.001%29.%20Those%20stunted%20at%2010%5Cu00a0years%20of%20age%20or%20at%20ART%20initiation%20had%20the%20greatest%20growth%20improvement%20during%20adolescence.%5CnCONCLUSIONS%3A%20Prevalence%20of%20stunting%20is%20high%20among%20APH%20worldwide.%20Substantial%20sex-based%20differences%20in%20growth%20evolution%20during%20adolescence%20were%20observed%20in%20this%20global%20cohort%2C%20which%20were%20not%20explained%20by%20differences%20in%20age%20of%20access%20to%20HIV%20care%2C%20degree%20of%20immunosuppression%20or%20region.%20Other%20factors%20influencing%20growth%20differences%20in%20APH%2C%20such%20as%20differences%20in%20pubertal%20development%2C%20should%20be%20better%20documented%2C%20to%20guide%20further%20research%20and%20inform%20interventions%20to%20optimize%20growth%20and%20health%20outcomes%20among%20APH.%22%2C%22date%22%3A%2211%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25412%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A09%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22R7A5I7V4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Vinhaes%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVinhaes%20CL%2C%20Oliveira-de-Souza%20D%2C%20Silveira-Mattos%20PS%2C%20Nogueira%20B%2C%20Shi%20R%2C%20Wei%20W%2C%20et%20al.%20Changes%20in%20inflammatory%20protein%20and%20lipid%20mediator%20profiles%20persist%20after%20antitubercular%20treatment%20of%20pulmonary%20and%20extrapulmonary%20tuberculosis%3A%20A%20prospective%20cohort%20study.%20Cytokine.%202019%3B123%3A154759.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DR7A5I7V4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Changes%20in%20inflammatory%20protein%20and%20lipid%20mediator%20profiles%20persist%20after%20antitubercular%20treatment%20of%20pulmonary%20and%20extrapulmonary%20tuberculosis%3A%20A%20prospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deivide%22%2C%22lastName%22%3A%22Oliveira-de-Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulo%20S.%22%2C%22lastName%22%3A%22Silveira-Mattos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betania%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruiru%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wang%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xing%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guolong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifton%20E.%22%2C%22lastName%22%3A%22Barry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20E.%22%2C%22lastName%22%3A%22Via%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrin%20D.%22%2C%22lastName%22%3A%22Mayer-Barber%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20identification%20of%20meaningful%20biomarkers%20of%20tuberculosis%20%28TB%29%20has%20potential%20to%20improve%20diagnosis%2C%20disease%20staging%20and%20prediction%20of%20treatment%20outcomes.%20It%20has%20been%20shown%20that%20active%20pulmonary%20TB%20%28PTB%29%20is%20associated%20with%20qualitative%20and%20quantitative%20changes%20in%20systemic%20immune%20profile%2C%20suggesting%20a%20chronic%20inflammatory%20imbalance.%20Here%20we%20characterized%20the%20profile%20of%20PTB%20and%20extrapulmonary%20TB%20%28EPTB%29%20in%20a%20prospective%20cohort%20study.%5CnMETHODS%3A%20We%20measured%20a%20panel%20of%2027%20inflammatory%20cytokines%2C%20soluble%20receptors%2C%20and%20lipid%20mediators%20in%20peripheral%20blood%20from%20patients%20with%20PTB%20or%20EPTB%20from%20a%20prospective%20clinical%20study%20in%20China.%20Multidimensional%20analyses%20were%20performed%20to%20describe%20associations%20between%20plasma%20levels%20of%20biomarkers%20and%20different%20TB%20disease%20presentation%20profiles.%5CnRESULTS%3A%20Mycobacterium%20tuberculosis%20infection%20induced%20changes%20in%20both%20the%20expression%20and%20correlation%20profiles%20of%20plasma%20mediators%20of%20inflammation%20in%20patients%20with%20PTB%20compared%20to%20those%20with%20EPTB.%20Increases%20in%20mycobacterial%20loads%20in%20sputum%20smears%20were%20associated%20with%20rises%20in%20concentrations%20of%20several%20molecules%20involved%20in%20TB%20pathogenesis%2C%20such%20as%20IL-1%5Cu03b2%2C%20IFN-%5Cu03b1%2C%20IL-10%20and%20PGF2%5Cu03b1.%20Moreover%2C%20PTB%20patients%20presenting%20with%20severe%20disease%20exhibited%20a%20distinct%20inflammatory%20profile%20hallmarked%20by%20heightened%20levels%20of%20TNF-%5Cu03b1%2C%20IL-1%5Cu03b2%2C%20IL17%2C%20IL-18%20and%20IL-27.%20Interestingly%2C%20while%20antitubercular%20treatment%20%28ATT%29%20resulted%20in%20early%20changes%20of%20plasma%20concentrations%20of%20markers%20in%20PTB%2C%20changes%20were%20delayed%20in%20EPTB%20patients.%20Exploratory%20analyses%20of%20the%20molecular%20degree%20of%20perturbation%20%28MDP%29%20of%20the%20inflammatory%20mediators%20before%20and%20during%20ATT%20suggested%20the%20occurrence%20of%20infection%20and%5C%2For%20treatment-induced%20long%20lasting%20%5C%22inflammatory%20imprinting%5C%22%20of%20biomarker%20profiles%20in%20TB.%20At%2024%5Cu202fweeks%20post%20ATT%20commencement%2C%20markers%20underlying%20the%20observed%20increases%20in%20MDP%20scores%20were%20IL-27%20in%20PTB%20and%20IL-1%5Cu03b2%20in%20EPTB%20patients.%5CnCONCLUSION%3A%20Our%20findings%20describe%20systemic%20and%20durable%20changes%20in%20the%20concentrations%20of%20inflammatory%20cytokines%20and%20lipid%20mediators%20in%20both%20PTB%20and%20EPTB%20and%20emphasize%20the%20role%20of%20M.%20tuberculosis%20bacterial%20burden%20and%20site%20of%20disease%20in%20modulating%20patient%20immune%20biomarkers.%22%2C%22date%22%3A%2211%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cyto.2019.154759%22%2C%22ISSN%22%3A%221096-0023%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A09%3A49Z%22%7D%7D%2C%7B%22key%22%3A%228P9E2G4E%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rivera%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERivera%20VR%2C%20Lu%20L%2C%20Ocheretina%20O%2C%20Jean%20Juste%20MA%2C%20Julma%20P%2C%20Archange%20D%2C%20et%20al.%20Diagnostic%20yield%20of%20active%20case%20finding%20for%20tuberculosis%20at%20human%20immunodeficiency%20virus%20testing%20in%20Haiti.%20Int%20J%20Tuberc%20Lung%20Dis.%202019%2001%3B23%2811%29%3A1217%26%23x2013%3B22.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D8P9E2G4E%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Diagnostic%20yield%20of%20active%20case%20finding%20for%20tuberculosis%20at%20human%20immunodeficiency%20virus%20testing%20in%20Haiti%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20R.%22%2C%22lastName%22%3A%22Rivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Ocheretina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20A.%22%2C%22lastName%22%3A%22Jean%20Juste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Julma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Archange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20G.%22%2C%22lastName%22%3A%22Moise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Homeus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20D.%22%2C%22lastName%22%3A%22Phanor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Peti%5Cu00f3n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.-Y.%22%2C%22lastName%22%3A%22Cremieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20W.%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20P.%22%2C%22lastName%22%3A%22Koenig%22%7D%5D%2C%22abstractNote%22%3A%22SETTING%3A%20The%20Groupe%20Ha%5Cu00eftien%20d%27%5Cu00e9tude%20du%20Sarcome%20de%20Kaposi%20et%20des%20Infections%20Opportunistes%20%28GHESKIO%29%20Centres%2C%20Port-au-Prince%2C%20Haiti%2C%20facilitate%20%5C%22test%20and%20treat%5C%22%20strategies%20by%20screening%20all%20patients%20for%20tuberculosis%20%28TB%29%20at%20human%20immunodeficiency%20virus%20%28HIV%29%20testing.OBJECTIVE%3A%201%29%20To%20determine%20the%20proportion%20of%20patients%20with%20chronic%20cough%20at%20HIV%20testing%20diagnosed%20with%20TB%2C%20stratified%20by%20HIV%20test%20results%3B%20and%202%29%20to%20evaluate%20the%20additional%20diagnostic%20yield%20of%20Xpert%5Cu00ae%20MTB%5C%2FRIF%20vs.%20sputum%20microscopy.DESIGN%3A%20We%20conducted%20a%20retrospective%20cohort%20analysis%20including%20all%20adults%20tested%20for%20HIV%20at%20GHESKIO%20from%20August%202014%20to%20July%202015.RESULTS%3A%20Of%2029%5Cu2009233%20adult%20patients%20tested%20for%20HIV%2C%202953%20%2810%25%29%20were%20diagnosed%20as%20HIV-positive.%20Chronic%20cough%20lasting%20%5Cu22652%20weeks%20was%20reported%20by%201116%20%2838%25%29%20HIV-positive%20patients%3B%20984%20%2888%25%29%20were%20tested%20and%20265%20%2827%25%29%20were%20diagnosed%20with%20TB.%20Chronic%20cough%20was%20reported%20by%205985%20%2823%25%29%20HIV-negative%20patients%3B%205654%20%2894%25%29%20were%20tested%20and%201179%20%2821%25%29%20were%20diagnosed%20with%20TB.%20Of%20all%20bacteriologically%20confirmed%20cases%2C%2027%25%20were%20smear-negative%20and%20Xpert-positive.%20Among%20all%20TB%20patients%2C%2081%25%20were%20HIV-negative.CONCLUSIONS%3A%20Screening%20for%20TB%20at%20HIV%20testing%20was%20high-yield%2C%20among%20both%20HIV-infected%20and%20HIV-negative%20individuals.%20Testing%20for%20both%20diseases%20should%20be%20conducted%20among%20patients%20who%20present%20with%20chronic%20cough%20at%20HIV%20testing.%22%2C%22date%22%3A%2211%2001%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.18.0835%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A08%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22P78M9WDS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Z%5Cu00fcrcher%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZ%26%23xFC%3Brcher%20K%2C%20Ballif%20M%2C%20Kiertiburanakul%20S%2C%20Chenal%20H%2C%20Yotebieng%20M%2C%20Grinsztejn%20B%2C%20et%20al.%20Diagnosis%20and%20clinical%20outcomes%20of%20extrapulmonary%20tuberculosis%20in%20antiretroviral%20therapy%20programmes%20in%20low-%20and%20middle-income%20countries%3A%20a%20multicohort%20study.%20J%20Int%20AIDS%20Soc.%202019%3B22%289%29%3Ae25392.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DP78M9WDS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Diagnosis%20and%20clinical%20outcomes%20of%20extrapulmonary%20tuberculosis%20in%20antiretroviral%20therapy%20programmes%20in%20low-%20and%20middle-income%20countries%3A%20a%20multicohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Z%5Cu00fcrcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasisopin%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Chenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denna%22%2C%22lastName%22%3A%22Michael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kapella%20M.%22%2C%22lastName%22%3A%22Ngonyani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20C.%22%2C%22lastName%22%3A%22Pettit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Extrapulmonary%20tuberculosis%20%28EPTB%29%20is%20difficult%20to%20confirm%20bacteriologically%20and%20requires%20specific%20diagnostic%20capacities.%20Diagnosis%20can%20be%20especially%20challenging%20in%20under-resourced%20settings.%20We%20studied%20diagnostic%20modalities%20and%20clinical%20outcomes%20of%20EPTB%20compared%20to%20pulmonary%20tuberculosis%20%28PTB%29%20among%20HIV-positive%20adults%20in%20antiretroviral%20therapy%20%28ART%29%20programmes%20in%20low-%20and%20middle-income%20countries%20%28LMIC%29.%5CnMETHODS%3A%20We%20collected%20data%20from%20HIV-positive%20TB%20patients%20%28%5Cu226516%5Cu00a0years%29%20in%2022%20ART%20programmes%20participating%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20in%20sub-Saharan%20Africa%2C%20Asia-Pacific%2C%20and%20Caribbean%2C%20Central%20and%20South%20America%20regions%20between%202012%20and%202014.%20We%20categorized%20TB%20as%20PTB%20or%20EPTB%20%28EPTB%20included%20mixed%20PTB%5C%2FEPTB%29.%20We%20used%20multivariable%20logistic%20regression%20to%20assess%20associations%20with%20clinical%20outcomes.%5CnRESULTS%20AND%20DISCUSSION%3A%20We%20analysed%202695%20HIV-positive%20TB%20patients.%20Median%20age%20was%2036%5Cu00a0years%20%28interquartile%20range%20%28IQR%29%2030%20to%2043%29%2C%201102%20were%20female%20%2841%25%29%2C%20and%20the%20median%20CD4%20count%20at%20TB%20treatment%20start%20was%20114%20cells%5C%2F%5Cu03bcL%20%28IQR%2040%20to%20248%29.%20Overall%2C%201930%20had%20PTB%20%2872%25%29%2C%20and%20765%20EPTB%20%2828%25%29.%20Among%20EPTB%20patients%2C%20the%20most%20frequently%20involved%20sites%20were%20the%20lymph%20nodes%20%2824%25%29%2C%20pleura%20%2815%25%29%2C%20abdomen%20%2811%25%29%20and%20meninges%20%286%25%29.%20The%20majority%20of%20PTB%20%281123%20of%201930%2C%2058%25%29%20and%20EPTB%20%28582%20of%20765%2C%2076%25%29%20patients%20were%20diagnosed%20based%20on%20clinical%20criteria.%20Bacteriological%20confirmation%20%28using%20positive%20smear%20microscopy%2C%20culture%2C%20Xpert%20MTB%5C%2FRIF%2C%20or%20other%20nucleic%20acid%20amplification%20tests%20result%29%20was%20obtained%20in%20897%20of%201557%20PTB%20%2852%25%29%20and%20183%20of%20438%20EPTB%20%2842%25%29%20patients.%20EPTB%20was%20not%20associated%20with%20higher%20mortality%20compared%20to%20PTB%20%28adjusted%20odd%20ratio%20%28aOR%29%201.0%2C%2095%25%20CI%200.8%20to%201.3%29%2C%20but%20TB%20meningitis%20was%20%28aOR%201.9%2C%2095%25%20CI%201.0%20to%203.1%29.%20Bacteriological%20confirmation%20was%20associated%20with%20reduced%20mortality%20among%20PTB%20patients%20%28aOR%200.7%2C%2095%25%20CI%200.6%20to%200.8%29%20and%20EPTB%20patients%20%28aOR%200.3%2095%25%20CI%200.1%20to%200.8%29%20compared%20to%20TB%20patients%20with%20a%20negative%20test%20result.%5CnCONCLUSIONS%3A%20Diagnosis%20of%20EPTB%20and%20PTB%20at%20ART%20programmes%20in%20LMIC%20was%20mainly%20based%20on%20clinical%20criteria.%20Greater%20availability%20and%20usage%20of%20TB%20diagnostic%20tests%20would%20improve%20the%20diagnosis%20and%20clinical%20outcomes%20of%20both%20EPTB%20and%20PTB.%22%2C%22date%22%3A%2209%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25392%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A07%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22G5KI737Z%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Cubillos-Angulo%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECubillos-Angulo%20JM%2C%20Arriaga%20MB%2C%20Silva%20EC%2C%20M%26%23xFC%3Bller%20BLA%2C%20Ramalho%20DMP%2C%20Fukutani%20KF%2C%20et%20al.%20Polymorphisms%20in%20TLR4%20and%20TNFA%20and%20Risk%20of%20Mycobacterium%20tuberculosis%20Infection%20and%20Development%20of%20Active%20Disease%20in%20Contacts%20of%20Tuberculosis%20Cases%20in%20Brazil%3A%20A%20Prospective%20Cohort%20Study.%20Clin%20Infect%20Dis.%202019%2030%3B69%286%29%3A1027%26%23x2013%3B35.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DG5KI737Z%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Polymorphisms%20in%20TLR4%20and%20TNFA%20and%20Risk%20of%20Mycobacterium%20tuberculosis%20Infection%20and%20Development%20of%20Active%20Disease%20in%20Contacts%20of%20Tuberculosis%20Cases%20in%20Brazil%3A%20A%20Prospective%20Cohort%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Manuel%22%2C%22lastName%22%3A%22Cubillos-Angulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elis%5Cu00e2ngela%20C.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%20L.%20A.%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20M.%20P.%22%2C%22lastName%22%3A%22Ramalho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pryscila%20F.%20C.%22%2C%22lastName%22%3A%22Miranda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%20S.%20R.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Ruffino-Netto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20R.%22%2C%22lastName%22%3A%22Lapa%20E%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afr%5Cu00e2nio%20L.%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%20M.%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20role%20of%20genetic%20polymorphisms%20in%20latent%20tuberculosis%20%28TB%29%20infection%20and%20progression%20to%20active%20TB%20is%20not%20fully%20understood.%5CnMETHODS%3A%20We%20tested%20the%20single-nucleotide%20polymorphisms%20%28SNPs%29%20rs5743708%20%28TLR2%29%2C%20rs4986791%20%28TLR4%29%2C%20rs361525%20%28TNFA%29%2C%20rs2430561%20%28IFNG%29%20rs1143627%20%28IL1B%29%20as%20risk%20factors%20for%20tuberculin%20skin%20test%20%28TST%29%20conversion%20or%20development%20of%20active%20TB%20in%20contacts%20of%20active%20TB%20cases.%20Contacts%20of%20microbiologically%20confirmed%20pulmonary%20TB%20cases%20were%20initially%20screened%20for%20longitudinal%20evaluation%20up%20to%2024%20months%2C%20with%20clinical%20examination%20and%20serial%20TST%2C%20between%201998%20and%202004%20at%20a%20referral%20center%20in%20Brazil.%20Data%20and%20biospecimens%20were%20collected%20from%20526%20individuals%20who%20were%20contacts%20of%20177%20active%20TB%20index%20cases.%20TST%20conversion%20was%20defined%20as%20induration%20%5Cu22655%20mm%20after%20a%20negative%20TST%20result%20%280%20mm%29%20at%20baseline%20or%20month%204%20visit.%20Independent%20associations%20were%20tested%20using%20logistic%20regression%20models.%5CnRESULTS%3A%20Among%20the%20526%20contacts%2C%2060%20had%20TST%20conversion%20and%2044%20developed%20active%20TB%20during%20follow-up.%20Multivariable%20regression%20analysis%20demonstrated%20that%20male%20sex%20%28odds%20ratio%20%5BOR%5D%3A%202.3%2C%2095%25%20confidence%20interval%20%5BCI%5D%3A%201.1-4.6%29%2C%20as%20well%20as%20SNPs%20in%20TLR4%20genes%20%28OR%3A%2062.8%2C%2095%25%20CI%3A%207.5-525.3%29%20and%20TNFA%20%28OR%3A%204.2%2C%2095%25%20CI%3A%201.9-9.5%29%20were%20independently%20associated%20with%20TST%20conversion.%20Moreover%2C%20a%20positive%20TST%20at%20baseline%20%28OR%3A%204.7%2C%2095%25%20CI%3A%202.3-9.7%29%20and%20SNPs%20in%20TLR4%20%28OR%3A%206.5%2C%2095%25%20CI%3A%201.1-36.7%29%20and%20TNFA%20%28OR%3A%2012.4%2C%2095%25%20CI%3A5.1-30.1%29%20were%20independently%20associated%20with%20incident%20TB.%5CnCONCLUSIONS%3A%20SNPs%20in%20TLR4%20and%20TNFA%20predicted%20both%20TST%20conversion%20and%20active%20TB%20among%20contacts%20of%20TB%20cases%20in%20Brazil.%22%2C%22date%22%3A%2208%2030%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciy1001%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A13%3A56Z%22%7D%7D%2C%7B%22key%22%3A%2292KWTWTE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrazier%20E%2C%20Maruri%20F%2C%20Duda%20SN%2C%20Tymejczyk%20O%2C%20Wester%20CW%2C%20Somi%20G%2C%20et%20al.%20Implementation%20of%20%26%23x201C%3BTreat-all%26%23x201D%3B%20at%20adult%20HIV%20care%20and%20treatment%20sites%20in%20the%20Global%20IeDEA%20Consortium%3A%20results%20from%20the%20Site%20Assessment%20Survey.%20J%20Int%20AIDS%20Soc.%202019%3B22%287%29%3Ae25331.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D92KWTWTE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Implementation%20of%20%5C%22Treat-all%5C%22%20at%20adult%20HIV%20care%20and%20treatment%20sites%20in%20the%20Global%20IeDEA%20Consortium%3A%20results%20from%20the%20Site%20Assessment%20Survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernanda%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Somi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fujie%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catrina%22%2C%22lastName%22%3A%22Mugglin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22April%20D.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Since%202015%2C%20the%20World%20Health%20Organization%20%28WHO%29%20has%20recommended%20that%20all%20people%20living%20with%20HIV%20%28PLHIV%29%20initiate%20antiretroviral%20treatment%20%28ART%29%2C%20irrespective%20of%20CD4%2B%20count%20or%20clinical%20stage.%20National%20adoption%20of%20universal%20treatment%20has%20accelerated%20since%20WHO%27s%202015%20%5C%22Treat%20All%5C%22%20recommendation%3B%20however%2C%20little%20is%20known%20about%20the%20translation%20of%20this%20guidance%20into%20practice.%20This%20study%20aimed%20to%20assess%20the%20status%20of%20Treat%20All%20implementation%20across%20regions%2C%20countries%2C%20and%20levels%20of%20the%20health%20care%20delivery%20system.%5CnMETHODS%3A%20Between%20June%20and%20December%202017%2C%20201%5C%2F221%20%2891%25%29%20adult%20HIV%20treatment%20sites%20that%20participate%20in%20the%20global%20IeDEA%20research%20consortium%20completed%20a%20survey%20on%20capacity%20and%20practices%20related%20to%20HIV%20care.%20Located%20in%2041%20countries%20across%20seven%20geographic%20regions%2C%20sites%20provided%20information%20on%20the%20status%20and%20timing%20of%20site-level%20introduction%20of%20Treat%20All%2C%20as%20well%20as%20site-level%20practices%20related%20to%20ART%20initiation.%5CnRESULTS%3A%20Almost%20all%20sites%20%2893%25%29%20reported%20that%20they%20had%20begun%20implementing%20Treat%20All%2C%20and%20there%20were%20no%20statistically%20significant%20differences%20in%20site-level%20Treat%20All%20introduction%20by%20health%20facility%20type%2C%20urban%5C%2Frural%20location%2C%20sector%20%28public%5C%2Fprivate%29%20or%20country%20income%20level.%20The%20median%20time%20between%20national%20policy%20adoption%20and%20site-level%20introduction%20was%20one%20month.%20In%20countries%20where%20Treat%20All%20was%20not%20yet%20adopted%20in%20national%20guidelines%2C%2069%25%20of%20sites%20reported%20initiating%20all%20patients%20on%20ART%2C%20regardless%20of%20clinical%20criteria%2C%20and%20these%20sites%20had%20been%20implementing%20Treat%20All%20for%20a%20median%20period%20of%20seven%20months%20at%20the%20time%20of%20the%20survey.%20The%20majority%20of%20sites%20%2877%25%29%20reported%20typically%20initiating%20patients%20on%20ART%20within%2014%5Cu00a0days%20of%20confirming%20diagnosis%2C%20with%2060%25%20to%2062%25%20of%20sites%20implementing%20Treat%20All%20in%20East%2C%20Southern%20and%20West%20Africa%20reporting%20same-day%20ART%20initiation%20for%20most%20patients.%5CnCONCLUSIONS%3A%20By%20mid-%20to%20late-2017%2C%20the%20Treat%20All%20strategy%20was%20the%20standard%20of%20care%20at%20almost%20all%20IeDEA%20sites%2C%20including%20rural%2C%20primary-level%20health%20facilities%20in%20low-resource%20settings.%20While%20further%20assessments%20of%20site-level%20capacity%20to%20provide%20high-quality%20HIV%20care%20under%20Treat%20All%20and%20to%20support%20sustained%20viral%20suppression%20after%20ART%20initiation%20are%20needed%2C%20the%20widespread%20introduction%20of%20Treat%20All%20at%20the%20service%20delivery%20level%20is%20a%20critical%20step%20towards%20global%20targets%20for%20ending%20the%20HIV%20epidemic%20as%20a%20public%20health%20threat.%22%2C%22date%22%3A%2207%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25331%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A07%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22G764QWME%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Tymejczyk%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETymejczyk%20O%2C%20Brazier%20E%2C%20Yiannoutsos%20CT%2C%20Vinikoor%20M%2C%20van%20Lettow%20M%2C%20Nalugoda%20F%2C%20et%20al.%20Changes%20in%20rapid%20HIV%20treatment%20initiation%20after%20national%20%26%23x201C%3Btreat%20all%26%23x201D%3B%20policy%20adoption%20in%206%20sub-Saharan%20African%20countries%3A%20Regression%20discontinuity%20analysis.%20PLoS%20Med.%202019%3B16%286%29%3Ae1002822.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DG764QWME%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Changes%20in%20rapid%20HIV%20treatment%20initiation%20after%20national%20%5C%22treat%20all%5C%22%20policy%20adoption%20in%206%20sub-Saharan%20African%20countries%3A%20Regression%20discontinuity%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Vinikoor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monique%22%2C%22lastName%22%3A%22van%20Lettow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%22%2C%22lastName%22%3A%22Nalugoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Urassa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20d%27Amour%22%2C%22lastName%22%3A%22Sinayobye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grace%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Most%20countries%20have%20formally%20adopted%20the%20World%20Health%20Organization%27s%202015%20recommendation%20of%20universal%20HIV%20treatment%20%28%5C%22treat%20all%5C%22%29.%20However%2C%20there%20are%20few%20rigorous%20assessments%20of%20the%20real-world%20impact%20of%20treat%20all%20policies%20on%20antiretroviral%20treatment%20%28ART%29%20uptake%20across%20different%20contexts.%5CnMETHODS%20AND%20FINDINGS%3A%20We%20used%20longitudinal%20data%20for%20814%2C603%20patients%20enrolling%20in%20HIV%20care%20between%201%20January%202004%20and%2010%20July%202018%20in%206%20countries%20participating%20in%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%3A%20Burundi%20%28N%20%3D%2011%2C176%29%2C%20Kenya%20%28N%20%3D%20179%2C941%29%2C%20Malawi%20%28N%20%3D%2084%2C558%29%2C%20Rwanda%20%28N%20%3D%2017%2C396%29%2C%20Uganda%20%28N%20%3D%2096%2C286%29%2C%20and%20Zambia%20%28N%20%3D%20425%2C246%29.%20Using%20a%20quasi-experimental%20regression%20discontinuity%20design%2C%20we%20assessed%20the%20change%20in%20the%20proportion%20initiating%20ART%20within%2030%20days%20of%20enrollment%20in%20HIV%20care%20%28rapid%20ART%20initiation%29%20after%20country-level%20adoption%20of%20the%20treat%20all%20policy.%20A%20modified%20Poisson%20model%20was%20used%20to%20identify%20factors%20associated%20with%20failure%20to%20initiate%20ART%20rapidly%20under%20treat%20all.%20In%20each%20of%20the%206%20countries%2C%20over%2060%25%20of%20included%20patients%20were%20female%2C%20and%20median%20age%20at%20enrollment%20ranged%20from%2032%20to%2036%20years.%20In%20all%20countries%20studied%2C%20national%20adoption%20of%20treat%20all%20was%20associated%20with%20large%20increases%20in%20rapid%20ART%20initiation.%20Significant%20increases%20in%20rapid%20ART%20initiation%20immediately%20after%20treat%20all%20policy%20adoption%20were%20observed%20in%20Rwanda%2C%20from%2044.4%25%20to%2078.9%25%20of%20patients%20%2834.5%20percentage%20points%20%5Bpp%5D%2C%2095%25%20CI%2027.2%20to%2041.7%3B%20p%20%3C%200.001%29%2C%20Kenya%20%2825.7%20pp%2C%2095%25%20CI%2021.8%20to%2029.5%3B%20p%20%3C%200.001%29%2C%20Burundi%20%2817.7%20pp%2C%2095%25%20CI%206.5%20to%2028.9%3B%20p%20%3D%200.002%29%2C%20and%20Malawi%20%2812.5%20pp%2C%2095%25%20CI%207.5%20to%2017.5%3B%20p%20%3C%200.001%29%2C%20while%20no%20immediate%20increase%20was%20observed%20in%20Zambia%20%280.4%20pp%2C%2095%25%20CI%20-2.9%20to%203.8%3B%20p%20%3D%200.804%29%20and%20Uganda%20%28-4.2%20pp%2C%2095%25%20CI%20-9.0%20to%200.7%3B%20p%20%3D%200.090%29.%20The%20rate%20of%20rapid%20ART%20initiation%20accelerated%20sharply%20following%20treat%20all%20policy%20adoption%20in%20Malawi%2C%20Uganda%2C%20and%20Zambia%3B%20slowed%20in%20Kenya%3B%20and%20did%20not%20change%20in%20Rwanda%20and%20Burundi.%20In%20post%20hoc%20analyses%20restricted%20to%20patients%20enrolling%20under%20treat%20all%2C%20young%20adults%20%2816-24%20years%29%20and%20men%20were%20at%20increased%20risk%20of%20not%20rapidly%20initiating%20ART%20%28compared%20to%20older%20patients%20and%20women%2C%20respectively%29.%20However%2C%20rapid%20ART%20initiation%20following%20enrollment%20increased%20for%20all%20groups%20as%20more%20time%20elapsed%20since%20treat%20all%20policy%20adoption.%20Study%20limitations%20include%20incomplete%20data%20on%20potential%20ART%20eligibility%20criteria%2C%20such%20as%20clinical%20status%2C%20pregnancy%2C%20and%20enrollment%20CD4%20count%2C%20which%20precluded%20the%20assessment%20of%20rapid%20ART%20initiation%20specifically%20among%20patients%20known%20to%20be%20eligible%20for%20ART%20before%20treat%20all.%5CnCONCLUSIONS%3A%20Our%20analysis%20indicates%20that%20adoption%20of%20treat%20all%20policies%20had%20a%20strong%20effect%20on%20increasing%20rates%20of%20rapid%20ART%20initiation%2C%20and%20that%20these%20increases%20followed%20different%20trajectories%20across%20the%206%20countries.%20Young%20adults%20and%20men%20still%20require%20additional%20attention%20to%20further%20improve%20rapid%20ART%20initiation.%22%2C%22date%22%3A%2206%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1002822%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A06%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22KIA7K7CQ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Oliveira-de-Souza%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOliveira-de-Souza%20D%2C%20Vinhaes%20CL%2C%20Arriaga%20MB%2C%20Kumar%20NP%2C%20Cubillos-Angulo%20JM%2C%20Shi%20R%2C%20et%20al.%20Molecular%20degree%20of%20perturbation%20of%20plasma%20inflammatory%20markers%20associated%20with%20tuberculosis%20reveals%20distinct%20disease%20profiles%20between%20Indian%20and%20Chinese%20populations.%20Sci%20Rep.%202019%2029%3B9%281%29%3A8002.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DKIA7K7CQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20degree%20of%20perturbation%20of%20plasma%20inflammatory%20markers%20associated%20with%20tuberculosis%20reveals%20distinct%20disease%20profiles%20between%20Indian%20and%20Chinese%20populations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deivide%22%2C%22lastName%22%3A%22Oliveira-de-Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caian%20L.%22%2C%22lastName%22%3A%22Vinhaes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20B.%22%2C%22lastName%22%3A%22Arriaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathella%20Pavan%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20M.%22%2C%22lastName%22%3A%22Cubillos-Angulo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruiru%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wang%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xing%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guolong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifton%20E.%22%2C%22lastName%22%3A%22Barry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20E.%22%2C%22lastName%22%3A%22Via%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Sher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subash%22%2C%22lastName%22%3A%22Babu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrin%20D.%22%2C%22lastName%22%3A%22Mayer-Barber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helder%20I.%22%2C%22lastName%22%3A%22Nakaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyoshi%20F.%22%2C%22lastName%22%3A%22Fukutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%20B.%22%2C%22lastName%22%3A%22Andrade%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20a%20chronic%20inflammatory%20disease%20caused%20by%20Mycobacterium%20tuberculosis%20infection%20which%20causes%20tremendous%20morbidity%20and%20mortality%20worldwide.%20Clinical%20presentation%20of%20TB%20patients%20is%20very%20diverse%20and%20disease%20heterogeneity%20is%20associated%20with%20changes%20in%20biomarker%20signatures.%20Here%2C%20we%20compared%20at%20the%20molecular%20level%20the%20extent%20of%20individual%20inflammatory%20perturbation%20of%20plasma%20protein%20and%20lipid%20mediators%20associated%20with%20TB%20in%20patients%20in%20China%20versus%20India.%20We%20performed%20a%20cross-sectional%20study%20analyzing%20the%20overall%20degree%20of%20inflammatory%20perturbation%20in%20treatment-na%5Cu00efve%20pulmonary%20TB%20patients%20and%20uninfected%20individuals%20from%20India%20%28TB%3A%20n%5Cu2009%3D%5Cu200997%2C%20healthy%3A%20n%5Cu2009%3D%5Cu200920%29%20and%20China%20%28TB%3A%20n%5Cu2009%3D%5Cu2009100%2C%20healthy%3A%20n%5Cu2009%3D%5Cu200911%29.%20We%20employed%20the%20molecular%20degree%20of%20perturbation%20%28MDP%29%20adapted%20to%20plasma%20biomarkers%20to%20examine%20the%20overall%20changes%20in%20inflammation%20between%20these%20countries.%20M.%20tuberculosis%20infection%20caused%20a%20significant%20degree%20of%20molecular%20perturbation%20in%20patients%20from%20both%20countries%2C%20with%20higher%20perturbation%20detected%20in%20India.%20Interestingly%2C%20there%20were%20differences%20in%20biomarker%20perturbation%20patterns%20and%20the%20overall%20degree%20of%20inflammation.%20Patients%20with%20severe%20TB%20exhibited%20increased%20MDP%20values%20and%20Indian%20patients%20with%20this%20condition%20exhibited%20even%20higher%20degree%20of%20perturbation%20compared%20to%20Chinese%20patients.%20Network%20analyses%20identified%20IFN-%5Cu03b1%2C%20IFN-%5Cu03b2%2C%20IL-1RI%20and%20TNF-%5Cu03b1%20as%20combined%20biomarkers%20that%20account%20for%20the%20overall%20molecular%20perturbation%20in%20the%20entire%20study%20population.%20Our%20results%20delineate%20the%20magnitude%20of%20the%20systemic%20inflammatory%20perturbation%20in%20pulmonary%20TB%20and%20reveal%20qualitative%20changes%20in%20inflammatory%20profiles%20between%20two%20countries%20with%20high%20disease%20prevalence.%22%2C%22date%22%3A%2205%2029%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-019-44513-8%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A06%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22R6JTWXTG%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Perez-Patrigeon%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPerez-Patrigeon%20S%2C%20Camiro-Z%26%23xFA%3B%26%23xF1%3Biga%20A%2C%20Jaramillo-Jante%20MR%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Crabtree-Ram%26%23xED%3Brez%20B%2C%20Soto-Ram%26%23xED%3Brez%20LE%2C%20et%20al.%20Immediate%20treatment%20of%20acute%20HIV%20in%20a%20tertiary%20healthcare%20center%3A%20bridging%20gaps%20in%20communication%20using%20smartphones.%20HIV%20Med.%202019%3B20%285%29%3A308%26%23x2013%3B16.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DR6JTWXTG%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immediate%20treatment%20of%20acute%20HIV%20in%20a%20tertiary%20healthcare%20center%3A%20bridging%20gaps%20in%20communication%20using%20smartphones%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Perez-Patrigeon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Camiro-Z%5Cu00fa%5Cu00f1iga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20R.%22%2C%22lastName%22%3A%22Jaramillo-Jante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20E.%22%2C%22lastName%22%3A%22Soto-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20J.%22%2C%22lastName%22%3A%22Calva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Hern%5Cu00e1ndez-Le%5Cu00f3n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22Mosqueda-G%5Cu00f3mez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Navarro-Alvarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Early%20initiation%20of%20antiretroviral%20therapy%20%28ART%29%20during%20acute%20HIV%20infection%20is%20associated%20with%20favourable%20clinical%20and%20epidemiological%20outcomes.%20Barriers%20to%20prompt%20treatment%20initiation%20limit%20the%20benefits%20of%20universal%20access%20to%20ART%20in%20Mexico.%20We%20sought%20to%20create%20an%20algorithm%20for%20the%20immediate%20detection%20and%20treatment%20of%20patients%20with%20acute%20HIV%20infection.%5CnMETHODS%3A%20A%20nationwide%20cohort%20of%20patients%20with%20acute%20HIV%20infection%20was%20created%20in%202015.%20In%20order%20to%20identify%20cases%20and%20treat%20them%20promptly%20at%20our%20centre%2C%20an%20interdisciplinary%20group%20coordinated%20through%20an%20instant-messaging%20tool%20using%20smart%20phones%20was%20established.%20When%20a%20probable%20case%20was%20detected%2C%20a%20discussion%20was%20initiated%20to%20confirm%20the%20diagnosis%20and%20facilitate%20the%20administrative%20processes%20to%20initiate%20ART%20as%20soon%20as%20possible.%20We%20compared%20time%20to%20ART%20initiation%20with%20that%20in%20a%20comparison%20group%20of%20patients%20with%20chronic%20HIV%20infection%20enrolled%20during%20the%20same%20period%20%28May%202015%20to%20February%202017%29%20through%20routine%20care%2C%20using%20survival%20analysis%20estimators%20and%20log-rank%20tests.%5CnRESULTS%3A%20We%20recruited%2029%20patients%20with%20acute%20HIV%20infection.%20The%20median%20time%20to%20ART%20initiation%20was%202%5Cu00a0days%20in%20these%20patients%2C%20in%20contrast%20to%2021%5Cu00a0days%20for%20patients%20with%20chronic%20infection.%20There%20were%20no%20significant%20differences%20in%20the%20percentages%20of%20patients%20engaged%20in%20care%2C%20on%20treatment%20or%20virologically%20suppressed%20at%201%5Cu00a0year%20of%20follow-up.%5CnCONCLUSIONS%3A%20Implementing%20immediate%20ART%20initiation%20programmes%20is%20feasible%20in%20Mexico%2C%20in%20spite%20of%20the%20substantial%20administrative%20barriers%20that%20exist%20in%20the%20country.%20More%20extensive%20replication%20of%20this%20model%20in%20other%20centres%20and%20in%20patients%20with%20chronic%20infection%20is%20warranted%20to%20evaluate%20its%20effect%20on%20the%20continuum%20of%20care.%22%2C%22date%22%3A%2205%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fhiv.12713%22%2C%22ISSN%22%3A%221468-1293%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A06%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22ZMB3V67B%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gygli%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGygli%20SM%2C%20Keller%20PM%2C%20Ballif%20M%2C%20Bl%26%23xF6%3Bchliger%20N%2C%20H%26%23xF6%3Bmke%20R%2C%20Reinhard%20M%2C%20et%20al.%20Whole-Genome%20Sequencing%20for%20Drug%20Resistance%20Profile%20Prediction%20in%20Mycobacterium%20tuberculosis.%20Antimicrob%20Agents%20Chemother.%202019%3B63%284%29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DZMB3V67B%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Whole-Genome%20Sequencing%20for%20Drug%20Resistance%20Profile%20Prediction%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%20M.%22%2C%22lastName%22%3A%22Gygli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20M.%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Bl%5Cu00f6chliger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rico%22%2C%22lastName%22%3A%22H%5Cu00f6mke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Reinhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Loiseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Ritter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Borrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Collantes%20Loo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anchalee%22%2C%22lastName%22%3A%22Avihingsanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joachim%22%2C%22lastName%22%3A%22Gnokoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%5D%2C%22abstractNote%22%3A%22Whole-genome%20sequencing%20allows%20rapid%20detection%20of%20drug-resistant%20Mycobacterium%20tuberculosis%20isolates.%20However%2C%20the%20availability%20of%20high-quality%20data%20linking%20quantitative%20phenotypic%20drug%20susceptibility%20testing%20%28DST%29%20and%20genomic%20data%20have%20thus%20far%20been%20limited.%20We%20determined%20drug%20resistance%20profiles%20of%20176%20genetically%20diverse%20clinical%20M.%20tuberculosis%20isolates%20from%20the%20Democratic%20Republic%20of%20the%20Congo%2C%20Ivory%20Coast%2C%20Peru%2C%20Thailand%2C%20and%20Switzerland%20by%20quantitative%20phenotypic%20DST%20for%2011%20antituberculous%20drugs%20using%20the%20BD%20Bactec%20MGIT%20960%20system%20and%207H10%20agar%20dilution%20to%20generate%20a%20cross-validated%20phenotypic%20DST%20readout.%20We%20compared%20DST%20results%20with%20predicted%20drug%20resistance%20profiles%20inferred%20by%20whole-genome%20sequencing.%20Classification%20of%20strains%20by%20the%20two%20phenotypic%20DST%20methods%20into%20resistotype%5C%2Fwild-type%20populations%20was%20concordant%20in%2073%20to%2099%25%20of%20cases%2C%20depending%20on%20the%20drug.%20Our%20data%20suggest%20that%20the%20established%20critical%20concentration%20%285%5Cu2009mg%5C%2Fliter%29%20for%20ethambutol%20resistance%20%28MGIT%20960%20system%29%20is%20too%20high%20and%20misclassifies%20strains%20as%20susceptible%2C%20unlike%207H10%20agar%20dilution.%20Increased%20minimal%20inhibitory%20concentrations%20were%20explained%20by%20mutations%20identified%20by%20whole-genome%20sequencing.%20Using%20whole-genome%20sequences%2C%20we%20were%20able%20to%20predict%20quantitative%20drug%20resistance%20levels%20for%20the%20majority%20of%20drug%20resistance%20mutations.%20Predicting%20quantitative%20levels%20of%20drug%20resistance%20by%20whole-genome%20sequencing%20was%20partially%20limited%20due%20to%20incompletely%20understood%20drug%20resistance%20mechanisms.%20The%20overall%20sensitivity%20and%20specificity%20of%20whole-genome-based%20DST%20were%2086.8%25%20and%2094.5%25%2C%20respectively.%20Despite%20some%20limitations%2C%20whole-genome%20sequencing%20has%20the%20potential%20to%20infer%20resistance%20profiles%20without%20the%20need%20for%20time-consuming%20phenotypic%20methods.%22%2C%22date%22%3A%2204%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.02175-18%22%2C%22ISSN%22%3A%221098-6596%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A06%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22E884HPVF%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Crabtree-Ram%5Cu00edrez%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree-Ram%26%23xED%3Brez%20B%2C%20Jenkins%20C%2C%20Jayathilake%20K%2C%20Carriquiry%20G%2C%20Veloso%20V%2C%20Padgett%20D%2C%20et%20al.%20HIV-related%20tuberculosis%3A%20mortality%20risk%20in%20persons%20without%20vs.%20with%20culture-confirmed%20disease.%20Int%20J%20Tuberc%20Lung%20Dis.%202019%2001%3B23%283%29%3A306%26%23x2013%3B14.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DE884HPVF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV-related%20tuberculosis%3A%20mortality%20risk%20in%20persons%20without%20vs.%20with%20culture-confirmed%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Tuberculosis%20%28TB%29%20diagnosis%20in%20human%20immunodeficiency%20virus%20%28HIV%29%20positive%20persons%20is%20difficult%2C%20particularly%20in%20resource-limited%20settings.%20The%20relationship%20between%20TB%20culture%20status%20and%20mortality%20in%20HIV-positive%20persons%20treated%20for%20TB%20is%20unclear.%5CnMETHODS%3A%20We%20evaluated%20HIV-positive%20adults%20treated%20for%20TB%20at%20or%20after%20their%20first%20HIV%20clinic%20visit%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Honduras%2C%20Mexico%20or%20Peru%20from%202000%20to%202015.%20Anti-tuberculosis%20treatment%20included%202%20months%20of%20isoniazid%2C%20rifampicin%20%28RMP%29%5C%2Frifabutin%20%28RBT%29%2C%20pyrazinamide%20%5Cu00b1%20ethambutol%2C%20followed%20by%20continuation%20phase%20treatment%20with%20isoniazid%20%2B%20RMP%5C%2FRBT.%5CnRESULTS%3A%20Of%20759%20TB-HIV%20patients%2C%20238%20%2831%25%29%20were%20culture-negative%2C%20228%20%2830%25%29%20had%20unknown%20culture%20status%20or%20did%20not%20undergo%20culture%20and%20293%20%2839%25%29%20were%20culture-positive.%20The%20median%20CD4%20at%20TB%20diagnosis%20was%2096%20%28interquartile%20range%2040-228%29%3B%20636%20%2884%25%29%20received%20concurrent%20antiretroviral%20therapy%20%28ART%29%20and%20anti-tuberculosis%20treatment.%20There%20were%20123%20%2816%25%29%20deaths%3A%2090%5C%2F466%20%2819%25%29%20with%20TB%20culture-negative%2C%20unknown%20or%20not%20performed%20vs.%2033%5C%2F293%20%2811%25%29%20who%20were%20TB%20culture-positive%20%28P%20%3D%200.005%29.%20In%20Kaplan-Meier%20analysis%2C%20mortality%20in%20TB%20patients%20without%20culture-confirmed%20disease%20was%20higher%20%28P%20%3D%200.002%29.%20In%20a%20Cox%20model%20adjusted%20for%20age%2C%20sex%2C%20CD4%2C%20ART%20timing%2C%20disease%20site%20and%20stratified%20by%20study%20site%2C%20mortality%20in%20persons%20without%20culture-confirmed%20TB%20was%20not%20significantly%20increased%20compared%20to%20those%20with%20culture-positive%20TB%20%28hazard%20ratio%201.39%2C%2095%25CI%200.89-2.16%2C%20P%20%3D%200.15%29.%5CnCONCLUSION%3A%20Most%20HIV-positive%20patients%20treated%20for%20TB%20did%20not%20have%20culture-confirmed%20TB%2C%20and%20mortality%20tended%20to%20be%20higher%20in%20patients%20without%20culture-confirmed%20disease%2C%20although%20the%20association%20was%20not%20statistically%20different%20after%20adjusting%20for%20other%20variables.%20Accurate%20TB%20diagnosis%20in%20HIV-positive%20persons%20is%20crucial.%22%2C%22date%22%3A%2203%2001%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.18.0111%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A05%3A55Z%22%7D%7D%2C%7B%22key%22%3A%229W7JF8IG%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A414120%2C%22username%22%3A%22sndu%22%2C%22name%22%3A%22Steph%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fsndu%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Castilho%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECastilho%20JL%2C%20Escuder%20MM%2C%20Veloso%20V%2C%20Gomes%20JO%2C%20Jayathilake%20K%2C%20Ribeiro%20S%2C%20et%20al.%20Trends%20and%20predictors%20of%20non-communicable%20disease%20multimorbidity%20among%20adults%20living%20with%20HIV%20and%20receiving%20antiretroviral%20therapy%20in%20Brazil.%20J%20Int%20AIDS%20Soc.%202019%3B22%281%29%3Ae25233.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9W7JF8IG%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Trends%20and%20predictors%20of%20non-communicable%20disease%20multimorbidity%20among%20adults%20living%20with%20HIV%20and%20receiving%20antiretroviral%20therapy%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20M.%22%2C%22lastName%22%3A%22Escuder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jackeline%20O.%22%2C%22lastName%22%3A%22Gomes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayonara%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%20A.%22%2C%22lastName%22%3A%22Souza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20L.%22%2C%22lastName%22%3A%22Ikeda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulo%20R.%22%2C%22lastName%22%3A%22de%20Alencastro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Unai%22%2C%22lastName%22%3A%22Tupinanbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Brites%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Grangeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20People%20living%20with%20HIV%20%28PLHIV%29%20on%20antiretroviral%20therapy%20%28ART%29%20experience%20high%20rates%20of%20non-communicable%20diseases%20%28NCDs%29.%20These%20co-morbidities%20often%20accumulate%20and%20older%20adults%20may%20suffer%20from%20multimorbidity.%20Multimorbidity%20has%20been%20associated%20with%20loss%20of%20quality%20of%20life%2C%20polypharmacy%2C%20and%20increased%20risk%20of%20frailty%20and%20mortality.%20Little%20is%20known%20of%20the%20trends%20or%20predictors%20NCD%20multimorbidity%20in%20PLHIV%20in%20low-%20and%20middle-income%20countries.%5CnMETHODS%3A%20We%20examined%20NCD%20multimorbidity%20in%20adult%20PLHIV%20initiating%20ART%20between%202003%20and%202014%20using%20a%20multi-site%2C%20observational%20cohort%20in%20Brazil.%20NCDs%20included%20cardiovascular%20artery%20disease%2C%20hyperlipidemia%20%28HLD%29%2C%20diabetes%2C%20chronic%20kidney%20disease%2C%20cirrhosis%2C%20osteoporosis%2C%20osteonecrosis%2C%20venous%20thromboembolism%20and%20non-AIDS-defining%20cancers.%20Multimorbidity%20was%20defined%20as%20the%20incident%20accumulation%20of%20two%20or%20more%20unique%20NCDs.%20We%20used%20Poisson%20regression%20to%20examine%20trends%20and%20Cox%20proportional%20hazard%20models%20to%20examine%20predictors%20of%20multimorbidity.%5CnRESULTS%3A%20Of%20the%206206%20adults%2C%20332%20%285%25%29%20developed%20multimorbidity%20during%20the%20study%20period.%20Parallel%20to%20the%20ageing%20of%20the%20cohort%2C%20the%20prevalence%20of%20multimorbidity%20rose%20from%203%25%20to%2011%25%20during%20the%20study%20period.%20Older%20age%2C%20female%20sex%20%28adjusted%20hazard%20ratio%20%28aHR%29%5Cu00a0%3D%5Cu00a01.30%20%2895%25%20confidence%20interval%20%28CI%29%201.03%20to%201.65%29%29%20and%20low%20CD4%20nadir%20%28%3C100%20vs.%20%5Cu2265200%5Cu00a0cells%5C%2Fmm3%20aHR%5Cu00a0%3D%5Cu00a01.52%20%2895%25%20CI%3A%201.15%20to%202.01%29%29%20at%20cohort%20entry%20were%20significantly%20associated%20with%20increased%20risk%20of%20multimorbidity.%20Among%20patients%20with%20incident%20multimorbidity%2C%20the%20most%20common%20NCDs%20were%20HLD%20and%20diabetes%3B%20however%2C%20osteoporosis%20was%20also%20frequent%20in%20women%20%2816%20vs.%2035%25%20of%20men%20and%20women%20with%20multimorbidity%20respectively%29.%5CnCONCLUSIONS%3A%20Among%20adult%20PLHIV%20in%20Brazil%2C%20NCD%20multimorbidity%20increased%20from%202003%20to%202014.%20Females%20and%20adults%20with%20low%20CD4%20nadir%20were%20at%20increased%20risk%20in%20adjusted%20analyses.%20Further%20studies%20examining%20prevention%2C%20screening%20and%20management%20of%20NCDs%20in%20PLHIV%20in%20low-%20and%20middle-income%20countries%20are%20needed.%22%2C%22date%22%3A%2201%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25233%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A05%3A24Z%22%7D%7D%5D%7D
1.
Giganti MJ, Shepherd BE, Caro-Vega Y, Luz PM, Rebeiro PF, Maia M, et al. The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data. BMC Public Health. 2019 Dec 30;19(1):1748. Cite
1.
Silveira-Mattos PS, Barreto-Duarte B, Vasconcelos B, Fukutani KF, Vinhaes CL, Oliveira-de-Souza D, et al. Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T-cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection. Clin Infect Dis. 2019 Oct 30; Cite
1.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. Lancet HIV. 2019 Feb;6(2):e105–15. Cite
1.
Pettit AC, Jenkins CA, Blevins Peratikos M, Yotebieng M, Diero L, Do CD, et al. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. J Int AIDS Soc. 2019;22(12):e25423. Cite
1.
Crabtree-Ramírez BE, Caro-Vega Y, Belaunzarán-Zamudio PF, Shepherd BE, Rebeiro PF, Veloso V, et al. Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study. J Int AIDS Soc. 2019;22(12):e25413. Cite
1.
Stover J, Glaubius R, Mofenson L, Dugdale CM, Davies MA, Patten G, et al. Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS. 2019 15;33 Suppl 3:S227–34. Cite
1.
Johnson LF, Anderegg N, Zaniewski E, Eaton JW, Rebeiro PF, Carriquiry G, et al. Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS. 2019 15;33 Suppl 3:S283–94. Cite
1.
Jesson J, Schomaker M, Malasteste K, Wati DK, Kariminia A, Sylla M, et al. Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. J Int AIDS Soc. 2019;22(11):e25412. Cite
1.
Vinhaes CL, Oliveira-de-Souza D, Silveira-Mattos PS, Nogueira B, Shi R, Wei W, et al. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study. Cytokine. 2019;123:154759. Cite
1.
Rivera VR, Lu L, Ocheretina O, Jean Juste MA, Julma P, Archange D, et al. Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti. Int J Tuberc Lung Dis. 2019 01;23(11):1217–22. Cite
1.
Zürcher K, Ballif M, Kiertiburanakul S, Chenal H, Yotebieng M, Grinsztejn B, et al. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. J Int AIDS Soc. 2019;22(9):e25392. Cite
1.
Cubillos-Angulo JM, Arriaga MB, Silva EC, Müller BLA, Ramalho DMP, Fukutani KF, et al. Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study. Clin Infect Dis. 2019 30;69(6):1027–35. Cite
1.
Brazier E, Maruri F, Duda SN, Tymejczyk O, Wester CW, Somi G, et al. Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. J Int AIDS Soc. 2019;22(7):e25331. Cite
1.
Tymejczyk O, Brazier E, Yiannoutsos CT, Vinikoor M, van Lettow M, Nalugoda F, et al. Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Med. 2019;16(6):e1002822. Cite
1.
Oliveira-de-Souza D, Vinhaes CL, Arriaga MB, Kumar NP, Cubillos-Angulo JM, Shi R, et al. Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations. Sci Rep. 2019 29;9(1):8002. Cite
1.
Perez-Patrigeon S, Camiro-Zúñiga A, Jaramillo-Jante MR, Belaunzarán-Zamudio PF, Crabtree-Ramírez B, Soto-Ramírez LE, et al. Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones. HIV Med. 2019;20(5):308–16. Cite
1.
Gygli SM, Keller PM, Ballif M, Blöchliger N, Hömke R, Reinhard M, et al. Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2019;63(4). Cite
1.
Crabtree-Ramírez B, Jenkins C, Jayathilake K, Carriquiry G, Veloso V, Padgett D, et al. HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease. Int J Tuberc Lung Dis. 2019 01;23(3):306–14. Cite
1.
Castilho JL, Escuder MM, Veloso V, Gomes JO, Jayathilake K, Ribeiro S, et al. Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil. J Int AIDS Soc. 2019;22(1):e25233. Cite
2018
76770
IP6F4TRX
2018
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-2348b6c8554c00d3e268eee96c54c0b2%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HDIFQZW4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zaniewski%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZaniewski%20E%2C%20Tymejczyk%20O%2C%20Kariminia%20A%2C%20Desmonde%20S%2C%20Leroy%20V%2C%20Ford%20N%2C%20et%20al.%20IeDEA-WHO%20Research-Policy%20Collaboration%3A%20contributing%20real-world%20evidence%20to%20HIV%20progress%20reporting%20and%20guideline%20development.%20J%20Virus%20Erad.%202018%20Nov%2015%3B4%28Suppl%202%29%3A9%26%23x2013%3B15.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DHDIFQZW4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22IeDEA-WHO%20Research-Policy%20Collaboration%3A%20contributing%20real-world%20evidence%20to%20HIV%20progress%20reporting%20and%20guideline%20development%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Desmonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%5D%2C%22abstractNote%22%3A%22Partnerships%20between%20researchers%20and%20policymakers%20can%20improve%20uptake%20and%20integration%20of%20scientific%20evidence.%20This%20article%20describes%20the%20research-policy%20partnership%20between%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20%28%20www.iedea.org%29%20and%20the%20World%20Health%20Organization%20%28WHO%29%2C%20which%20was%20established%20in%202014.%20IeDEA%20is%20an%20international%20research%20consortium%2C%20which%20analyses%20data%20on%20almost%202%20million%20people%20living%20with%20HIV%20under%20care%20in%20routine%20settings%20in%2046%20countries%20in%20Asia-Pacific%2C%20the%20Caribbean%2C%20Central%20and%20South%20America%2C%20North%20America%20and%20sub-Saharan%20Africa.%20Five%20multiregional%20analyses%20were%20identified%20to%20inform%20the%20WHO%20on%20progress%20towards%20the%20second%20and%20third%2090s%20of%20the%2090-90-90%20targets%20in%20adults%20and%20children%3A%20%28i%29%20trends%20in%20CD4%20cell%20counts%20at%20the%20start%20of%20antiretroviral%20therapy%20%28ART%29%3B%20%28ii%29%20delays%20from%20enrolment%20in%20HIV%20care%20to%20ART%20initiation%3B%20%28iii%29%20the%20impact%20of%20ART%20guideline%20changes%3B%20%28iv%29%20retention%20in%20care%2C%20mortality%20and%20loss%20to%20follow-up%3B%20and%20%28v%29%20viral%20suppression%20within%20the%20first%203%20years%20after%20initiating%20ART.%20Results%20from%20these%20analyses%20were%20contributed%20to%20the%202015%20and%202016%20WHO%20global%20HIV%20progress%20reports%2C%20will%20contribute%20to%20the%202018%20report%2C%20and%20were%20published%20in%20academic%20journals.%20The%20partnership%20has%20been%20mutually%20beneficial%3A%20discussion%20of%20WHO%20policy%20agendas%20led%20to%20more%20policy-framed%2C%20relevant%20and%20timely%20IeDEA%20research%2C%20and%20the%20collaboration%20provided%20the%20WHO%20with%20timely%20access%20to%20the%20latest%20data%20from%20IeDEA%2C%20as%20it%20was%20shared%20prior%20to%20peer-review%20publication.%22%2C%22date%22%3A%22Nov%2015%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222055-6640%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A02%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22UZMKW2G5%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ford%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFord%20N%2C%20Penazzato%20M%2C%20Vitoria%20M%2C%20Doherty%20M%2C%20Davies%20MA%2C%20Zaniewski%20E%2C%20et%20al.%20The%20contribution%20of%20observational%20studies%20in%20supporting%20the%20WHO%20%26%23x201C%3Btreat%20all%26%23x201D%3B%20recommendation%20for%20HIV%5C%2FAIDS.%20J%20Virus%20Erad.%202018%20Nov%2015%3B4%28Suppl%202%29%3A5%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DUZMKW2G5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20contribution%20of%20observational%20studies%20in%20supporting%20the%20WHO%20%27treat%20all%27%20recommendation%20for%20HIV%5C%2FAIDS%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Penazzato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Vitoria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meg%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22In%202015%2C%20the%20World%20Health%20Organization%20%28WHO%29%20recommended%20that%20all%20people%20living%20with%20HIV%20%28PLWH%29%20should%20start%20antiretroviral%20therapy%20%28ART%29%20irrespective%20of%20clinical%20or%20immune%20status.%20This%20recommendation%20followed%20almost%2020%20years%20of%20research%20into%20the%20clinical%20and%20population-level%20benefits%20and%20risks%20of%20starting%20ART%20early%20compared%20with%20deferring%20treatment.%20This%20article%20summarises%20the%20ways%20in%20which%20observational%20data%20support%20the%20work%20of%20WHO%2C%20including%20the%20support%20provided%20by%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%2C%20taking%20the%20example%20of%20%27treat%20all%27.%22%2C%22date%22%3A%22Nov%2015%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222055-6640%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A01%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22RWL2D3KL%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guiteau%20Moise%20et%20al.%22%2C%22parsedDate%22%3A%222018-09-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGuiteau%20Moise%20C%2C%20Rivera%20VR%2C%20Hennessey%20KA%2C%20Bellot%20C%2C%20Nicholas%20C%2C%20Fang%20AP%2C%20et%20al.%20A%20Successful%20Model%20of%20Expedited%20Antiretroviral%20Therapy%20for%20Clinically%20Stable%20Patients%20Living%20With%20HIV%20in%20Haiti.%20J%20Acquir%20Immune%20Defic%20Syndr.%202018%20Sep%201%3B79%281%29%3A70%26%23x2013%3B6.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DRWL2D3KL%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Successful%20Model%20of%20Expedited%20Antiretroviral%20Therapy%20for%20Clinically%20Stable%20Patients%20Living%20With%20HIV%20in%20Haiti%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colette%22%2C%22lastName%22%3A%22Guiteau%20Moise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%20R.%22%2C%22lastName%22%3A%22Rivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%20A.%22%2C%22lastName%22%3A%22Hennessey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clovy%22%2C%22lastName%22%3A%22Bellot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Nicholas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20P.%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rose%20Ir%5Cu00e8ne%22%2C%22lastName%22%3A%22Verdier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrice%22%2C%22lastName%22%3A%22Severe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Sainvil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benedict%22%2C%22lastName%22%3A%22Charles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derothy%22%2C%22lastName%22%3A%22Dorval%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juseline%22%2C%22lastName%22%3A%22St%20Amour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%20P.%22%2C%22lastName%22%3A%22Koenig%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Recommendations%20for%20universal%20antiretroviral%20therapy%20have%20greatly%20increased%20the%20number%20of%20HIV-infected%20patients%20who%20qualify%20for%20treatment%2C%20particularly%20with%20early%20clinical%20disease.%20Less%20intensive%20models%20of%20care%20are%20needed%20for%20clinically%20stable%20patients.%5CnSETTING%3A%20A%20rapid%20pathway%20%28RP%29%20model%20of%20expedited%20outpatient%20care%20for%20clinically%20stable%20patients%20was%20implemented%20at%20the%20Haitian%20Group%20for%20the%20Study%20of%20Kaposi%27s%20Sarcoma%20and%20Opportunistic%20Infections%20%28GHESKIO%29%20Center%2C%20Port-au-Prince%2C%20Haiti.%20Expedited%20visits%20included%20nurse-led%20assessments%20and%20point-of-service%20antiretroviral%20therapy%20dispensing.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20analysis%20including%20patients%20who%20initiated%20RP%20care%20between%20June%201%2C%202014%2C%20and%20September%2030%2C%202015%2C%20comparing%20outcomes%20of%20patients%20with%20timely%20visit%20attendance%20%28never%20%3E3%20days%20late%29%20with%20patients%20with%20%5Cu22651%20nontimely%20visit%20within%206%20months%20before%20RP%20enrollment.%20We%20calculated%20retention%20in%20care%20and%20adherence%20at%2012%20months%2C%20and%20assessed%20predictors%20of%20both%20outcomes.%5CnRESULTS%3A%20Of%20the%202361%20patients%20who%20initiated%20RP%20care%20during%20the%20study%20period%2C%201429%20%2861%25%29%20had%20timely%20visit%20attendance%20and%20932%20%2839%25%29%20had%20%5Cu22651%20nontimely%20visit%20before%20RP%20enrollment.%20Among%20RP-enrolled%20patients%2C%2094%25%20were%20retained%20at%2012%20months%20and%2075%25%20had%20%5Cu226590%25%20adherence%2C%20with%20higher%20proportions%20in%20those%20with%20timely%20pre-RP%20visits%20%2895%25%20vs.%2092%25%3B%2087%25%20vs.%2055%25%29.%20In%20multivariable%20analysis%2C%20pre-RP%20visit%20timeliness%20was%20associated%20with%20both%20retention%20%28adjusted%20odds%20ratio%3A%201.67%3B%2095%25%20confidence%20interval%3A%201.08%20to%202.59%29%20and%20adherence%20%28adjusted%20odds%20ratio%3A%204.53%3B%2095%25%20confidence%20interval%3A%203.58%20to%205.72%29.%5CnCONCLUSIONS%3A%20RP%20care%20was%20associated%20with%20high%20levels%20of%20retention%20and%20adherence%20for%20clinically%20stable%20patients.%20Timeliness%20of%20pre-RP%20visits%20was%20predictive%20of%20outcomes%20after%20RP%20initiation.%22%2C%22date%22%3A%22Sep%2001%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000001725%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A24%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22SWLBTK4P%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bakal%20et%20al.%22%2C%22parsedDate%22%3A%222018-08-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBakal%20DR%2C%20Coelho%20LE%2C%20Luz%20PM%2C%20Clark%20JL%2C%20De%20Boni%20RB%2C%20Cardoso%20SW%2C%20et%20al.%20Obesity%20following%20ART%20initiation%20is%20common%20and%20influenced%20by%20both%20traditional%20and%20HIV-%5C%2FART-specific%20risk%20factors.%20J%20Antimicrob%20Chemother.%202018%20Aug%201%3B73%288%29%3A2177%26%23x2013%3B85.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DSWLBTK4P%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Obesity%20following%20ART%20initiation%20is%20common%20and%20influenced%20by%20both%20traditional%20and%20HIV-%5C%2FART-specific%20risk%20factors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20R.%22%2C%22lastName%22%3A%22Bakal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20L.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%20B.%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20W.%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20E.%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Obesity%20rates%20are%20increasing%20among%20HIV-infected%20individuals%2C%20but%20risk%20factors%20for%20obesity%20development%20on%20ART%20remain%20unclear.%5CnObjectives%3A%20In%20a%20cohort%20of%20HIV-infected%20adults%20in%20Rio%20de%20Janeiro%2C%20Brazil%2C%20we%20aimed%20to%20determine%20obesity%20rates%20before%20and%20after%20ART%20initiation%20and%20to%20analyse%20risk%20factors%20for%20obesity%20on%20ART.%5CnMethods%3A%20We%20retrospectively%20analysed%20data%20from%20individuals%20initiating%20ART%20between%202000%20and%202015.%20BMI%20was%20calculated%20at%20baseline%20%28time%20of%20ART%20initiation%29.%20Participants%20who%20were%20non-obese%20at%20baseline%20and%20had%20%5Cu226590%5Cu2009days%20of%20ART%20exposure%20were%20followed%20until%20the%20development%20of%20obesity%20or%20the%20end%20of%20follow-up.%20Obesity%20incidence%20rates%20were%20estimated%20using%20Poisson%20regression%20models%20and%20risk%20factors%20were%20assessed%20using%20Cox%20regression%20models.%5CnResults%3A%20Of%20participants%20analysed%20at%20baseline%20%28n%5Cu2009%3D%5Cu20091794%29%2C%2061.3%25%20were%20male%2C%2048.3%25%20were%20white%20and%207.9%25%20were%20obese.%20Among%20participants%20followed%20longitudinally%20%28n%5Cu2009%3D%5Cu20091567%29%2C%2066.2%25%20primarily%20used%20an%20NNRTI%2C%2032.9%25%20a%20PI%20and%200.9%25%20an%20integrase%20strand%20transfer%20inhibitor%20%28INSTI%29%3B%2018.3%25%20developed%20obesity%20and%20obesity%20incidence%20was%2037.4%20per%201000%20person-years.%20In%20multivariable%20analysis%2C%20the%20greatest%20risk%20factor%20for%20developing%20obesity%20was%20the%20use%20of%20an%20INSTI%20as%20the%20primary%20ART%20core%20drug%20%28adjusted%20HR%207.12%2C%20P%5Cu2009%3C%5Cu20090.0001%29%3B%20other%20risk%20factors%20included%20younger%20age%2C%20female%20sex%2C%20higher%20baseline%20BMI%2C%20lower%20baseline%20CD4%2B%20T%20lymphocyte%20count%2C%20higher%20baseline%20HIV-1%20RNA%2C%20hypertension%20and%20diabetes%20mellitus.%5CnConclusions%3A%20Obesity%20following%20ART%20initiation%20is%20frequent%20among%20HIV-infected%20adults.%20Key%20risk%20factors%20include%20female%20sex%2C%20HIV%20disease%20severity%20and%20INSTI%20use.%20Further%20research%20regarding%20the%20association%20between%20INSTIs%20and%20the%20development%20of%20obesity%20is%20needed.%22%2C%22date%22%3A%22Aug%2001%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdky145%22%2C%22ISSN%22%3A%221460-2091%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A25%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22BW5BS9Y4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222018-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoelho%20L%2C%20Rebeiro%20PF%2C%20Castilho%20JL%2C%20Caro-Veja%20Y%2C%20Mejia%20FA%2C%20Cesar%20C%2C%20et%20al.%20Early%20Retention%20in%20Care%20Neither%20Mediates%20Nor%20Modifies%20the%20Effect%20of%20Sex%20and%20Sexual%20Mode%20of%20HIV%20Acquisition%20on%20HIV%20Survival%20in%20the%20Americas.%20AIDS%20Patient%20Care%20STDS.%202018%20Aug%3B32%288%29%3A306%26%23x2013%3B13.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DBW5BS9Y4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Early%20Retention%20in%20Care%20Neither%20Mediates%20Nor%20Modifies%20the%20Effect%20of%20Sex%20and%20Sexual%20Mode%20of%20HIV%20Acquisition%20on%20HIV%20Survival%20in%20the%20Americas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Veja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%20A.%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22Early%20retention%20in%20care%2C%20sex%2C%20and%20sexual%20mode%20of%20HIV%20acquisition%20has%20been%20associated%20with%20mortality%20risk%20among%20persons%20living%20with%20HIV%20%28PLWH%29.%20We%20assessed%20whether%20early%20retention%20in%20care%20mediates%20or%20modifies%20the%20association%20between%20mortality%20and%20sex%20and%20sexual%20mode%20of%20HIV%20acquisition%20among%20PLWH%20on%20antiretroviral%20therapy%20%28ART%29%20in%20the%20Americas.%20ART-na%5Cu00efve%2C%20adult%20PLWH%20%28%5Cu226518%20years%29%20enrolling%20at%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20and%20Vanderbilt%20Comprehensive%20Care%20Clinic%20sites%202000-2015%2C%20starting%20ART%2C%20and%20with%20%5Cu22651%20visit%20after%20ART-start%20were%20included.%20Early%20retention%20in%20care%20was%20defined%20as%20%5Cu22652%20HIV%20care%20visits%5C%2Flabs%20%5Cu226590%20days%20apart%20in%20the%20first%20year%20of%20ART.%20Cox%20models%20assessed%20the%20association%20between%20early%20retention%20in%20care%2C%20sex%2C%20and%20sexual%20mode%20of%20HIV%20acquisition%20%5Bi.e.%2C%20women%2C%20heterosexual%20men%20and%20men%20who%20have%20sex%20with%20men%20%28MSM%29%5D%2C%20and%20mortality.%20Associations%20were%20estimated%20separately%20by%20site%20and%20pooled.%20Among%2011%2C721%20included%20PLWH%20%28median%20follow-up%2C%204.3%20years%3B%20interquartile%20range%2C%202.0-7.6%29%2C%20647%20died%20%28rate%5Cu2009%3D%5Cu200910.9%5C%2F1000%20person-years%29%20and%201985%20were%20lost%20to%20follow-up%20%28rate%5Cu2009%3D%5Cu200933.6%5C%2F1000%20person-years%29.%20After%20adjustment%20for%20confounders%2C%20early%20retention%20in%20care%20was%20associated%20with%20lower%20mortality%20during%20subsequent%20years%20%28pooled%20hazard%20ratio%5Cu2009%3D%5Cu20090.47%3B%2095%25%20confidence%20interval%5Cu2009%3D%5Cu20090.39-0.57%29.%20MSM%20had%20lower%20and%20heterosexual%20men%20had%20comparable%20mortality%20risk%20to%20women%3B%20risks%20were%20similar%20when%20adjusting%20for%20early%20retention%20in%20care.%20Additionally%2C%20no%20evidence%20of%20an%20interaction%20between%20early%20retention%20in%20care%20and%20sex%20and%20sexual%20mode%20of%20HIV%20acquisition%20on%20mortality%20was%20observed%20%28p%5Cu2009%3E%5Cu20090.05%29.%20Early%20retention%20in%20care%20substantially%20reduced%20mortality%20but%20does%20not%20mediate%20or%20modify%20the%20association%20between%20sex%20and%20sexual%20mode%20of%20HIV%20acquisition%20and%20mortality%20in%20our%20population.%22%2C%22date%22%3A%22Aug%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2Fapc.2018.0028%22%2C%22ISSN%22%3A%221557-7449%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A22%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22E5H6F4HW%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Arriv%5Cu00e9%20et%20al.%22%2C%22parsedDate%22%3A%222018-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EArriv%26%23xE9%3B%20E%2C%20Ayaya%20S%2C%20Davies%20MA%2C%20Chimbetete%20C%2C%20Edmonds%20A%2C%20Lelo%20P%2C%20et%20al.%20Models%20of%20support%20for%20disclosure%20of%20HIV%20status%20to%20HIV-infected%20children%20and%20adolescents%20in%20resource-limited%20settings.%20J%20Int%20AIDS%20Soc.%202018%20Jul%3B21%287%29%3Ae25157.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DE5H6F4HW%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Models%20of%20support%20for%20disclosure%20of%20HIV%20status%20to%20HIV-infected%20children%20and%20adolescents%20in%20resource-limited%20settings%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elise%22%2C%22lastName%22%3A%22Arriv%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Ayaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siew%20Moy%22%2C%22lastName%22%3A%22Fong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamarul%20Azahar%22%2C%22lastName%22%3A%22Razali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouadio%22%2C%22lastName%22%3A%22Kouakou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20C.%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Pediatric%20Working%20Group%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Disclosure%20of%20HIV%20status%20to%20HIV-infected%20children%20and%20adolescents%20is%20a%20major%20care%20challenge.%20We%20describe%20current%20site%20characteristics%20related%20to%20disclosure%20of%20HIV%20status%20in%20resource-limited%20paediatric%20HIV%20care%20settings%20within%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20An%20online%20site%20assessment%20survey%20was%20conducted%20across%20the%20paediatric%20HIV%20care%20sites%20within%20six%20global%20regions%20of%20IeDEA.%20A%20standardized%20questionnaire%20was%20administered%20to%20the%20sites%20through%20the%20REDCap%20platform.%5CnRESULTS%3A%20From%20June%202014%20to%20March%202015%2C%20all%20180%20sites%20of%20the%20IeDEA%20consortium%20in%2031%20countries%20completed%20the%20online%20survey%3A%2057%25%20were%20urban%2C%2043%25%20were%20health%20centres%20and%2086%25%20were%20integrated%20clinics%20%28serving%20both%20adults%20and%20children%29.%20Almost%20all%20the%20sites%20%2898%25%29%20reported%20offering%20disclosure%20counselling%20services.%20Disclosure%20counselling%20was%20most%20often%20provided%20by%20counsellors%20%2887%25%20of%20sites%29%2C%20but%20also%20by%20nurses%20%2877%25%29%2C%20physicians%20%2874%25%29%2C%20social%20workers%20%2868%25%29%2C%20or%20other%20clinicians%20%2865%25%29.%20It%20was%20offered%20to%20both%20caregivers%20and%20children%20in%2092%25%20of%20177%20sites%20with%20disclosure%20counselling.%20Disclosure%20resources%20and%20procedures%20varied%20across%20geographical%20regions.%20Most%20sites%20in%20each%20region%20reported%20performing%20staff%20members%27%20training%20on%20disclosure%20%2872%25%20to%2096%25%20of%20sites%20per%20region%29%2C%20routinely%20collecting%20HIV%20disclosure%20status%20%2850%25%20to%2091%25%29%20and%20involving%20caregivers%20in%20the%20disclosure%20process%20%2871%25%20to%20100%25%29.%20A%20disclosure%20protocol%20was%20available%20in%2014%25%20to%2071%25%20of%20sites.%20Among%20the%20143%20sites%20%2879%25%29%20routinely%20collecting%20disclosure%20status%20process%2C%20the%20main%20collection%20method%20was%20by%20asking%20the%20caregiver%20or%20child%20%2885%25%29%20about%20the%20child%27s%20knowledge%20of%20his%5C%2Fher%20HIV%20status.%20Frequency%20of%20disclosure%20status%20assessment%20was%20every%20three%20months%20in%2063%25%20of%20the%20sites%2C%20and%2071%25%20stored%20disclosure%20status%20data%20electronically.%5CnCONCLUSION%3A%20The%20majority%20of%20the%20sites%20reported%20offering%20disclosure%20counselling%20services%2C%20but%20educational%20and%20social%20support%20resources%20and%20capacities%20for%20data%20collection%20varied%20across%20regions.%20Paediatric%20HIV%20care%20sites%20worldwide%20still%20need%20specific%20staff%20members%27%20training%20on%20disclosure%2C%20development%20and%20implementation%20of%20guidelines%20for%20HIV%20disclosure%2C%20and%20standardized%20data%20collection%20on%20this%20key%20issue%20to%20ensure%20the%20long-term%20health%20and%20wellbeing%20of%20HIV-infected%20youth.%22%2C%22date%22%3A%22Jul%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25157%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A37%3A33Z%22%7D%7D%2C%7B%22key%22%3A%223QWLYECY%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Caro-Vega%20et%20al.%22%2C%22parsedDate%22%3A%222018-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECaro-Vega%20Y%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Crabtree-Ram%26%23xED%3Brez%20B%2C%20Shepherd%20BE%2C%20Mejia%20F%2C%20Giganti%20MJ%2C%20et%20al.%20Trends%20in%20proportion%20of%20older%20HIV-infected%20people%20in%20care%20in%20Latin%20America%20and%20the%20Caribbean%3A%20a%20growing%20challenge.%20Epidemiol%20Infect.%202018%20Jul%3B146%2810%29%3A1308%26%23x2013%3B11.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D3QWLYECY%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Trends%20in%20proportion%20of%20older%20HIV-infected%20people%20in%20care%20in%20Latin%20America%20and%20the%20Caribbean%3A%20a%20growing%20challenge%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mejia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Patterson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22We%20aimed%20to%20quantify%20the%20proportion%20of%20people%20receiving%20care%20for%20HIV-infection%20that%20are%2050%20years%20or%20older%20%28older%20HIV%20patients%29%20in%20Latin%20America%20and%20the%20Caribbean%20between%202000%20and%202015%20and%20to%20estimate%20the%20contribution%20to%20the%20growth%20of%20this%20population%20of%20people%20enrolled%20before%20%28%3C50yo%29%20and%20after%2050%20years%20old%20%28yo%29%20%28%5Cu2a7e50yo%29.%20We%20used%20a%20series%20of%20repeated%2C%20cross-sectional%20measurements%20over%20time%20in%20the%20Caribbean%2C%20Central%20and%20South%20American%20network%20%28CCASAnet%29%20cohort.%20We%20estimated%20the%20percentage%20of%20patients%20retained%20in%20care%20each%20year%20that%20were%20older%20HIV%20patients.%20For%20every%20calendar%20year%2C%20we%20divided%20patients%20into%20two%20groups%3A%20those%20who%20enrolled%20before%20age%2050%20and%20after%20age%2050.%20We%20used%20logistic%20regression%20models%20to%20estimate%20the%20change%20in%20the%20proportion%20of%20older%20HIV%20patients%20between%202000%20and%202015.%20The%20percentage%20of%20CCASAnet%20HIV%20patients%20over%2050%20years%20had%20a%20threefold%20increase%20%288%25%20to%2024%25%29%20between%202000%20and%202015.%20Most%20of%20the%20growth%20of%20this%20population%20can%20be%20explained%20by%20the%20increasing%20proportion%20of%20people%20that%20enrolled%20before%2050%20years%20and%20aged%20in%20care.%20These%20changes%20will%20impact%20needs%20of%20care%20for%20people%20living%20with%20HIV%2C%20due%20to%20multiple%20comorbidities%20and%20high%20risk%20of%20disability%20associated%20with%20aging.%22%2C%22date%22%3A%22Jul%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1017%5C%2FS0950268818001346%22%2C%22ISSN%22%3A%221469-4409%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A22%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22UWJHDCYQ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Giles%20et%20al.%22%2C%22parsedDate%22%3A%222018-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiles%20ML%2C%20Achhra%20AC%2C%20Abraham%20AG%2C%20Haas%20AD%2C%20Gill%20MJ%2C%20Lee%20MP%2C%20et%20al.%20Sex-based%20differences%20in%20antiretroviral%20therapy%20initiation%2C%20switching%20and%20treatment%20interruptions%3A%20global%20overview%20from%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%20J%20Int%20AIDS%20Soc.%202018%20Jun%3B21%286%29%3Ae25149.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DUWJHDCYQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sex-based%20differences%20in%20antiretroviral%20therapy%20initiation%2C%20switching%20and%20treatment%20interruptions%3A%20global%20overview%20from%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20L.%22%2C%22lastName%22%3A%22Giles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amit%20C.%22%2C%22lastName%22%3A%22Achhra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20G.%22%2C%22lastName%22%3A%22Abraham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20John%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Man%20Po%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%22%2C%22lastName%22%3A%22Braitstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22de%20Rekeneire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renaud%22%2C%22lastName%22%3A%22Becquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Law%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%202015%2C%20the%20World%20Health%20Organization%20recommended%20that%20all%20HIV-infected%20individuals%20consider%20ART%20initiation%20as%20soon%20as%20possible%20after%20diagnosis.%20Sex%20differences%20in%20choice%20of%20initial%20ART%20regimen%2C%20indications%20for%20switching%2C%20time%20to%20switching%20and%20choice%20of%20second-line%20regimens%20have%20not%20been%20well%20described.%20The%20aims%20of%20this%20study%20were%20to%20describe%20first-line%20ART%20and%20CD4%20count%20at%20ART%20initiation%20by%20sex%2C%20calendar%20year%20and%20region%2C%20and%20to%20analyse%20time%20to%20change%20or%20interruption%20in%20first-line%20ART%2C%20according%20to%20sex%20in%20each%20region.%5CnMETHODS%3A%20Participating%20cohorts%20included%3A%20Southern%2C%20East%20and%20West%20Africa%20%28IeDEA-Africa%29%2C%20North%20America%20%28NA-ACCORD%29%2C%20Caribbean%2C%20Central%5C%2FSouth%20America%20%28CCASAnet%29%20and%20Asia-Pacific%20including%20Australia%20%28IeDEA%20Asia-Pacific%29.%20The%20primary%20outcomes%20analysed%20for%20each%20region%20and%20according%20to%20sex%20were%20choice%20of%20initial%20ART%2C%20time%20to%20switching%20and%20time%20to%20discontinuation%20of%20the%20first-line%20regimen.%5CnRESULTS%20AND%20DISCUSSION%3A%20The%20combined%20cohort%20data%20set%20comprised%20of%20715%2C252%20participants%20across%20seven%20regions%20from%20low-%20to%20high-income%20settings.%20The%20median%20CD4%20count%20at%20treatment%20initiation%20was%20lower%20in%20men%20compared%20with%20women%20in%20nearly%20all%20regions%20and%20time%20periods.%20Women%20from%20North%20America%20and%20Southern%20Africa%20were%20more%20likely%20to%20switch%20ART%20compared%20to%20men%20%28p%5Cu00a0%3C%5Cu00a00.001%29%20with%20approximately%2090%25%20of%20women%20reporting%20a%20major%20change%20after%2010%5Cu00a0years%20in%20North%20America.%20Overall%2C%20after%208%5Cu00a0years%20on%20ART%2C%20%3E50%25%20of%20HIV-%20positive%20men%20and%20women%20from%20Southern%20Africa%2C%20East%20Africa%2C%20South%20and%20Central%20America%20remained%20on%20their%20original%20regimen.%20Men%20were%20more%20likely%20to%20have%20a%20treatment%20interruption%20compared%20with%20women%20in%20low-%20and%20middle-income%20countries%20from%20the%20Asia%5C%2FPacific%20region%20%28p%5Cu00a0%3C%5Cu00a00.001%29%20as%20were%20men%20from%20Southern%20Africa%20%28p%5Cu00a0%3C%5Cu00a00.001%29.%20Greater%20than%2075%25%20of%20men%20and%20women%20did%20not%20report%20a%20treatment%20interruption%20after%2010%5Cu00a0years%20on%20ART%20from%20all%20regions%20except%20North%20America%20and%20Southern%20Africa.%5CnCONCLUSIONS%3A%20There%20are%20regional%20variations%20in%20the%20ART%20regimen%20commenced%20at%20baseline%20and%20rates%20of%20major%20change%20and%20treatment%20interruption%20according%20to%20sex.%20Some%20of%20this%20is%20likely%20to%20reflect%20changes%20in%20local%20and%20international%20antiretroviral%20guideline%20recommendations%20but%20other%20sex-specific%20factors%20such%20as%20pregnancy%20may%20contribute%20to%20these%20differences.%22%2C%22date%22%3A%22Jun%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25149%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A22%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22T39CNNIA%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zamudio-Rodr%5Cu00edguez%20et%20al.%22%2C%22parsedDate%22%3A%222018-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZamudio-Rodr%26%23xED%3Bguez%20A%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Sierra-Madero%20JG%2C%20Cuellar-Rodr%26%23xED%3Bguez%20J%2C%20Crabtree-Ram%26%23xED%3Brez%20BE%2C%20Alcala-Zermeno%20JL%2C%20et%20al.%20Association%20Between%20Frailty%20and%20HIV-Associated%20Neurodegenerative%20Disorders%20Among%20Older%20Adults%20Living%20with%20HIV.%20AIDS%20Res%20Hum%20Retroviruses.%202018%20May%3B34%285%29%3A449%26%23x2013%3B55.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DT39CNNIA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20Between%20Frailty%20and%20HIV-Associated%20Neurodegenerative%20Disorders%20Among%20Older%20Adults%20Living%20with%20HIV%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfonso%22%2C%22lastName%22%3A%22Zamudio-Rodr%5Cu00edguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Cuellar-Rodr%5Cu00edguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Luis%22%2C%22lastName%22%3A%22Alcala-Zermeno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Amieva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Alberto%22%2C%22lastName%22%3A%22Avila-Funes%22%7D%5D%2C%22abstractNote%22%3A%22The%20population%20of%20aging%20adults%20living%20with%20human%20immunodeficiency%20virus%20%28HIV%29%20is%20growing%20worldwide%20and%20evidence%20suggests%20that%20frailty%20occurs%20prematurely%20among%20them.%20In%20turn%2C%20frailty%20has%20been%20associated%20with%20cognitive%20decline.%20It%20is%20unknown%2C%20however%2C%20if%20people%20with%20both%20frailty%20and%20HIV%20infection%20have%20a%20higher%20risk%20of%20cognitive%20impairment%20compared%20with%20nonfrail%20HIV-infected%20persons.%20Therefore%2C%20the%20main%20objective%20of%20this%20study%20was%20to%20determine%20the%20association%20between%20the%20phenotype%20of%20frailty%20and%20HIV-associated%20neurocognitive%20disorders%20%28HAND%29%20among%20adults%20aged%2050%20years%20or%20older%20living%20with%20HIV%5C%2FAIDS.%20A%20cross-sectional%20study%20was%20conducted%20on%20206%20adults%20living%20with%20HIV%20receiving%20care%20in%20a%20university-affiliated%20tertiary%20care%20hospital%20in%20Mexico%20City.%20Frailty%20was%20defined%20as%20per%20the%20Fried%20criteria.%20The%20presence%20of%20HAND%20was%20established%20according%20to%20the%20Antinori%20criteria%3A%20HIV-associated%20asymptomatic%20neurocognitive%20impairment%20%28ANI%29%2C%20HIV-associated%20mild%20neurocognitive%20disorder%20%28MND%29%2C%20or%20cognitively%20nonimpaired.%20Multinomial%20logistic%20regression%20models%20were%20used%20to%20test%20the%20independent%20association%20between%20frailty%20and%20HAND%20adjusting%20for%20potential%20confounders.%20Mean%20age%20of%20participants%20was%2060.5%5Cu2009%5Cu00b1%5Cu20096.3%20years%20and%2084.9%25%20were%20male.%20Prevalence%20of%20HAND%20and%20frailty%20phenotype%20was%2066.0%25%20and%202.9%25%2C%20respectively.%20The%20unadjusted%20analysis%20showed%20that%20both%20prefrail%20and%20frail%20statuses%20were%20associated%20with%20MND%20but%20not%20with%20ANI.%20However%2C%20after%20adjustment%2C%20the%20association%20with%20MND%20remained%20significant%20only%20among%20prefrail%20participants%20and%20no%20longer%20for%20frail%20persons%20%28risk%20ratio%20%5BRR%5D%5Cu2009%3D%5Cu20095.7%2C%2095%25%20confidence%20intervals%20%5BCI%5D%201.09-29.82%3B%20p%5Cu2009%3D%5Cu2009.039%20and%20RR%5Cu2009%3D%5Cu200918.3%2C%2095%25%20CI%200.93-362.6%3B%20p%5Cu2009%3D%5Cu2009.056%2C%20respectively%29.%20Prefrailty%20is%20associated%20with%20symptomatic%20neurocognitive%20disorders%20in%20older%20adults%20living%20with%20HIV.%20The%20spectrum%20of%20the%20frailty%20phenotype%20in%20this%20already%20vulnerable%20population%20should%20serve%20as%20an%20indicator%20of%20concomitant%20cognitive%20decline.%22%2C%22date%22%3A%22May%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2FAID.2017.0100%22%2C%22ISSN%22%3A%221931-8405%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A23%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22PJAL4UAB%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Oh%20et%20al.%22%2C%22parsedDate%22%3A%222018-04-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOh%20EJ%2C%20Shepherd%20BE%2C%20Lumley%20T%2C%20Shaw%20PA.%20Considerations%20for%20analysis%20of%20time-to-event%20outcomes%20measured%20with%20error%3A%20Bias%20and%20correction%20with%20SIMEX.%20Stat%20Med.%202018%20Apr%2015%3B37%288%29%3A1276%26%23x2013%3B89.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPJAL4UAB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Considerations%20for%20analysis%20of%20time-to-event%20outcomes%20measured%20with%20error%3A%20Bias%20and%20correction%20with%20SIMEX%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20J.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Lumley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A.%22%2C%22lastName%22%3A%22Shaw%22%7D%5D%2C%22abstractNote%22%3A%22For%20time-to-event%20outcomes%2C%20a%20rich%20literature%20exists%20on%20the%20bias%20introduced%20by%20covariate%20measurement%20error%20in%20regression%20models%2C%20such%20as%20the%20Cox%20model%2C%20and%20methods%20of%20analysis%20to%20address%20this%20bias.%20By%20comparison%2C%20less%20attention%20has%20been%20given%20to%20understanding%20the%20impact%20or%20addressing%20errors%20in%20the%20failure%20time%20outcome.%20For%20many%20diseases%2C%20the%20timing%20of%20an%20event%20of%20interest%20%28such%20as%20progression-free%20survival%20or%20time%20to%20AIDS%20progression%29%20can%20be%20difficult%20to%20assess%20or%20reliant%20on%20self-report%20and%20therefore%20prone%20to%20measurement%20error.%20For%20linear%20models%2C%20it%20is%20well%20known%20that%20random%20errors%20in%20the%20outcome%20variable%20do%20not%20bias%20regression%20estimates.%20With%20nonlinear%20models%2C%20however%2C%20even%20random%20error%20or%20misclassification%20can%20introduce%20bias%20into%20estimated%20parameters.%20We%20compare%20the%20performance%20of%202%20common%20regression%20models%2C%20the%20Cox%20and%20Weibull%20models%2C%20in%20the%20setting%20of%20measurement%20error%20in%20the%20failure%20time%20outcome.%20We%20introduce%20an%20extension%20of%20the%20SIMEX%20method%20to%20correct%20for%20bias%20in%20hazard%20ratio%20estimates%20from%20the%20Cox%20model%20and%20discuss%20other%20analysis%20options%20to%20address%20measurement%20error%20in%20the%20response.%20A%20formula%20to%20estimate%20the%20bias%20induced%20into%20the%20hazard%20ratio%20by%20classical%20measurement%20error%20in%20the%20event%20time%20for%20a%20log-linear%20survival%20model%20is%20presented.%20Detailed%20numerical%20studies%20are%20presented%20to%20examine%20the%20performance%20of%20the%20proposed%20SIMEX%20method%20under%20varying%20levels%20and%20parametric%20forms%20of%20the%20error%20in%20the%20outcome.%20We%20further%20illustrate%20the%20method%20with%20observational%20data%20on%20HIV%20outcomes%20from%20the%20Vanderbilt%20Comprehensive%20Care%20Clinic.%22%2C%22date%22%3A%22Apr%2015%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fsim.7554%22%2C%22ISSN%22%3A%221097-0258%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A18%3A49Z%22%7D%7D%2C%7B%22key%22%3A%227J4EVE5D%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22IeDEA%20and%20COHERE%20Cohort%20Collaborations%22%2C%22parsedDate%22%3A%222018-03-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIeDEA%20and%20COHERE%20Cohort%20Collaborations.%20Global%20Trends%20in%20CD4%20Cell%20Count%20at%20the%20Start%20of%20Antiretroviral%20Therapy%3A%20Collaborative%20Study%20of%20Treatment%20Programs.%20Clin%20Infect%20Dis.%202018%20Mar%205%3B66%286%29%3A893%26%23x2013%3B903.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7J4EVE5D%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20Trends%20in%20CD4%20Cell%20Count%20at%20the%20Start%20of%20Antiretroviral%20Therapy%3A%20Collaborative%20Study%20of%20Treatment%20Programs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20and%20COHERE%20Cohort%20Collaborations%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Early%20initiation%20of%20combination%20antiretroviral%20therapy%20%28cART%29%2C%20at%20higher%20CD4%20cell%20counts%2C%20prevents%20disease%20progression%20and%20reduces%20sexual%20transmission%20of%20human%20immunodeficiency%20virus%20%28HIV%29.%20We%20describe%20the%20temporal%20trends%20in%20CD4%20cell%20counts%20at%20the%20start%20of%20cART%20in%20adults%20from%20low-income%2C%20lower-middle-income%2C%20upper-middle-income%2C%20and%20high-income%20countries%20%28LICs%2C%20LMICs%2C%20UMICs%2C%20and%20HICs%2C%20respectively%29.%5CnMethods%3A%20We%20included%20HIV-infected%20individuals%20aged%20%5Cu226516%20years%20who%20started%20cART%20between%202002%20and%202015%20in%20a%20clinic%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20or%20the%20Collaboration%20of%20Observational%20HIV%20Epidemiological%20Research%20in%20Europe%20%28COHERE%29.%20Missing%20CD4%20cell%20counts%20at%20the%20start%20of%20cART%20were%20estimated%20through%20multiple%20imputation.%20Weighted%20mixed-effect%20models%20were%20used%20to%20smooth%20trends%20in%20median%20CD4%20cell%20counts.%5CnResults%3A%20A%20total%20of%20951855%20adults%20from%2016%20LICs%2C%2011%20LMICs%2C%209%20UMICs%2C%20and%2019%20HICs%20were%20included.%20Overall%2C%20the%20modeled%20median%20CD4%20cell%20count%20at%20the%20start%20of%20cART%20increased%20from%202002%20to%202015%2C%20from%2078%5C%2F%5Cu00b5L%20%2895%25%20confidence%20interval%2C%2058-104%5C%2F%5Cu00b5L%29%20to%20287%5C%2F%5Cu00b5L%20%28250-328%5C%2F%5Cu00b5L%29%20in%20LICs%2C%20from%2099%5C%2F%5Cu00b5L%20%2871-140%5C%2F%5Cu00b5L%29%20to%20234%5C%2F%5Cu00b5L%20%28192-285%5C%2F%5Cu00b5L%29%20in%20LMICs%2C%20from%2071%5C%2F%5Cu00b5L%20%2849-104%5C%2F%5Cu00b5L%29%20to%20311%5C%2F%5Cu00b5L%20%28255-379%5C%2F%5Cu00b5L%29%20in%20UMICs%2C%20and%20from%20161%5C%2F%5Cu00b5L%20%28143-181%5C%2F%5Cu00b5L%29%20to%20327%5C%2F%5Cu00b5L%20%28286-372%5C%2F%5Cu00b5L%29%20in%20HICs.%20In%20LICs%2C%20LMICs%2C%20and%20UMICs%2C%20the%20increase%20was%20more%20pronounced%20in%20women%3B%20in%20HICs%2C%20the%20opposite%20was%20observed.%5CnConclusions%3A%20Median%20CD4%20cell%20counts%20at%20the%20start%20of%20cART%20increased%20in%20all%20income%20groups%2C%20but%20generally%20remained%20below%20350%5C%2F%5Cu03bcL%20in%202015.%20Substantial%20additional%20efforts%20and%20resources%20are%20required%20to%20achieve%20earlier%20diagnosis%2C%20linkage%20to%20care%2C%20and%20initiation%20of%20cART.%22%2C%22date%22%3A%22Mar%2005%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fcix915%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A20%3A26Z%22%7D%7D%2C%7B%22key%22%3A%224KSUYKTM%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECollaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%2C%20Slogrove%20AL%2C%20Schomaker%20M%2C%20Davies%20MA%2C%20Williams%20P%2C%20Balkan%20S%2C%20et%20al.%20The%20epidemiology%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%3A%20A%20cross-region%20global%20cohort%20analysis.%20PLoS%20Med.%202018%20Mar%3B15%283%29%3Ae1002514.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D4KSUYKTM%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20epidemiology%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%3A%20A%20cross-region%20global%20cohort%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20Global%20Cohort%20Collaboration%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20L.%22%2C%22lastName%22%3A%22Slogrove%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Schomaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paige%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suna%22%2C%22lastName%22%3A%22Balkan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jihane%22%2C%22lastName%22%3A%22Ben-Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Calles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kulkanya%22%2C%22lastName%22%3A%22Chokephaibulkit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Duff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanoh%20Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Eboua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adeodata%22%2C%22lastName%22%3A%22Kekitiinwa-Rukyalekere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Seage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chloe%20A.%22%2C%22lastName%22%3A%22Teasdale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Wanless%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josiane%22%2C%22lastName%22%3A%22Warszawski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venessa%22%2C%22lastName%22%3A%22Timmerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Intira%20J.%22%2C%22lastName%22%3A%22Collins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%22%2C%22lastName%22%3A%22Goodall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colette%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kunjal%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Gibb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elaine%20J.%22%2C%22lastName%22%3A%22Abrams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%22%2C%22lastName%22%3A%22Hazra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%22%2C%22lastName%22%3A%22Van%20Dyke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda-Gail%22%2C%22lastName%22%3A%22Bekker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynne%22%2C%22lastName%22%3A%22Mofenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marissa%22%2C%22lastName%22%3A%22Vicari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaffiq%22%2C%22lastName%22%3A%22Essajee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Penazzato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Anabwani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Q%20Mohapi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22N%20Kazembe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Makhosazana%22%2C%22lastName%22%3A%22Hlatshwayo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mwita%22%2C%22lastName%22%3A%22Lumumba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tessa%22%2C%22lastName%22%3A%22Goetghebuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Thorne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisa%22%2C%22lastName%22%3A%22Galli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annemarie%22%2C%22lastName%22%3A%22van%20Rossum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlo%22%2C%22lastName%22%3A%22Giaquinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Magdalena%22%2C%22lastName%22%3A%22Marczynska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Marques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filipa%22%2C%22lastName%22%3A%22Prata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luminita%22%2C%22lastName%22%3A%22Ene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liubov%22%2C%22lastName%22%3A%22Okhonskaia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%22%2C%22lastName%22%3A%22Rojo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Fortuny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lars%22%2C%22lastName%22%3A%22Naver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Rudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Le%20Coeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alla%22%2C%22lastName%22%3A%22Volokha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Ayaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Ongwen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20F.%22%2C%22lastName%22%3A%22Jefferys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sam%22%2C%22lastName%22%3A%22Phiri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mwangelwa%22%2C%22lastName%22%3A%22Mubiana-Mbewe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shobna%22%2C%22lastName%22%3A%22Sawry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorna%22%2C%22lastName%22%3A%22Renner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariam%22%2C%22lastName%22%3A%22Sylla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Abzug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Myron%22%2C%22lastName%22%3A%22Levin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Oleske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Chernoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shirley%22%2C%22lastName%22%3A%22Traite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murli%22%2C%22lastName%22%3A%22Purswani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%20G.%22%2C%22lastName%22%3A%22Chadwick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Judd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9riane%22%2C%22lastName%22%3A%22Leroy%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Globally%2C%20the%20population%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%20%28APHs%29%20continues%20to%20expand.%20In%20this%20study%2C%20we%20pooled%20data%20from%20observational%20pediatric%20HIV%20cohorts%20and%20cohort%20networks%2C%20allowing%20comparisons%20of%20adolescents%20with%20perinatally%20acquired%20HIV%20in%20%5C%22real-life%5C%22%20settings%20across%20multiple%20regions.%20We%20describe%20the%20geographic%20and%20temporal%20characteristics%20and%20mortality%20outcomes%20of%20APHs%20across%20multiple%20regions%2C%20including%20South%20America%20and%20the%20Caribbean%2C%20North%20America%2C%20Europe%2C%20sub-Saharan%20Africa%2C%20and%20South%20and%20Southeast%20Asia.%5CnMETHODS%20AND%20FINDINGS%3A%20Through%20the%20Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%2C%20individual%20retrospective%20longitudinal%20data%20from%2012%20cohort%20networks%20were%20pooled.%20All%20children%20infected%20with%20HIV%20who%20entered%20care%20before%20age%2010%20years%2C%20were%20not%20known%20to%20have%20horizontally%20acquired%20HIV%2C%20and%20were%20followed%20up%20beyond%20age%2010%20years%20were%20included%20in%20this%20analysis%20conducted%20from%20May%202016%20to%20January%202017.%20Our%20primary%20analysis%20describes%20patient%20and%20treatment%20characteristics%20of%20APHs%20at%20key%20time%20points%2C%20including%20first%20HIV-associated%20clinic%20visit%2C%20antiretroviral%20therapy%20%28ART%29%20start%2C%20age%2010%20years%2C%20and%20last%20visit%2C%20and%20compares%20these%20characteristics%20by%20geographic%20region%2C%20country%20income%20group%20%28CIG%29%2C%20and%20birth%20period.%20Our%20secondary%20analysis%20describes%20mortality%2C%20transfer%20out%2C%20and%20lost%20to%20follow-up%20%28LTFU%29%20as%20outcomes%20at%20age%2015%20years%2C%20using%20competing%20risk%20analysis.%20Among%20the%2038%2C187%20APHs%20included%2C%2051%25%20were%20female%2C%2079%25%20were%20from%20sub-Saharan%20Africa%20and%2065%25%20lived%20in%20low-income%20countries.%20APHs%20from%2051%20countries%20were%20included%20%28Europe%3A%2014%20countries%20and%203%2C054%20APHs%3B%20North%20America%3A%201%20country%20and%201%2C032%20APHs%3B%20South%20America%20and%20the%20Caribbean%3A%204%20countries%20and%20903%20APHs%3B%20South%20and%20Southeast%20Asia%3A%207%20countries%20and%202%2C902%20APHs%3B%20sub-Saharan%20Africa%2C%2025%20countries%20and%2030%2C296%20APHs%29.%20Observation%20started%20as%20early%20as%201982%20in%20Europe%20and%201996%20in%20sub-Saharan%20Africa%2C%20and%20continued%20until%20at%20least%202014%20in%20all%20regions.%20The%20median%20%28interquartile%20range%20%5BIQR%5D%29%20duration%20of%20adolescent%20follow-up%20was%203.1%20%281.5-5.2%29%20years%20for%20the%20total%20cohort%20and%206.4%20%283.6-8.0%29%20years%20in%20Europe%2C%203.7%20%282.0-5.4%29%20years%20in%20North%20America%2C%202.5%20%281.2-4.4%29%20years%20in%20South%20and%20Southeast%20Asia%2C%205.0%20%282.7-7.5%29%20years%20in%20South%20America%20and%20the%20Caribbean%2C%20and%202.1%20%280.9-3.8%29%20years%20in%20sub-Saharan%20Africa.%20Median%20%28IQR%29%20age%20at%20first%20visit%20differed%20substantially%20by%20region%2C%20ranging%20from%200.7%20%280.3-2.1%29%20years%20in%20North%20America%20to%207.1%20%285.3-8.6%29%20years%20in%20sub-Saharan%20Africa.%20The%20median%20age%20at%20ART%20start%20varied%20from%200.9%20%280.4-2.6%29%20years%20in%20North%20America%20to%207.9%20%286.0-9.3%29%20years%20in%20sub-Saharan%20Africa.%20The%20cumulative%20incidence%20estimates%20%2895%25%20confidence%20interval%20%5BCI%5D%29%20at%20age%2015%20years%20for%20mortality%2C%20transfers%20out%2C%20and%20LTFU%20for%20all%20APHs%20were%202.6%25%20%282.4%25-2.8%25%29%2C%2015.6%25%20%2815.1%25-16.0%25%29%2C%20and%2011.3%25%20%2810.9%25-11.8%25%29%2C%20respectively.%20Mortality%20was%20lowest%20in%20Europe%20%280.8%25%20%5B0.5%25-1.1%25%5D%29%20and%20highest%20in%20South%20America%20and%20the%20Caribbean%20%284.4%25%20%5B3.1%25-6.1%25%5D%29.%20However%2C%20LTFU%20was%20lowest%20in%20South%20America%20and%20the%20Caribbean%20%284.8%25%20%5B3.4%25-6.7%25%5D%29%20and%20highest%20in%20sub-Saharan%20Africa%20%2813.2%25%20%5B12.6%25-13.7%25%5D%29.%20Study%20limitations%20include%20the%20high%20LTFU%20rate%20in%20sub-Saharan%20Africa%2C%20which%20could%20have%20affected%20the%20comparison%20of%20mortality%20across%20regions%3B%20inclusion%20of%20data%20only%20for%20APHs%20receiving%20ART%20from%20some%20countries%3B%20and%20unavailability%20of%20data%20from%20high-burden%20countries%20such%20as%20Nigeria.%5CnCONCLUSION%3A%20To%20our%20knowledge%2C%20our%20study%20represents%20the%20largest%20multiregional%20epidemiological%20analysis%20of%20APHs.%20Despite%20probable%20under-ascertained%20mortality%2C%20mortality%20in%20APHs%20remains%20substantially%20higher%20in%20sub-Saharan%20Africa%2C%20South%20and%20Southeast%20Asia%2C%20and%20South%20America%20and%20the%20Caribbean%20than%20in%20Europe.%20Collaborations%20such%20as%20CIPHER%20enable%20us%20to%20monitor%20current%20global%20temporal%20trends%20in%20outcomes%20over%20time%20to%20inform%20appropriate%20policy%20responses.%22%2C%22date%22%3A%22Mar%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1002514%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A43%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22MVKV2DUJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EParcesepe%20AM%2C%20Mugglin%20C%2C%20Nalugoda%20F%2C%20Bernard%20C%2C%20Yunihastuti%20E%2C%20Althoff%20K%2C%20et%20al.%20Screening%20and%20management%20of%20mental%20health%20and%20substance%20use%20disorders%20in%20HIV%20treatment%20settings%20in%20low-%20and%20middle-income%20countries%20within%20the%20global%20IeDEA%20consortium.%20J%20Int%20AIDS%20Soc.%202018%20Mar%3B21%283%29%3Ae25101.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DMVKV2DUJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Screening%20and%20management%20of%20mental%20health%20and%20substance%20use%20disorders%20in%20HIV%20treatment%20settings%20in%20low-%20and%20middle-income%20countries%20within%20the%20global%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catrina%22%2C%22lastName%22%3A%22Mugglin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%22%2C%22lastName%22%3A%22Nalugoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evy%22%2C%22lastName%22%3A%22Yunihastuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Integration%20of%20services%20to%20screen%20and%20manage%20mental%20health%20and%20substance%20use%20disorders%20%28MSDs%29%20into%20HIV%20care%20settings%20has%20been%20identified%20as%20a%20promising%20strategy%20to%20improve%20mental%20health%20and%20HIV%20treatment%20outcomes%20among%20people%20living%20with%20HIV%5C%2FAIDS%20%28PLWHA%29%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29.%20Data%20on%20the%20extent%20to%20which%20HIV%20treatment%20sites%20in%20LMICs%20screen%20and%20manage%20MSDs%20are%20limited.%20The%20objective%20of%20this%20study%20was%20to%20assess%20practices%20for%20screening%20and%20treatment%20of%20MSDs%20at%20HIV%20clinics%20in%20LMICs%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20We%20surveyed%20a%20stratified%20random%20sample%20of%2095%20HIV%20clinics%20in%2029%20LMICs%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%2C%20Asia-Pacific%20and%20sub-Saharan%20Africa.%20The%20survey%20captured%20information%20onsite%20characteristics%20and%20screening%20and%20treatment%20practices%20for%20depression%2C%20post-traumatic%20stress%20disorder%20%28PTSD%29%2C%20substance%20use%20disorders%20%28SUDs%29%20and%20other%20mental%20health%20disorders.%5CnRESULTS%3A%20Most%20sites%20%28n%5Cu00a0%3D%5Cu00a076%2C%2080%25%29%20were%20in%20urban%20areas.%20Mental%20health%20screening%20varied%20by%20disorder%3A%2057%25%20of%20sites%20surveyed%20screened%20for%20depression%2C%2019%25%20for%20PTSD%2C%2055%25%20for%20SUDs%20and%2029%25%20for%20other%20mental%20health%20disorders.%20Depression%2C%20PTSD%2C%20SUDs%20and%20other%20mental%20health%20disorders%20were%20reported%20as%20managed%20on%20site%20%28having%20services%20provided%20at%20the%20HIV%20clinic%20or%20same%20health%20facility%29%20at%2070%25%2C%2051%25%2C%2041%25%20and%2047%25%20of%20sites%20respectively.%20Combined%20availability%20of%20screening%20and%20on-site%20management%20of%20depression%2C%20PTSD%2C%20and%20SUDs%2C%20and%20other%20mental%20health%20disorders%20was%20reported%20by%2042%25%2C%2014%25%2C%2026%25%20and%2019%25%20of%20sites%2C%20respectively.%20On-site%20management%20of%20depression%20and%20PTSD%20was%20reported%20significantly%20less%20often%20in%20rural%20as%20compared%20to%20urban%20settings%20%28depression%3A%2033%25%20and%2078%25%20respectively%3B%20PTSD%3A%2024%25%20and%2058%25%20respectively%29.%20Screening%20for%20depression%20and%20SUDs%20was%20least%20commonly%20reported%20by%20HIV%20programmes%20that%20treated%20only%20children%20as%20compared%20to%20HIV%20programmes%20that%20treated%20only%20adults%20or%20treated%20both%20adults%20and%20children.%5CnCONCLUSIONS%3A%20Significant%20gaps%20exist%20in%20the%20management%20of%20MSDs%20in%20HIV%20care%20settings%20in%20LMICs%2C%20particularly%20in%20rural%20settings.%20Identification%20and%20evaluation%20of%20optimal%20implementation%20strategies%20to%20scale%20and%20sustain%20integrated%20MSDs%20and%20HIV%20care%20is%20needed.%22%2C%22date%22%3A%22Mar%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25101%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A21%3A27Z%22%7D%7D%2C%7B%22key%22%3A%224PWH6FFS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tymejczyk%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETymejczyk%20O%2C%20Brazier%20E%2C%20Yiannoutsos%20C%2C%20Wools-Kaloustian%20K%2C%20Althoff%20K%2C%20Crabtree-Ram%26%23xED%3Brez%20B%2C%20et%20al.%20HIV%20treatment%20eligibility%20expansion%20and%20timely%20antiretroviral%20treatment%20initiation%20following%20enrollment%20in%20HIV%20care%3A%20A%20metaregression%20analysis%20of%20programmatic%20data%20from%2022%20countries.%20PLoS%20Med.%202018%20Mar%3B15%283%29%3Ae1002534.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D4PWH6FFS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20treatment%20eligibility%20expansion%20and%20timely%20antiretroviral%20treatment%20initiation%20following%20enrollment%20in%20HIV%20care%3A%20A%20metaregression%20analysis%20of%20programmatic%20data%20from%2022%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Tymejczyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kinh%22%2C%22lastName%22%3A%22Van%20Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francois%22%2C%22lastName%22%3A%22Dabis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20d%27Amour%22%2C%22lastName%22%3A%22Sinayobye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radhika%22%2C%22lastName%22%3A%22Wikramanayake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20effect%20of%20antiretroviral%20treatment%20%28ART%29%20eligibility%20expansions%20on%20patient%20outcomes%2C%20including%20rates%20of%20timely%20ART%20initiation%20among%20those%20enrolling%20in%20care%2C%20has%20not%20been%20assessed%20on%20a%20large%20scale.%20In%20addition%2C%20it%20is%20not%20known%20whether%20ART%20eligibility%20expansions%20may%20lead%20to%20%5C%22crowding%20out%5C%22%20of%20sicker%20patients.%5CnMETHODS%20AND%20FINDINGS%3A%20We%20examined%20changes%20in%20timely%20ART%20initiation%20%28within%206%20months%29%20at%20the%20original%20site%20of%20HIV%20care%20enrollment%20after%20ART%20eligibility%20expansions%20among%20284%2C740%20adult%20ART-na%5Cu00efve%20patients%20at%20171%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20network%20sites%20in%2022%20countries%20where%20national%20policies%20expanding%20ART%20eligibility%20were%20introduced%20between%202007%20and%202015.%20Half%20of%20the%20sites%20included%20in%20this%20analysis%20were%20from%20Southern%20Africa%2C%20one-third%20were%20from%20East%20Africa%2C%20and%20the%20remainder%20were%20from%20the%20Asia-Pacific%2C%20Central%20Africa%2C%20North%20America%2C%20and%20South%20and%20Central%20America%20regions.%20The%20median%20age%20of%20patients%20enrolling%20in%20care%20at%20contributing%20sites%20was%2033.5%20years%2C%20and%20the%20median%20percentage%20of%20female%20patients%20at%20these%20clinics%20was%2062.5%25.%20We%20assessed%20the%206-month%20cumulative%20incidence%20of%20timely%20ART%20initiation%20%28CI-ART%29%20before%20and%20after%20major%20expansions%20of%20ART%20eligibility%20%28i.e.%2C%20expansion%20to%20treat%20persons%20with%20CD4%20%5Cu2264%20350%20cells%5C%2F%5Cu03bcL%20%5B145%20sites%20in%2022%20countries%5D%20and%20CD4%20%5Cu2264%20500%20cells%5C%2F%5Cu03bcL%20%5B152%20sites%20in%2015%20countries%5D%29.%20Random%20effects%20metaregression%20models%20were%20used%20to%20estimate%20absolute%20changes%20in%20CI-ART%20at%20each%20site%20before%20and%20after%20guideline%20expansion.%20The%20crude%20pooled%20estimate%20of%20change%20in%20CI-ART%20was%204.3%20percentage%20points%20%2895%25%20confidence%20interval%20%5BCI%5D%202.6%20to%206.1%29%20after%20ART%20eligibility%20expansion%20to%20CD4%20%5Cu2264%20350%2C%20from%20a%20baseline%20median%20CI-ART%20of%2053%25%3B%20and%2015.9%20percentage%20points%20%28pp%29%20%2895%25%20CI%2014.3%20to%2017.4%29%20after%20ART%20eligibility%20expansion%20to%20CD4%20%5Cu2264%20500%2C%20from%20a%20baseline%20median%20CI-ART%20of%2057%25.%20The%20largest%20increases%20in%20CI-ART%20were%20observed%20among%20those%20newly%20eligible%20for%20treatment%20%2818.2%20pp%20after%20expansion%20to%20CD4%20%5Cu2264%20350%20and%2047.4%20pp%20after%20expansion%20to%20CD4%20%5Cu2264%20500%29%2C%20with%20no%20change%20or%20small%20increases%20among%20those%20eligible%20under%20prior%20guidelines%20%28CD4%20%5Cu2264%20350%3A%20-0.6%20pp%2C%2095%25%20CI%20-2.0%20to%200.7%20pp%3B%20CD4%20%5Cu2264%20500%3A%204.9%20pp%2C%2095%25%20CI%203.3%20to%206.5%20pp%29.%20For%20ART%20eligibility%20expansion%20to%20CD4%20%5Cu2264%20500%2C%20changes%20in%20CI-ART%20were%20largest%20among%20younger%20patients%20%2816-24%20years%3A%2021.5%20pp%2C%2095%25%20CI%2018.9%20to%2024.2%20pp%29.%20Key%20limitations%20include%20the%20lack%20of%20a%20counterfactual%20and%20difficulty%20accounting%20for%20secular%20outcome%20trends%2C%20due%20to%20universal%20exposure%20to%20guideline%20changes%20in%20each%20country.%5CnCONCLUSIONS%3A%20These%20findings%20underscore%20the%20potential%20of%20ART%20eligibility%20expansion%20to%20improve%20the%20timeliness%20of%20ART%20initiation%20globally%2C%20particularly%20for%20young%20adults.%22%2C%22date%22%3A%22Mar%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1002534%22%2C%22ISSN%22%3A%221549-1676%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A21%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22HLFWKVAA%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Caro-Vega%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECaro-Vega%20Y%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Crabtree-Ram%26%23xED%3Brez%20BE%2C%20Shepherd%20BE%2C%20Grinsztejn%20B%2C%20Wolff%20M%2C%20et%20al.%20Durability%20of%20Efavirenz%20Compared%20With%20Boosted%20Protease%20Inhibitor-Based%20Regimens%20in%20Antiretroviral-Na%26%23xEF%3Bve%20Patients%20in%20the%20Caribbean%20and%20Central%20and%20South%20America.%20Open%20Forum%20Infect%20Dis.%202018%20Mar%3B5%283%29%3Aofy004.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DHLFWKVAA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Durability%20of%20Efavirenz%20Compared%20With%20Boosted%20Protease%20Inhibitor-Based%20Regimens%20in%20Antiretroviral-Na%5Cu00efve%20Patients%20in%20the%20Caribbean%20and%20Central%20and%20South%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%20E.%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Efavirenz%20%28EFV%29%20and%20boosted%20protease%20inhibitors%20%28bPIs%29%20are%20still%20the%20preferred%20options%20for%20firstline%20antiretroviral%20regimens%20%28firstline%20ART%29%20in%20Latin%20America%20and%20have%20comparable%20short-term%20efficacy.%20We%20assessed%20the%20long-term%20durability%20and%20outcomes%20of%20patients%20receiving%20EFV%20or%20bPIs%20as%20firstline%20ART%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29.%5CnMethods%3A%20We%20included%20ART-na%5Cu00efve%2C%20HIV-positive%20adults%20on%20EFV%20or%20bPIs%20as%20firstline%20ART%20in%20CCASAnet%20between%202000%20and%202016.%20We%20investigated%20the%20time%20from%20starting%20until%20ending%20firstline%20ART%20according%20to%20changes%20of%20third%20component%20for%20any%20reason%2C%20including%20toxicity%20and%20treatment%20failure%2C%20death%2C%20and%5C%2For%20loss%20to%20follow-up.%20Use%20of%20a%20third-line%20regimen%20was%20a%20secondary%20outcome.%20Kaplan-Meier%20estimators%20of%20composite%20end%20points%20were%20generated.%20Crude%20cumulative%20incidence%20of%20events%20and%20adjusted%20hazard%20ratios%20%28aHRs%29%20were%20estimated%20accounting%20for%20competing%20risk%20events.%5CnResults%3A%20We%20included%2014%20519%20patients%3A%2012%20898%20%2889%25%29%20started%20EFV%20and%201621%20%2811%25%29%20bPIs.%20The%20adjusted%20median%20years%20on%20firstline%20ART%20were%204.6%20%2895%25%20confidence%20interval%20%5BCI%5D%2C%204.4-4.7%29%20on%20EFV%20and%203.8%20%2895%25%20CI%2C%203.8-4.0%29%20on%20bPI%20%28P%20%3C%20.001%29.%20Cumulative%20incidence%20of%20firstline%20ART%20ending%20at%2010%20years%20of%20follow-up%20was%2032%25%20%2895%25%20CI%2C%2031-33%29%20on%20EFV%20and%2044%25%20%2895%25%20CI%2C%2039-48%29%20on%20bPI%20%28aHR%2C%200.88%3B%2095%25%20CI%2C%200.78-0.97%29.%20The%20cumulative%20incidence%20rates%20of%20third-line%20initiation%20in%20the%20bPI-based%20group%20were%206%25%20%2895%25%20CI%2C%202.4-9.6%29%20and%202%25%20%2895%25%20CI%2C%201.4-2.2%29%20among%20the%20EFV-based%20group%20%28P%20%3C%20.01%29.%5CnConclusions%3A%20Durability%20of%20firstline%20ART%20was%20longer%20with%20EFV%20than%20with%20bPIs.%20EFV-based%20regimens%20may%20continue%20to%20be%20the%20preferred%20firstline%20regimen%20for%20our%20region%20in%20the%20near%20future%20due%20to%20their%20high%20efficacy%2C%20relatively%20low%20toxicity%20%28especially%20at%20lower%20doses%29%2C%20existence%20of%20generic%20formulations%2C%20and%20affordability%20for%20national%20programs.%22%2C%22date%22%3A%22Mar%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofy004%22%2C%22ISSN%22%3A%222328-8957%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A20%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22ITJJI7AG%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carriquiry%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECarriquiry%20G%2C%20Giganti%20MJ%2C%20Castilho%20JL%2C%20Jayathilake%20K%2C%20Cahn%20P%2C%20Grinsztejn%20B%2C%20et%20al.%20Virologic%20failure%20and%20mortality%20in%20older%20ART%20initiators%20in%20a%20multisite%20Latin%20American%20and%20Caribbean%20Cohort.%20J%20Int%20AIDS%20Soc.%202018%20Mar%3B21%283%29%3Ae25088.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DITJJI7AG%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Virologic%20failure%20and%20mortality%20in%20older%20ART%20initiators%20in%20a%20multisite%20Latin%20American%20and%20Caribbean%20Cohort%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20The%20%5C%22greying%5C%22%20of%20the%20HIV%20epidemic%20necessitates%20a%20better%20understanding%20of%20the%20healthcare%20needs%20of%20older%20HIV-positive%20adults.%20As%20these%20individuals%20age%2C%20it%20is%20unclear%20whether%20comorbidities%20and%20their%20associated%20therapies%20or%20the%20ageing%20process%20itself%20alter%20the%20response%20to%20antiretroviral%20therapy%20%28ART%29.%20In%20this%20study%2C%20HIV%20treatment%20outcomes%20and%20corresponding%20risk%20factors%20were%20compared%20between%20older%20ART%20initiators%20and%20those%20who%20were%20younger%20using%20data%20from%20the%20Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20Epidemiology%20%28CCASAnet%29.%5CnMETHODS%3A%20HIV-positive%20adults%20%28%5Cu226518%5Cu00a0years%29%20initiating%20ART%20at%20nine%20sites%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%20and%20Peru%20were%20included.%20Patients%20were%20classified%20as%20older%20%28%5Cu226550%5Cu00a0years%29%20or%20younger%20%28%3C50%5Cu00a0years%29%20based%20on%20age%20at%20ART%20initiation.%20ART%20effectiveness%20was%20measured%20using%20three%20outcomes%3A%20death%2C%20virologic%20failure%20and%20ART%20treatment%20modification.%20Cox%20regression%20models%20for%20each%20outcome%20compared%20risk%20between%20older%20and%20younger%20patients%2C%20adjusting%20for%20other%20covariates.%5CnRESULTS%3A%20Among%2026%2C311%20patients%20initiating%20ART%20between%201996%20and%202016%2C%203389%20%2813%25%29%20were%20%5Cu226550%5Cu00a0years.%20The%20majority%20of%20patients%20in%20both%20%5Cu226550%20and%20%3C50%20age%20groups%20received%20a%20non-nucleoside%20reverse%20transcriptase%20inhibitor-based%20regimen%20%2889%25%20vs.%2087%25%29%2C%20did%20not%20have%20AIDS%20at%20baseline%20%2863%25%20vs.%2062%25%29%2C%20and%20were%20male%20%2859%25%20vs.%2058%25%29.%20Older%20patients%20had%20a%20higher%20risk%20of%20death%20%28adjusted%20hazard%20ratio%20%28aHR%29%201.64%3B%2095%25%20confidence%20intervals%20%28CI%29%3A%201.48%20to%201.83%29%20and%20a%20lower%20risk%20of%20virologic%20failure%20%28aHR%3A%200.73%3B%2095%25%20CI%3A%200.63%20to%200.84%29.%20There%20was%20no%20difference%20in%20risk%20of%20ART%20modification%20%28aHR%3A%201.00%3B%2095%25%20CI%3A%200.94%20to%201.06%29.%20Risk%20factors%20for%20death%2C%20virologic%20failure%20and%20treatment%20modification%20were%20similar%20for%20each%20group.%5CnCONCLUSIONS%3A%20Older%20age%20at%20ART%20initiation%20was%20associated%20with%20increased%20mortality%20and%20decreased%20risk%20of%20virologic%20failure%20in%20our%20cohort%20of%20more%20than%2026%2C000%20ART%20initiators%20in%20Latin%20America%20and%20the%20Caribbean.%20To%20the%20best%20of%20our%20knowledge%20this%20is%20the%20first%20study%20from%20the%20region%20to%20evaluate%20ART%20outcomes%20in%20this%20growing%20and%20important%20population.%20Given%20the%20complexity%20of%20issues%20related%20to%20ageing%20with%20HIV%2C%20a%20greater%20understanding%20is%20needed%20in%20order%20to%20properly%20respond%20to%20this%20shifting%20epidemic.%22%2C%22date%22%3A%22Mar%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25088%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A19%3A49Z%22%7D%7D%2C%7B%22key%22%3A%228W27789H%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kariminia%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKariminia%20A%2C%20Law%20M%2C%20Davies%20MA%2C%20Vinikoor%20M%2C%20Wools-Kaloustian%20K%2C%20Leroy%20V%2C%20et%20al.%20Mortality%20and%20losses%20to%20follow-up%20among%20adolescents%20living%20with%20HIV%20in%20the%20IeDEA%20global%20cohort%20collaboration.%20J%20Int%20AIDS%20Soc.%202018%3B21%2812%29%3Ae25215.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D8W27789H%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20and%20losses%20to%20follow-up%20among%20adolescents%20living%20with%20HIV%20in%20the%20IeDEA%20global%20cohort%20collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Vinikoor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeriane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Fairlie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Ayaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elom%22%2C%22lastName%22%3A%22Takassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20M.%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Penazzato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohan%22%2C%22lastName%22%3A%22Hazra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20We%20assessed%20mortality%20and%20losses%20to%20follow-up%20%28LTFU%29%20during%20adolescence%20in%20routine%20care%20settings%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%5CnMETHODS%3A%20Cohorts%20in%20the%20Asia-Pacific%2C%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%2C%20and%20sub-Saharan%20Africa%20%28Central%2C%20East%2C%20Southern%2C%20West%29%20contributed%20data%2C%20and%20included%20adolescents%20living%20with%20HIV%20%28ALHIV%29%20enrolled%20from%20January%202003%20and%20aged%2010%20to%2019%5Cu00a0years%20%28period%20of%20adolescence%29%20while%20under%20care%20up%20to%20database%20closure%20%28June%202016%29.%20Follow-up%20started%20at%20age%2010%5Cu00a0years%20or%20the%20first%20clinic%20visit%2C%20whichever%20was%20later.%20Entering%20care%20at%20%3C15%5Cu00a0years%20was%20a%20proxy%20for%20perinatal%20infection%2C%20while%20entering%20care%20%5Cu226515%5Cu00a0years%20represented%20infection%20acquired%20during%20adolescence.%20Competing%20risk%20regression%20was%20used%20to%20assess%20associations%20with%20death%20and%20LTFU%20among%20those%20ever%20receiving%20triple-drug%20antiretroviral%20therapy%20%28triple-ART%29.%5CnRESULTS%3A%20Of%20the%2061%2C242%20ALHIV%20from%20270%20clinics%20in%2034%20countries%20included%20in%20the%20analysis%2C%2069%25%20%28n%5Cu00a0%3D%5Cu00a042%2C138%29%20entered%20care%20%3C15%5Cu00a0years%20of%20age%20%2853%25%20female%29%2C%20and%2031%25%20%28n%5Cu00a0%3D%5Cu00a019%2C104%29%20entered%20care%20%5Cu226515%5Cu00a0years%20%2881%25%20female%29.%20During%20adolescence%2C%203.9%25%20died%2C%2030%25%20were%20LTFU%20and%208.1%25%20were%20transferred.%20For%20those%20with%20infection%20acquired%20perinatally%20versus%20during%20adolescence%2C%20the%20four-year%20cumulative%20incidences%20of%20mortality%20were%203.9%25%20versus%205.4%25%20and%20of%20LTFU%20were%2026%25%20versus%2069%25%20respectively%20%28both%20p%5Cu00a0%3C%5Cu00a00.001%29.%20Overall%2C%20there%20were%20higher%20hazards%20of%20death%20for%20females%20%28adjusted%20sub-hazard%20ratio%20%28asHR%29%201.19%2C%2095%25%20confidence%20interval%20%28CI%29%201.07%20to%201.33%29%2C%20and%20those%20starting%20treatment%20at%20%5Cu22655%5Cu00a0years%20of%20age%20%28highest%20asHR%20for%20age%20%5Cu226515%3A%208.72%2C%2095%25%20CI%205.85%20to%2013.02%29%2C%20and%20in%20care%20in%20mostly%20urban%20%28asHR%201.40%2C%2095%25%20CI%201.13%20to%201.75%29%20and%20mostly%20rural%20settings%20%28asHR%201.39%2C%2095%25%20CI%201.03%20to%201.87%29%20compared%20to%20urban%20settings.%20Overall%2C%20higher%20hazards%20of%20LTFU%20were%20observed%20among%20females%20%28asHR%201.12%2C%2095%25%20CI%201.07%20to%201.17%29%2C%20and%20those%20starting%20treatment%20at%20age%20%5Cu22655%5Cu00a0years%20%28highest%20asHR%20for%20age%20%5Cu226515%3A%2011.11%2C%2095%25%20CI%209.86%20to%2012.53%29%2C%20in%20care%20at%20district%20hospitals%20%28asHR%201.27%2C%2095%25%20CI%201.18%20to%201.37%29%20or%20in%20rural%20settings%20%28asHR%201.21%2C%2095%25%20CI%201.13%20to%201.29%29%2C%20and%20starting%20triple-ART%20after%202006%20%28highest%20asHR%20for%202011%20to%202016%201.84%2C%2095%25%20CI%201.71%20to%201.99%29.%5CnCONCLUSIONS%3A%20Both%20mortality%20and%20LTFU%20were%20worse%20among%20those%20entering%20care%20at%20%5Cu226515%5Cu00a0years.%20ALHIV%20should%20be%20evaluated%20apart%20from%20younger%20children%20and%20adults%20to%20identify%20population-specific%20reasons%20for%20death%20and%20LTFU.%22%2C%22date%22%3A%2212%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25215%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A03%3A10Z%22%7D%7D%2C%7B%22key%22%3A%222ZSFN275%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AIDS-defining%20Cancer%20Project%20Working%20Group%20of%20IeDEA%2C%20COHERE%20in%20EuroCoord%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAIDS-defining%20Cancer%20Project%20Working%20Group%20of%20IeDEA%2C%20COHERE%20in%20EuroCoord.%20Non-Hodgkin%20lymphoma%20risk%20in%20adults%20living%20with%20HIV%20across%20five%20continents.%20AIDS.%202018%2028%3B32%2818%29%3A2777%26%23x2013%3B86.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D2ZSFN275%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Non-Hodgkin%20lymphoma%20risk%20in%20adults%20living%20with%20HIV%20across%20five%20continents%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22AIDS-defining%20Cancer%20Project%20Working%20Group%20of%20IeDEA%2C%20COHERE%20in%20EuroCoord%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20compare%20non-Hodgkin%20lymphoma%20%28NHL%29%20incidence%20rates%20in%20adults%20who%20started%20antiretroviral%20therapy%20%28ART%29%20across%20the%20Asia-Pacific%2C%20South%20Africa%2C%20Europe%2C%20Latin%2C%20and%20North%20America.%5CnMETHODS%3A%20We%20included%20cohort%20data%20of%20adults%20living%20with%20HIV%20who%20started%20ART%20after%201995%20within%20the%20framework%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20and%20the%20Collaboration%20of%20Observational%20HIV%20Epidemiological%20Research%20in%20Europe%20%28COHERE%29.%20We%20used%20flexible%20parametric%20survival%20models%20to%20compare%20regional%20NHL%20rates%20at%202%20years%20after%20ART%20start%20and%20to%20identify%20risk%20factors%20for%20NHL.%5CnRESULTS%3A%20We%20included%20210%5Cu200a898%20adults%20with%201.1%20million%20person-years%20%28pys%29%20of%20follow-up%20and%201552%20incident%20NHL%20cases%20%28raw%20overall%20incidence%20rate%20142%5C%2F100%5Cu200a000%20pys%29.%20After%20adjusting%20for%20age%20at%20ART%20start%2C%20first-line%20ART%20regimen%2C%20calendar%20period%20of%20ART%20start%2C%20and%20especially%20current%20CD4%20cell%20count%2C%20NHL%20rates%20were%20similar%20across%20regions%20for%20most%20population%20groups.%20However%2C%20South%20African%20women%20remained%20at%20increased%20risk%20of%20developing%20NHL%20compared%20with%20their%20European%20counterparts%20%5Badjusted%20hazard%20ratio%20%5BaHR%5D%201.79%2C%2095%25%20CI%201.19-2.70%5D.%20In%20Europe%2C%20Latin%2C%20and%20North%20America%2C%20NHL%20risk%20was%20highest%20in%20MSM%20%28aHR%201.30%2C%2095%25%20CI%201.14-1.48%29%2C%20followed%20by%20heterosexual%20men%20%28referent%29%2C%20and%20women%20%28aHR%200.66%2C%2095%25%20CI%200.57-0.78%29.%5CnCONCLUSIONS%3A%20The%20risk%20of%20developing%20NHL%20is%20higher%20in%20women%20in%20South%20Africa%20than%20in%20Europe%20and%20higher%20in%20MSM%20compared%20with%20heterosexual%20men%20and%20women.%20Reasons%20for%20these%20differences%20remain%20unclear.%20Early%20ART%20access%20and%20regular%20patient%20monitoring%20to%20avert%20low%20CD4%20cell%20counts%20remain%20key%20for%20NHL%20prevention.%22%2C%22date%22%3A%2211%2028%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000002003%22%2C%22ISSN%22%3A%221473-5571%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A03%3A28Z%22%7D%7D%2C%7B%22key%22%3A%227DFC2K53%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Panayidou%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPanayidou%20K%2C%20Davies%20MA%2C%20Anderegg%20N%2C%20Egger%20M%2C%20IeDEA%2C%20COHERE%2C%20PHACS%20and%20IMPAACT%20219C%20Collaborations%20Writing%20Group.%20Global%20temporal%20changes%20in%20the%20proportion%20of%20children%20with%20advanced%20disease%20at%20the%20start%20of%20combination%20antiretroviral%20therapy%20in%20an%20era%20of%20changing%20criteria%20for%20treatment%20initiation.%20J%20Int%20AIDS%20Soc.%202018%3B21%2811%29%3Ae25200.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7DFC2K53%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20temporal%20changes%20in%20the%20proportion%20of%20children%20with%20advanced%20disease%20at%20the%20start%20of%20combination%20antiretroviral%20therapy%20in%20an%20era%20of%20changing%20criteria%20for%20treatment%20initiation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klea%22%2C%22lastName%22%3A%22Panayidou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanina%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%2C%20COHERE%2C%20PHACS%20and%20IMPAACT%20219C%20Collaborations%20Writing%20Group%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20The%20CD4%20cell%20count%20and%20percent%20at%20initiation%20of%20combination%20antiretroviral%20therapy%20%28cART%29%20are%20measures%20of%20advanced%20HIV%20disease%20and%20thus%20are%20important%20indicators%20of%20programme%20performance%20for%20children%20living%20with%20HIV.%20In%20particular%2C%20World%20Health%20Organization%20%28WHO%29%202017%20guidelines%20on%20advanced%20HIV%20disease%20noted%20that%20%3E80%25%20of%20children%20aged%20%3C5%5Cu00a0years%20started%20cART%20with%20WHO%20Stage%203%20or%204%20disease%20or%20severe%20immune%20suppression.%20We%20compared%20temporal%20trends%20in%20CD4%20measures%20at%20cART%20start%20in%20children%20from%20low-%2C%20middle-%20and%20high-income%20countries%2C%20and%20examined%20the%20effect%20of%20WHO%20treatment%20initiation%20guidelines%20on%20reducing%20the%20proportion%20of%20children%20initiating%20cART%20with%20advanced%20disease.%5CnMETHODS%3A%20We%20included%20children%20aged%20%3C16%5Cu00a0years%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20acquired%20immunodeficiency%20syndrome%20%28AIDS%29%20%28IeDEA%29%20Collaboration%20%28Caribbean%2C%20Central%20and%20South%20America%2C%20Asia-Pacific%2C%20and%20West%2C%20Central%2C%20East%20and%20Southern%20Africa%29%2C%20the%20Collaboration%20of%20Observational%20HIV%20Epidemiological%20Research%20in%20Europe%20%28COHERE%29%2C%20the%20North%20American%20Pediatric%20HIV%5C%2FAIDS%20Cohort%20Study%20%28PHACS%29%20and%20International%20Maternal%20Pediatric%20Adolescent%20AIDS%20Clinical%20Trials%20%28IMPAACT%29%20219C%20study.%20Severe%20immunodeficiency%20was%20defined%20using%20WHO%20guidelines.%20We%20used%20generalized%20weighted%20additive%20mixed%20effect%20models%20to%20analyse%20temporal%20trends%20in%20CD4%20measurements%20and%20piecewise%20regression%20to%20examine%20the%20impact%20of%202006%20and%202010%20WHO%20cART%20initiation%20guidelines.%5CnRESULTS%3A%20We%20included%2052%2C153%20children%20from%20fourteen%20low-%2C%20eight%20lower%20middle-%2C%20five%20upper%20middle-%20and%20five%20high-income%20countries.%20From%202004%20to%202013%2C%20the%20estimated%20percentage%20of%20children%20starting%20cART%20with%20severe%20immunodeficiency%20declined%20from%2070%25%20to%2042%25%20%28low-income%29%2C%2067%25%20to%2064%25%20%28lower%20middle-income%29%20and%2061%25%20to%2043%25%20%28upper%20middle-income%20countries%29.%20In%20high-income%20countries%2C%20severe%20immunodeficiency%20at%20cART%20initiation%20declined%20from%2045%25%20%281996%29%20to%2014%25%20%282012%29.%20There%20were%20annual%20decreases%20in%20the%20percentage%20of%20children%20with%20severe%20immunodeficiency%20at%20cART%20initiation%20after%20the%20WHO%20guidelines%20revisions%20in%202006%20%28low-%2C%20lower%20middle-%20and%20upper%20middle-income%20countries%29%20and%202010%20%28all%20countries%29.%5CnCONCLUSIONS%3A%20By%202013%2C%20less%20than%20half%20of%20children%20initiating%20cART%20had%20severe%20immunodeficiency%20worldwide.%20WHO%20treatment%20initiation%20guidelines%20have%20contributed%20to%20reducing%20the%20proportion%20of%20children%20and%20adolescents%20starting%20cART%20with%20advanced%20disease.%20However%2C%20considerable%20global%20inequity%20remains%2C%20in%202013%2C%20%3E40%25%20of%20children%20in%20low-%20and%20middle-income%20countries%20started%20cART%20with%20severe%20immunodeficiency%20compared%20to%20%3C20%25%20in%20high-income%20countries.%22%2C%22date%22%3A%2211%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25200%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A02%3A11Z%22%7D%7D%2C%7B%22key%22%3A%2272J5PV3I%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rebeiro%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERebeiro%20PF%2C%20Howe%20CJ%2C%20Rogers%20WB%2C%20Bebawy%20SS%2C%20Turner%20M%2C%20Kheshti%20A%2C%20et%20al.%20The%20relationship%20between%20adverse%20neighborhood%20socioeconomic%20context%20and%20HIV%20continuum%20of%20care%20outcomes%20in%20a%20diverse%20HIV%20clinic%20cohort%20in%20the%20Southern%20United%20States.%20AIDS%20Care.%202018%3B30%2811%29%3A1426%26%23x2013%3B34.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D72J5PV3I%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20relationship%20between%20adverse%20neighborhood%20socioeconomic%20context%20and%20HIV%20continuum%20of%20care%20outcomes%20in%20a%20diverse%20HIV%20clinic%20cohort%20in%20the%20Southern%20United%20States%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chanelle%20J.%22%2C%22lastName%22%3A%22Howe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20B.%22%2C%22lastName%22%3A%22Rogers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sally%20S.%22%2C%22lastName%22%3A%22Bebawy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asghar%22%2C%22lastName%22%3A%22Kheshti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20P.%22%2C%22lastName%22%3A%22Raffanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%5D%2C%22abstractNote%22%3A%22Retention%20in%20care%20and%20viral%20suppression%20are%20critical%20to%20delaying%20HIV%20progression%20and%20reducing%20transmission.%20Neighborhood%20socioeconomic%20context%20%28NSEC%29%20may%20affect%20HIV%20care%20receipt.%20We%20therefore%20assessed%20NSEC%27s%20impact%20on%20retention%20and%20viral%20suppression%20in%20a%20diverse%20HIV%20clinical%20cohort.%20HIV-positive%20adults%20with%20%5Cu22651%20visit%20at%20the%20Vanderbilt%20Comprehensive%20Care%20Clinic%20and%205-digit%20ZIP%20code%20tabulation%20area%20%28ZCTA%29%20information%20between%202008%20and%202012%20contributed.%20NSEC%20z-score%20indices%20used%20neighborhood-level%20socioeconomic%20indicators%20for%20poverty%2C%20education%2C%20labor-force%20participation%2C%20proportion%20of%20males%2C%20median%20age%2C%20and%20proportion%20of%20residents%20of%20black%20race%20by%20ZCTA.%20Retention%20was%20defined%20as%20%5Cu22652%20HIV%20care%20visits%20per%20calendar%20year%2C%20%3E90%20days%20apart.%20Viral%20suppression%20was%20defined%20as%20an%20HIV-1%20RNA%20%3C200%20copies%5C%2FmL%20at%20last%20measurement%20per%20calendar%20year.%20Modified%20Poisson%20regression%20was%20used%20to%20estimate%20risk%20ratios%20%28RR%29%20and%2095%25%20confidence%20intervals%20%28CI%29.%20Among%202272%20and%202541%20adults%20included%20for%20retention%20and%20viral%20suppression%20analyses%2C%20respectively%2C%20median%20age%20and%20CD4%20count%20at%20enrollment%20were%20approximately%2038%20%281st%20and%203rd%20quartile%3A%2030%2C%2044%29%20years%20and%20351%20%28176%2C%20540%29%20cells%5C%2F%5Cu03bcL%2C%20respectively%2C%20while%2024%25%20were%20female%2C%20and%2039%25%20were%20black.%20Across%20243%20ZCTAs%2C%20median%20NSEC%20z-score%20was%200.09%20%28-0.66%2C%200.48%29.%20Overall%2C%2079%25%20of%20person-time%20contributed%20was%20retained%20and%2074%25%20was%20virally%20suppressed.%20In%20adjusted%20models%2C%20NSEC%20was%20not%20associated%20with%20retention%2C%20though%20being%20in%20the%204th%20vs.%201st%20NSEC%20quartile%20was%20associated%20with%20lack%20of%20viral%20suppression%20%28RR%5Cu2009%3D%5Cu20090.88%3B%2095%25%20CI%3A%200.80-0.97%29.%20Residing%20in%20the%20most%20adverse%20NSEC%20was%20associated%20with%20lack%20of%20viral%20suppression.%20Future%20studies%20are%20needed%20to%20confirm%20this%20finding.%22%2C%22date%22%3A%2211%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F09540121.2018.1465526%22%2C%22ISSN%22%3A%221360-0451%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222020-09-15T16%3A02%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22G3HPGL8K%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Prochazka%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EProchazka%20M%2C%20Otero%20L%2C%20Konda%20KA%2C%20Gonz%26%23xE1%3Blez-Lagos%20E%2C%20Echevarr%26%23xED%3Ba%20J%2C%20Gotuzzo%20E.%20Patient-nominated%20supporters%20as%20facilitators%20for%20engagement%20in%20HIV%20care%20in%20a%20referral%20hospital%20in%20Peru%3A%20A%20retrospective%20cohort%20study.%20PLoS%20ONE.%202018%3B13%284%29%3Ae0195389.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DG3HPGL8K%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Patient-nominated%20supporters%20as%20facilitators%20for%20engagement%20in%20HIV%20care%20in%20a%20referral%20hospital%20in%20Peru%3A%20A%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateo%22%2C%22lastName%22%3A%22Prochazka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larissa%22%2C%22lastName%22%3A%22Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelika%20A.%22%2C%22lastName%22%3A%22Konda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elsa%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez-Lagos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Echevarr%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%5D%2C%22abstractNote%22%3A%22Patient-nominated%20supporters%20can%20potentially%20improve%20the%20continuum%20of%20HIV%20care.%20We%20retrospectively%20determined%20factors%20associated%20with%20having%20a%20patient-nominated%20supporter%20among%20people%20living%20with%20HIV%20%28PLWH%29%2C%20and%20its%20association%20with%20retention%20in%20care%20and%20viral%20suppression.%20We%20analysed%20registries%20of%20adults%20evaluated%20by%20social%20workers%20%28n%20%3D%201345%29%20at%20a%20referral%20hospital%20in%20Peru%20between%202011-2014.%20Nondisclosure%20of%20HIV%20status%20was%20associated%20with%20lacking%20supporters%20%28aPR%3A%205.41%2C%2095%25%20CI%3A%203.83-7.64%29.%20Retention%20in%20care%20was%2076.4%25%20and%2034.2%25%20after%20one%20and%20two%20years%20of%20enrolment%2C%20respectively.%20PLWH%20with%20supporters%20were%20more%20likely%20to%20be%20retained%20in%20care%20after%20two%20years%20%28aRR%20%3D%201.36%2C%2095%25%20CI%3A%201.02-1.81%29%2C%20but%20not%20after%20one%20year%20%28aRR%20%3D%201.10%2C%2095%25%20CI%3A%200.98-1.23%29%20compared%20to%20PLWH%20without%20supporters.%20Having%20supporters%20who%20were%20parents%20or%20friends%20was%20associated%20with%20an%20increased%20probability%20of%20being%20retained%20in%20care%20after%20one%20and%20two%20years%20of%20enrolment.%20Viral%20suppression%20after%20one%20year%20of%20enrolment%20was%2058.7%25.%20Having%20a%20supporter%20was%20not%20associated%20with%20viral%20suppression%20%28aRR%20%3D%201.18%2C%2095%25%20CI%3A%200.99-1.41%29%2C%20but%20PLWH%20with%20supporters%20were%20more%20likely%20to%20have%20viral%20load%20measurements%20%28p%20%3D%200.005%29.%20Patient-nominated%20supporters%20appear%20beneficial%20for%20engagement%20in%20HIV%20care%3B%20these%20benefits%20may%20be%20related%20to%20the%20nature%20of%20their%20relationship%20with%20PLWH.%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0195389%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A24%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22D824H943%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fink%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFink%20VI%2C%20Jenkins%20CA%2C%20Castilho%20JL%2C%20Person%20AK%2C%20Shepherd%20BE%2C%20Grinsztejn%20B%2C%20et%20al.%20Survival%20after%20cancer%20diagnosis%20in%20a%20cohort%20of%20HIV-positive%20individuals%20in%20Latin%20America.%20Infect%20Agents%20Cancer.%202018%3B13%3A16.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DD824H943%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Survival%20after%20cancer%20diagnosis%20in%20a%20cohort%20of%20HIV-positive%20individuals%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20I.%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliana%22%2C%22lastName%22%3A%22Netto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CCASAnet%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20This%20study%20aimed%20to%20evaluate%20trends%20and%20predictors%20of%20survival%20after%20cancer%20diagnosis%20in%20persons%20living%20with%20HIV%20in%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20for%20HIV%20epidemiology%20cohort.%5CnMethods%3A%20Demographic%2C%20cancer%2C%20and%20HIV-related%20data%20from%20HIV-positive%20adults%20diagnosed%20with%20cancer%20%5Cu2264%201%20year%20before%20or%20any%20time%20after%20HIV%20diagnosis%20from%20January%201%2C%202000-June%2030%2C%202015%20were%20retrospectively%20collected.%20Cancer%20cases%20were%20classified%20as%20AIDS-defining%20cancers%20%28ADC%29%20and%20non-AIDS-defining%20cancers%20%28NADC%29.%20The%20association%20of%20mortality%20with%20cancer-%20and%20HIV-related%20factors%20was%20assessed%20using%20Kaplan-Meier%20curves%20and%20Cox%20proportional%20hazards%20models%20stratified%20by%20clinic%20site%20and%20cancer%20type.%5CnResults%3A%20Among%2015%2C869%20patients%2C%20783%20had%20an%20eligible%20cancer%20diagnosis%3B%2082%25%20were%20male%20and%20median%20age%20at%20cancer%20diagnosis%20was%2039%5Cu00a0years%20%28interquartile%20range%20%5BIQR%5D%3A%2032-47%29.%20Patients%20were%20from%20Brazil%20%2836.5%25%29%2C%20Argentina%20%2819.9%25%29%2C%20Chile%20%2819.7%25%29%2C%20Mexico%20%2819.3%25%29%2C%20and%20Honduras%20%284.6%25%29.%20A%20total%20of%20564%20ADC%20and%20219%20NADC%20were%20diagnosed.%20Patients%20with%20NADC%20had%20similar%20survival%20probabilities%20as%20those%20with%20ADC%20at%20one%20year%20%2881%25%20vs.%2079%25%29%20but%20lower%20survival%20at%20five%20years%20%2860%25%20vs.%2069%25%29.%20In%20the%20adjusted%20analysis%2C%20risk%20of%20mortality%20increased%20with%20detectable%20viral%20load%20%28adjusted%20hazard%20ratio%20%5BaHR%5D%5Cu2009%3D%5Cu20091.63%2C%20p%5Cu2009%3D%5Cu20090.02%29%2C%20age%20%28aHR%5Cu2009%3D%5Cu20091.02%20per%20year%2C%20p%5Cu2009%3D%5Cu20090.002%29%20and%20time%20between%20HIV%20and%20cancer%20diagnoses%20%28aHR%5Cu2009%3D%5Cu20091.03%20per%20year%2C%20p%5Cu2009%3D%5Cu20090.01%29.%5CnConclusion%3A%20ADC%20remain%20the%20most%20frequent%20cancers%20in%20the%20region.%20Overall%20mortality%20was%20related%20to%20detectable%20viral%20load%20and%20age.%20Longer-term%20survival%20was%20lower%20after%20diagnosis%20of%20NADC%20than%20for%20ADC%2C%20which%20may%20be%20due%20to%20factors%20unrelated%20to%20HIV.%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13027-018-0188-3%22%2C%22ISSN%22%3A%221750-9378%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A22%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22VLGC84FJ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22De%20Boni%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDe%20Boni%20RB%2C%20Peratikos%20MB%2C%20Shepherd%20BE%2C%20Grinsztejn%20B%2C%20Cort%26%23xE9%3Bs%20C%2C%20Padgett%20D%2C%20et%20al.%20Is%20substance%20use%20associated%20with%20HIV%20cascade%20outcomes%20in%20Latin%20America%3F%20PLoS%20ONE.%202018%3B13%283%29%3Ae0194228.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DVLGC84FJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Is%20substance%20use%20associated%20with%20HIV%20cascade%20outcomes%20in%20Latin%20America%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%20B.%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meridith%20B.%22%2C%22lastName%22%3A%22Peratikos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F.%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22for%20CCASAnet%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20HIV%20care%20cascade%20has%20improved%20in%20Latin%20America%20over%20the%20last%20decade.%20However%2C%20the%20influence%20of%20alcohol%20and%20noninjected%20drug%20use%20%28NIDU%29%20on%20cascade%20outcomes%20is%20mostly%20unknown.%20This%20study%20estimated%20the%20association%20of%20alcohol%20and%20NIDU%20with%20retention%20in%20care%2C%20loss%20to%20follow%20up%20%28LTFU%29%2C%20and%20virologic%20failure%20%28VF%29.%5CnMETHODS%3A%20Individuals%20%5Cu226518%20years%20attending%20routine%20HIV%20clinic%20visits%20and%20completing%20the%20Rapid%20Screening%20Tool%20%28RST%3B%20evaluating%20NIDU%20and%20ART%20adherence%20in%207-day%20recall%20period%29%20during%202012-13%20were%20followed%20up%20to%202015%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology.%20Adjusted%20odds%20ratios%20%28aOR%29%20were%20calculated%20for%20the%20association%20of%20alcohol%20consumption%20and%20NIDU%20with%20retention%20in%20care%20by%20logistic%20regression%3B%20adjusted%20hazard%20ratios%20%28aHR%29%20were%20estimated%20for%20the%20associations%20with%20LTFU%20and%20VF%20by%20Cox%20regression.%5CnRESULTS%3A%20Among%203604%20individuals%2C%20the%20proportions%20retained%20in%20care%20for%20one%20year%20were%2084%25%2C%2079%25%2C%2072%25%2C%20and%2069%25%20for%20patients%20reporting%20non-use%2C%20alcohol%20use%2C%20NIDU%2C%20and%20both%20alcohol%20and%20NIDU%2C%20respectively.%20For%20the%20same%20patient%20groups%2C%20the%20proportions%20LTFU%20over%2018%20months%20were%206%25%2C%208%25%2C%2012%25%2C%20and%2013%25%2C%20respectively.%20There%20were%201901%20patients%20%2853%25%29%20with%20HIV%20RNA%20results%3B%20VF%20proportions%20were%20similar%20between%20users%20and%20nonusers%20%28ranging%20from%2014-16%25%29.%20After%20controlling%20for%20age%2C%20sex%2C%20study%20site%2C%20HIV%20transmission%20mode%2C%20time%20on%20ART%2C%20AIDS%20status%2C%20and%20CD4%20count%2C%20neither%20alcohol%20use%20%28aOR%20%3D%201.1%2C%20CI%20%3D%200.9-1.4%3B%20aHR%20%3D%201.0%2C%20CI%20%3D%200.8-1.3%29%20nor%20NIDU%20%28aOR%20%3D%201.3%2C%20CI%20%3D%200.9-1.8%3B%20aHR%20%3D%201.4%2C%20CI%20%3D%200.9-2.1%29%20were%20significantly%20associated%20with%20retention%20or%20VF%2C%20respectively.%20However%2C%20both%20alcohol%20use%20%28aHR%20%3D%201.2%2C%20CI%20%3D%201.02-1.4%29%20and%20NIDU%20%28aHR%20%3D%201.3%2C%20CI%20%3D%201.00-1.8%29%20were%20associated%20with%20increased%20LTFU.%5CnCONCLUSION%3A%20Alcohol%20use%20and%20NIDU%20in%20a%207-day%20recall%20period%20increased%20the%20risk%20of%20being%20LTFU%20during%20the%20next%2018%20months%2C%20highlighting%20the%20need%20for%20routine%20screening%20and%20targeted%20interventions%20to%20keep%20these%20individuals%20in%20care%20and%20on%20ART.%22%2C%22date%22%3A%222018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0194228%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A20%3A49Z%22%7D%7D%5D%7D
1.
Zaniewski E, Tymejczyk O, Kariminia A, Desmonde S, Leroy V, Ford N, et al. IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development. J Virus Erad. 2018 Nov 15;4(Suppl 2):9–15. Cite
1.
Ford N, Penazzato M, Vitoria M, Doherty M, Davies MA, Zaniewski E, et al. The contribution of observational studies in supporting the WHO “treat all” recommendation for HIV/AIDS. J Virus Erad. 2018 Nov 15;4(Suppl 2):5–8. Cite
1.
Guiteau Moise C, Rivera VR, Hennessey KA, Bellot C, Nicholas C, Fang AP, et al. A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living With HIV in Haiti. J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):70–6. Cite
1.
Bakal DR, Coelho LE, Luz PM, Clark JL, De Boni RB, Cardoso SW, et al. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors. J Antimicrob Chemother. 2018 Aug 1;73(8):2177–85. Cite
1.
Coelho L, Rebeiro PF, Castilho JL, Caro-Veja Y, Mejia FA, Cesar C, et al. Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas. AIDS Patient Care STDS. 2018 Aug;32(8):306–13. Cite
1.
Arrivé E, Ayaya S, Davies MA, Chimbetete C, Edmonds A, Lelo P, et al. Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. J Int AIDS Soc. 2018 Jul;21(7):e25157. Cite
1.
Caro-Vega Y, Belaunzarán-Zamudio PF, Crabtree-Ramírez B, Shepherd BE, Mejia F, Giganti MJ, et al. Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge. Epidemiol Infect. 2018 Jul;146(10):1308–11. Cite
1.
Giles ML, Achhra AC, Abraham AG, Haas AD, Gill MJ, Lee MP, et al. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2018 Jun;21(6):e25149. Cite
1.
Zamudio-Rodríguez A, Belaunzarán-Zamudio PF, Sierra-Madero JG, Cuellar-Rodríguez J, Crabtree-Ramírez BE, Alcala-Zermeno JL, et al. Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV. AIDS Res Hum Retroviruses. 2018 May;34(5):449–55. Cite
1.
Oh EJ, Shepherd BE, Lumley T, Shaw PA. Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX. Stat Med. 2018 Apr 15;37(8):1276–89. Cite
1.
IeDEA and COHERE Cohort Collaborations. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis. 2018 Mar 5;66(6):893–903. Cite
1.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, et al. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med. 2018 Mar;15(3):e1002514. Cite
1.
Parcesepe AM, Mugglin C, Nalugoda F, Bernard C, Yunihastuti E, Althoff K, et al. Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. J Int AIDS Soc. 2018 Mar;21(3):e25101. Cite
1.
Tymejczyk O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, Althoff K, Crabtree-Ramírez B, et al. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med. 2018 Mar;15(3):e1002534. Cite
1.
Caro-Vega Y, Belaunzarán-Zamudio PF, Crabtree-Ramírez BE, Shepherd BE, Grinsztejn B, Wolff M, et al. Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America. Open Forum Infect Dis. 2018 Mar;5(3):ofy004. Cite
1.
Carriquiry G, Giganti MJ, Castilho JL, Jayathilake K, Cahn P, Grinsztejn B, et al. Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort. J Int AIDS Soc. 2018 Mar;21(3):e25088. Cite
1.
Kariminia A, Law M, Davies MA, Vinikoor M, Wools-Kaloustian K, Leroy V, et al. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc. 2018;21(12):e25215. Cite
1.
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord. Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS. 2018 28;32(18):2777–86. Cite
1.
Panayidou K, Davies MA, Anderegg N, Egger M, IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. J Int AIDS Soc. 2018;21(11):e25200. Cite
1.
Rebeiro PF, Howe CJ, Rogers WB, Bebawy SS, Turner M, Kheshti A, et al. The relationship between adverse neighborhood socioeconomic context and HIV continuum of care outcomes in a diverse HIV clinic cohort in the Southern United States. AIDS Care. 2018;30(11):1426–34. Cite
1.
Prochazka M, Otero L, Konda KA, González-Lagos E, Echevarría J, Gotuzzo E. Patient-nominated supporters as facilitators for engagement in HIV care in a referral hospital in Peru: A retrospective cohort study. PLoS ONE. 2018;13(4):e0195389. Cite
1.
Fink VI, Jenkins CA, Castilho JL, Person AK, Shepherd BE, Grinsztejn B, et al. Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America. Infect Agents Cancer. 2018;13:16. Cite
1.
De Boni RB, Peratikos MB, Shepherd BE, Grinsztejn B, Cortés C, Padgett D, et al. Is substance use associated with HIV cascade outcomes in Latin America? PLoS ONE. 2018;13(3):e0194228. Cite
2017
76770
IP6F4TRX
2017
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-03f8e8390153c64a115a138d14d3ab36%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WAWD2I69%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lamas%20et%20al.%22%2C%22parsedDate%22%3A%222017-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELamas%20CC%2C%20Coelho%20LE%2C%20Grinsztejn%20BJ%2C%20Veloso%20VG.%20Community-acquired%20lower%20respiratory%20tract%20infections%20in%20HIV-infected%20patients%20on%20antiretroviral%20therapy%3A%20predictors%20in%20a%20contemporary%20cohort%20study.%20Infection.%202017%20Dec%3B45%286%29%3A801%26%23x2013%3B9.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DWAWD2I69%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Community-acquired%20lower%20respiratory%20tract%20infections%20in%20HIV-infected%20patients%20on%20antiretroviral%20therapy%3A%20predictors%20in%20a%20contemporary%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristiane%20C.%22%2C%22lastName%22%3A%22Lamas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%20J.%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%5D%2C%22abstractNote%22%3A%22Community-acquired%20pneumonia%20represents%20the%20most%20frequent%20bacterial%20infection%20in%20patients%20with%20HIV%5C%2FAIDS.%5CnPURPOSE%3A%20We%20aimed%20to%20assess%20variables%20associated%20with%20lower%20respiratory%20tract%20infection%20%28LRTI%29%20among%20HIV-infected%20adults%20using%20ART.%5CnMETHODS%3A%20A%20cohort%20study%20of%20HIV-infected%20patients%20aged%20%5Cu226518%5Cu00a0years%2C%20enrolled%20from%202000%20to%202015%2C%20on%20ART%20for%20at%20least%2060%5Cu00a0days%2C%20with%20primary%20outcome%20as%20the%201st%20episode%20of%20LRTI%20during%20follow-up.%20The%20independent%20variables%20included%20were%20sex%20at%20birth%2C%20age%2C%20race%5C%2Fskin%20color%2C%20educational%20level%2C%20tobacco%20smoking%2C%20alcohol%20use%2C%20cocaine%20use%2C%20diabetes%20mellitus%2C%20CD4%20count%2C%20HIV%20viral%20load%2C%20influenza%20and%20pneumococcal%20vaccination.%20Extended%20Cox%20proportional%20hazards%20models%20accounting%20for%20time-updated%20variables%20were%20fitted%20to%20assess%20LRTI%20predictors.%5CnRESULTS%3A%202669%20patients%20were%20included%3B%20median%20follow-up%20was%203.9%5Cu00a0years%20per%20patient.%20LRTI%20was%20diagnosed%20in%20384%20patients%3B%20incidence%20rate%20was%2030.7%5C%2F1000%20PY.%20In%20the%20unadjusted%20Cox%20extended%20models%2C%20non-white%20race%20%5Bcrude%20hazard%20ratio%20%28cHR%29%201.28%2C%20p%5Cu00a0%3D%5Cu00a00.020%5D%2C%20cocaine%20use%20%28cHR%202.01%2C%20p%5Cu00a0%3C%5Cu00a00.001%29%2C%20tobacco%20smoking%20%28cHR%201.34%2C%20p%20value%200.007%29%2C%20and%20HIV%20viral%20load%20%5Cu2265400%20copies%5C%2FmL%20%28cHR%203.40%2C%20p%5Cu00a0%3C%5Cu00a00.001%29%20increased%20the%20risk%20of%20LRTI.%20Lower%20risk%20of%20LRTI%20was%20seen%20with%20higher%20educational%20level%20%28cHR%200.61%2C%20p%5Cu00a0%3C%5Cu00a00.001%29%2C%20rise%20in%20CD4%20counts%20%28cHR%200.81%2C%20p%5Cu00a0%3C%5Cu00a00.001%2C%20per%20100%20cells%5C%2Fmm3%20increase%29%2C%20influenza%20%28cHR%200.60%2C%20p%5Cu00a0%3D%5Cu00a00.002%29%20and%20pneumococcal%20vaccination%20%28cHR%200.57%2C%20p%5Cu00a0%3C%5Cu00a00.001%29.%20In%20the%20adjusted%20model%2C%20aHR%20for%20CD4%20count%20was%200.86%2C%20for%20cocaine%20use%201.47%20and%20for%20viral%20load%20%5Cu2265400%20copies%202.20.%5CnCONCLUSIONS%3A%20LRTI%20has%20a%20high%20incidence%20in%20HIV-infected%20adults%20using%20ART.%20Higher%20CD4%20counts%20and%20undetectable%20viral%20loads%20were%20protective%2C%20as%20were%20pneumococcal%20and%20influenza%20vaccines.%22%2C%22date%22%3A%22Dec%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs15010-017-1041-0%22%2C%22ISSN%22%3A%221439-0973%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A16%3A49Z%22%7D%7D%2C%7B%22key%22%3A%222GCZMG9M%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222017-11-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELiu%20Q%2C%20Shepherd%20BE%2C%20Li%20C%2C%20Harrell%20FE.%20Modeling%20continuous%20response%20variables%20using%20ordinal%20regression.%20Stat%20Med.%202017%20Nov%2030%3B36%2827%29%3A4316%26%23x2013%3B35.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D2GCZMG9M%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Modeling%20continuous%20response%20variables%20using%20ordinal%20regression%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%20E.%22%2C%22lastName%22%3A%22Harrell%22%7D%5D%2C%22abstractNote%22%3A%22We%20study%20the%20application%20of%20a%20widely%20used%20ordinal%20regression%20model%2C%20the%20cumulative%20probability%20model%20%28CPM%29%2C%20for%20continuous%20outcomes.%20Such%20models%20are%20attractive%20for%20the%20analysis%20of%20continuous%20response%20variables%20because%20they%20are%20invariant%20to%20any%20monotonic%20transformation%20of%20the%20outcome%20and%20because%20they%20directly%20model%20the%20cumulative%20distribution%20function%20from%20which%20summaries%20such%20as%20expectations%20and%20quantiles%20can%20easily%20be%20derived.%20Such%20models%20can%20also%20readily%20handle%20mixed%20type%20distributions.%20We%20describe%20the%20motivation%2C%20estimation%2C%20inference%2C%20model%20assumptions%2C%20and%20diagnostics.%20We%20demonstrate%20that%20CPMs%20applied%20to%20continuous%20outcomes%20are%20semiparametric%20transformation%20models.%20Extensive%20simulations%20are%20performed%20to%20investigate%20the%20finite%20sample%20performance%20of%20these%20models.%20We%20find%20that%20properly%20specified%20CPMs%20generally%20have%20good%20finite%20sample%20performance%20with%20moderate%20sample%20sizes%2C%20but%20that%20bias%20may%20occur%20when%20the%20sample%20size%20is%20small.%20Cumulative%20probability%20models%20are%20fairly%20robust%20to%20minor%20or%20moderate%20link%20function%20misspecification%20in%20our%20simulations.%20For%20certain%20purposes%2C%20the%20CPMs%20are%20more%20efficient%20than%20other%20models.%20We%20illustrate%20their%20application%2C%20with%20model%20diagnostics%2C%20in%20a%20study%20of%20the%20treatment%20of%20HIV.%20CD4%20cell%20count%20and%20viral%20load%206%5Cu00a0months%20after%20the%20initiation%20of%20antiretroviral%20therapy%20are%20modeled%20using%20CPMs%3B%20both%20variables%20typically%20require%20transformations%2C%20and%20viral%20load%20has%20a%20large%20proportion%20of%20measurements%20below%20a%20detection%20limit.%22%2C%22date%22%3A%22Nov%2030%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fsim.7433%22%2C%22ISSN%22%3A%221097-0258%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A17%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22WHENC8IX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22AIDS-defining%20Cancer%20Project%20Working%20Group%20for%20IeDEA%20and%20COHERE%20in%20EuroCoord%22%2C%22parsedDate%22%3A%222017-10-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAIDS-defining%20Cancer%20Project%20Working%20Group%20for%20IeDEA%20and%20COHERE%20in%20EuroCoord.%20Comparison%20of%20Kaposi%20Sarcoma%20Risk%20in%20Human%20Immunodeficiency%20Virus-Positive%20Adults%20Across%205%20Continents%3A%20A%20Multiregional%20Multicohort%20Study.%20Clin%20Infect%20Dis.%202017%20Oct%2015%3B65%288%29%3A1316%26%23x2013%3B26.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DWHENC8IX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20Kaposi%20Sarcoma%20Risk%20in%20Human%20Immunodeficiency%20Virus-Positive%20Adults%20Across%205%20Continents%3A%20A%20Multiregional%20Multicohort%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22AIDS-defining%20Cancer%20Project%20Working%20Group%20for%20IeDEA%20and%20COHERE%20in%20EuroCoord%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20We%20compared%20Kaposi%20sarcoma%20%28KS%29%20risk%20in%20adults%20who%20started%20antiretroviral%20therapy%20%28ART%29%20across%20the%20Asia-Pacific%2C%20South%20Africa%2C%20Europe%2C%20Latin%2C%20and%20North%20America.%5CnMethods%3A%20We%20included%20cohort%20data%20of%20human%20immunodeficiency%20virus%20%28HIV%29-positive%20adults%20who%20started%20ART%20after%201995%20within%20the%20framework%20of%202%20large%20collaborations%20of%20observational%20HIV%20cohorts.%20We%20present%20incidence%20rates%20and%20adjusted%20hazard%20ratios%20%28aHRs%29.%5CnResults%3A%20We%20included%20208140%20patients%20from%2057%20countries.%20Over%20a%20period%20of%201066572%20person-years%2C%202046%20KS%20cases%20were%20diagnosed.%20KS%20incidence%20rates%20per%20100000%20person-years%20were%2052%20in%20the%20Asia-Pacific%20and%20ranged%20between%20180%20and%20280%20in%20the%20other%20regions.%20KS%20risk%20was%205%20times%20higher%20in%20South%20African%20women%20%28aHR%2C%204.56%3B%2095%25%20confidence%20intervals%20%5BCI%5D%2C%202.73-7.62%29%20than%20in%20their%20European%20counterparts%2C%20and%202%20times%20higher%20in%20South%20African%20men%20%282.21%3B%201.34-3.63%29.%20In%20Europe%2C%20Latin%2C%20and%20North%20America%20KS%20risk%20was%206%20times%20higher%20in%20men%20who%20have%20sex%20with%20men%20%28aHR%2C%205.95%3B%2095%25%20CI%2C%205.09-6.96%29%20than%20in%20women.%20Comparing%20patients%20with%20current%20CD4%20cell%20counts%20%5Cu2265700%20cells%5C%2F%5Cu00b5L%20with%20those%20whose%20counts%20were%20%3C50%20cells%5C%2F%5Cu00b5L%2C%20the%20KS%20risk%20was%20halved%20in%20South%20Africa%20%28aHR%2C%200.53%3B%2095%25%20CI%2C%20.17-1.63%29%20but%20reduced%20by%20%5Cu226595%25%20in%20other%20regions.%5CnConclusions%3A%20Despite%20important%20ART-related%20declines%20in%20KS%20incidence%2C%20men%20and%20women%20in%20South%20Africa%20and%20men%20who%20have%20sex%20with%20men%20remain%20at%20increased%20KS%20risk%2C%20likely%20due%20to%20high%20human%20herpesvirus%208%20coinfection%20rates.%20Early%20ART%20initiation%20and%20maintenance%20of%20high%20CD4%20cell%20counts%20are%20essential%20to%20further%20reducing%20KS%20incidence%20worldwide%2C%20but%20additional%20measures%20might%20be%20needed%2C%20especially%20in%20Southern%20Africa.%22%2C%22date%22%3A%22Oct%2015%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fcix480%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A18%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22PPZSN9XR%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rebeiro%20et%20al.%22%2C%22parsedDate%22%3A%222017-10-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERebeiro%20PF%2C%20Bakoyannis%20G%2C%20Musick%20BS%2C%20Braithwaite%20RS%2C%20Wools-Kaloustian%20KK%2C%20Nyandiko%20W%2C%20et%20al.%20Observational%20Study%20of%20the%20Effect%20of%20Patient%20Outreach%20on%20Return%20to%20Care%3A%20The%20Earlier%20the%20Better.%20J%20Acquir%20Immune%20Defic%20Syndr.%202017%20Oct%201%3B76%282%29%3A141%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPPZSN9XR%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Observational%20Study%20of%20the%20Effect%20of%20Patient%20Outreach%20on%20Return%20to%20Care%3A%20The%20Earlier%20the%20Better%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giorgos%22%2C%22lastName%22%3A%22Bakoyannis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20S.%22%2C%22lastName%22%3A%22Braithwaite%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winstone%22%2C%22lastName%22%3A%22Nyandiko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatma%22%2C%22lastName%22%3A%22Some%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%22%2C%22lastName%22%3A%22Braitstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20burden%20of%20HIV%20remains%20heaviest%20in%20resource-limited%20settings%2C%20where%20problems%20of%20losses%20to%20care%2C%20silent%20transfers%2C%20gaps%20in%20care%2C%20and%20incomplete%20mortality%20ascertainment%20have%20been%20recognized.%5CnMETHODS%3A%20Patients%20in%20care%20at%20Academic%20Model%20Providing%20Access%20to%20Healthcare%20%28AMPATH%29%20clinics%20from%202001-2011%20were%20included%20in%20this%20retrospective%20observational%20study.%20Patients%20missing%20an%20appointment%20were%20traced%20by%20trained%20staff%3B%20those%20found%20alive%20were%20counseled%20to%20return%20to%20care%20%28RTC%29.%20Relative%20hazards%20of%20RTC%20were%20estimated%20among%20those%20having%20a%20true%20gap%3A%20missing%20a%20clinic%20appointment%20and%20confirmed%20as%20neither%20dead%20nor%20receiving%20care%20elsewhere.%20Sample-based%20multiple%20imputation%20accounted%20for%20missing%20vital%20status.%5CnRESULTS%3A%20Among%2034%2C522%20patients%20lost%20to%20clinic%2C%2015%2C331%20%2844.4%25%29%20had%20a%20true%20gap%20per%20outreach%2C%202754%20%288.0%25%29%20were%20deceased%2C%20and%20837%20%282.4%25%29%20had%20documented%20transfers.%20Of%2015%2C600%20%2845.2%25%29%20remaining%20without%20active%20ascertainment%2C%208762%20%2856.2%25%29%20with%20later%20RTC%20were%20assumed%20to%20have%20a%20true%20gap.%20Adjusted%20cause-specific%20hazard%20ratios%20%28aHRs%29%20showed%20early%20outreach%20%28a%20%5Cu22648-day%20window%2C%20defined%20by%20grid-search%20approach%29%20had%20twice%20the%20hazard%20for%20RTC%20vs.%20those%20without%20%28aHR%20%3D%202.06%3B%20P%20%3C%200.001%29.%20HRs%20for%20RTC%20were%20lower%20the%20later%20the%20outreach%20effort%20after%20disengagement%20%28aHR%20%3D%200.86%20per%20unit%20increase%20in%20time%3B%20P%20%3C%200.001%29.%20Older%20age%2C%20female%20sex%20%28vs.%20male%29%2C%20antiretroviral%20therapy%20use%20%28vs.%20none%29%2C%20and%20HIV%20status%20disclosure%20%28vs.%20none%29%20were%20also%20associated%20with%20greater%20likelihood%20of%20RTC%2C%20and%20higher%20enrollment%20CD4%20count%20with%20lower%20likelihood%20of%20RTC.%5CnCONCLUSION%3A%20Patient%20outreach%20efforts%20have%20a%20positive%20impact%20on%20patient%20RTC%2C%20regardless%20of%20when%20undertaken%2C%20but%20particularly%20soon%20after%20the%20patient%20misses%20an%20appointment.%22%2C%22date%22%3A%22Oct%2001%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000001474%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A19%3A24Z%22%7D%7D%2C%7B%22key%22%3A%229EP8LBC6%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabtree%20Ram%5Cu00edrez%20et%20al.%22%2C%22parsedDate%22%3A%222017-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree%20Ram%26%23xED%3Brez%20B%2C%20Caro%20Vega%20Y%2C%20Shepherd%20BE%2C%20Le%20C%2C%20Turner%20M%2C%20Frola%20C%2C%20et%20al.%20Outcomes%20of%20HIV-positive%20patients%20with%20cryptococcal%20meningitis%20in%20the%20Americas.%20Int%20J%20Infect%20Dis.%202017%20Oct%3B63%3A57%26%23x2013%3B63.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9EP8LBC6%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcomes%20of%20HIV-positive%20patients%20with%20cryptococcal%20meningitis%20in%20the%20Americas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Crabtree%20Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Caro%20Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Le%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Frola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Person%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Cryptococcal%20meningitis%20%28CM%29%20is%20associated%20with%20substantial%20mortality%20in%20HIV-infected%20patients.%20Optimal%20timing%20of%20antiretroviral%20therapy%20%28ART%29%20in%20persons%20with%20CM%20represents%20a%20clinical%20challenge%2C%20and%20the%20burden%20of%20CM%20in%20Latin%20America%20has%20not%20been%20well%20described.%20Studies%20suggest%20that%20early%20ART%20initiation%20is%20associated%20with%20higher%20mortality%2C%20but%20data%20from%20the%20Americas%20are%20scarce.%5CnMETHODS%3A%20HIV-infected%20adults%20in%20care%20between%201985-2014%20at%20participating%20sites%20in%20the%20Latin%20America%20%28the%20Caribbean%2C%20Central%20and%20South%20America%20network%20%28CCASAnet%29%29%20and%20the%20Vanderbilt%20Comprehensive%20Care%20Clinic%20%28VCCC%29%20and%20who%20had%20CM%20were%20included.%20Survival%20probabilities%20were%20estimated.%20Risk%20of%20death%20when%20initiating%20ART%20within%20the%20first%202%20weeks%20after%20CM%20diagnosis%20versus%20initiating%20between%202-8%20weeks%20was%20assessed%20using%20dynamic%20marginal%20structural%20models%20adjusting%20for%20site%2C%20age%2C%20sex%2C%20year%20of%20CM%2C%20CD4%20count%2C%20and%20route%20of%20HIV%20transmission.%5CnFINDINGS%3A%20340%20patients%20were%20included%20%28Argentina%2058%2C%20Brazil%20138%2C%20Chile%2028%2C%20Honduras%2027%2C%20Mexico%2034%2C%20VCCC%2055%29%20and%20142%20%2842%25%29%20died%20during%20the%20observation%20period.%20Among%20151%20patients%20with%20CM%20prior%20to%20ART%2056%20%2837%25%29%20patients%20died%20compared%20to%2086%20%2845%25%29%20of%20189%20with%20CM%20after%20ART%20initiation%20%28p%3D0.14%29.%20Patients%20diagnosed%20with%20CM%20after%20ART%20had%20a%20higher%20risk%20of%20death%20%28p%3D0.03%2C%20log-rank%20test%29.%20The%20probability%20of%20survival%20was%20not%20statistically%20different%20between%20patients%20who%20started%20ART%20within%202%20weeks%20of%20CM%20%287%5C%2F24%2C%2029%25%29%20vs.%20those%20initiating%20between%202-8%20weeks%20%2814%5C%2F53%2C%2026%25%29%20%28p%3D0.96%29%2C%20potentially%20due%20to%20lack%20of%20power.%5CnINTERPRETATION%3A%20In%20this%20large%20Latin-American%20cohort%2C%20patients%20with%20CM%20had%20very%20high%20mortality%20rates%2C%20especially%20those%20diagnosed%20after%20ART%20initiation.%20This%20study%20reflects%20the%20overwhelming%20burden%20of%20CM%20in%20HIV-infected%20patients%20in%20Latin%20America.%22%2C%22date%22%3A%22Oct%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2017.08.004%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A17%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22AIJP3RZD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rohner%20and%20et%20al%22%2C%22parsedDate%22%3A%222017-05-20%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERohner%20E%2C%20et%20al.%20Comparison%20of%20Kaposi%20sarcoma%20risk%20in%20HIV-positive%20adults%20across%20five%20continents%3A%20a%20multiregional%20multicohort%20study.%20Clin%20Infect%20Dis%20%5BInternet%5D.%202017%20May%2020%3B%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28531260%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28531260%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DAIJP3RZD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20Kaposi%20sarcoma%20risk%20in%20HIV-positive%20adults%20across%20five%20continents%3A%20a%20multiregional%20multicohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22et%20al%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22May%2020%2C%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28531260%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A31%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22XX6CB7RK%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shepherd%20et%20al.%22%2C%22parsedDate%22%3A%222017-05-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShepherd%20B%2C%20Blevins%20M%2C%20Rebeiro%20P%2C%20Duda%20N%2C%20McGowan%20C.%20A%20Pragmatic%20Approach%20for%20Reproducible%20Research%20with%20Sensitive%20Data.%20Am%20Journal%20Epidemiol.%202017%20May%2010%3B%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DXX6CB7RK%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Pragmatic%20Approach%20for%20Reproducible%20Research%20with%20Sensitive%20Data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22NS%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22May%2010%2C%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A47%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22JJN8CMAX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anderegg%20et%20al.%22%2C%22parsedDate%22%3A%222017-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAnderegg%20N%2C%20Johnson%20L%2C%20Zaniewski%20E%2C%20Althoff%20K%2C%20Balestre%20E%2C%20Law%20M%2C%20et%20al.%20All-cause%20mortality%20in%20HIV-positive%20adults%20starting%20combination%20antiretroviral%20therapy%3A%20correcting%20for%20loss%20to%20follow-up.%20AIDS%20%5BInternet%5D.%202017%20Apr%3B31%281%29%3A31%26%23x2013%3B40.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28296798%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28296798%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DJJN8CMAX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22All-cause%20mortality%20in%20HIV-positive%20adults%20starting%20combination%20antiretroviral%20therapy%3A%20correcting%20for%20loss%20to%20follow-up%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Anderegg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22LF%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22KN%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Balestre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CT%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Egger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22April%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2Fqad.0000000000001321%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28296798%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A32%3A43Z%22%7D%7D%2C%7B%22key%22%3A%224FJ5WF94%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoelho%20L%2C%20Ribeiro%20S%2C%20Japiassu%20A%2C%20Moreira%20R%2C%20Lara%20P%2C%20Veloso%20V%2C%20et%20al.%2030-day%20readmission%20rates%20in%20an%20HIV-infected%20cohort%20from%20Rio%20de%20Janeiro%2C%20Brazil.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202017%20Mar%2010%3B75%284%29%3A90%26%23x2013%3B8.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28291051%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28291051%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D4FJ5WF94%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%2230-day%20readmission%20rates%20in%20an%20HIV-infected%20cohort%20from%20Rio%20de%20Janeiro%2C%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22LE%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SR%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AM%22%2C%22lastName%22%3A%22Japiassu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RI%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PC%22%2C%22lastName%22%3A%22Lara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22March%2010%2C%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28291051%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A36%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22F66U4NRU%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222017-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoelho%20L%2C%20Ribeiro%20S%2C%20Veloso%20V%2C%20Grinsztejn%20B%2C%20Luz%20P.%20Hospitalization%20rates%2C%20length%20of%20stay%20and%20in-hospital%20mortality%20in%20a%20cohort%20of%20HIV%20infected%20patients%20from%20Rio%20de%20Janeiro%2C%20Brazil.%20Braz%20J%20Infect%20Dis%20%5BInternet%5D.%202017%20Mar%3B21%282%29%3A190%26%23x2013%3B5.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27918889%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27918889%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DF66U4NRU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hospitalization%20rates%2C%20length%20of%20stay%20and%20in-hospital%20mortality%20in%20a%20cohort%20of%20HIV%20infected%20patients%20from%20Rio%20de%20Janeiro%2C%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22LE%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SR%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22March%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27918889%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A37%3A56Z%22%7D%7D%2C%7B%22key%22%3A%229PP9W7Q6%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shepherd%20and%20Rebeiro%22%2C%22parsedDate%22%3A%222017-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShepherd%20B%2C%20Rebeiro%20P.%20Brief%20Report%3A%20Assessing%20and%20Interpreting%20the%20Association%20Between%20Continuous%20Covariates%20and%20Outcomes%20in%20Observational%20Studies%20of%20HIV%20Using%20Splines.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202017%20Mar%3B74%283%29%3A60%26%23x2013%3B3.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5303133%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5303133%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9PP9W7Q6%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Brief%20Report%3A%20Assessing%20and%20Interpreting%20the%20Association%20Between%20Continuous%20Covariates%20and%20Outcomes%20in%20Observational%20Studies%20of%20HIV%20Using%20Splines%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22March%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5303133%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A33%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22G8FKW3CU%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Luque%20et%20al.%22%2C%22parsedDate%22%3A%222017-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELuque%20M%2C%20Jenkins%20C%2C%20Shepherd%20B%2C%20Padgett%20D%2C%20Rouzier%20V%2C%20Succi%20R%2C%20et%20al.%20Mortality%20in%20Children%20with%20Human%20Immunodeficiency%20Virus%20Initiating%20Treatment%3A%20A%20Six-Cohort%20Study%20in%20Latin%20America.%20J%20Pediatr%20%5BInternet%5D.%202017%20Mar%3B182%3A245%26%23x2013%3B52.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5328796%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5328796%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DG8FKW3CU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20in%20Children%20with%20Human%20Immunodeficiency%20Virus%20Initiating%20Treatment%3A%20A%20Six-Cohort%20Study%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MT%22%2C%22lastName%22%3A%22Luque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CA%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RC%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22DM%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SH%22%2C%22lastName%22%3A%22Vermund%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JA%22%2C%22lastName%22%3A%22Pinto%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22March%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5328796%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T16%3A57%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22JAG6RRUF%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Teixeira%20da%20Silva%20et%20al.%22%2C%22parsedDate%22%3A%222017-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETeixeira%20da%20Silva%20D%2C%20Luz%20P%2C%20Lake%20J%2C%20Cardoso%20S%2C%20Ribeiro%20S%2C%20Moreira%20R%2C%20et%20al.%20Poor%20retention%20in%20early%20care%20increases%20risk%20of%20mortality%20in%20a%20Brazilian%20HIV-infected%20clinical%20cohort.%20AIDS%20Care%20%5BInternet%5D.%202017%20Feb%3B29%282%29%3A263%26%23x2013%3B7.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5138101%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5138101%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DJAG6RRUF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Poor%20retention%20in%20early%20care%20increases%20risk%20of%20mortality%20in%20a%20Brazilian%20HIV-infected%20clinical%20cohort%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22DS%22%2C%22lastName%22%3A%22Teixeira%20da%20Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JE%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SW%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RI%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JL%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RB%22%2C%22lastName%22%3A%22De%20Boni%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22February%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5138101%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T16%3A42%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22X24CTH8D%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fritz%20et%20al.%22%2C%22parsedDate%22%3A%222017-01-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFritz%20C%2C%20Blevins%20M%2C%20Lindegren%20M%2C%20Wools-Kaloutsian%20K%2C%20Musick%20B%2C%20Cornell%20M%2C%20et%20al.%20Comprehensiveness%20of%20HIV%20care%20provided%20at%20global%20HIV%20treatment%20sites%20in%20the%20IeDEA%20consortium%3A%202009%20and%202014.%20J%20Int%20AIDS%20Soc%20%5BInternet%5D.%202017%20Jan%206%3B20%281%29%3A1%26%23x2013%3B14.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28364561%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28364561%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DX24CTH8D%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comprehensiveness%20of%20HIV%20care%20provided%20at%20global%20HIV%20treatment%20sites%20in%20the%20IeDEA%20consortium%3A%202009%20and%202014%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CQ%22%2C%22lastName%22%3A%22Fritz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22ML%22%2C%22lastName%22%3A%22Lindegren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%22%2C%22lastName%22%3A%22Wools-Kaloutsian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BS%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%22%2C%22lastName%22%3A%22Goodwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Addison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JC%22%2C%22lastName%22%3A%22Dusingize%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SN%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MG%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RD%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CW%22%2C%22lastName%22%3A%22Wester%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22January%206%2C%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28364561%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A39%3A03Z%22%7D%7D%2C%7B%22key%22%3A%2272UZKBTV%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Machado%20et%20al.%22%2C%22parsedDate%22%3A%222017-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMachado%20I%2C%20Luz%20P%2C%20Lake%20J%2C%20Castro%20R%2C%20Velasque%20L%2C%20Clark%20J%2C%20et%20al.%20Self-rated%20health%20and%20substance%20use%20among%20individuals%20in%20HIV%20care%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20a%20cross-sectional%20study.%20Int%20J%20STD%20AIDS%20%5BInternet%5D.%202017%20Jan%3B%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5501998%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5501998%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D72UZKBTV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Self-rated%20health%20and%20substance%20use%20among%20individuals%20in%20HIV%20care%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20a%20cross-sectional%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22IK%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JE%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Velasque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JL%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RB%22%2C%22lastName%22%3A%22De%20Boni%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22January%202017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5501998%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A59%3A14Z%22%7D%7D%2C%7B%22key%22%3A%222SU2X8XW%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jiamsakul%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJiamsakul%20A%2C%20Kariminia%20A%2C%20Althoff%20KN%2C%20Cesar%20C%2C%20Cortes%20CP%2C%20Davies%20MA%2C%20et%20al.%20HIV%20Viral%20Load%20Suppression%20in%20Adults%20and%20Children%20Receiving%20Antiretroviral%20Therapy-Results%20From%20the%20IeDEA%20Collaboration.%20J%20Acquir%20Immune%20Defic%20Syndr.%202017%2001%3B76%283%29%3A319%26%23x2013%3B29.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D2SU2X8XW%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20Viral%20Load%20Suppression%20in%20Adults%20and%20Children%20Receiving%20Antiretroviral%20Therapy-Results%20From%20the%20IeDEA%20Collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azar%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viet%20Chau%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daisy%20Maria%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Zaniewski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Law%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Having%2090%25%20of%20patients%20on%20antiretroviral%20therapy%20%28ART%29%20and%20achieving%20an%20undetectable%20viral%20load%20%28VL%29%20is%201%20of%20the%2090%3A90%3A90%20by%202020%20targets.%20In%20this%20global%20analysis%2C%20we%20investigated%20the%20proportions%20of%20adult%20and%20paediatric%20patients%20with%20VL%20suppression%20in%20the%20first%203%20years%20after%20ART%20initiation.%5CnMETHODS%3A%20Patients%20from%20the%20IeDEA%20cohorts%20who%20initiated%20ART%20between%202010%20and%202014%20were%20included.%20Proportions%20with%20VL%20suppression%20%28%3C1000%20copies%5C%2FmL%29%20were%20estimated%20using%20%281%29%20strict%20intention%20to%20treat%20%28ITT%29-loss%20to%20follow-up%20%28LTFU%29%20and%20dead%20patients%20counted%20as%20having%20detectable%20VL%3B%20and%20%282%29%20modified%20ITT-LTFU%20and%20dead%20patients%20were%20excluded.%20Logistic%20regression%20was%20used%20to%20identify%20predictors%20of%20viral%20suppression%20at%201%20year%20after%20ART%20initiation%20using%20modified%20ITT.%5CnRESULTS%3A%20A%20total%20of%2035%2C561%20adults%20from%2038%20sites%5C%2F16%20countries%20and%202601%20children%20from%2018%20sites%5C%2F6%20countries%20were%20included.%20When%20comparing%20strict%20with%20modified%20ITT%20methods%2C%20the%20proportion%20achieving%20VL%20suppression%20at%203%20years%20from%20ART%20initiation%20changed%20from%2045.1%25%20to%2090.2%25%20in%20adults%2C%20and%2060.6%25%20to%2080.4%25%20in%20children.%20In%20adults%2C%20older%20age%2C%20higher%20CD4%20count%20pre-ART%2C%20and%20homosexual%5C%2Fbisexual%20HIV%20exposure%20were%20associated%20with%20VL%20suppression.%20In%20children%2C%20older%20age%20and%20higher%20CD4%20percentage%20pre-ART%20showed%20significant%20associations%20with%20VL%20suppression.%5CnCONCLUSIONS%3A%20Large%20increases%20in%20the%20proportion%20of%20VL%20suppression%20in%20adults%20were%20observed%20when%20we%20excluded%20those%20who%20were%20LTFU%20or%20had%20died.%20The%20increases%20were%20less%20pronounced%20in%20children.%20Greater%20emphasis%20should%20be%20made%20to%20minimize%20LTFU%20and%20maximize%20patient%20retention%20in%20HIV-infected%20patients%20of%20all%20age%20groups.%22%2C%22date%22%3A%2211%2001%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000001499%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A19%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22DSLGAXEM%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Machado%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMachado%20IK%2C%20Luz%20PM%2C%20Lake%20JE%2C%20Castro%20R%2C%20Velasque%20L%2C%20Clark%20JL%2C%20et%20al.%20Substance%20use%20among%20HIV-infected%20patients%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20Agreement%20between%20medical%20records%20and%20the%20ASSIST%20questionnaire.%20Drug%20Alcohol%20Depend.%202017%2001%3B178%3A115%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DDSLGAXEM%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Substance%20use%20among%20HIV-infected%20patients%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20Agreement%20between%20medical%20records%20and%20the%20ASSIST%20questionnaire%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iona%20K.%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordan%20E.%22%2C%22lastName%22%3A%22Lake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodolfo%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luciane%22%2C%22lastName%22%3A%22Velasque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jesse%20L.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%20B.%22%2C%22lastName%22%3A%22De%20Boni%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Substance%20use%20assessment%20is%20a%20challenge%20in%20busy%20clinical%20settings%20that%20may%20adversely%20affect%20HIV-infected%20persons.%20This%20study%20aimed%20to%20evaluate%20agreement%20between%20the%20medical%20chart%20and%20a%20standardized%20substance%20use%20screening%20questionnaire.%5CnMETHODS%3A%20Of%20adults%20%28n%3D1050%29%20in%20HIV%20care%20in%20Rio%20de%20Janeiro%20who%20completed%20the%20World%20Health%20Organization%27s%20Alcohol%2C%20Smoking%2C%20and%20Substance%20Involvement%20Screening%20Test%20%28ASSIST%29%2C%20we%20randomly%20selected%20200%20participants%20for%20medical%20chart%20review.%20Lifetime%20use%20of%20tobacco%2C%20alcohol%2C%20marijuana%2C%20and%20cocaine%20agreement%20between%20the%20medical%20record%20and%20ASSIST%20was%20evaluated%20using%20Kappa%20statistics.%20Sensitivity%20and%20specificity%20of%20chart%20information%20were%20also%20calculated.%5CnRESULTS%3A%20The%20median%20age%20was%2042.4%20years%2C%2060.3%25%20were%20male%20and%2049.5%25%20were%20white.%20Prevalence%20of%20lifetime%20use%20reported%20in%20ASSIST%20was%2055.3%25%20%28tobacco%29%2C%2079.4%25%20%28alcohol%29%2C%2023.1%25%20%28marijuana%29%2C%20and%2020.7%25%20%28cocaine%29.%20Any%20information%20on%20lifetime%20use%20was%20found%20in%20the%20medical%20chart%20for%20tobacco%20%28n%3D180%2C%2090.5%25%29%2C%20alcohol%20%28n%3D183%2C%2092.0%25%29%2C%20marijuana%20%28n%3D143%2C%2071.8%25%29%2C%20and%20cocaine%20%28n%3D151%2C%2075.9%25%29.%20The%20Kappa%20statistic%2C%20sensitivity%20and%20specificity%20of%20the%20medical%20chart%20accurately%20identifying%20lifetime%20substance%20users%20per%20ASSIST%20were%20respectively%200.60%2C%200.71%2C%20and%200.91%20for%20tobacco%3B%200.22%2C%200.75%2C%20and%200.51%20for%20alcohol%3B%200.58%2C%200.51%2C%20and%200.98%20for%20marijuana%3B%20and%200.73%2C%200.75%2C%20and%200.96%20for%20cocaine.%5CnCONCLUSION%3A%20Considering%20inaccuracies%20in%20the%20medical%20chart%2C%20the%20implementation%20of%20brief%2C%20standardized%20substance%20use%20screening%20is%20recommended%20in%20HIV%20care%20settings.%22%2C%22date%22%3A%2209%2001%2C%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.drugalcdep.2017.04.033%22%2C%22ISSN%22%3A%221879-0046%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-09T16%3A18%3A10Z%22%7D%7D%2C%7B%22key%22%3A%223F2AWRJV%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rebeiro%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERebeiro%20P%2C%20Ivey%20K%2C%20Craig%20K%2C%20Hulgan%20T%2C%20Huaman%20M%2C%20Nash%20R%2C%20et%20al.%20New%20Faces%20of%20HIV%20Infection%3A%20Age%2C%20Race%2C%20and%20Timing%20of%20Entry%20into%20HIV%20Care%20in%20the%20Southeastern%20United%20States.%20J%20Int%20Assoc%20Provid%20AIDS%20Care%20%5BInternet%5D.%202017%3B16%284%29%3A347%26%23x2013%3B52.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28560901%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28560901%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D3F2AWRJV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22New%20Faces%20of%20HIV%20Infection%3A%20Age%2C%20Race%2C%20and%20Timing%20of%20Entry%20into%20HIV%20Care%20in%20the%20Southeastern%20United%20States%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22KS%22%2C%22lastName%22%3A%22Ivey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22KS%22%2C%22lastName%22%3A%22Craig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T%22%2C%22lastName%22%3A%22Hulgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MA%22%2C%22lastName%22%3A%22Huaman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Raffanti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22KA%22%2C%22lastName%22%3A%22Equakun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AK%22%2C%22lastName%22%3A%22Person%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1177%5C%2F2325957417710719%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28560901%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A34%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22VS5SHJ59%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brown%20and%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrown%20S%2C%20et%20al.%20Pediatric%20Cancer%20Burden%20and%20Treatment%20Resources%20within%20the%20Pediatric%20IeDEA%20Consortium.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202017%3B%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28520616%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28520616%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DVS5SHJ59%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pediatric%20Cancer%20Burden%20and%20Treatment%20Resources%20within%20the%20Pediatric%20IeDEA%20Consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22et%20al.%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F28520616%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T17%3A04%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22GZN858HX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wolff%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWolff%20M%2C%20Giganti%20M%2C%20Cortes%20C%2C%20Cahn%20P%2C%20Grinsztejn%20B%2C%20Pape%20J%2C%20et%20al.%20A%20decade%20of%20HAART%20in%20Latin%20America%3A%20long%20term%20outcomes%20among%20the%20first%20wave%20of%20HIV%20patients%20to%20receive%20combination%20therapy.%20Plos%20One%20%5BInternet%5D.%202017%3B12%286%29.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5484471%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5484471%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DGZN858HX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20decade%20of%20HAART%20in%20Latin%20America%3A%20long%20term%20outcomes%20among%20the%20first%20wave%20of%20HIV%20patients%20to%20receive%20combination%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MJ%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MJ%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CP%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JW%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JS%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5484471%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T16%3A31%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22W5VA4PWH%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wolff%20and%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWolff%20M%2C%20et%20al.%20Evaluation%20of%20HIV%20Cascade%20of%20Care.%20International%20Journal%20of%20STD%20and%20AIDS.%202017%3B%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DW5VA4PWH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20HIV%20Cascade%20of%20Care%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22et%20al.%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-10T21%3A12%3A50Z%22%7D%7D%5D%7D
1.
Lamas CC, Coelho LE, Grinsztejn BJ, Veloso VG. Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study. Infection. 2017 Dec;45(6):801–9. Cite
1.
Liu Q, Shepherd BE, Li C, Harrell FE. Modeling continuous response variables using ordinal regression. Stat Med. 2017 Nov 30;36(27):4316–35. Cite
1.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study. Clin Infect Dis. 2017 Oct 15;65(8):1316–26. Cite
1.
Rebeiro PF, Bakoyannis G, Musick BS, Braithwaite RS, Wools-Kaloustian KK, Nyandiko W, et al. Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the Better. J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):141–8. Cite
1.
Crabtree Ramírez B, Caro Vega Y, Shepherd BE, Le C, Turner M, Frola C, et al. Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas. Int J Infect Dis. 2017 Oct;63:57–63. Cite
1.
Rohner E, et al. Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study. Clin Infect Dis [Internet]. 2017 May 20; Available from: https://www.ncbi.nlm.nih.gov/pubmed/28531260 Cite
1.
Shepherd B, Blevins M, Rebeiro P, Duda N, McGowan C. A Pragmatic Approach for Reproducible Research with Sensitive Data. Am Journal Epidemiol. 2017 May 10; Cite
1.
Anderegg N, Johnson L, Zaniewski E, Althoff K, Balestre E, Law M, et al. All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS [Internet]. 2017 Apr;31(1):31–40. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28296798 Cite
1.
Coelho L, Ribeiro S, Japiassu A, Moreira R, Lara P, Veloso V, et al. 30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr [Internet]. 2017 Mar 10;75(4):90–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28291051 Cite
1.
Coelho L, Ribeiro S, Veloso V, Grinsztejn B, Luz P. Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio de Janeiro, Brazil. Braz J Infect Dis [Internet]. 2017 Mar;21(2):190–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27918889 Cite
1.
Shepherd B, Rebeiro P. Brief Report: Assessing and Interpreting the Association Between Continuous Covariates and Outcomes in Observational Studies of HIV Using Splines. J Acquir Immune Defic Syndr [Internet]. 2017 Mar;74(3):60–3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303133/ Cite
1.
Luque M, Jenkins C, Shepherd B, Padgett D, Rouzier V, Succi R, et al. Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America. J Pediatr [Internet]. 2017 Mar;182:245–52. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328796/ Cite
1.
Teixeira da Silva D, Luz P, Lake J, Cardoso S, Ribeiro S, Moreira R, et al. Poor retention in early care increases risk of mortality in a Brazilian HIV-infected clinical cohort. AIDS Care [Internet]. 2017 Feb;29(2):263–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138101/ Cite
1.
Fritz C, Blevins M, Lindegren M, Wools-Kaloutsian K, Musick B, Cornell M, et al. Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. J Int AIDS Soc [Internet]. 2017 Jan 6;20(1):1–14. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28364561 Cite
1.
Machado I, Luz P, Lake J, Castro R, Velasque L, Clark J, et al. Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study. Int J STD AIDS [Internet]. 2017 Jan; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501998/ Cite
1.
Jiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, et al. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr. 2017 01;76(3):319–29. Cite
1.
Machado IK, Luz PM, Lake JE, Castro R, Velasque L, Clark JL, et al. Substance use among HIV-infected patients in Rio de Janeiro, Brazil: Agreement between medical records and the ASSIST questionnaire. Drug Alcohol Depend. 2017 01;178:115–8. Cite
1.
Rebeiro P, Ivey K, Craig K, Hulgan T, Huaman M, Nash R, et al. New Faces of HIV Infection: Age, Race, and Timing of Entry into HIV Care in the Southeastern United States. J Int Assoc Provid AIDS Care [Internet]. 2017;16(4):347–52. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28560901 Cite
1.
Brown S, et al. Pediatric Cancer Burden and Treatment Resources within the Pediatric IeDEA Consortium. J Acquir Immune Defic Syndr [Internet]. 2017; Available from: https://www.ncbi.nlm.nih.gov/pubmed/28520616 Cite
1.
Wolff M, Giganti M, Cortes C, Cahn P, Grinsztejn B, Pape J, et al. A decade of HAART in Latin America: long term outcomes among the first wave of HIV patients to receive combination therapy. Plos One [Internet]. 2017;12(6). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484471/ Cite
1.
Wolff M, et al. Evaluation of HIV Cascade of Care. International Journal of STD and AIDS. 2017; Cite
2016
76770
IP6F4TRX
2016
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-387d62b0660902b7c688d60c50698cf4%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22RUZHI977%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cesar%20et%20al.%22%2C%22parsedDate%22%3A%222016-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECesar%20C%2C%20Blugerman%20G%2C%20Valiente%20J%2C%20Rebeiro%20P%2C%20Sued%20O%2C%20Fink%20V%2C%20et%20al.%20The%20HIV%20Care%20Cascade%20in%20Buenos%20Aires%2C%20Argentina%3A%20Results%20in%20a%20Tertiary%20Referral%20Hospital.%20Rev%20Panam%20Salud%20Publica%20%5BInternet%5D.%202016%20Dec%3B40%286%29%3A448%26%23x2013%3B54.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5518480%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5518480%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DRUZHI977%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20HIV%20Care%20Cascade%20in%20Buenos%20Aires%2C%20Argentina%3A%20Results%20in%20a%20Tertiary%20Referral%20Hospital%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%22%2C%22lastName%22%3A%22Blugerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JoseA%22%2C%22lastName%22%3A%22Valiente%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MR%22%2C%22lastName%22%3A%22Soto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Cillis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Yamamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Falistocco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%22%2C%22lastName%22%3A%22Perez%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22December%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5518480%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A05%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22RG7NUSMZ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shepherd%20et%20al.%22%2C%22parsedDate%22%3A%222016-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShepherd%20B%2C%20Li%20C%2C%20Liu%20Q.%20Probability-scale%20residuals%20for%20continuous%2C%20discrete%2C%20and%20censored%20data.%20The%20Canadian%20Journal%20of%20Statistics%20%5BInternet%5D.%202016%20Dec%3B44%284%29%3A463%26%23x2013%3B79.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5364820%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5364820%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DRG7NUSMZ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Probability-scale%20residuals%20for%20continuous%2C%20discrete%2C%20and%20censored%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Q%22%2C%22lastName%22%3A%22Liu%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22December%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5364820%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A01%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22KWTJ4ATD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22De%20Boni%20et%20al.%22%2C%22parsedDate%22%3A%222016-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDe%20Boni%20R%2C%20Shepherd%20B%2C%20Grinsztejn%20B%2C%20Cesar%20C%2C%20Cort%26%23xE9%3Bs%20C%2C%20Padgett%20D%2C%20et%20al.%20Substance%20Use%20and%20Adherence%20Among%20People%20Living%20with%20HIV%5C%2FAIDS%20Receiving%20cART%20in%20Latin%20America.%20AIDS%20and%20behavior.%20AIDS%20behav%20%5BInternet%5D.%202016%20Nov%3B20%2811%29%3A2692%26%23x2013%3B9.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5069110%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5069110%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DKWTJ4ATD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Substance%20Use%20and%20Adherence%20Among%20People%20Living%20with%20HIV%5C%2FAIDS%20Receiving%20cART%20in%20Latin%20America.%20AIDS%20and%20behavior%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RB%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SN%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22November%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5069110%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A03%3A27Z%22%7D%7D%2C%7B%22key%22%3A%226K4SHXEA%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rachlis%20et%20al.%22%2C%22parsedDate%22%3A%222016-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERachlis%20B%2C%20Karwa%20R%2C%20Chema%20C%2C%20Pastakia%20S%2C%20Olsson%20S%2C%20Wools-Kaloustian%20K%2C%20et%20al.%20Drug%20saf%20%5BInternet%5D.%202016%20Oct%3B39%2810%29%3A959%26%23x2013%3B76.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5018020%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5018020%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D6K4SHXEA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Rachlis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Karwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Chema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Pastakia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Olsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Jakait%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Maina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22de%20Rekeneire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SN%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MA%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Braitstein%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22October%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5018020%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T18%3A36%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22F34AP73A%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Diaz%20et%20al.%22%2C%22parsedDate%22%3A%222016-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDiaz%20C%2C%20Segura%20E%2C%20Luz%20P%2C%20Clark%20J%2C%20Ribeiro%20S%2C%20De%20Boni%20R%2C%20et%20al.%20Traditional%20and%20HIV-specific%20risk%20factors%20for%20cardiovascular%20morbidity%20and%20mortality%20among%20HIV-infected%20adults%20in%20Brazil%3A%20a%20retrospective%20cohort%20study.%20BMC%20Infect%20Dis.%202016%20Aug%3B8%2816%29%3A376.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DF34AP73A%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Traditional%20and%20HIV-specific%20risk%20factors%20for%20cardiovascular%20morbidity%20and%20mortality%20among%20HIV-infected%20adults%20in%20Brazil%3A%20a%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CM%22%2C%22lastName%22%3A%22Diaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22ER%22%2C%22lastName%22%3A%22Segura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JL%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SR%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Eksterman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JS%22%2C%22lastName%22%3A%22Currier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JE%22%2C%22lastName%22%3A%22Lake%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Aug%202016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12879-016-1735-4%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A15%3A18Z%22%7D%7D%2C%7B%22key%22%3A%2223E5N3R4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222016-03-22%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoelho%20LE%2C%20Cardoso%20SW%2C%20Amancio%20RT%2C%20Moreira%20RI%2C%20Ribeiro%20SR%2C%20Coelho%20AB%2C%20et%20al.%20Predictors%20of%20opportunistic%20illnesses%20incidence%20in%20post%20combination%20antiretroviral%20therapy%20era%20in%20an%20urban%20cohort%20from%20Rio%20de%20Janeiro%2C%20Brazil.%20BMC%20Infect%20Dis%20%5BInternet%5D.%202016%20Mar%2022%20%5Bcited%202016%20Apr%204%5D%3B16.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4802913%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4802913%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D23E5N3R4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Predictors%20of%20opportunistic%20illnesses%20incidence%20in%20post%20combination%20antiretroviral%20therapy%20era%20in%20an%20urban%20cohort%20from%20Rio%20de%20Janeiro%2C%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%20E.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20W.%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20T.%22%2C%22lastName%22%3A%22Amancio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronaldo%20I.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayonara%20R.%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandra%20B.%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dayse%20P.%22%2C%22lastName%22%3A%22Campos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnOpportunistic%20illnesses%20still%20account%20for%20a%20huge%20proportion%20of%20hospitalizations%20and%20deaths%20among%20HIV-infected%20patients%20in%20the%20post%20combination%20antiretroviral%20therapy%20%28cART%29%20era%2C%20particularly%20in%20middle-%20and%20low-income%20countries.%20The%20aim%20of%20this%20study%20was%20to%20assess%20predictors%20of%20the%20top%20four%20most%20incident%20opportunistic%20illnesses%20%28tuberculosis%2C%20esophageal%20candidiasis%2C%20cerebral%20toxoplasmosis%20and%20Pneumocystis%20jiroveci%20pneumonia%29%20in%20an%20HIV%20clinical%20cohort%20from%20a%20middle-income%20country%20in%20the%20post%20cART%20era.%5Cn%5CnMethods%5CnA%20total%20of%202835%20HIV%20infected%20participants%20aged%5Cu2009%5Cu2265%5Cu200918%5Cu00a0years%20at%20enrollment%20were%20followed%20from%20January%202000%20to%20December%202012%20until%20the%20occurrence%20of%20their%20first%20opportunistic%20illness%2C%20death%20or%20end%20of%20study%2C%20whichever%20occurred%20first.%20Extended%20Cox%20proportional%20hazards%20regression%20models%2C%20stratified%20by%20use%20of%20cART%2C%20were%20fitted%20to%20assess%20predictors%20of%20opportunistic%20illness%20incidence%20during%20follow-up.%5Cn%5CnResults%5CnThe%20incidence%20rates%20of%20tuberculosis%2C%20esophageal%20candidiasis%2C%20cerebral%20toxoplasmosis%20and%20Pneumocystis%20jiroveci%20pneumonia%20were%2015.3%2C%208.6%2C%206.0%2C%204.8%20per%201000%20persons-year%2C%20respectively.%20Disease%20specific%20adjusted%20Cox%20models%20showed%20that%20presence%20of%20an%20opportunistic%20illness%20at%20enrollment%20significantly%20increased%20disease%20incidence%20while%20higher%20nadir%20CD4%2B%20T%20lymphocyte%20count%20had%20a%20significant%20protective%20effect%20in%20patients%20not%20in%20use%20of%20cART.%20Duration%20of%20cART%20use%20also%20significantly%20reduced%20disease%20incidence.%5Cn%5CnConclusions%5CnOur%20findings%20show%20that%2C%20still%20in%20the%20post-cART%20era%2C%20prevention%20of%20opportunistic%20infections%20can%20be%20achieved%20by%20preventing%20immune%20deterioration%20by%20instituting%20early%20use%20of%20cART.%20Interventions%20focusing%20on%20early%20diagnosis%20and%20linkage%20to%20care%20in%20addition%20to%20the%20prompt%20initiation%20of%20cART%20are%20essential%20to%20reduce%20the%20incidence%20of%20opportunistic%20illnesses%20among%20HIV%20infected%20patients%20in%20post-cART%20era.%22%2C%22date%22%3A%222016-3-22%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12879-016-1462-x%22%2C%22ISSN%22%3A%221471-2334%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4802913%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-04-04T23%3A52%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22NBZCR4P8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Blevins%20et%20al.%22%2C%22parsedDate%22%3A%222016-03-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBlevins%20M%2C%20Wehbe%20FH%2C%20Rebeiro%20PF%2C%20Caro-Vega%20Y%2C%20McGowan%20CC%2C%20Shepherd%20BE.%20Interactive%20Data%20Visualization%20for%20HIV%20Cohorts%3A%20Leveraging%20Data%20Exchange%20Standards%20to%20Share%20and%20Reuse%20Research%20Tools.%20PLoS%20One%20%5BInternet%5D.%202016%20Mar%2010%20%5Bcited%202016%20Apr%204%5D%3B11%283%29.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4786152%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4786152%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DNBZCR4P8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Interactive%20Data%20Visualization%20for%20HIV%20Cohorts%3A%20Leveraging%20Data%20Exchange%20Standards%20to%20Share%20and%20Reuse%20Research%20Tools%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meridith%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firas%20H.%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22Objective%5CnTo%20develop%20and%20disseminate%20tools%20for%20interactive%20visualization%20of%20HIV%20cohort%20data.%5Cn%5CnDesign%20and%20Methods%5CnIf%20a%20picture%20is%20worth%20a%20thousand%20words%2C%20then%20an%20interactive%20video%2C%20composed%20of%20a%20long%20string%20of%20pictures%2C%20can%20produce%20an%20even%20richer%20presentation%20of%20HIV%20population%20dynamics.%20We%20developed%20an%20HIV%20cohort%20data%20visualization%20tool%20using%20open-source%20software%20%28R%20statistical%20language%29.%20The%20tool%20requires%20that%20the%20data%20structure%20conform%20to%20the%20HIV%20Cohort%20Data%20Exchange%20Protocol%20%28HICDEP%29%2C%20and%20our%20implementation%20utilized%20Caribbean%2C%20Central%20and%20South%20America%20network%20%28CCASAnet%29%20data.%5Cn%5CnResults%5CnThis%20tool%20currently%20presents%20patient-level%20data%20in%20three%20classes%20of%20plots%3A%20%281%29%20Longitudinal%20plots%20showing%20changes%20in%20measurements%20viewed%20alongside%20event%20probability%20curves%20allowing%20for%20simultaneous%20inspection%20of%20outcomes%20by%20relevant%20patient%20classes.%20%282%29%20Bubble%20plots%20showing%20changes%20in%20indicators%20over%20time%20allowing%20for%20observation%20of%20group%20level%20dynamics.%20%283%29%20Heat%20maps%20of%20levels%20of%20indicators%20changing%20over%20time%20allowing%20for%20observation%20of%20spatial-temporal%20dynamics.%20Examples%20of%20each%20class%20of%20plot%20are%20given%20using%20CCASAnet%20data%20investigating%20trends%20in%20CD4%20count%20and%20AIDS%20at%20antiretroviral%20therapy%20%28ART%29%20initiation%2C%20CD4%20trajectories%20after%20ART%20initiation%2C%20and%20mortality.%5Cn%5CnConclusions%5CnWe%20invite%20researchers%20interested%20in%20this%20data%20visualization%20effort%20to%20use%20these%20tools%20and%20to%20suggest%20new%20classes%20of%20data%20visualization.%20We%20aim%20to%20contribute%20additional%20shareable%20tools%20in%20the%20spirit%20of%20open%20scientific%20collaboration%20and%20hope%20that%20these%20tools%20further%20the%20participation%20in%20open%20data%20standards%20like%20HICDEP%20by%20the%20HIV%20research%20community.%22%2C%22date%22%3A%222016-3-10%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0151201%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4786152%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-04-04T23%3A59%3A49Z%22%7D%7D%2C%7B%22key%22%3A%226BKPGTI5%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wolff%20et%20al.%22%2C%22parsedDate%22%3A%222016-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWolff%20M%2C%20Shepherd%20BE%2C%20Cort%26%23xE9%3Bs%20C%2C%20Rebeiro%20P%2C%20Cesar%20C%2C%20Wagner%20Cardoso%20S%2C%20et%20al.%20Clinical%20and%20Virologic%20Outcomes%20After%20Changes%20in%20First%20Antiretroviral%20Regimen%20at%207%20Sites%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20Network.%20J%20Acquir%20Immune%20Defic%20Syndr.%202016%20Jan%201%3B71%281%29%3A102%26%23x2013%3B10.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D6BKPGTI5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20and%20Virologic%20Outcomes%20After%20Changes%20in%20First%20Antiretroviral%20Regimen%20at%207%20Sites%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20Network%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Wagner%20Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Echevarria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20HIV-infected%20persons%20in%20resource-limited%20settings%20may%20experience%20high%20rates%20of%20antiretroviral%20therapy%20%28ART%29%20change%2C%20particularly%20because%20of%20toxicity%20or%20other%20nonfailure%20reasons.%20Few%20reports%20address%20patient%20outcomes%20after%20these%20modifications.%5CnMETHODS%3A%20HIV-infected%20adults%20from%20the%207%20Caribbean%2C%20Central%20and%20South%20America%20network%20clinical%20cohorts%20who%20modified%20%3E1%20drug%20from%20the%20first%20ART%20regimen%20%28ART-1%29%20for%20any%20reason%20thereby%20starting%20a%20second%20regimen%20%28ART-2%29%20were%20included.%20We%20assessed%20cumulative%20incidence%20of%2C%20and%20factors%20associated%20with%2C%20death%2C%20virologic%20failure%20%28VF%29%2C%20and%20regimen%20change%20after%20starting%20ART-2.%5CnRESULTS%3A%20Five%20thousand%20five%20hundred%20sixty-five%20ART-naive%20highly%20active%20ART%20initiators%20started%20ART-2%20after%20a%20median%20of%209.8%20months%20on%20ART-1%3B%2039%25%20changed%20to%20ART-2%20because%20of%20toxicity%20and%2011%25%20because%20of%20failure.%20Median%20follow-up%20after%20starting%20ART-2%20was%202.9%20years%3B%2045%25%20subsequently%20modified%20ART-2.%20Cumulative%20incidences%20of%20death%20at%201%2C%203%2C%20and%205%20years%20after%20starting%20ART-2%20were%205.1%25%2C%208.4%25%2C%20and%2010.5%25%2C%20respectively.%20In%20adjusted%20analyses%2C%20death%20was%20associated%20with%20older%20age%2C%20clinical%20AIDS%2C%20lower%20CD4%20at%20ART-2%20start%2C%20earlier%20calendar%20year%2C%20and%20starting%20ART-2%20because%20of%20toxicity%20%28adjusted%20hazard%20ratio%20%3D%201.5%20vs.%20failure%2C%2095%25%20confidence%20interval%3A%201.0%20to%202.1%29.%20Cumulative%20incidences%20of%20VF%20after%201%2C%203%2C%20and%205%20years%20were%209%25%2C%2019%25%2C%20and%2025%25.%20In%20adjusted%20analyses%2C%20VF%20was%20associated%20with%20younger%20age%2C%20earlier%20calendar%20year%2C%20lower%20CD4%20at%20the%20start%20of%20ART-2%2C%20and%20starting%20ART-2%20because%20of%20failure%20%28adjusted%20hazard%20ratio%20%3D%202.1%20vs.%20toxicity%2C%2095%25%20confidence%20interval%3A%201.5%20to%202.8%29.%5CnCONCLUSIONS%3A%20Among%20patients%20modifying%20the%20first%20ART%20regimen%2C%20risks%20of%20subsequent%20modifications%2C%20mortality%2C%20and%20virologic%20failure%20were%20high.%20Access%20to%20improved%20antiretrovirals%20in%20the%20region%20is%20needed%20to%20improve%20initial%20treatment%20success.%22%2C%22date%22%3A%22Jan%201%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0000000000000817%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A02%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22UN8H2RX7%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabtree-Ram%5Cu00edrez%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree-Ram%26%23xED%3Brez%20B%2C%20Caro-Vega%20Y%2C%20Shepherd%20BE%2C%20Grinsztejn%20B%2C%20Wolff%20M%2C%20Cortes%20CP%2C%20et%20al.%20Time%20to%20HAART%20Initiation%20after%20Diagnosis%20and%20Treatment%20of%20Opportunistic%20Infections%20in%20Patients%20with%20AIDS%20in%20Latin%20America.%20PLoS%20ONE.%202016%3B11%286%29%3Ae0153921.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DUN8H2RX7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Time%20to%20HAART%20Initiation%20after%20Diagnosis%20and%20Treatment%20of%20Opportunistic%20Infections%20in%20Patients%20with%20AIDS%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20K.%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%2C%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Program%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Since%202009%2C%20earlier%20initiation%20of%20highly%20active%20antiretroviral%20therapy%20%28HAART%29%20after%20an%20opportunistic%20infection%20%28OI%29%20has%20been%20recommended%20based%20on%20lower%20risks%20of%20death%20and%20AIDS-related%20progression%20found%20in%20clinical%20trials.%20Delay%20in%20HAART%20initiation%20after%20OIs%20may%20be%20an%20important%20barrier%20for%20successful%20outcomes%20in%20patients%20with%20advanced%20disease.%20Timing%20of%20HAART%20initiation%20after%20an%20OI%20in%20%5C%22real%20life%5C%22%20settings%20in%20Latin%20America%20has%20not%20been%20evaluated.%5CnMETHODS%3A%20Patients%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%20%5Cu226518%20years%20of%20age%20at%20enrolment%2C%20from%202001-2012%20who%20had%20an%20OI%20before%20HAART%20initiation%20were%20included.%20Patients%20were%20divided%20in%20an%20early%20HAART%20%28EH%29%20group%20%28those%20initiating%20within%204%20weeks%20of%20an%20OI%29%20and%20a%20delayed%20HAART%20%28DH%29%20group%20%28those%20initiating%20more%20than%204%20weeks%20after%20an%20OI%29.%20All%20patients%20with%20an%20AIDS-defining%20OI%20were%20included.%20In%20patients%20with%20more%20than%20one%20OI%20the%20first%20event%20reported%20was%20considered.%20Calendar%20trends%20in%20the%20proportion%20of%20patients%20in%20the%20EH%20group%20%28before%20and%20after%202009%29%20were%20estimated%20by%20site%20and%20for%20the%20whole%20cohort.%20Factors%20associated%20with%20EH%20were%20estimated%20using%20multivariable%20logistic%20regression%20models.%5CnRESULTS%3A%20A%20total%20of%201457%20patients%20had%20an%20OI%20before%20HAART%20initiation%20and%20were%20included%20in%20the%20analysis%3A%20213%20from%20Argentina%2C%20686%20from%20Brazil%2C%20283%20from%20Chile%2C%20119%20from%20Honduras%20and%20156%20from%20Mexico.%20Most%20prevalent%20OI%20were%20Tuberculosis%20%2831%25%29%2C%20followed%20by%20Pneumocystis%20pneumonia%20%2824%25%29%2C%20Invasive%20Candidiasis%20%2816%25%29%20and%20Toxoplasmosis%20%289%25%29.%20Median%20time%20from%20OI%20to%20HAART%20initiation%20decreased%20significantly%20from%205.7%20%28interquartile%20range%20%5BIQR%5D%202.8-12.1%29%20weeks%20before%202009%20to%204.3%20%28IQR%202.0-7.1%29%20after%202009%20%28p%3C0.01%29.%20Factors%20associated%20with%20starting%20HAART%20within%204%20weeks%20of%20OI%20diagnosis%20were%20lower%20CD4%20count%20at%20enrolment%20%28p-%3C0.001%29%2C%20having%20a%20non-tuberculosis%20OI%20%28p%3C0.001%29%2C%20study%20site%20%28p%3C0.001%29%2C%20and%20more%20recent%20years%20of%20OI%20diagnosis%20%28p%3C0.001%29.%5CnDISCUSSION%3A%20The%20time%20from%20diagnosis%20of%20an%20OI%20to%20HAART%20initiation%20has%20decreased%20in%20Latin%20America%20coinciding%20with%20the%20publication%20of%20evidence%20of%20its%20benefit.%20We%20found%20important%20heterogeneity%20between%20sites%20which%20may%20reflect%20differences%20in%20clinical%20practices%2C%20local%20guidelines%2C%20and%20access%20to%20HAART.%20The%20impact%20of%20the%20timing%20of%20HAART%20initiation%20after%20OI%20on%20patient%20survival%20in%20this%20%5C%22real%20life%5C%22%20context%20needs%20further%20evaluation.%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0153921%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-05T15%3A11%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22ZMRBZBRX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cesar%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECesar%20C%2C%20Koethe%20JR%2C%20Giganti%20MJ%2C%20Rebeiro%20P%2C%20Althoff%20KN%2C%20Napravnik%20S%2C%20et%20al.%20Health%20outcomes%20among%20HIV-positive%20Latinos%20initiating%20antiretroviral%20therapy%20in%20North%20America%20versus%20Central%20and%20South%20America.%20J%20Int%20AIDS%20Soc.%202016%3B19%281%29%3A20684.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DZMRBZBRX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Health%20outcomes%20among%20HIV-positive%20Latinos%20initiating%20antiretroviral%20therapy%20in%20North%20America%20versus%20Central%20and%20South%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20R.%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Napravnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Mayor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Willig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Levison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mari%22%2C%22lastName%22%3A%22Kitahata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20C.%22%2C%22lastName%22%3A%22Rodriguez-Barradas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20epidemiology%20%28CCASAnet%29%20and%20North%20American%20AIDS%20Cohort%20Collaboration%20on%20Research%20and%20Design%20%28NA-ACCORD%29%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Latinos%20living%20with%20HIV%20in%20the%20Americas%20share%20a%20common%20ethnic%20and%20cultural%20heritage.%20In%20North%20America%2C%20Latinos%20have%20a%20relatively%20high%20rate%20of%20new%20HIV%20infections%20but%20lower%20rates%20of%20engagement%20at%20all%20stages%20of%20the%20care%20continuum%2C%20whereas%20in%20Latin%20America%20antiretroviral%20therapy%20%28ART%29%20services%20continue%20to%20expand%20to%20meet%20treatment%20needs.%20In%20this%20analysis%2C%20we%20compare%20HIV%20treatment%20outcomes%20between%20Latinos%20receiving%20ART%20in%20North%20America%20versus%20Latin%20America.%5CnMETHODS%3A%20HIV-positive%20adults%20initiating%20ART%20at%20Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20%28CCASAnet%29%20sites%20were%20compared%20to%20Latino%20patients%20%28based%20on%20country%20of%20origin%20or%20ethnic%20identity%29%20starting%20treatment%20at%20North%20American%20AIDS%20Cohort%20Collaboration%20on%20Research%20and%20Design%20%28NA-ACCORD%29%20sites%20in%20the%20United%20States%20and%20Canada%20between%202000%20and%202011.%20Cox%20proportional%20hazards%20models%20compared%20mortality%2C%20treatment%20interruption%2C%20antiretroviral%20regimen%20change%2C%20virologic%20failure%20and%20loss%20to%20follow-up%20between%20cohorts.%5CnRESULTS%3A%20The%20study%20included%208400%20CCASAnet%20and%202786%20NA-ACCORD%20patients%20initiating%20ART.%20CCASAnet%20patients%20were%20younger%20%28median%2035%20vs.%2037%20years%29%2C%20more%20likely%20to%20be%20female%20%2827%25%20vs.%2020%25%29%20and%20had%20lower%20nadir%20CD4%20count%20%28median%20148%20vs.%20195%20cells%5C%2F%5Cu00b5L%2C%20p%3C0.001%20for%20all%29.%20In%20multivariable%20analyses%2C%20CCASAnet%20patients%20had%20a%20higher%20risk%20of%20mortality%20after%20ART%20initiation%20%28adjusted%20hazard%20ratio%20%28AHR%29%201.61%3B%2095%25%20confidence%20interval%20%28CI%29%3A%201.32%20to%201.96%29%2C%20particularly%20during%20the%20first%20year%2C%20but%20a%20lower%20hazard%20of%20treatment%20interruption%20%28AHR%3A%200.46%3B%2095%25%20CI%3A%200.42%20to%200.50%29%2C%20change%20to%20second-line%20ART%20%28AHR%3A%200.56%3B%2095%25%20CI%3A%200.51%20to%200.62%29%20and%20virologic%20failure%20%28AHR%3A%200.52%3B%2095%25%20CI%3A%200.48%20to%200.57%29.%5CnCONCLUSIONS%3A%20HIV-positive%20Latinos%20initiating%20ART%20in%20Latin%20America%20have%20greater%20continuity%20of%20treatment%20but%20are%20at%20higher%20risk%20of%20death%20than%20Latinos%20in%20North%20America.%20Factors%20underlying%20these%20differences%2C%20such%20as%20HIV%20testing%2C%20linkage%20and%20access%20to%20care%2C%20warrant%20further%20investigation.%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222018-10-05T15%3A10%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22PH4EARTV%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A2872895%2C%22username%22%3A%22kaylaecooper%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fkaylaecooper%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Althoff%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlthoff%20KN%2C%20Rebeiro%20PF%2C%20Hanna%20DB%2C%20Padgett%20D%2C%20Horberg%20MA%2C%20Grinsztejn%20B%2C%20et%20al.%20A%20picture%20is%20worth%20a%20thousand%20words%3A%20maps%20of%20HIV%20indicators%20to%20inform%20research%2C%20programs%2C%20and%20policy%20from%20NA-ACCORD%20and%20CCASAnet%20clinical%20cohorts.%20J%20Int%20AIDS%20Soc%20%5BInternet%5D.%202016%3B19%281%29%3A20707.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27049052%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27049052%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPH4EARTV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20picture%20is%20worth%20a%20thousand%20words%3A%20maps%20of%20HIV%20indicators%20to%20inform%20research%2C%20programs%2C%20and%20policy%20from%20NA-ACCORD%20and%20CCASAnet%20clinical%20cohorts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20B.%22%2C%22lastName%22%3A%22Hanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Horberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20G.%22%2C%22lastName%22%3A%22Abraham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Hogg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20John%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%20J.%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Mayor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Rachlis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mari%20M.%22%2C%22lastName%22%3A%22Kitahata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Buchacz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20E.%22%2C%22lastName%22%3A%22Thorne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%20M.%22%2C%22lastName%22%3A%22Cordero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20B.%22%2C%22lastName%22%3A%22Rourke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22North%20American%20Aids%20Cohort%20Collaboration%20on%20Research%20and%20Design%20%28na-Accord%29%20and%20the%20Caribbean%2C%20Central%20and%20the%20South%20America%20Network%20for%20Hiv%20Epidemiology%20%28ccasanet%29%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Maps%20are%20powerful%20tools%20for%20visualization%20of%20differences%20in%20health%20indicators%20by%20geographical%20region%2C%20but%20multi-country%20maps%20of%20HIV%20indicators%20do%20not%20exist%2C%20perhaps%20due%20to%20lack%20of%20consistent%20data%20across%20countries.%20Our%20objective%20was%20to%20create%20maps%20of%20four%20HIV%20indicators%20in%20North%2C%20Central%2C%20and%20South%20American%20countries.%5CnMETHODS%3A%20Using%20data%20from%20the%20North%20American%20AIDS%20Cohort%20Collaboration%20on%20Research%20and%20Design%20%28NA-ACCORD%29%20and%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%2C%20we%20mapped%20median%20CD4%20at%20presentation%20for%20HIV%20clinical%20care%2C%20proportion%20retained%20in%20HIV%20primary%20care%2C%20proportion%20prescribed%20antiretroviral%20therapy%20%28ART%29%2C%20and%20the%20proportion%20with%20suppressed%20plasma%20HIV%20viral%20load%20%28VL%29%20from%202010%20to%202012%20for%20North%2C%20Central%2C%20and%20South%20America.%20The%2015%20Canadian%20and%20US%20clinical%20cohorts%20and%207%20clinical%20cohorts%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%2C%20and%20Peru%20represented%20approximately%202-7%25%20of%20persons%20known%20to%20be%20living%20with%20HIV%20in%20these%20countries.%5CnRESULTS%3A%20Study%20populations%20were%20selected%20for%20each%20indicator%3A%20median%20CD4%20at%20presentation%20for%20care%20was%20estimated%20among%2014%2C811%20adults%3B%20retention%20was%20estimated%20among%2087%2C979%20adults%3B%20ART%20use%20was%20estimated%20among%2084%2C757%20adults%3B%20and%20suppressed%20VL%20was%20estimated%20among%2051%2C118%20adults.%20Only%20three%20US%20states%20and%20the%20District%20of%20Columbia%20had%20a%20median%20CD4%20at%20presentation%20%3E350%20cells%5C%2Fmm%283%29.%20Haiti%2C%20Mexico%2C%20and%20several%20states%20had%20%3E85%25%20retention%20in%20care%3B%20lower%20%2850-74%25%29%20retention%20in%20care%20was%20observed%20in%20the%20US%20West%2C%20South%2C%20and%20Mid-Atlantic%2C%20and%20in%20Argentina%2C%20Brazil%2C%20and%20Peru.%20ART%20use%20was%20highest%20%2890%25%29%20in%20Mexico.%20The%20percentages%20of%20patients%20with%20suppressed%20VL%20in%20the%20US%20South%20and%20Northeast%20were%20lower%20than%20in%20most%20of%20Central%20and%20South%20America.%5CnCONCLUSIONS%3A%20These%20maps%20provide%20visualization%20of%20gaps%20in%20the%20quality%20of%20HIV%20care%20and%20allow%20for%20comparison%20between%20and%20within%20countries%20as%20well%20as%20monitoring%20policy%20and%20programme%20goals%20within%20geographical%20boundaries.%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22ENG%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F27049052%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A29%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22R7Z9GBW7%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cesar%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECesar%20C%2C%20Koethe%20J%2C%20Rebeiro%20P%2C%20Althoff%20K%2C%20Napravnik%20S%2C%20Mayor%20A%2C%20et%20al.%20Health%20outcomes%20among%20HIV-positive%20Latinos%20initiating%20antiretroviral%20therapy%20in%20North%20America%20versus%20Central%20and%20South%20America.%20Journal%20of%20the%20International%20AIDS%20Society.%20J%20Int%20AIDS%20Soc%20%5BInternet%5D.%202016%3B19%281%29%3A20684.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4800379%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4800379%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DR7Z9GBW7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Health%20outcomes%20among%20HIV-positive%20Latinos%20initiating%20antiretroviral%20therapy%20in%20North%20America%20versus%20Central%20and%20South%20America.%20Journal%20of%20the%20International%20AIDS%20Society%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JR%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22reviewedAuthor%22%2C%22firstName%22%3A%22MJ%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22KN%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Napravnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Mayor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22TR%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Willig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Levison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Kitahata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MC%22%2C%22lastName%22%3A%22Rodriguez-Barradas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RD%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Cahn%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4800379%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A20%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22VNKKPAS8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabtree-Ram%5Cu00edrez%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree-Ram%26%23xED%3Brez%20B%2C%20Caro-Vega%20Y%2C%20Shepherd%20B%2C%20Grinsztejn%20B%2C%20Wolff%20M%2C%20Cortes%20C%2C%20et%20al.%20Time%20to%20HAART%20Initiation%20after%20Diagnosis%20and%20Treatment%20of%20Opportunistic%20Infections%20in%20Patients%20with%20AIDS%20in%20Latin%20America.%20PloS%20one%20%5BInternet%5D.%202016%3B11%286%29.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4896474%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4896474%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DVNKKPAS8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Time%20to%20HAART%20Initiation%20after%20Diagnosis%20and%20Treatment%20of%20Opportunistic%20Infections%20in%20Patients%20with%20AIDS%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CP%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AK%22%2C%22lastName%22%3A%22Person%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4896474%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A19%3A40Z%22%7D%7D%2C%7B%22key%22%3A%229T45NM6T%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rebeiro%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERebeiro%20P%2C%20Cesar%20C%2C%20Shepherd%20B%2C%20De%20Boni%20R%2C%20Cort%26%23xE9%3Bs%20C%2C%20Rodriguez%20F%2C%20et%20al.%20Assessing%20the%20HIV%20Care%20Continuum%20in%20Latin%20America%3A%20progress%20in%20clinical%20retention%2C%20cART%20use%20and%20viral%20suppression.%20J%20Int%20AIDS%20Soc%20%5BInternet%5D.%202016%3B19%281%29.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4827101%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4827101%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9T45NM6T%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Assessing%20the%20HIV%20Care%20Continuum%20in%20Latin%20America%3A%20progress%20in%20clinical%20retention%2C%20cART%20use%20and%20viral%20suppression%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RB%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CP%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JW%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Hoces%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Cahn%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4827101%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A18%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22KCADUUGA%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Charles%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECharles%20M%2C%20Lindegren%20M%2C%20Wester%20C%2C%20Blevins%20M%2C%20Sterling%20T%2C%20Dung%20N%2C%20et%20al.%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Collaboration.%26%23xA0%3B%20Implementation%20of%20Tuberculosis%20Intensive%20Case%20Finding%2C%20Isoniazid%20Preventive%20Therapy%2C%20and%20Infection%20Control%20%28%26%23x201C%3BThree%20I%26%23x2019%3Bs%26%23x201D%3B%29%20and%20HIV-Tuberculosis%20Service%20Integration%20in%20Lower%20Income%20Countries.%20PLoS%20One%20%5BInternet%5D.%202016%3B11%284%29.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4830552%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4830552%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DKCADUUGA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Collaboration.%20%20Implementation%20of%20Tuberculosis%20Intensive%20Case%20Finding%2C%20Isoniazid%20Preventive%20Therapy%2C%20and%20Infection%20Control%20%28%5C%22Three%20I%27s%5C%22%29%20and%20HIV-Tuberculosis%20Service%20Integration%20in%20Lower%20Income%20Countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MK%22%2C%22lastName%22%3A%22Charles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22ML%22%2C%22lastName%22%3A%22Lindegren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CW%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22TR%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22NT%22%2C%22lastName%22%3A%22Dung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JC%22%2C%22lastName%22%3A%22Dusingize%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Avit-Edi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Durier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%22%2C%22lastName%22%3A%22Nakigozi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CP%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Fenner%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0153243%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4830552%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A17%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22DKWMANHW%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coelho%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECoelho%20L%2C%20Grinsztejn%20B%2C%20Castilho%20J%2C%20De%20Boni%20R%2C%20Quintana%20M%2C%20Campos%20D%2C%20et%20al.%20Mortality%20in%20HIV-infected%20women%2C%20heterosexual%20men%2C%20and%20men%20who%20have%20sex%20with%20men%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20an%20observational%20cohort%20study.%20The%20lancet%20%5BInternet%5D.%202016%3B3%2810%29%3A490%26%23x2013%3B8.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5084911%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5084911%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DDKWMANHW%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20in%20HIV-infected%20women%2C%20heterosexual%20men%2C%20and%20men%20who%20have%20sex%20with%20men%20in%20Rio%20de%20Janeiro%2C%20Brazil%3A%20an%20observational%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Coelho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JL%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22De%20Boni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MS%22%2C%22lastName%22%3A%22Quintana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22DP%22%2C%22lastName%22%3A%22Campos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SR%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AG%22%2C%22lastName%22%3A%22Pacheco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC5084911%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T19%3A13%3A40Z%22%7D%7D%5D%7D
1.
Cesar C, Blugerman G, Valiente J, Rebeiro P, Sued O, Fink V, et al. The HIV Care Cascade in Buenos Aires, Argentina: Results in a Tertiary Referral Hospital. Rev Panam Salud Publica [Internet]. 2016 Dec;40(6):448–54. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518480/ Cite
1.
Shepherd B, Li C, Liu Q. Probability-scale residuals for continuous, discrete, and censored data. The Canadian Journal of Statistics [Internet]. 2016 Dec;44(4):463–79. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364820/ Cite
1.
De Boni R, Shepherd B, Grinsztejn B, Cesar C, Cortés C, Padgett D, et al. Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America. AIDS and behavior. AIDS behav [Internet]. 2016 Nov;20(11):2692–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069110 Cite
1.
Rachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K, et al. Drug saf [Internet]. 2016 Oct;39(10):959–76. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018020/ Cite
1.
Diaz C, Segura E, Luz P, Clark J, Ribeiro S, De Boni R, et al. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infect Dis. 2016 Aug;8(16):376. Cite
1.
Coelho LE, Cardoso SW, Amancio RT, Moreira RI, Ribeiro SR, Coelho AB, et al. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil. BMC Infect Dis [Internet]. 2016 Mar 22 [cited 2016 Apr 4];16. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802913/ Cite
1.
Blevins M, Wehbe FH, Rebeiro PF, Caro-Vega Y, McGowan CC, Shepherd BE. Interactive Data Visualization for HIV Cohorts: Leveraging Data Exchange Standards to Share and Reuse Research Tools. PLoS One [Internet]. 2016 Mar 10 [cited 2016 Apr 4];11(3). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786152/ Cite
1.
Wolff M, Shepherd BE, Cortés C, Rebeiro P, Cesar C, Wagner Cardoso S, et al. Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):102–10. Cite
1.
Crabtree-Ramírez B, Caro-Vega Y, Shepherd BE, Grinsztejn B, Wolff M, Cortes CP, et al. Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America. PLoS ONE. 2016;11(6):e0153921. Cite
1.
Cesar C, Koethe JR, Giganti MJ, Rebeiro P, Althoff KN, Napravnik S, et al. Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. J Int AIDS Soc. 2016;19(1):20684. Cite
1.
Althoff KN, Rebeiro PF, Hanna DB, Padgett D, Horberg MA, Grinsztejn B, et al. A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. J Int AIDS Soc [Internet]. 2016;19(1):20707. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27049052 Cite
1.
Cesar C, Koethe J, Rebeiro P, Althoff K, Napravnik S, Mayor A, et al. Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. Journal of the International AIDS Society. J Int AIDS Soc [Internet]. 2016;19(1):20684. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800379 Cite
1.
Crabtree-Ramírez B, Caro-Vega Y, Shepherd B, Grinsztejn B, Wolff M, Cortes C, et al. Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America. PloS one [Internet]. 2016;11(6). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896474 Cite
1.
Rebeiro P, Cesar C, Shepherd B, De Boni R, Cortés C, Rodriguez F, et al. Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression. J Int AIDS Soc [Internet]. 2016;19(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827101 Cite
1.
Charles M, Lindegren M, Wester C, Blevins M, Sterling T, Dung N, et al. International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (“Three I’s”) and HIV-Tuberculosis Service Integration in Lower Income Countries. PLoS One [Internet]. 2016;11(4). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830552 Cite
1.
Coelho L, Grinsztejn B, Castilho J, De Boni R, Quintana M, Campos D, et al. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. The lancet [Internet]. 2016;3(10):490–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084911 Cite
2015
76770
IP6F4TRX
2015
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-cc832bfc6e4ddef071d3d678f54fac32%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22QEAQ87E2%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cesar%20et%20al.%22%2C%22parsedDate%22%3A%222015-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECesar%20C%2C%20Jenkins%20CA%2C%20Shepherd%20BE%2C%20Padgett%20D%2C%20Mej%26%23xED%3Ba%20F%2C%20Ribeiro%20SR%2C%20et%20al.%20Incidence%20of%20virological%20failure%20and%20major%20regimen%20change%20of%20initial%20combination%20antiretroviral%20therapy%20in%20the%20Latin%20America%20and%20the%20Caribbean%3A%20an%20observational%20cohort%20study.%20Lancet%20HIV.%202015%20Nov%3B2%2811%29%3Ae492-500.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DQEAQ87E2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Incidence%20of%20virological%20failure%20and%20major%20regimen%20change%20of%20initial%20combination%20antiretroviral%20therapy%20in%20the%20Latin%20America%20and%20the%20Caribbean%3A%20an%20observational%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Mej%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayonara%20Rocha%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20Epidemiology%20%28CCASAnet%29%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Program%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Access%20to%20combination%20antiretroviral%20therapy%20%28ART%29%20is%20expanding%20in%20Latin%20America%20%28Mexico%2C%20Central%20America%2C%20and%20South%20America%29%20and%20the%20Caribbean.%20We%20assessed%20the%20incidence%20of%20and%20factors%20associated%20with%20regimen%20failure%20and%20regimen%20change%20of%20initial%20ART%20in%20this%20region.%5CnMETHODS%3A%20This%20observational%20cohort%20study%20included%20antiretroviral-naive%20adults%20starting%20ART%20from%202000%20to%202014%20at%20sites%20in%20seven%20countries%20throughout%20Latin%20America%20and%20the%20Caribbean.%20Primary%20outcomes%20were%20time%20from%20ART%20initiation%20until%20virological%20failure%2C%20major%20regimen%20modification%2C%20and%20a%20composite%20endpoint%20of%20the%20first%20of%20virological%20failure%20or%20major%20regimen%20modification.%20Cumulative%20incidence%20of%20the%20primary%20outcomes%20was%20estimated%20with%20death%20considered%20a%20competing%20event.%5CnFINDINGS%3A%2014%2C027%20patients%20starting%20ART%20were%20followed%20up%20for%20a%20median%20of%203.9%20years%20%282.0-6.5%29%3A%208374%20%2860%25%29%20men%2C%20median%20age%2037%20years%20%28IQR%2030-44%29%2C%20median%20CD4%20count%20156%20cells%20per%20%5Cu03bcL%20%2861-253%29%2C%20median%20plasma%20HIV%20RNA%205.0%20log10%20copies%20per%20mL%20%284.4-5.4%29%2C%20and%203567%20%2828%25%29%20had%20clinical%20AIDS.%201719%20%2812%25%29%20patients%20had%20virological%20failure%20and%201955%20%2814%25%29%20had%20a%20major%20regimen%20change.%20Excluding%20the%20site%20in%20Haiti%2C%20which%20did%20not%20regularly%20measure%20HIV%20RNA%2C%20cumulative%20incidence%20of%20virological%20failure%20was%207.8%25%20%2895%25%20CI%207.2-8.5%29%201%20year%20after%20ART%20initiation%2C%2019.2%25%20%2818.2-20.2%29%20at%203%20years%2C%20and%2025.8%25%20%2824.6-27.0%29%20at%205%20years%3B%20cumulative%20incidence%20of%20major%20regimen%20change%20was%205.9%25%20%285.3-6.4%29%20at%201%20year%2C%2012.7%25%20%2811.9-13.5%29%20at%203%20years%2C%20and%2018.2%25%20%2817.2-19.2%29%20at%205%20years.%20Incidence%20of%20major%20regimen%20change%20at%20the%20site%20in%20Haiti%20was%2010.7%25%20%2895%25%20CI%209.7-11.6%29%20at%205%20years.%20Virological%20failure%20was%20associated%20with%20younger%20age%20%28adjusted%20hazard%20ratio%20%5BHR%5D%202.03%2C%2095%25%20CI%201.68-2.44%2C%20for%2020%20years%20vs%2040%20years%29%2C%20infection%20through%20injection%20drug%20use%20%28vs%20infection%20through%20heterosexual%20sex%3B%201.60%2C%201.02-2.52%29%2C%20and%20initiation%20in%20earlier%20calendar%20years%20%281.28%2C%201.13-1.46%2C%20for%202002%20vs%202006%29%2C%20but%20was%20not%20significantly%20associated%20with%20boosted%20protease%20inhibitor-based%20regimens%20%28vs%20non-nucleoside%20reverse%20transcriptase%20inhibitor%3B%201.17%2C%201.00-1.36%29.%5CnINTERPRETATION%3A%20Incidence%20of%20virological%20failure%20in%20Latin%20America%20and%20the%20Caribbean%20was%20generally%20lower%20than%20that%20reported%20in%20North%20America%20or%20Europe.%20Our%20results%20suggest%20the%20need%20to%20design%20strategies%20to%20reduce%20failure%20and%20major%20regimen%20change%20in%20young%20patients%20and%20those%20with%20a%20history%20of%20injection%20drug%20use.%5CnFUNDING%3A%20US%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%22Nov%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2815%2900183-6%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A01%3A59Z%22%7D%7D%2C%7B%22key%22%3A%229IBTHSMQ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hamilton%20et%20al.%22%2C%22parsedDate%22%3A%222015-10-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHamilton%20CD%2C%20Swaminathan%20S%2C%20Christopher%20DJ%2C%20Ellner%20J%2C%20Gupta%20A%2C%20Sterling%20TR%2C%20et%20al.%20RePORT%20International%3A%20Advancing%20Tuberculosis%20Biomarker%20Research%20Through%20Global%20Collaboration.%20Clin%20Infect%20Dis.%202015%20Oct%2015%3B61Suppl%203%3AS155-159.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9IBTHSMQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22RePORT%20International%3A%20Advancing%20Tuberculosis%20Biomarker%20Research%20Through%20Global%20Collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carol%20D.%22%2C%22lastName%22%3A%22Hamilton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soumya%22%2C%22lastName%22%3A%22Swaminathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devasahayam%20J.%22%2C%22lastName%22%3A%22Christopher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerrold%22%2C%22lastName%22%3A%22Ellner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amita%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Rolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudha%22%2C%22lastName%22%3A%22Srinivasan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Karyana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophia%22%2C%22lastName%22%3A%22Siddiqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%20K.%22%2C%22lastName%22%3A%22Stoszek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Kim%22%7D%5D%2C%22abstractNote%22%3A%22Progress%20in%20tuberculosis%20clinical%20research%20is%20hampered%20by%20a%20lack%20of%20reliable%20biomarkers%20that%20predict%20progression%20from%20latent%20to%20active%20tuberculosis%2C%20and%20subsequent%20cure%2C%20relapse%2C%20or%20failure.%20Regional%20Prospective%20Observational%20Research%20in%20Tuberculosis%20%28RePORT%29%20International%20represents%20a%20consortium%20of%20regional%20cohorts%20%28RePORT%20India%2C%20RePORT%20Brazil%2C%20and%20RePORT%20Indonesia%29%20that%20are%20linked%20through%20the%20implementation%20of%20a%20Common%20Protocol%20for%20data%20and%20specimen%20collection%2C%20and%20are%20poised%20to%20address%20this%20critical%20research%20need.%20Each%20RePORT%20network%20is%20designed%20to%20support%20local%2C%20in-country%20tuberculosis-specific%20data%20and%20specimen%20biorepositories%2C%20and%20associated%20research.%20Taken%20together%2C%20the%20expected%20results%20include%20greater%20global%20clinical%20research%20capacity%20in%20high-burden%20settings%2C%20and%20increased%20local%20access%20to%20quality%20data%20and%20specimens%20for%20members%20of%20each%20network%20and%20their%20domestic%20and%20international%20collaborators.%20Additional%20networks%20are%20expected%20to%20be%20added%2C%20helping%20to%20spur%20tuberculosis%20treatment%20and%20prevention%20research%20around%20the%20world.%22%2C%22date%22%3A%22Oct%2015%2C%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciv611%22%2C%22ISSN%22%3A%221537-6591%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A02%3A19Z%22%7D%7D%2C%7B%22key%22%3A%2224Z9BHM3%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Belaunzaran-Zamudio%20et%20al.%22%2C%22parsedDate%22%3A%222015-08-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBelaunzaran-Zamudio%20P%2C%20Caro-Vega%20Y%2C%20Shepherd%20B%2C%20Crabtree-Ramirez%20B%2C%20Luz%20P%2C%20Grinsztejn%20B%2C%20et%20al.%20Monitoring%20of%20HIV%20treatment%20in%20seven%20countries%20in%20WHO%20Region%20of%20the%20Americas.%20Bull%20World%20Health%20Organ%20%5BInternet%5D.%202015%20Aug%201%3B93%288%29%3A529%26%23x2013%3B39.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4581655%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4581655%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D24Z9BHM3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Monitoring%20of%20HIV%20treatment%20in%20seven%20countries%20in%20WHO%20Region%20of%20the%20Americas%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22YN%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JW%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JG%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%5Cn%5CnTo%20determine%20the%20prevalence%20of%20adequate%20monitoring%20and%20the%20costs%20of%20measuring%20CD4%2B%20T-lymphocytes%20%28CD4%2B%20cell%29%20and%20human%20immunodeficiency%20virus%20%28HIV%29%20viral%20load%20in%20people%20receiving%20antiretroviral%20therapy%20%28ART%29%20in%20seven%20countries%20in%20the%20WHO%20Region%20of%20the%20Americas.%5CnMETHODS%3A%5Cn%5CnWe%20obtained%20retrospective%2C%20longitudinal%20data%20for%2014%5Cu2009476%20adults%20who%20started%20a%20first%20ART%20regimen%20at%20seven%20HIV%20clinics%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%20and%20Peru%20between%202000%20and%202011.%20We%20estimated%20the%20proportion%20of%20180-day%20periods%20with%20adequate%20monitoring%2C%20which%20we%20defined%20as%20at%20least%20one%20CD4%2B%20cell%20count%20and%20one%20viral%20load%20measurement.%20Factors%20associated%20with%20adequate%20monitoring%20were%20analysed%20using%20regression%20methods.%20The%20costs%20of%20the%20tests%20were%20estimated.%5CnFINDINGS%3A%5Cn%5CnThe%20median%20follow-up%20time%20was%2050.4%20months%3B%20the%20proportion%20of%20180-day%20periods%20with%20adequate%20CD4%2B%20cell%20counts%20was%2069%25%20while%20the%20proportion%20with%20adequate%20monitoring%20was%2062%25.%20Adequate%20monitoring%20was%20more%20likely%20in%20participants%20who%20were%20older%2C%20who%20started%20ART%20more%20recently%2C%20whose%20first%20regimen%20included%20a%20non-nucleoside%20reverse%20transcriptase%20inhibitor%20or%20who%20had%20a%20CD4%2B%20cell%20count%20less%20than%20200%20cells%5C%2F%5Cu00b5l%20at%20ART%20initiation.%20The%20cost%20of%20one%20CD4%2B%20cell%20count%20ranged%20from%207.37%20United%20States%20dollars%20%28US%24%29%20in%20Argentina%20to%20US%24%2064.09%20in%20Chile%3B%20the%20cost%20of%20one%20viral%20load%20measurement%20ranged%20from%20US%24%2020.34%20in%20Brazil%20to%20US%24%20186.28%20in%20Haiti.%5CnCONCLUSION%3A%5Cn%5CnIn%20HIV-infected%20participants%20receiving%20ART%20in%20the%20WHO%20Region%20of%20the%20Americas%2C%20CD4%2B%20cell%20count%20and%20viral%20load%20monitoring%20was%20often%20carried%20out%20less%20frequently%20than%20regional%20guidelines%20recommend.%20The%20laboratory%20costs%20of%20monitoring%20varied%20greatly.%22%2C%22date%22%3A%2208-01-2015%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.2471%5C%2FBLT.14.147447%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4581655%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-14T21%3A57%3A09Z%22%7D%7D%2C%7B%22key%22%3A%229B2DCVSZ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Luz%20et%20al.%22%2C%22parsedDate%22%3A%222015-06-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELuz%20P%2C%20Belaunzaran-Zamudio%20P%2C%20Crabtree-Ramirez%20B%2C%20Caro-Vega%20Y%2C%20Hoces%20D%2C%20Rebeiro%20P%2C%20et%20al.%20CD4%20response%20up%20to%205%20years%20following%20combination%20antiretroviral%20therapy%20in%20HIV-infected%20patients%20in%20Latin%20America%20and%20the%20Caribbean.%20Open%20Forum%20Infect%20Dis%20%5BInternet%5D.%202015%20Jun%205%20%5Bcited%202015%20Mar%2015%5D%3B2%282%29%3Aofv079.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4498272%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4498272%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9B2DCVSZ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CD4%20response%20up%20to%205%20years%20following%20combination%20antiretroviral%20therapy%20in%20HIV-infected%20patients%20in%20Latin%20America%20and%20the%20Caribbean%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Belaunzaran-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Hoces%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PF%22%2C%22lastName%22%3A%22Rebeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JW%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CP%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22We%20describe%20CD4%20counts%20at%206-month%20intervals%20for%205%20years%20after%20combination%20antiretroviral%20therapy%20initiation%20among%2012%20879%20antiretroviral-naive%20human%20immunodeficiency%20virus-infected%20adults%20from%20Latin%20America%20and%20the%20Caribbean.%20Median%20CD4%20counts%20increased%20from%20154%20cells%5C%2Fmm%283%29%20at%20baseline%20%28interquartile%20range%20%5BIQR%5D%2C%2060-251%29%20to%20413%20cells%5C%2Fmm%283%29%20%28IQR%2C%20234-598%29%20by%20year%205.%22%2C%22date%22%3A%222015-06-05%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4498272%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-17T19%3A35%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22VIADJPUW%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ballif%20et%20al.%22%2C%22parsedDate%22%3A%222015-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBallif%20M%2C%20Renner%20L%2C%20Claude%20Dusingize%20J%2C%20Leroy%20V%2C%20Ayaya%20S%2C%20Wools-Kaloustian%20K%2C%20et%20al.%20Tuberculosis%20in%20Pediatric%20Antiretroviral%20Therapy%20Programs%20in%20Low-%20and%20Middle-Income%20Countries%3A%20Diagnosis%20and%20Screening%20Practices.%20J%20Pediatric%20Infect%20Dis%20Soc.%202015%20Mar%3B4%281%29%3A30%26%23x2013%3B8.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DVIADJPUW%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20in%20Pediatric%20Antiretroviral%20Therapy%20Programs%20in%20Low-%20and%20Middle-Income%20Countries%3A%20Diagnosis%20and%20Screening%20Practices%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorna%22%2C%22lastName%22%3A%22Renner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Claude%20Dusingize%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeriane%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Ayaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Graber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynne%20M.%22%2C%22lastName%22%3A%22Mofenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ketut%20Dewi%22%2C%22lastName%22%3A%22Kumara%20Wati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Revathy%22%2C%22lastName%22%3A%22Nallusamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Reubenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20global%20burden%20of%20childhood%20tuberculosis%20%28TB%29%20is%20estimated%20to%20be%200.5%20million%20new%20cases%20per%20year.%20Human%20immunodeficiency%20virus%20%28HIV%29-infected%20children%20are%20at%20high%20risk%20for%20TB.%20Diagnosis%20of%20TB%20in%20HIV-infected%20children%20remains%20a%20major%20challenge.%5CnMETHODS%3A%20We%20describe%20TB%20diagnosis%20and%20screening%20practices%20of%20pediatric%20antiretroviral%20treatment%20%28ART%29%20programs%20in%20Africa%2C%20Asia%2C%20the%20Caribbean%2C%20and%20Central%20and%20South%20America.%20We%20used%20web-based%20questionnaires%20to%20collect%20data%20on%20ART%20programs%20and%20patients%20seen%20from%20March%20to%20July%202012.%20Forty-three%20ART%20programs%20treating%20children%20in%2023%20countries%20participated%20in%20the%20study.%5CnRESULTS%3A%20Sputum%20microscopy%20and%20chest%20Radiograph%20were%20available%20at%20all%20programs%2C%20mycobacterial%20culture%20in%2040%20%2893%25%29%20sites%2C%20gastric%20aspiration%20in%2027%20%2863%25%29%2C%20induced%20sputum%20in%2023%20%2854%25%29%2C%20and%20Xpert%20MTB%5C%2FRIF%20in%2016%20%2837%25%29%20sites.%20Screening%20practices%20to%20exclude%20active%20TB%20before%20starting%20ART%20included%20contact%20history%20in%2041%20sites%20%2884%25%29%2C%20symptom%20screening%20in%2038%20%2888%25%29%2C%20and%20chest%20Radiograph%20in%2034%20sites%20%2879%25%29.%20The%20use%20of%20diagnostic%20tools%20was%20examined%20among%20146%20children%20diagnosed%20with%20TB%20during%20the%20study%20period.%20Chest%20Radiograph%20was%20used%20in%20125%20%2886%25%29%20children%2C%20sputum%20microscopy%20in%2076%20%2852%25%29%2C%20induced%20sputum%20microscopy%20in%2038%20%2826%25%29%2C%20gastric%20aspirate%20microscopy%20in%2035%20%2824%25%29%2C%20culture%20in%2025%20%2817%25%29%2C%20and%20Xpert%20MTB%5C%2FRIF%20in%2011%20%288%25%29%20children.%5CnCONCLUSIONS%3A%20Induced%20sputum%20and%20Xpert%20MTB%5C%2FRIF%20were%20infrequently%20available%20to%20diagnose%20childhood%20TB%2C%20and%20screening%20was%20largely%20based%20on%20symptom%20identification.%20There%20is%20an%20urgent%20need%20to%20improve%20the%20capacity%20of%20ART%20programs%20in%20low-%20and%20middle-income%20countries%20to%20exclude%20and%20diagnose%20TB%20in%20HIV-infected%20children.%22%2C%22date%22%3A%22Mar%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fjpids%5C%2Fpiu020%22%2C%22ISSN%22%3A%222048-7207%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A09%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22PMJ7WBTX%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castilho%20et%20al.%22%2C%22parsedDate%22%3A%222015-02-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECastilho%20J%2C%20Luz%20P%2C%20Shepherd%20B%2C%20Turner%20M%2C%20Ribeiro%20S%2C%20Bebawy%20S%2C%20et%20al.%20HIV%20and%20Cancer%3A%20A%20comparative%20retrospective%20study%20of%20Brazilian%20and%20U.S.%20clinical%20cohorts.%20Infect%20Agent%20Cancer%20%5BInternet%5D.%202015%20Feb%202%3B%2810%29%3A4.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25685180%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25685180%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPMJ7WBTX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20and%20Cancer%3A%20A%20comparative%20retrospective%20study%20of%20Brazilian%20and%20U.S.%20clinical%20cohorts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JL%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SR%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SS%22%2C%22lastName%22%3A%22Bebawy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JS%22%2C%22lastName%22%3A%22Netto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22VG%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22EA%22%2C%22lastName%22%3A%22Engels%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22TR%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%5Cn%5CnWith%20successful%20antiretroviral%20therapy%2C%20non-communicable%20diseases%2C%20including%20malignancies%2C%20are%20increasingly%20contributing%20to%20morbidity%20and%20mortality%20among%20HIV-infected%20persons.%20The%20epidemiology%20of%20AIDS-defining%20cancers%20%28ADCs%29%20and%20non-AIDS-defining%20cancers%20%28NADCs%29%20in%20HIV-infected%20populations%20in%20Brazil%20has%20not%20been%20well%20described.%20It%20is%20not%20known%20if%20cancer%20trends%20in%20HIV-infected%20populations%20in%20Brazil%20are%20similar%20to%20those%20of%20other%20countries%20where%20antiretroviral%20therapy%20is%20also%20widely%20available.%5CnMETHODS%3A%5Cn%5CnWe%20performed%20a%20retrospective%20analysis%20of%20clinical%20cohorts%20at%20Instituto%20Nacional%20de%20Infectologia%20Evandro%20Chagas%20%28INI%29%20in%20Rio%20de%20Janeiro%20and%20Vanderbilt%20Comprehensive%20Care%20Clinic%20%28VCCC%29%20in%20Nashville%20from%201998%20to%202010.%20We%20used%20Poisson%20regression%20and%20standardized%20incidence%20ratios%20%28SIRs%29%20to%20examine%20incidence%20trends.%20Clinical%20and%20demographic%20predictors%20of%20ADCs%20and%20NADCs%20were%20examined%20using%20Cox%20proportional%20hazards%20models.%5CnRESULTS%3A%5Cn%5CnThis%20study%20included%202%2C925%20patients%20at%20INI%20and%203%2C927%20patients%20at%20VCCC.%20There%20were%2057%20ADCs%20at%20INI%20%2865%25%20Kaposi%20sarcoma%29%2C%2047%20at%20VCCC%20%2840%25%20Kaposi%20sarcoma%29%2C%2045%20NADCs%20at%20INI%2C%20and%2082%20at%20VCCC.%20From%201998%20to%202004%2C%20incidence%20of%20ADCs%20remained%20statistically%20unchanged%20at%20both%20sites.%20From%202005%20to%202010%2C%20ADC%20incidence%20decreased%20in%20both%20cohorts%20%28INI%20incidence%20rate%20ratio%20per%20year%5Cu2009%3D%5Cu20090.74%2C%20p%5Cu2009%3C%5Cu20090.01%3B%20VCCC%5Cu2009%3D%5Cu20090.75%2C%20p%5Cu2009%3C%5Cu20090.01%29.%20Overall%20Kaposi%20sarcoma%20incidence%20was%20greater%20at%20INI%20than%20VCCC%20%283.0%20vs.%201.2%20cases%20per%201%2C000%20person-years%2C%20p%5Cu2009%3C%5Cu20090.01%29.%20Incidence%20of%20NADCs%20remained%20constant%20throughout%20the%20study%20period%20%28overall%20INI%20incidence%203.6%20per%201%2C000%20person-years%20and%20VCCC%20incidence%205.3%20per%201%2C000%20person-years%29.%20Compared%20to%20general%20populations%2C%20overall%20risk%20of%20NADCs%20was%20increased%20at%20both%20sites%20%28INI%20SIR%5Cu2009%3D%5Cu20091.4%20%5B95%25%20CI%201.1-1.9%5D%20and%20VCCC%20SIR%5Cu2009%3D%5Cu20091.3%20%5B1.0-1.7%5D%29.%20After%20non-melanoma%20skin%20cancers%2C%20the%20most%20frequent%20NADCs%20were%20anal%20cancer%20at%20INI%20%28n%5Cu2009%3D%5Cu20097%29%20and%20lung%20cancer%20at%20VCCC%20%28n%5Cu2009%3D%5Cu200911%29.%20In%20multivariate%20models%2C%20risk%20of%20ADC%20was%20associated%20with%20male%20sex%20and%20immunosuppression.%20Risk%20of%20NADC%20was%20associated%20with%20increased%20age.%5CnCONCLUSIONS%3A%5Cn%5CnIn%20both%20cohorts%2C%20ADCs%20have%20decreased%20over%20time%2C%20though%20incidence%20of%20KS%20was%20higher%20at%20INI%20than%20VCCC.%20Rates%20of%20NADCs%20remained%20constant%20over%20time%20at%20both%20sites.%22%2C%22date%22%3A%2202-02-2015%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2F1750-9378-10-4%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25685180%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-14T21%3A57%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22AZAPABN4%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Castilho%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECastilho%20JL%2C%20Levi%20JE%2C%20Luz%20PM%2C%20Cambou%20MC%2C%20Vanni%20T%2C%20de%20Andrade%20A%2C%20et%20al.%20A%20cross-sectional%20study%20of%20high-risk%20human%20papillomavirus%20clustering%20and%20cervical%20outcomes%20in%20HIV-infected%20women%20in%20Rio%20de%20Janeiro%2C%20Brazil.%20BMC%20Cancer.%202015%3B15%3A478.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DAZAPABN4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20cross-sectional%20study%20of%20high-risk%20human%20papillomavirus%20clustering%20and%20cervical%20outcomes%20in%20HIV-infected%20women%20in%20Rio%20de%20Janeiro%2C%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Eduardo%22%2C%22lastName%22%3A%22Levi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20Catherine%22%2C%22lastName%22%3A%22Cambou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tazio%22%2C%22lastName%22%3A%22Vanni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22de%20Andrade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00f4nica%22%2C%22lastName%22%3A%22Derrico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdil%5Cu00e9a%20G.%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%20K.%22%2C%22lastName%22%3A%22Friedman%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%20Brazil%2C%20the%20rate%20of%20cervical%20cancer%20remains%20high%20despite%20the%20availability%20of%20screening%20programs.%20With%20ongoing%20vaccine%20development%20and%20implementation%2C%20information%20on%20the%20prevalence%20of%20specific%20HPV%20types%20is%20needed%2C%20particularly%20among%20high-risk%20populations%2C%20such%20as%20HIV-infected%20women.%5CnMETHODS%3A%20We%20performed%20a%20study%20of%20HIV-infected%20women%20in%20Rio%20de%20Janeiro%2C%20Brazil%2C%20who%20underwent%20cervical%20HPV%20genotype%20testing%20between%202005-2013.%20We%20examined%20the%20prevalence%20of%20high-risk%20HPV%20types%20and%20the%20patterns%20of%20high-risk%20HPV%20type%20clustering.%20Using%20logarithmic%20binomial%20regression%2C%20we%20estimated%20the%20risk%20of%20abnormal%20cytology%20by%20HPV%20genotype%20result.%5CnRESULTS%3A%20Of%20the%20562%20women%20included%2C%20498%20%2889%20%25%29%20had%20at%20least%20one%20HPV%20type%20detected.%20364%20women%20%2865%20%25%29%20had%20at%20least%20one%20high-risk%20HPV%20type%20detected%20and%20181%20%2832%20%25%29%20had%20more%20than%20one%20high-risk%20type%20detected.%20HPV%2058%20was%20the%20most%20frequent%20HPV%20type%20detected%20overall%20%28prevalence%2019.8%20%25%20%5B95%20%25%20confidence%20interval%2016.4-23.1%5D%29%2C%20followed%20by%20HPV%2053%20%28prevalence%2015.5%20%25%20%5B12.5-18.5%5D%29%20and%20HPV%2016%20%28prevalence%2013%20%25%20%5B10.2-15.8%5D%29.%20Women%20infected%20with%20more%20than%20one%20high-risk%20HPV%20type%20were%20younger%2C%20had%20lower%20CD4%2B%20lymphocyte%20counts%2C%20and%20were%20more%20likely%20to%20be%20infected%20with%20HPV%2016%20or%2018.%20In%20adjusted%20analyses%2C%20presence%20of%20more%20than%20one%20high-risk%20HPV%20type%20was%20associated%20with%20a%20two-fold%20increased%20risk%20of%20abnormal%20cytology%20after%20adjusting%20for%20presence%20of%20individual%20high-risk%20type%2C%20age%2C%20and%20CD4%2B%20lymphocyte%20count%20%28adjusted%20prevalence%20ratios%201.88-2.07%2C%20all%20p%20%3C0.001%29.%20No%20single%20high-risk%20HPV%20type%20was%20statistically%20associated%20with%20abnormal%20cytology%20after%20adjusting%20for%20the%20presence%20of%20more%20than%20one%20high-risk%20HPV%20type.%5CnCONCLUSIONS%3A%20In%20the%20largest%20study%20of%20cervical%20HPV%20genotypes%20among%20HIV-infected%20women%20in%20Latin%20America%2C%20infection%20by%20high-risk%20HPV%20types%20other%20than%2016%20or%2018%20and%20infection%20by%20more%20than%20one%20high-risk%20HPV%20types%20were%20common.%20Infection%20by%20more%20than%20one%20high-risk%20type%20was%20more%20strongly%20associated%20with%20abnormal%20cervical%20cytology%20than%20any%20individual%20high-risk%20HPV%20type%2C%20highlighting%20the%20need%20for%20multi-valent%20HPV%20vaccines.%22%2C%22date%22%3A%222015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12885-015-1486-4%22%2C%22ISSN%22%3A%221471-2407%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A00%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22744NAX59%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Marcelin%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMarcelin%20A%2C%20Perodin%20C%2C%20Baja%20C%2C%20Bright%20A%2C%20Duperval%20J%2C%20Duplan%20M%2C%20et%20al.%20Developing%20an%20Electronic%20Medical%20Record%20for%20Interlinked%20Care%20Services%20in%20Haiti.%20Stud%20Health%20Technol%20Inform.%202015%3B216%3A883.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D744NAX59%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Developing%20an%20Electronic%20Medical%20Record%20for%20Interlinked%20Care%20Services%20in%20Haiti%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Marcelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Perodin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Baja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Duperval%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Duplan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22D%5Cu00e9rilus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Pape%22%7D%5D%2C%22abstractNote%22%3A%22A%20large%20clinical%20care%20and%20research%20organization%20in%20Haiti%20required%20an%20electronic%20medical%20record%20system%20%28EMR%29%20to%20serve%20the%20needs%20of%20its%2030%20interlinked%20clinical%20programs.%20After%20assessing%20available%20open%20source%20software%2C%20the%20local%20team%20designed%20and%20implemented%20a%20modular%20proprietary%20EMR%20that%20is%20improving%20data%20quality%20and%20patient%20care.%20Despite%20the%20many%20benefits%20of%20existing%20open%20source%20medical%20record%20systems%2C%20clinical%20centers%20with%20complex%20workflow%20patterns--even%20those%20in%20resource-limited%20settings--should%20consider%20developing%20sustainable%2C%20local%20systems%20that%20fit%20their%20care%20model.%22%2C%22date%22%3A%222015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220926-9630%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A01%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22I8KSM8FT%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20SN%2C%20McGowan%20CC%2C%20Gadd%20CS.%20Perceived%20Reasons%20for%20High%20and%20Low%20Quality%20Observational%20HIV%20Research%20Data.%20Stud%20Health%20Technol%20Inform.%202015%3B216%3A994.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DI8KSM8FT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Perceived%20Reasons%20for%20High%20and%20Low%20Quality%20Observational%20HIV%20Research%20Data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20S.%22%2C%22lastName%22%3A%22Gadd%22%7D%5D%2C%22abstractNote%22%3A%22Audits%20of%20data%20quality%20in%20a%20Latin%20America%20HIV%20research%20network%20revealed%20that%20study%20sites%20collected%20weight%20measurements%2C%20laboratory%20results%2C%20and%20medication%20data%20of%20inconsistent%20quality.%20We%20surveyed%20site%20personnel%20about%20perceived%20drivers%20of%20their%20high%20or%20low%20quality%20data.%20Most%20sites%20reported%20their%20research%20teams%20contained%20no%20data%20specialists%20and%20that%20missing%20data%20stemmed%20primarily%20from%20incomplete%20patient%20assessments%20at%20the%20point%20of%20care%20rather%20than%20inconsistent%20data%20recording.%20The%20root%20causes%20of%20data%20errors%20resulted%20from%20limited%20clinic%20resources%20%28e.g.%2C%20broken%20scales%2C%20limited%20record%20storage%20space%29%2C%20workflow%20complications%2C%20or%20the%20indifference%20of%20external%20participants%20towards%20research%20activities.%20Understanding%20these%20factors%20supports%20targeted%20quality%20improvement%20processes.%22%2C%22date%22%3A%222015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220926-9630%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A01%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22FH3FBAWR%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carriquiry%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECarriquiry%20G%2C%20Fink%20V%2C%20Koethe%20JR%2C%20Giganti%20MJ%2C%20Jayathilake%20K%2C%20Blevins%20M%2C%20et%20al.%20Mortality%20and%20loss%20to%20follow-up%20among%20HIV-infected%20persons%20on%20long-term%20antiretroviral%20therapy%20in%20Latin%20America%20and%20the%20Caribbean.%20J%20Int%20AIDS%20Soc.%202015%3B18%281%29%3A20016.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DFH3FBAWR%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20and%20loss%20to%20follow-up%20among%20HIV-infected%20persons%20on%20long-term%20antiretroviral%20therapy%20in%20Latin%20America%20and%20the%20Caribbean%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20Robert%22%2C%22lastName%22%3A%22Koethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20Joseph%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karu%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meridith%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20William%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20Carey%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20Earl%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Long-term%20survival%20of%20HIV%20patients%20after%20initiating%20highly%20active%20antiretroviral%20therapy%20%28ART%29%20has%20not%20been%20sufficiently%20described%20in%20Latin%20America%20and%20the%20Caribbean%2C%20as%20compared%20to%20other%20regions.%20The%20aim%20of%20this%20study%20was%20to%20describe%20the%20incidence%20of%20mortality%2C%20loss%20to%20follow-up%20%28LTFU%29%20and%20associated%20risk%20factors%20for%20patients%20enrolled%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20Network%20%28CCASAnet%29.%5CnMETHODS%3A%20We%20assessed%20time%20from%20ART%20initiation%20%28baseline%29%20to%20death%20or%20LTFU%20between%202000%20and%202014%20among%20ART-na%5Cu00efve%20adults%20%28%5Cu226518%20years%29%20from%20sites%20in%20seven%20countries%20included%20in%20CCASAnet%3A%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%20and%20Peru.%20Kaplan-Meier%20techniques%20were%20used%20to%20estimate%20the%20probability%20of%20mortality%20over%20time.%20Risk%20factors%20for%20death%20were%20assessed%20using%20Cox%20regression%20models%20stratified%20by%20site%20and%20adjusted%20for%20sex%2C%20baseline%20age%2C%20nadir%20pre-ART%20CD4%20count%2C%20calendar%20year%20of%20ART%20initiation%2C%20clinical%20AIDS%20at%20baseline%20and%20type%20of%20ART%20regimen.%5CnRESULTS%3A%20A%20total%20of%2016%2C996%20ART%20initiators%20were%20followed%20for%20a%20median%20of%203.5%20years%20%28interquartile%20range%20%28IQR%29%3A%201.6-6.2%29.%20The%20median%20age%20at%20ART%20initiation%20was%2036%20years%20%28IQR%3A%2030-44%29%2C%20subjects%20were%20predominantly%20male%20%2863%25%29%2C%20median%20CD4%20count%20was%20156%20cells%5C%2F%5Cu00b5L%20%28IQR%3A%2060-251%29%20and%2026%25%20of%20subjects%20had%20clinical%20AIDS%20prior%20to%20starting%20ART.%20Initial%20ART%20regimens%20were%20predominantly%20non-nucleoside%20reverse%20transcriptase%20inhibitor%20based%20%2886%25%29.%20The%20cumulative%20incidence%20of%20LTFU%20five%20years%20after%20ART%20initiation%20was%2018.2%25%20%2895%25%20confidence%20interval%20%28CI%29%2017.5-18.8%25%29.%20A%20total%20of%201582%20%289.3%25%29%20subjects%20died%3B%20the%20estimated%20probability%20of%20death%20one%2C%20three%20and%20five%20years%20after%20ART%20initiation%20was%205.4%2C%208.3%20and%2010.3%25%2C%20respectively.%20The%20estimated%20five-year%20mortality%20probability%20varied%20substantially%20across%20sites%2C%20from%203.5%20to%2014.0%25.%20Risk%20factors%20for%20death%20were%20clinical%20AIDS%20at%20baseline%20%28adjusted%20hazard%20ratio%20%28HR%29%3D1.65%20%2895%25%20CI%201.47-1.87%29%3B%20p%3C0.001%29%2C%20lower%20baseline%20CD4%20%28HR%3D1.95%20%2895%25%20CI%201.63-2.32%29%20for%2050%20vs.%20350%20cells%5C%2F%5Cu00b5L%3B%20p%3C0.001%29%20and%20older%20age%20%28HR%3D1.47%20%2895%25%20CI%201.29-1.69%29%20for%2050%20vs.%2030%20years%20at%20ART%20initiation%3B%20p%3C0.001%29.%5CnCONCLUSIONS%3A%20In%20this%20large%2C%20long-term%20study%20of%20mortality%20among%20HIV-positive%20adults%20initiating%20ART%20in%20Latin%20America%20and%20the%20Caribbean%2C%20overall%20estimates%20of%20mortality%20were%20heterogeneous%2C%20generally%20falling%20between%20those%20reported%20in%20high-income%20countries%20and%20sub-Saharan%20Africa.%22%2C%22date%22%3A%222015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-18T20%3A00%3A09Z%22%7D%7D%2C%7B%22key%22%3A%227SM4IWB2%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabtree-Ramirez%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree-Ramirez%20B%2C%20Neried%20Caro%20Vega%20Y%2C%20Shepherd%20B%2C%20Turner%20M%2C%20Carriquiry%20G%2C%20Fink%20V%2C%20et%20al.%20Temporal%20trends%20in%20age%20at%20HIV%20diagnosis%20in%20cohorts%20in%20the%20United%20States%2C%20the%20Caribbean%2C%20and%20Central%20and%20South%20America.%20AIDS%20Behav%20%5BInternet%5D.%202015%20%5Bcited%202015%20Mar%2014%5D%3B19%289%29%3A1599%26%23x2013%3B608.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25613592%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25613592%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7SM4IWB2%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20trends%20in%20age%20at%20HIV%20diagnosis%20in%20cohorts%20in%20the%20United%20States%2C%20the%20Caribbean%2C%20and%20Central%20and%20South%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y%22%2C%22lastName%22%3A%22Neried%20Caro%20Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CP%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AK%22%2C%22lastName%22%3A%22Person%22%7D%5D%2C%22abstractNote%22%3A%22In%20the%20United%20States%20%28USA%29%2C%20the%20age%20of%20those%20newly%20diagnosed%20with%20HIV%20is%20changing%2C%20particularly%20among%20men%20who%20have%20sex%20with%20men%20%28MSM%29.%20A%20retrospective%20analysis%20included%20HIV-infected%20adults%20from%20seven%20sites%20in%20the%20Caribbean%2C%20Central%20and%20South%20America%20network%20%28CCASAnet%29%20and%20the%20Vanderbilt%20Comprehensive%20Care%20Clinic%20%28VCCC-Nashville%2C%20Tennessee%2C%20USA%29.%20We%20estimated%20the%20proportion%20of%20patients%20%3C25%20years%20at%20HIV%20diagnosis%20by%20calendar%20year%20among%20the%20general%20population%20and%20MSM.%2019%2C466%20%28CCASAnet%29%20and%203%2C746%20%28VCCC%29%20patients%20were%20included.%20The%20proportion%20%3C25%20years%20at%20diagnosis%20in%20VCCC%20increased%20over%20time%20for%20both%20the%20general%20population%20and%20MSM%20%28p%20%3C%200.001%29.%20Only%20in%20the%20Chilean%20site%20for%20the%20general%20population%20and%20the%20Brazilian%20site%20for%20MSM%20were%20similar%20trends%20seen.%20Subjects%20%3C25%20years%20of%20age%20at%20diagnosis%20were%20less%20likely%20to%20be%20immunocompromised%20at%20enrollment%20at%20both%20the%20VCCC%20and%20CCASAnet.%20Recent%20trends%20in%20the%20USA%20of%20greater%20numbers%20of%20newly%20diagnosed%20young%20patients%20were%20not%20consistently%20observed%20in%20Latin%20America%20and%20the%20Caribbean.%20Prevention%20efforts%20tailored%20to%20young%20adults%20should%20be%20increased.%22%2C%22date%22%3A%222015%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10461-014-0974-x%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25613592%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-14T22%3A01%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22PKMRJ2TE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Giganti%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGiganti%20M%2C%20Luz%20P%2C%20Caro-Vega%20Y%2C%20Cesar%20C%2C%20Padgett%20D%2C%20Koenig%20S%2C%20et%20al.%20A%20comparison%20of%20seven%20Cox%20regression-based%20models%20to%20account%20for%20heterogeneity%20across%20multiple%20HIV%20treatment%20cohorts%20in%20Latin%20America%20and%20the%20Caribbean.%20AIDS%20Res%20Hum%20Retroviruses%20%5BInternet%5D.%202015%3B31%285%29%3A496%26%23x2013%3B503.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25647087%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25647087%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPKMRJ2TE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20comparison%20of%20seven%20Cox%20regression-based%20models%20to%20account%20for%20heterogeneity%20across%20multiple%20HIV%20treatment%20cohorts%20in%20Latin%20America%20and%20the%20Caribbean%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MJ%22%2C%22lastName%22%3A%22Giganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22PM%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Koenig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Echevarria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22BE%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22Many%20studies%20of%20HIV%5C%2FAIDS%20aggregate%20data%20from%20multiple%20cohorts%20to%20improve%20power%20and%20generalizability.%20There%20are%20several%20analysis%20approaches%20to%20account%20for%20cross-cohort%20heterogeneity%3B%20we%20assessed%20how%20different%20approaches%20can%20impact%20results%20from%20an%20HIV%5C%2FAIDS%20study%20investigating%20predictors%20of%20mortality.%20Using%20data%20from%2013%2C658%20HIV-infected%20patients%20starting%20antiretroviral%20therapy%20from%20seven%20Latin%20American%20and%20Caribbean%20cohorts%2C%20we%20illustrate%20the%20assumptions%20of%20seven%20readily%20implementable%20approaches%20to%20account%20for%20across%20cohort%20heterogeneity%20with%20Cox%20proportional%20hazards%20models%2C%20and%20we%20compare%20hazard%20ratio%20estimates%20across%20approaches.%20As%20a%20sensitivity%20analysis%2C%20we%20modify%20cohort%20membership%20to%20generate%20specific%20heterogeneity%20conditions.%20Hazard%20ratio%20estimates%20varied%20slightly%20between%20the%20seven%20analysis%20approaches%2C%20but%20differences%20were%20not%20clinically%20meaningful.%20Adjusted%20hazard%20ratio%20estimates%20for%20the%20association%20between%20AIDS%20at%20treatment%20initiation%20and%20death%20varied%20from%202.00%20to%202.20%20across%20approaches%20that%20accounted%20for%20heterogeneity%3B%20the%20adjusted%20hazard%20ratio%20was%20estimated%20as%201.73%20in%20analyses%20that%20ignored%20across%20cohort%20heterogeneity.%20In%20sensitivity%20analyses%20with%20more%20extreme%20heterogeneity%2C%20we%20noted%20a%20slightly%20greater%20distinction%20between%20approaches.%20Despite%20substantial%20heterogeneity%20between%20cohorts%2C%20the%20impact%20of%20the%20specific%20approach%20to%20account%20for%20heterogeneity%20was%20minimal%20in%20our%20case%20study.%20Our%20results%20suggest%20that%20it%20is%20important%20to%20account%20for%20across%20cohort%20heterogeneity%20in%20analyses%2C%20but%20that%20the%20specific%20technique%20for%20addressing%20heterogeneity%20may%20be%20less%20important.%20Because%20of%20their%20flexibility%20in%20accounting%20for%20cohort%20heterogeneity%2C%20we%20prefer%20stratification%20or%20meta-analysis%20methods%2C%20but%20we%20encourage%20investigators%20to%20consider%20their%20specific%20study%20conditions%20and%20objectives.%22%2C%22date%22%3A%222015%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1089%5C%2FAID.2014.0241%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F25647087%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222016-03-14T21%3A56%3A41Z%22%7D%7D%5D%7D
1.
Cesar C, Jenkins CA, Shepherd BE, Padgett D, Mejía F, Ribeiro SR, et al. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study. Lancet HIV. 2015 Nov;2(11):e492-500. Cite
1.
Hamilton CD, Swaminathan S, Christopher DJ, Ellner J, Gupta A, Sterling TR, et al. RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. Clin Infect Dis. 2015 Oct 15;61Suppl 3:S155-159. Cite
1.
Belaunzaran-Zamudio P, Caro-Vega Y, Shepherd B, Crabtree-Ramirez B, Luz P, Grinsztejn B, et al. Monitoring of HIV treatment in seven countries in WHO Region of the Americas. Bull World Health Organ [Internet]. 2015 Aug 1;93(8):529–39. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581655/ Cite
1.
Luz P, Belaunzaran-Zamudio P, Crabtree-Ramirez B, Caro-Vega Y, Hoces D, Rebeiro P, et al. CD4 response up to 5 years following combination antiretroviral therapy in HIV-infected patients in Latin America and the Caribbean. Open Forum Infect Dis [Internet]. 2015 Jun 5 [cited 2015 Mar 15];2(2):ofv079. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498272/ Cite
1.
Ballif M, Renner L, Claude Dusingize J, Leroy V, Ayaya S, Wools-Kaloustian K, et al. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc. 2015 Mar;4(1):30–8. Cite
1.
Castilho J, Luz P, Shepherd B, Turner M, Ribeiro S, Bebawy S, et al. HIV and Cancer: A comparative retrospective study of Brazilian and U.S. clinical cohorts. Infect Agent Cancer [Internet]. 2015 Feb 2;(10):4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25685180 Cite
1.
Castilho JL, Levi JE, Luz PM, Cambou MC, Vanni T, de Andrade A, et al. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer. 2015;15:478. Cite
1.
Marcelin A, Perodin C, Baja C, Bright A, Duperval J, Duplan M, et al. Developing an Electronic Medical Record for Interlinked Care Services in Haiti. Stud Health Technol Inform. 2015;216:883. Cite
1.
Duda SN, McGowan CC, Gadd CS. Perceived Reasons for High and Low Quality Observational HIV Research Data. Stud Health Technol Inform. 2015;216:994. Cite
1.
Carriquiry G, Fink V, Koethe JR, Giganti MJ, Jayathilake K, Blevins M, et al. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. J Int AIDS Soc. 2015;18(1):20016. Cite
1.
Crabtree-Ramirez B, Neried Caro Vega Y, Shepherd B, Turner M, Carriquiry G, Fink V, et al. Temporal trends in age at HIV diagnosis in cohorts in the United States, the Caribbean, and Central and South America. AIDS Behav [Internet]. 2015 [cited 2015 Mar 14];19(9):1599–608. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25613592 Cite
1.
Giganti M, Luz P, Caro-Vega Y, Cesar C, Padgett D, Koenig S, et al. A comparison of seven Cox regression-based models to account for heterogeneity across multiple HIV treatment cohorts in Latin America and the Caribbean. AIDS Res Hum Retroviruses [Internet]. 2015;31(5):496–503. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25647087 Cite
2014
76770
IP6F4TRX
2014
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-93737c18ab2cb40a8955cf86abef5d63%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22E2WNKHWD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222014-12-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20SN%2C%20Farr%20AM%2C%20Lindegren%20ML%2C%20Blevins%20M%2C%20Wester%20CW%2C%20Wools-Kaloustian%20K%2C%20et%20al.%20Characteristics%20and%20comprehensiveness%20of%20adult%20HIV%20care%20and%20treatment%20programmes%20in%20Asia-Pacific%2C%20sub-Saharan%20Africa%20and%20the%20Americas%3A%20results%20of%20a%20site%20assessment%20conducted%20by%20the%20International%20epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Collaboration.%20J%20Int%20AIDS%20Soc%20%5BInternet%5D.%202014%20Dec%2015%20%5Bcited%202014%20Dec%2024%5D%3B17%281%29.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4268491%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4268491%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DE2WNKHWD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characteristics%20and%20comprehensiveness%20of%20adult%20HIV%20care%20and%20treatment%20programmes%20in%20Asia-Pacific%2C%20sub-Saharan%20Africa%20and%20the%20Americas%3A%20results%20of%20a%20site%20assessment%20conducted%20by%20the%20International%20epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Collaboration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20M%22%2C%22lastName%22%3A%22Farr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20Lou%22%2C%22lastName%22%3A%22Lindegren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meridith%22%2C%22lastName%22%3A%22Blevins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%20K%22%2C%22lastName%22%3A%22Ekouevi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Hemingway-Foday%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%5CnHIV%20care%20and%20treatment%20programmes%20worldwide%20are%20transforming%20as%20they%20push%20to%20deliver%20universal%20access%20to%20essential%20prevention%2C%20care%20and%20treatment%20services%20to%20persons%20living%20with%20HIV%20and%20their%20communities.%20The%20characteristics%20and%20capacity%20of%20these%20HIV%20programmes%20affect%20patient%20outcomes%20and%20quality%20of%20care.%20Despite%20the%20importance%20of%20ensuring%20optimal%20outcomes%2C%20few%20studies%20have%20addressed%20the%20capacity%20of%20HIV%20programmes%20to%20deliver%20comprehensive%20care.%20We%20sought%20to%20describe%20such%20capacity%20in%20HIV%20programmes%20in%20seven%20regions%20worldwide.%5Cn%5CnMethods%5CnStaff%20from%20128%20sites%20in%2041%20countries%20participating%20in%20the%20International%20epidemiologic%20Databases%20to%20Evaluate%20AIDS%20completed%20a%20site%20survey%20from%202009%20to%202010%2C%20including%20sites%20in%20the%20Asia-Pacific%20region%20%28n%3D20%29%2C%20Latin%20America%20and%20the%20Caribbean%20%28n%3D7%29%2C%20North%20America%20%28n%3D7%29%2C%20Central%20Africa%20%28n%3D12%29%2C%20East%20Africa%20%28n%3D51%29%2C%20Southern%20Africa%20%28n%3D16%29%20and%20West%20Africa%20%28n%3D15%29.%20We%20computed%20a%20measure%20of%20the%20comprehensiveness%20of%20care%20based%20on%20seven%20World%20Health%20Organization-recommended%20essential%20HIV%20services.%5Cn%5CnResults%5CnMost%20sites%20reported%20serving%20urban%20%2861%25%3B%20region%20range%20%28rr%29%3A%2033%5Cu2013100%25%29%20and%20both%20adult%20and%20paediatric%20populations%20%2877%25%3B%20rr%3A%2029%5Cu201396%25%29.%20Only%2045%25%20of%20HIV%20clinics%20that%20reported%20treating%20children%20had%20paediatricians%20on%20staff.%20As%20for%20the%20seven%20essential%20services%2C%20survey%20respondents%20reported%20that%20CD4%2B%20cell%20count%20testing%20was%20available%20to%20all%20but%20one%20site%2C%20while%20tuberculosis%20%28TB%29%20screening%20and%20community%20outreach%20services%20were%20available%20in%2080%20and%2072%25%2C%20respectively.%20The%20remaining%20four%20essential%20services%20%5Cu2013%20nutritional%20support%20%2882%25%29%2C%20combination%20antiretroviral%20therapy%20adherence%20support%20%2888%25%29%2C%20prevention%20of%20mother-to-child%20transmission%20%28PMTCT%29%20%2894%25%29%20and%20other%20prevention%20and%20clinical%20management%20services%20%2897%25%29%20%5Cu2013%20were%20uniformly%20available.%20Approximately%20half%20%2846%25%29%20of%20sites%20reported%20offering%20all%20seven%20services.%20Newer%20sites%20and%20sites%20in%20settings%20with%20low%20rankings%20on%20the%20UN%20Human%20Development%20Index%20%28HDI%29%2C%20especially%20those%20in%20the%20President%27s%20Emergency%20Plan%20for%20AIDS%20Relief%20focus%20countries%2C%20tended%20to%20offer%20a%20more%20comprehensive%20array%20of%20essential%20services.%20HIV%20care%20programme%20characteristics%20and%20comprehensiveness%20varied%20according%20to%20the%20number%20of%20years%20the%20site%20had%20been%20in%20operation%20and%20the%20HDI%20of%20the%20site%20setting%2C%20with%20more%20recently%20established%20clinics%20in%20low-HDI%20settings%20reporting%20a%20more%20comprehensive%20array%20of%20available%20services.%20Survey%20respondents%20frequently%20identified%20contact%20tracing%20of%20patients%2C%20patient%20outreach%2C%20nutritional%20counselling%2C%20onsite%20viral%20load%20testing%2C%20universal%20TB%20screening%20and%20the%20provision%20of%20isoniazid%20preventive%20therapy%20as%20unavailable%20services.%5Cn%5CnConclusions%5CnThis%20study%20serves%20as%20a%20baseline%20for%20on-going%20monitoring%20of%20the%20evolution%20of%20care%20delivery%20over%20time%20and%20lays%20the%20groundwork%20for%20evaluating%20HIV%20treatment%20outcomes%20in%20relation%20to%20site%20capacity%20for%20comprehensive%20care.%22%2C%22date%22%3A%222014-12-15%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.7448%5C%2FIAS.17.1.19045%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4268491%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222014-12-24T00%3A43%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22IH8JU49V%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ballif%20et%20al.%22%2C%22parsedDate%22%3A%222014-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBallif%20M%2C%20Nhandu%20V%2C%20Wood%20R%2C%20Dusingize%20JC%2C%20Carter%20EJ%2C%20Cortes%20CP%2C%20et%20al.%20Detection%20and%20management%20of%20drug-resistant%20tuberculosis%20in%20HIV-infected%20patients%20in%20lower-income%20countries.%20Int%20J%20Tuberc%20Lung%20Dis.%202014%20Nov%3B18%2811%29%3A1327%26%23x2013%3B36.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIH8JU49V%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Detection%20and%20management%20of%20drug-resistant%20tuberculosis%20in%20HIV-infected%20patients%20in%20lower-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Nhandu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20C.%22%2C%22lastName%22%3A%22Dusingize%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20J.%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Graber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Renner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Hawerlander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Q.%20T.%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiological%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22SETTING%3A%20Drug%20resistance%20threatens%20tuberculosis%20%28TB%29%20control%2C%20particularly%20among%20human%20immunodeficiency%20virus%20%28HIV%29%20infected%20persons.%5CnOBJECTIVE%3A%20To%20describe%20practices%20in%20the%20prevention%20and%20management%20of%20drug-resistant%20TB%20under%20antiretroviral%20therapy%20%28ART%29%20programs%20in%20lower-income%20countries.%5CnDESIGN%3A%20We%20used%20online%20questionnaires%20to%20collect%20program-level%20data%20on%2047%20ART%20programs%20in%20Southern%20Africa%20%28n%20%3D%2014%29%2C%20East%20Africa%20%28n%20%3D%208%29%2C%20West%20Africa%20%28n%20%3D%207%29%2C%20Central%20Africa%20%28n%20%3D%205%29%2C%20Latin%20America%20%28n%20%3D%207%29%20and%20the%20Asia-Pacific%20%28n%20%3D%206%20programs%29%20in%202012.%20Patient-level%20data%20were%20collected%20on%201002%20adult%20TB%20patients%20seen%20at%2040%20of%20the%20participating%20ART%20programs.%5CnRESULTS%3A%20Phenotypic%20drug%20susceptibility%20testing%20%28DST%29%20was%20available%20in%2036%20%2877%25%29%20ART%20programs%2C%20but%20was%20only%20used%20for%2022%25%20of%20all%20TB%20patients.%20Molecular%20DST%20was%20available%20in%2033%20%2870%25%29%20programs%20and%20was%20used%20in%2023%25%20of%20all%20TB%20patients.%20Twenty%20ART%20programs%20%2843%25%29%20provided%20directly%20observed%20therapy%20%28DOT%29%20during%20the%20entire%20course%20of%20treatment%2C%2016%20%2834%25%29%20during%20the%20intensive%20phase%20only%2C%20and%2011%20%2823%25%29%20did%20not%20follow%20DOT.%20Fourteen%20%2830%25%29%20ART%20programs%20reported%20no%20access%20to%20second-line%20anti-tuberculosis%20regimens%3B%2018%20%2838%25%29%20reported%20TB%20drug%20shortages.%5CnCONCLUSIONS%3A%20Capacity%20to%20diagnose%20and%20treat%20drug-resistant%20TB%20was%20limited%20across%20ART%20programs%20in%20lower-income%20countries.%20DOT%20was%20not%20always%20implemented%20and%20drug%20supplies%20were%20regularly%20interrupted%2C%20which%20may%20contribute%20to%20the%20global%20emergence%20of%20drug%20resistance.%22%2C%22date%22%3A%22Nov%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.14.0106%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222014-11-10T23%3A00%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22WJ3SIVXN%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cesar%20et%20al.%22%2C%22parsedDate%22%3A%222014-09-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECesar%20C%2C%20Shepherd%20BE%2C%20Jenkins%20CA%2C%20Ghidinelli%20M%2C%20Castro%20JL%2C%20Veloso%20VG%2C%20et%20al.%20Use%20of%20Third%20Line%20Antiretroviral%20Therapy%20in%20Latin%20America.%20PLoS%20One%20%5BInternet%5D.%202014%20Sep%2015%20%5Bcited%202014%20Oct%206%5D%3B9%289%29.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4164470%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4164470%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DWJ3SIVXN%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Use%20of%20Third%20Line%20Antiretroviral%20Therapy%20in%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Massimo%22%2C%22lastName%22%3A%22Ghidinelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20Luis%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valdilea%20Goncalves%22%2C%22lastName%22%3A%22Veloso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adriana%22%2C%22lastName%22%3A%22Duran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnAccess%20to%20highly%20active%20antiretroviral%20therapy%20%28HAART%29%20is%20expanding%20in%20Latin%20America.%20Many%20patients%20require%20second%20and%20third%20line%20therapy%20due%20to%20toxicity%2C%20tolerability%2C%20failure%2C%20or%20a%20combination%20of%20factors.%20The%20need%20for%20third%20line%20HAART%2C%20essential%20for%20program%20planning%2C%20is%20not%20known.%5Cn%5CnMethods%5CnAntiretroviral-na%5Cu00efve%20patients%20%5Cu226518%20years%20who%20started%20first%20HAART%20after%20January%201%2C%202000%20in%20Caribbean%2C%20Central%20and%20South%20America%20Network%20%28CCASAnet%29%20sites%20in%20Argentina%2C%20Brazil%2C%20Honduras%2C%20Mexico%2C%20and%20Peru%20were%20included.%20Clinical%20trials%20participants%20were%20excluded.%20Third%20line%20HAART%20was%20defined%20as%20use%20of%20darunavir%2C%20tipranavir%2C%20etravirine%2C%20enfuvirtide%2C%20maraviroc%20or%20raltegravir.%20Need%20for%20third%20line%20HAART%20was%20defined%20as%20virologic%20failure%20while%20on%20second%20line%20HAART.%5Cn%5CnResults%5CnOf%205853%20HAART%20initiators%20followed%20for%20a%20median%20of%203.5%20years%2C%20310%20%285.3%25%29%20failed%20a%20second%20line%20regimen%20and%2044%20%280.8%25%29%20received%20a%20third%20line%20regimen.%20Cumulative%20incidence%20of%20failing%20a%202nd%20or%20starting%20a%203rd%20line%20regimen%20was%202.7%25%20and%206.0%25%20three%20and%20five%20years%20after%20HAART%20initiation%2C%20respectively.%20Predictors%20at%20HAART%20initiation%20for%20failing%20a%20second%20or%20starting%20a%20third%20line%20included%20female%20sex%20%28hazard%20ratio%20%5BHR%5D%5Cu200a%3D%5Cu200a1.54%2C%2095%25%20confidence%20interval%20%5BCI%5D%201.18%5Cu20132.00%2C%20p%5Cu200a%3D%5Cu200a0.001%29%2C%20younger%20age%20%28HR%5Cu200a%3D%5Cu200a2.76%20for%2020%20vs.%2040%20years%2C%2095%25%20CI%201.86%5Cu20134.10%2C%20p%3C0.001%29%2C%20and%20prior%20AIDS%20%28HR%5Cu200a%3D%5Cu200a2.17%2C%2095%25%20CI%201.62%5Cu20132.90%2C%20p%3C0.001%29.%5Cn%5CnConclusions%5CnThird%20line%20regimens%20may%20be%20needed%20for%20at%20least%206%25%20of%20patients%20in%20Latin%20America%20within%205%20years%20of%20starting%20HAART%2C%20a%20substantial%20proportion%20given%20the%20large%20numbers%20of%20patients%20on%20HAART%20in%20the%20region.%20Improved%20accessibility%20to%20third%20line%20regimens%20is%20warranted.%22%2C%22date%22%3A%222014-9-15%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0106887%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC4164470%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222014-10-06T16%3A59%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22KQ7NDBAI%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22IeDEA%20and%20ART%20Cohort%20Collaborations%20et%20al.%22%2C%22parsedDate%22%3A%222014-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EIeDEA%20and%20ART%20Cohort%20Collaborations%2C%20Avila%20D%2C%20Althoff%20KN%2C%20Mugglin%20C%2C%20Wools-Kaloustian%20K%2C%20Koller%20M%2C%20et%20al.%20Immunodeficiency%20at%20the%20start%20of%20combination%20antiretroviral%20therapy%20in%20low-%2C%20middle-%2C%20and%20high-income%20countries.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202014%20Jan%201%3B65%281%29%3Ae8-16.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F24419071%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F24419071%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DKQ7NDBAI%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immunodeficiency%20at%20the%20start%20of%20combination%20antiretroviral%20therapy%20in%20low-%2C%20middle-%2C%20and%20high-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20and%20ART%20Cohort%20Collaborations%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dorita%22%2C%22lastName%22%3A%22Avila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catrina%22%2C%22lastName%22%3A%22Mugglin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuel%22%2C%22lastName%22%3A%22Koller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Dabis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Gsponer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Somnuek%22%2C%22lastName%22%3A%22Sungkanuparph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22May%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ann%22%2C%22lastName%22%3A%22Collier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hamish%22%2C%22lastName%22%3A%22McManus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Costagliola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romanee%22%2C%22lastName%22%3A%22Chaiwarith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Cescon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morna%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praphan%22%2C%22lastName%22%3A%22Phanuphak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%22%2C%22lastName%22%3A%22Sawadogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jochen%22%2C%22lastName%22%3A%22Ehmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serge%20P%22%2C%22lastName%22%3A%22Eholie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20C%20K%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neel%20R%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elsa%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20K%20C%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J%22%2C%22lastName%22%3A%22Hoffmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Kambugu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivia%22%2C%22lastName%22%3A%22Keiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rossana%22%2C%22lastName%22%3A%22Ditangco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%22%2C%22lastName%22%3A%22Lampe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nagalingeswaran%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mari%22%2C%22lastName%22%3A%22Kitahata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Lugina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saphonn%22%2C%22lastName%22%3A%22Vonthanak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonella%22%2C%22lastName%22%3A%22d%27Arminio%20Monforte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20Mendes%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi-Ming%20A%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jordi%22%2C%22lastName%22%3A%22Casabona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Mwango%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%20Y%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Louise%22%2C%22lastName%22%3A%22Newell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A%22%2C%22lastName%22%3A%22Bukusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kapella%22%2C%22lastName%22%3A%22Ngonyani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuti%20P%22%2C%22lastName%22%3A%22Merati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliana%22%2C%22lastName%22%3A%22Otieno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mwebesa%20B%22%2C%22lastName%22%3A%22Bosco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sam%22%2C%22lastName%22%3A%22Phiri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oon%20T%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00fcrgen%22%2C%22lastName%22%3A%22Rockstroh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ignacio%22%2C%22lastName%22%3A%22Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shinichi%22%2C%22lastName%22%3A%22Oka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Somi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Stephan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramon%22%2C%22lastName%22%3A%22Teira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deo%22%2C%22lastName%22%3A%22Wabwire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Reiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20H%22%2C%22lastName%22%3A%22Chi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20A%22%2C%22lastName%22%3A%22Sterne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20describe%20the%20CD4%20cell%20count%20at%20the%20start%20of%20combination%20antiretroviral%20therapy%20%28cART%29%20in%20low-income%20%28LIC%29%2C%20lower%20middle-income%20%28LMIC%29%2C%20upper%20middle-income%20%28UMIC%29%2C%20and%20high-income%20%28HIC%29%20countries.%5CnMETHODS%3A%20Patients%20aged%2016%20years%20or%20older%20starting%20cART%20in%20a%20clinic%20participating%20in%20a%20multicohort%20collaboration%20spanning%206%20continents%20%28International%20epidemiological%20Databases%20to%20Evaluate%20AIDS%20and%20ART%20Cohort%20Collaboration%29%20were%20eligible.%20Multilevel%20linear%20regression%20models%20were%20adjusted%20for%20age%2C%20gender%2C%20and%20calendar%20year%3B%20missing%20CD4%20counts%20were%20imputed.%5CnRESULTS%3A%20In%20total%2C%20379%2C865%20patients%20from%209%20LIC%2C%204%20LMIC%2C%204%20UMIC%2C%20and%206%20HIC%20were%20included.%20In%20LIC%2C%20the%20median%20CD4%20cell%20count%20at%20cART%20initiation%20increased%20by%2083%25%20from%2080%20to%20145%20cells%5C%2F%5Cu03bcL%20between%202002%20and%202009.%20Corresponding%20increases%20in%20LMIC%2C%20UMIC%2C%20and%20HIC%20were%20from%2087%20to%20155%20cells%5C%2F%5Cu03bcL%20%2876%25%20increase%29%2C%2088%20to%20135%20cells%5C%2F%5Cu03bcL%20%2853%25%29%2C%20and%20209%20to%20274%20cells%5C%2F%5Cu03bcL%20%2831%25%29.%20In%202009%2C%20compared%20with%20LIC%2C%20median%20counts%20were%2013%20cells%5C%2F%5Cu03bcL%20%5B95%25%20confidence%20interval%20%28CI%29%3A%20-56%20to%20%2B30%5D%20lower%20in%20LMIC%2C%2022%20cells%5C%2F%5Cu03bcL%20%28-62%20to%20%2B18%29%20lower%20in%20UMIC%2C%20and%20112%20cells%5C%2F%5Cu03bcL%20%28%2B75%20to%20%2B149%29%20higher%20in%20HIC.%20They%20were%2023%20cells%5C%2F%5Cu03bcL%20%2895%25%20CI%3A%20%2B18%20to%20%2B28%20cells%5C%2F%5Cu03bcL%29%20higher%20in%20women%20than%20men.%20Median%20counts%20were%2088%20cells%5C%2F%5Cu03bcL%20%2895%25%20CI%3A%20%2B35%20to%20%2B141%20cells%5C%2F%5Cu03bcL%29%20higher%20in%20countries%20with%20an%20estimated%20national%20cART%20coverage%20%3E80%25%2C%20compared%20with%20countries%20with%20%3C40%25%20coverage.%5CnCONCLUSIONS%3A%20Median%20CD4%20cell%20counts%20at%20the%20start%20of%20cART%20increased%202000-2009%20but%20remained%20below%20200%20cells%5C%2F%5Cu03bcL%20in%20LIC%20and%20MIC%20and%20below%20300%20cells%5C%2F%5Cu03bcL%20in%20HIC.%20Earlier%20start%20of%20cART%20will%20require%20substantial%20efforts%20and%20resources%20globally.%22%2C%22date%22%3A%22Jan%201%2C%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0b013e3182a39979%22%2C%22ISSN%22%3A%221944-7884%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F24419071%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222014-08-27T01%3A48%3A25Z%22%7D%7D%5D%7D
1.
Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, et al. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. J Int AIDS Soc [Internet]. 2014 Dec 15 [cited 2014 Dec 24];17(1). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268491/ Cite
1.
Ballif M, Nhandu V, Wood R, Dusingize JC, Carter EJ, Cortes CP, et al. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. Int J Tuberc Lung Dis. 2014 Nov;18(11):1327–36. Cite
1.
Cesar C, Shepherd BE, Jenkins CA, Ghidinelli M, Castro JL, Veloso VG, et al. Use of Third Line Antiretroviral Therapy in Latin America. PLoS One [Internet]. 2014 Sep 15 [cited 2014 Oct 6];9(9). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164470/ Cite
1.
IeDEA and ART Cohort Collaborations, Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr [Internet]. 2014 Jan 1;65(1):e8-16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24419071 Cite
2013
76770
IP6F4TRX
2013
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b5747c267e3858280aaebb752b71e023%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22GQES7PR8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cortes%20et%20al.%22%2C%22parsedDate%22%3A%222013-09-16%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECortes%20CP%2C%20Wehbe%20FH%2C%20McGowan%20CC%2C%20Shepherd%20BE%2C%20Duda%20SN%2C%20Jenkins%20CA%2C%20et%20al.%20Duration%20of%20Anti-Tuberculosis%20Therapy%20and%20Timing%20of%20Antiretroviral%20Therapy%20Initiation%3A%20Association%20with%20Mortality%20in%20HIV-Related%20Tuberculosis.%20PLoS%20ONE%20%5BInternet%5D.%202013%20Sep%2016%20%5Bcited%202013%20Oct%2025%5D%3B8%289%29%3Ae74057.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3774609%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3774609%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DGQES7PR8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Duration%20of%20Anti-Tuberculosis%20Therapy%20and%20Timing%20of%20Antiretroviral%20Therapy%20Initiation%3A%20Association%20with%20Mortality%20in%20HIV-Related%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firas%20H.%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%20A.%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elsa%22%2C%22lastName%22%3A%22Gonzalez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauro%22%2C%22lastName%22%3A%22Schechter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22%20Caribbean%2C%20Central%20American%2C%20South%20American%20Network%20for%20HIV%20Research%20%28CCASAnet%29%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22BackgroundAntiretroviral%20therapy%20%28ART%29%20decreases%20mortality%20risk%20in%20HIV-infected%20tuberculosis%20patients%2C%20but%20the%20effect%20of%20the%20duration%20of%20anti-tuberculosis%20therapy%20and%20timing%20of%20anti-tuberculosis%20therapy%20initiation%20in%20relation%20to%20ART%20initiation%20on%20mortality%2C%20is%20unclear.MethodsWe%20conducted%20a%20retrospective%20observational%20multi-center%20cohort%20study%20among%20HIV-infected%20persons%20concomitantly%20treated%20with%20Rifamycin-based%20anti-tuberculosis%20therapy%20and%20ART%20in%20Latin%20America.%20The%20study%20population%20included%20persons%20for%20whom%206%20months%20of%20anti-tuberculosis%20therapy%20is%20recommended.ResultsOf%20253%20patients%20who%20met%20inclusion%20criteria%2C%20median%20CD4%2B%20lymphocyte%20count%20at%20ART%20initiation%20was%2064%20cells%5C%2Fmm3%2C%20171%20%2868%25%29%20received%20%3E180%20days%20of%20anti-tuberculosis%20therapy%2C%20168%20%2866%25%29%20initiated%20anti-tuberculosis%20therapy%20before%20ART%2C%20and%2043%20%2817%25%29%20died.%20In%20a%20multivariate%20Cox%20proportional%20hazards%20model%20that%20adjusted%20for%20CD4%2B%20lymphocytes%20and%20HIV-1%20RNA%2C%20tuberculosis%20diagnosed%20after%20ART%20initiation%20was%20associated%20with%20an%20increased%20risk%20of%20death%20compared%20to%20tuberculosis%20diagnosis%20before%20ART%20initiation%20%28HR%202.40%3B%2095%25%20CI%201.15%2C%205.02%3B%20P%20%3D%200.02%29.%20In%20a%20separate%20model%20among%20patients%20surviving%20%3E6%20months%20after%20tuberculosis%20diagnosis%2C%20after%20adjusting%20for%20CD4%2B%20lymphocytes%2C%20HIV-1%20RNA%2C%20and%20timing%20of%20ART%20initiation%20relative%20to%20tuberculosis%20diagnosis%2C%20receipt%20of%20%3E6%20months%20of%20anti-tuberculosis%20therapy%20was%20associated%20with%20a%20decreased%20risk%20of%20death%20%28HR%200.23%3B%2095%25%20CI%200.08%2C%200.66%3B%20P%3D0.007%29.ConclusionsThe%20increased%20risk%20of%20death%20among%20persons%20diagnosed%20with%20tuberculosis%20after%20ART%20initiation%20highlights%20the%20importance%20of%20screening%20for%20tuberculosis%20before%20ART%20initiation.%20The%20decreased%20risk%20of%20death%20among%20persons%20receiving%20%3E%206%20months%20of%20anti-tuberculosis%20therapy%20suggests%20that%20current%20anti-tuberculosis%20treatment%20duration%20guidelines%20should%20be%20re-evaluated.%22%2C%22date%22%3A%22September%2016%2C%202013%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0074057%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3774609%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-10-25T05%3A41%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22IXSPPU25%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fenner%20et%20al.%22%2C%22parsedDate%22%3A%222013%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFenner%20L%2C%20Ballif%20M%2C%20Graber%20C%2C%20Nhandu%20V%2C%20Dusingize%20JC%2C%20Cortes%20CP%2C%20et%20al.%20Tuberculosis%20in%20antiretroviral%20treatment%20programs%20in%20lower%20income%20countries%3A%20availability%20and%20use%20of%20diagnostics%20and%20screening.%20PLoS%20ONE%20%5BInternet%5D.%202013%3B8%2810%29%3Ae77697.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3798412%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3798412%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIXSPPU25%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tuberculosis%20in%20antiretroviral%20treatment%20programs%20in%20lower%20income%20countries%3A%20availability%20and%20use%20of%20diagnostics%20and%20screening%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Graber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venerandah%22%2C%22lastName%22%3A%22Nhandu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Claude%22%2C%22lastName%22%3A%22Dusingize%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Garone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eefje%22%2C%22lastName%22%3A%22Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joachim%20Charles%22%2C%22lastName%22%3A%22Gnokoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Ajayi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasisopin%22%2C%22lastName%22%3A%22Kiertiburanakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Lewden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Durier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R%22%2C%22lastName%22%3A%22Sterling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiological%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20In%20resource-constrained%20settings%2C%20tuberculosis%20%28TB%29%20is%20a%20common%20opportunistic%20infection%20and%20cause%20of%20death%20in%20HIV-infected%20persons.%20TB%20may%20be%20present%20at%20the%20start%20of%20antiretroviral%20therapy%20%28ART%29%2C%20but%20it%20is%20often%20under-diagnosed.%20We%20describe%20approaches%20to%20TB%20diagnosis%20and%20screening%20of%20TB%20in%20ART%20programs%20in%20low-%20and%20middle-income%20countries.%5CnMETHODS%20AND%20FINDINGS%3A%20We%20surveyed%20ART%20programs%20treating%20HIV-infected%20adults%20in%20sub-Saharan%20Africa%2C%20Asia%20and%20Latin%20America%20in%202012%20using%20online%20questionnaires%20to%20collect%20program-level%20and%20patient-level%20data.%20Forty-seven%20sites%20from%2026%20countries%20participated.%20Patient-level%20data%20were%20collected%20on%20987%20adult%20TB%20patients%20from%2040%20sites%20%28median%20age%2034.7%20years%3B%2054%25%20female%29.%20Sputum%20smear%20microscopy%20and%20chest%20radiograph%20were%20available%20in%2047%20%28100%25%29%20sites%2C%20TB%20culture%20in%2044%20%2894%25%29%2C%20and%20Xpert%20MTB%5C%2FRIF%20in%2023%20%2849%25%29.%20Xpert%20MTB%5C%2FRIF%20was%20rarely%20available%20in%20Central%20Africa%20and%20South%20America.%20In%20sites%20with%20access%20to%20these%20diagnostics%2C%20microscopy%20was%20used%20in%20745%20%2876%25%29%20patients%20diagnosed%20with%20TB%2C%20culture%20in%20220%20%2824%25%29%2C%20and%20chest%20X-ray%20in%20688%20%2870%25%29%20patients.%20When%20free%20of%20charge%20culture%20was%20done%20in%2027%25%20of%20patients%2C%20compared%20to%2021%25%20when%20there%20was%20a%20fee%20%28p%5Cu200a%3D%5Cu200a0.033%29.%20Corresponding%20percentages%20for%20Xpert%20MTB%5C%2FRIF%20were%2026%25%20and%2015%25%20of%20patients%20%28p%5Cu200a%3D%5Cu200a0.001%29.%20Screening%20practices%20for%20active%20disease%20before%20starting%20ART%20included%20symptom%20screening%20%2846%20sites%2C%2098%25%29%2C%20chest%20X-ray%20%2838%2C%2081%25%29%2C%20sputum%20microscopy%20%2837%2C%2079%25%29%2C%20culture%20%2816%2C%2034%25%29%2C%20and%20Xpert%20MTB%5C%2FRIF%20%285%2C%2011%25%29.%5CnCONCLUSIONS%3A%20Mycobacterial%20culture%20was%20infrequently%20used%20despite%20its%20availability%20at%20most%20sites%2C%20while%20Xpert%20MTB%5C%2FRIF%20was%20not%20generally%20available.%20Use%20of%20available%20diagnostics%20was%20higher%20when%20offered%20free%20of%20charge.%22%2C%22date%22%3A%222013%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0077697%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3798412%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222014-08-27T01%3A47%3A58Z%22%7D%7D%5D%7D
1.
Cortes CP, Wehbe FH, McGowan CC, Shepherd BE, Duda SN, Jenkins CA, et al. Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis. PLoS ONE [Internet]. 2013 Sep 16 [cited 2013 Oct 25];8(9):e74057. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774609/ Cite
1.
Fenner L, Ballif M, Graber C, Nhandu V, Dusingize JC, Cortes CP, et al. Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PLoS ONE [Internet]. 2013;8(10):e77697. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798412/ Cite
2012
76770
IP6F4TRX
2012
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-6ecac9f65748e7332177a9ff83d09f82%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22AITVWWCU%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shepherd%20et%20al.%22%2C%22parsedDate%22%3A%222012-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShepherd%20BE%2C%20Shaw%20PA%2C%20Dodd%20LE.%20Using%20audit%20information%20to%20adjust%20parameter%20estimates%20for%20data%20errors%20in%20clinical%20trials.%20Clin%20Trials%20%5BInternet%5D.%202012%20Dec%20%5Bcited%202013%20Jul%204%5D%3B9%286%29%3A721%26%23x2013%3B9.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3728661%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3728661%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DAITVWWCU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Using%20audit%20information%20to%20adjust%20parameter%20estimates%20for%20data%20errors%20in%20clinical%20trials%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20A%22%2C%22lastName%22%3A%22Shaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lori%20E%22%2C%22lastName%22%3A%22Dodd%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Audits%20are%20often%20performed%20to%20assess%20the%20quality%20of%20clinical%20trial%20data%2C%20but%20beyond%20detecting%20fraud%20or%20sloppiness%2C%20the%20audit%20data%20are%20generally%20ignored.%20In%20an%20earlier%20study%2C%20using%20data%20from%20a%20nonrandomized%20study%2C%20Shepherd%20and%20Yu%20developed%20statistical%20methods%20to%20incorporate%20audit%20results%20into%20study%20estimates%20and%20demonstrated%20that%20audit%20data%20could%20be%20used%20to%20eliminate%20bias.%5CnPURPOSE%3A%20In%20this%20article%2C%20we%20examine%20the%20usefulness%20of%20audit-based%20error-correction%20methods%20in%20clinical%20trial%20settings%20where%20a%20continuous%20outcome%20is%20of%20primary%20interest.%5CnMETHODS%3A%20We%20demonstrate%20the%20bias%20of%20multiple%20linear%20regression%20estimates%20in%20general%20settings%20with%20an%20outcome%20that%20may%20have%20errors%20and%20a%20set%20of%20covariates%20for%20which%20some%20may%20have%20errors%20and%20others%2C%20including%20treatment%20assignment%2C%20are%20recorded%20correctly%20for%20all%20subjects.%20We%20study%20this%20bias%20under%20different%20assumptions%2C%20including%20independence%20between%20treatment%20assignment%2C%20covariates%2C%20and%20data%20errors%20%28conceivable%20in%20a%20double-blinded%20randomized%20trial%29%20and%20independence%20between%20treatment%20assignment%20and%20covariates%20but%20not%20data%20errors%20%28possible%20in%20an%20unblinded%20randomized%20trial%29.%20We%20review%20moment-based%20estimators%20to%20incorporate%20the%20audit%20data%20and%20propose%20new%20multiple%20imputation%20estimators.%20The%20performance%20of%20estimators%20is%20studied%20in%20simulations.%5CnRESULTS%3A%20When%20treatment%20is%20randomized%20and%20unrelated%20to%20data%20errors%2C%20estimates%20of%20the%20treatment%20effect%20using%20the%20original%20error-prone%20data%20%28i.e.%2C%20ignoring%20the%20audit%20results%29%20are%20unbiased.%20In%20this%20setting%2C%20both%20moment%20and%20multiple%20imputation%20estimators%20incorporating%20audit%20data%20are%20more%20variable%20than%20standard%20analyses%20using%20the%20original%20data.%20In%20contrast%2C%20in%20settings%20where%20treatment%20is%20randomized%20but%20correlated%20with%20data%20errors%20and%20in%20settings%20where%20treatment%20is%20not%20randomized%2C%20standard%20treatment-effect%20estimates%20will%20be%20biased.%20And%20in%20all%20settings%2C%20parameter%20estimates%20for%20the%20original%2C%20error-prone%20covariates%20will%20be%20biased.%20The%20treatment%20and%20covariate%20effect%20estimates%20can%20be%20corrected%20by%20incorporating%20audit%20data%20using%20either%20the%20multiple%20imputation%20or%20moment-based%20approaches.%20Bias%2C%20precision%2C%20and%20coverage%20of%20confidence%20intervals%20improve%20as%20the%20audit%20size%20increases.%5CnLIMITATIONS%3A%20The%20extent%20of%20bias%20and%20the%20performance%20of%20methods%20depend%20on%20the%20extent%20and%20nature%20of%20the%20error%20as%20well%20as%20the%20size%20of%20the%20audit.%20This%20study%20only%20considers%20methods%20for%20the%20linear%20model.%20Settings%20much%20different%20than%20those%20considered%20here%20need%20further%20study.%5CnCONCLUSIONS%3A%20In%20randomized%20trials%20with%20continuous%20outcomes%20and%20treatment%20assignment%20independent%20of%20data%20errors%2C%20standard%20analyses%20of%20treatment%20effects%20will%20be%20unbiased%20and%20are%20recommended.%20However%2C%20if%20treatment%20assignment%20is%20correlated%20with%20data%20errors%20or%20other%20covariates%2C%20naive%20analyses%20may%20be%20biased.%20In%20these%20settings%2C%20and%20when%20covariate%20effects%20are%20of%20interest%2C%20approaches%20for%20incorporating%20audit%20results%20should%20be%20considered.%22%2C%22date%22%3A%22Dec%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F1740774512450100%22%2C%22ISSN%22%3A%221740-7753%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3728661%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222015-09-08T06%3A03%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22TGX53Z5F%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yiannoutsos%20et%20al.%22%2C%22parsedDate%22%3A%222012-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYiannoutsos%20CT%2C%20Johnson%20LF%2C%20Boulle%20A%2C%20Musick%20BS%2C%20Gsponer%20T%2C%20Balestre%20E%2C%20et%20al.%20Estimated%20mortality%20of%20adult%20HIV-infected%20patients%20starting%20treatment%20with%20combination%20antiretroviral%20therapy.%20Sex%20Transm%20Infect%20%5BInternet%5D.%202012%20Dec%20%5Bcited%202013%20Jun%2022%5D%3B88%28Suppl_2%29%3Ai33%26%23x2013%3B43.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3512431%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3512431%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DTGX53Z5F%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimated%20mortality%20of%20adult%20HIV-infected%20patients%20starting%20treatment%20with%20combination%20antiretroviral%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20Theodore%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20Francis%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%20Sue%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Gsponer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Balestre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Law%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%5D%2C%22abstractNote%22%3A%22Objective%5CnTo%20provide%20estimates%20of%20mortality%20among%20HIV-infected%20patients%20starting%20combination%20antiretroviral%20therapy.%5Cn%5CnMethods%5CnWe%20report%20on%20the%20death%20rates%20from%20122%5Cu2005925%20adult%20HIV-infected%20patients%20aged%2015%5Cu2005years%20or%20older%20from%20East%2C%20Southern%20and%20West%20Africa%2C%20Asia%20Pacific%20and%20Latin%20America.%20We%20use%20two%20methods%20to%20adjust%20for%20biases%20in%20mortality%20estimation%20resulting%20from%20loss%20from%20follow-up%2C%20based%20on%20double-sampling%20methods%20applied%20to%20patient%20outreach%20%28Kenya%29%20and%20linkage%20with%20vital%20registries%20%28South%20Africa%29%2C%20and%20apply%20these%20to%20mortality%20estimates%20in%20the%20other%20three%20regions.%20Age%2C%20gender%20and%20CD4%20count%20at%20the%20initiation%20of%20therapy%20were%20the%20factors%20considered%20as%20predictors%20of%20mortality%20at%206%2C%2012%2C%2024%20and%20%3E24%5Cu2005months%20after%20the%20start%20of%20treatment.%5Cn%5CnResults%5CnPatient%20mortality%20was%20high%20during%20the%20first%206%5Cu2005months%20after%20therapy%20for%20all%20patient%20subgroups%20and%20exceeded%2040%20per%20100%20patient%20years%20among%20patients%20who%20started%20treatment%20at%20low%20CD4%20count.%20This%20trend%20was%20seen%20regardless%20of%20region%2C%20demographic%20or%20disease-related%20risk%20factor.%20Mortality%20was%20under-reported%20by%20up%20to%20or%20exceeding%20100%25%20when%20comparing%20estimates%20obtained%20from%20passive%20monitoring%20of%20patient%20vital%20status.%5Cn%5CnConclusions%5CnDespite%20advances%20in%20antiretroviral%20treatment%20coverage%20many%20patients%20start%20treatment%20at%20very%20low%20CD4%20counts%20and%20experience%20significant%20mortality%20during%20the%20first%206%5Cu2005months%20after%20treatment%20initiation.%20Active%20patient%20tracing%20and%20linkage%20with%20vital%20registries%20are%20critical%20in%20adjusting%20estimates%20of%20mortality%2C%20particularly%20in%20low-%20and%20middle-income%20settings.%22%2C%22date%22%3A%222012-12%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fsextrans-2012-050658%22%2C%22ISSN%22%3A%221368-4973%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3512431%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-06-22T19%3A00%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22E2WERPM9%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222012-04-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20SN%2C%20Shepherd%20BE%2C%20Gadd%20CS%2C%20Masys%20DR%2C%20McGowan%20CC.%20Measuring%20the%20Quality%20of%20Observational%20Study%20Data%20in%20an%20International%20HIV%20Research%20Network.%20PLOS%20ONE%20%5BInternet%5D.%202012%20Apr%206%20%5Bcited%202013%20Jul%204%5D%3B7%284%29%3Ae33908.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3320898%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3320898%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DE2WERPM9%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Measuring%20the%20Quality%20of%20Observational%20Study%20Data%20in%20an%20International%20HIV%20Research%20Network%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20S.%22%2C%22lastName%22%3A%22Gadd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%5D%2C%22abstractNote%22%3A%22Observational%20studies%20of%20health%20conditions%20and%20outcomes%20often%20combine%20clinical%20care%20data%20from%20many%20sites%20without%20explicitly%20assessing%20the%20accuracy%20and%20completeness%20of%20these%20data.%20In%20order%20to%20improve%20the%20quality%20of%20data%20in%20an%20international%20multi-site%20observational%20cohort%20of%20HIV-infected%20patients%2C%20the%20authors%20conducted%20on-site%2C%20Good%20Clinical%20Practice-based%20audits%20of%20the%20clinical%20care%20datasets%20submitted%20by%20participating%20HIV%20clinics.%20Discrepancies%20between%20data%20submitted%20for%20research%20and%20data%20in%20the%20clinical%20records%20were%20categorized%20using%20the%20audit%20codes%20published%20by%20the%20European%20Organization%20for%20the%20Research%20and%20Treatment%20of%20Cancer.%20Five%20of%20seven%20sites%20had%20error%20rates%20%3E10%25%20in%20key%20study%20variables%2C%20notably%20laboratory%20data%2C%20weight%20measurements%2C%20and%20antiretroviral%20medications.%20All%20sites%20had%20significant%20discrepancies%20in%20medication%20start%20and%20stop%20dates.%20Clinical%20care%20data%2C%20particularly%20antiretroviral%20regimens%20and%20associated%20dates%2C%20are%20prone%20to%20substantial%20error.%20Verifying%20data%20against%20source%20documents%20through%20audits%20will%20improve%20the%20quality%20of%20databases%20and%20research%20and%20can%20be%20a%20technique%20for%20retraining%20staff%20responsible%20for%20clinical%20data%20collection.%20The%20authors%20recommend%20that%20all%20participants%20in%20observational%20cohorts%20use%20data%20audits%20to%20assess%20and%20improve%20the%20quality%20of%20data%20and%20to%20guide%20future%20data%20collection%20and%20abstraction%20efforts%20at%20the%20point%20of%20care.%22%2C%22date%22%3A%22April%2006%2C%202012%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0033908%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3320898%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222015-09-08T06%3A06%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22IISZVAXB%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhou%20et%20al.%22%2C%22parsedDate%22%3A%222012-01-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZhou%20J%2C%20Jaquet%20A%2C%20Bissagnene%20E%2C%20Musick%20B%2C%20Wools-Kaloustian%20K%2C%20Maxwell%20N%2C%20et%20al.%20Short-term%20risk%20of%20anaemia%20following%20initiation%20of%20combination%20antiretroviral%20treatment%20in%20HIV-infected%20patients%20in%20countries%20in%20sub-Saharan%20Africa%2C%20Asia-Pacific%2C%20and%20central%20and%20South%20America.%20J%20Int%20AIDS%20Soc%20%5BInternet%5D.%202012%20Jan%2030%20%5Bcited%202013%20Jul%204%5D%3B15%3A5.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3292983%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3292983%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DIISZVAXB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Short-term%20risk%20of%20anaemia%20following%20initiation%20of%20combination%20antiretroviral%20treatment%20in%20HIV-infected%20patients%20in%20countries%20in%20sub-Saharan%20Africa%2C%20Asia-Pacific%2C%20and%20central%20and%20South%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jialun%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Bissagnene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kara%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firas%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeniffer%22%2C%22lastName%22%3A%22Iriondo-Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%22%2C%22lastName%22%3A%22Hemingway-Foday%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Law%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnThe%20objective%20was%20to%20examine%20the%20short-term%20risk%20and%20predictors%20of%20anaemia%20following%20initiation%20of%20combination%20antiretroviral%20therapy%20%28cART%29%20in%20HIV-infected%20patients%20from%20the%20Western%20Africa%2C%20Eastern%20Africa%2C%20Southern%20Africa%2C%20Central%20Africa%2C%20Asian-Pacific%2C%20and%20Caribbean%20and%20Central%20and%20South%20America%20regions%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20collaboration.%5Cn%5CnMethods%5CnAnaemia%20was%20defined%20as%20haemoglobin%20of%20%3C%2010%20g%5C%2FdL.%20Patients%20were%20included%20if%20they%20started%20cART%20with%20three%20or%20more%20drugs%2C%20had%20prior%20haemoglobin%20of%20%3E%20%3D%2010%20g%5C%2FdL%2C%20and%20had%20one%20or%20more%20follow-up%20haemoglobin%20tests.%20Factors%20associated%20with%20anaemia%20up%20to%2012%20months%20were%20examined%20using%20Cox%20proportional%20hazards%20models%20and%20stratified%20by%20IeDEA%20region.%5Cn%5CnResults%5CnBetween%201998%20and%202008%2C%2019%2C947%20patients%20initiated%20cART%20with%20baseline%20and%20follow-up%20haemoglobin%20tests%20%287358%2C%207289%2C%202853%2C%20471%2C%201550%20and%20426%20in%20the%20Western%20Africa%2C%20Eastern%20Africa%2C%20Southern%20Africa%2C%20Central%20Africa%2C%20Asian-Pacific%2C%20and%20Caribbean%20and%20Central%20and%20South%20America%20regions%2C%20respectively%29.%20At%20initiation%2C%20anaemia%20was%20found%20in%2045%25%20of%20Western%20Africa%20patients%2C%2029%25%20of%20Eastern%20Africa%20patients%2C%2021%25%20of%20Southern%20Africa%20patients%2C%2036%25%20of%20Central%20Africa%20patients%2C%2015%25%20of%20patients%20in%20Asian-Pacific%20and%2014%25%20of%20patients%20in%20Caribbean%20and%20Central%20and%20South%20America.%20Among%20patients%20with%20haemoglobin%20of%20%3E%20%3D%2010%20g%5C%2FdL%20at%20baseline%20%2813%2C445%29%2C%20the%20risks%20of%20anaemia%20were%2018.2%2C%206.6%2C%209.7%2C%2022.9%2C%2011.8%20and%2019.5%20per%20100%20person-years%20in%20the%20Western%20Africa%2C%20Eastern%20Africa%2C%20Southern%20Africa%2C%20Central%20Africa%2C%20Asian%2C%20and%20Caribbean%20and%20Central%20and%20South%20America%20regions%2C%20respectively.%20Factors%20associated%20with%20anaemia%20were%20female%20sex%2C%20low%20baseline%20haemoglobin%20level%2C%20low%20baseline%20CD4%20count%2C%20more%20advanced%20disease%20stage%2C%20and%20initial%20cART%20containing%20zidovudine.%5Cn%5CnConclusions%5CnIn%20data%20from%2034%20cohorts%20of%20HIV-infected%20patients%20from%20sub-Saharan%20Africa%2C%20Central%20and%20South%20America%2C%20and%20Asia%2C%20the%20risk%20of%20anaemia%20within%2012%20months%20of%20initiating%20cART%20was%20moderate.%20Routine%20haemoglobin%20monitoring%20was%20recommended%20in%20patients%20at%20risk%20of%20developing%20anaemia%20following%20cART%20initiation.%22%2C%22date%22%3A%222012-1-30%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2F1758-2652-15-5%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3292983%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T15%3A00%3A10Z%22%7D%7D%5D%7D
1.
Shepherd BE, Shaw PA, Dodd LE. Using audit information to adjust parameter estimates for data errors in clinical trials. Clin Trials [Internet]. 2012 Dec [cited 2013 Jul 4];9(6):721–9. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728661/ Cite
1.
Yiannoutsos CT, Johnson LF, Boulle A, Musick BS, Gsponer T, Balestre E, et al. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Transm Infect [Internet]. 2012 Dec [cited 2013 Jun 22];88(Suppl_2):i33–43. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512431/ Cite
1.
Duda SN, Shepherd BE, Gadd CS, Masys DR, McGowan CC. Measuring the Quality of Observational Study Data in an International HIV Research Network. PLOS ONE [Internet]. 2012 Apr 6 [cited 2013 Jul 4];7(4):e33908. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320898/ Cite
1.
Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, et al. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. J Int AIDS Soc [Internet]. 2012 Jan 30 [cited 2013 Jul 4];15:5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292983/ Cite
2011
76770
IP6F4TRX
2011
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-11d8c4697a18b537de1f17ee5f6d1856%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22NCRJTKBF%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chi%20et%20al.%22%2C%22parsedDate%22%3A%222011-10-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EChi%20BH%2C%20Yiannoutsos%20CT%2C%20Westfall%20AO%2C%20Newman%20JE%2C%20Zhou%20J%2C%20Cesar%20C%2C%20et%20al.%20Universal%20Definition%20of%20Loss%20to%20Follow-Up%20in%20HIV%20Treatment%20Programs%3A%20A%20Statistical%20Analysis%20of%20111%20Facilities%20in%20Africa%2C%20Asia%2C%20and%20Latin%20America.%20PLoS%20Med%20%5BInternet%5D.%202011%20Oct%2025%20%5Bcited%202013%20Jul%204%5D%3B8%2810%29%3Ae1001111.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3201937%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3201937%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DNCRJTKBF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Universal%20Definition%20of%20Loss%20to%20Follow-Up%20in%20HIV%20Treatment%20Programs%3A%20A%20Statistical%20Analysis%20of%20111%20Facilities%20in%20Africa%2C%20Asia%2C%20and%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20H.%22%2C%22lastName%22%3A%22Chi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constantin%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20O.%22%2C%22lastName%22%3A%22Westfall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%20E.%22%2C%22lastName%22%3A%22Newman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jialun%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20W.%20G.%22%2C%22lastName%22%3A%22Brinkhof%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Mwango%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Balestre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Carriquiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thira%22%2C%22lastName%22%3A%22Sirisanthana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Mukumbi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20N.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Grimsrud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Bacon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodolphe%22%2C%22lastName%22%3A%22Thiebaut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22on%20behalf%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22Based%20on%20a%20statistical%20analysis%20of%20111%20facilities%20in%20Africa%2C%20Asia%2C%20and%20Latin%20America%2C%20Benjamin%20Chi%20and%20colleagues%20develop%20a%20standard%20loss-to-follow-up%20%28LTFU%29%20definition%20that%20can%20be%20used%20by%20HIV%20antiretroviral%20programs%20worldwide.%22%2C%22date%22%3A%22October%2025%2C%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1001111%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3201937%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A49%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22PHBJUN3B%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shepherd%20and%20Yu%22%2C%22parsedDate%22%3A%222011-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShepherd%20BE%2C%20Yu%20C.%20Accounting%20for%20data%20errors%20discovered%20from%20an%20audit%20in%20multiple%20linear%20regression.%20Biometrics%20%5BInternet%5D.%202011%20Sep%20%5Bcited%202013%20Jul%204%5D%3B67%283%29%3A1083%26%23x2013%3B91.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3092800%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3092800%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DPHBJUN3B%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accounting%20for%20data%20errors%20discovered%20from%20an%20audit%20in%20multiple%20linear%20regression%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chang%22%2C%22lastName%22%3A%22Yu%22%7D%5D%2C%22abstractNote%22%3A%22A%20data%20coordinating%20team%20performed%20onsite%20audits%20and%20discovered%20discrepancies%20between%20the%20data%20sent%20to%20the%20coordinating%20center%20and%20that%20recorded%20at%20sites.%20We%20present%20statistical%20methods%20for%20incorporating%20audit%20results%20into%20analyses.%20This%20can%20be%20thought%20of%20as%20a%20measurement%20error%20problem%2C%20where%20the%20distribution%20of%20errors%20is%20a%20mixture%20with%20a%20point%20mass%20at%200.%20If%20the%20error%20rate%20is%20nonzero%2C%20then%20even%20if%20the%20mean%20of%20the%20discrepancy%20between%20the%20reported%20and%20correct%20values%20of%20a%20predictor%20is%200%2C%20naive%20estimates%20of%20the%20association%20between%20two%20continuous%20variables%20will%20be%20biased.%20We%20consider%20scenarios%20where%20there%20are%20%281%29%20errors%20in%20the%20predictor%2C%20%282%29%20errors%20in%20the%20outcome%2C%20and%20%283%29%20possibly%20correlated%20errors%20in%20the%20predictor%20and%20outcome.%20We%20show%20how%20to%20incorporate%20the%20error%20rate%20and%20magnitude%2C%20estimated%20from%20a%20random%20subset%20%28the%20audited%20records%29%2C%20to%20compute%20unbiased%20estimates%20of%20association%20and%20proper%20confidence%20intervals.%20We%20then%20extend%20these%20results%20to%20multiple%20linear%20regression%20where%20multiple%20covariates%20may%20be%20incorrect%20in%20the%20database%20and%20the%20rate%20and%20magnitude%20of%20the%20errors%20may%20depend%20on%20study%20site.%20We%20study%20the%20finite%20sample%20properties%20of%20our%20estimators%20using%20simulations%2C%20discuss%20some%20practical%20considerations%2C%20and%20illustrate%20our%20methods%20with%20data%20from%202815%20HIV-infected%20patients%20in%20Latin%20America%2C%20of%20whom%20234%20had%20their%20data%20audited%20using%20a%20sequential%20auditing%20plan.%22%2C%22date%22%3A%22Sep%202011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1111%252Fj.1541-0420.2010.01543.x%22%2C%22ISSN%22%3A%221541-0420%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3092800%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A47%3A13Z%22%7D%7D%2C%7B%22key%22%3A%223NBPQHZE%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoyo-Ulloa%20et%20al.%22%2C%22parsedDate%22%3A%222011-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHoyo-Ulloa%20I%2C%20Belaunzar%26%23xE1%3Bn-Zamudio%20PF%2C%20Crabtree-Ramirez%20B%2C%20Galindo-Fraga%20A%2C%20P%26%23xE9%3Brez-Aguinaga%20ME%2C%20Sierra-Madero%20JG.%20Impact%20of%20the%20immune%20reconstitution%20inflammatory%20syndrome%20%28IRIS%29%20on%20mortality%20and%20morbidity%20in%20HIV-infected%20patients%20in%20Mexico.%20Int%20J%20Infect%20Dis%20%5BInternet%5D.%202011%20Jun%3B15%286%29%3Ae408-414.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3732828%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3732828%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D3NBPQHZE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20the%20immune%20reconstitution%20inflammatory%20syndrome%20%28IRIS%29%20on%20mortality%20and%20morbidity%20in%20HIV-infected%20patients%20in%20Mexico%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irma%22%2C%22lastName%22%3A%22Hoyo-Ulloa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%20F%22%2C%22lastName%22%3A%22Belaunzar%5Cu00e1n-Zamudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arturo%22%2C%22lastName%22%3A%22Galindo-Fraga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20Eugenia%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Aguinaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20estimate%20the%20impact%20of%20immune%20reconstitution%20inflammatory%20syndrome%20%28IRIS%29%20on%20morbidity%20and%20mortality%20in%20patients%20starting%20highly-active%20antiretroviral%20therapy%20%28HAART%29.%5CnMETHODS%3A%20A%20retrospective%20cohort%20study%20of%20HIV-positive%20patients%20starting%20HAART%20was%20conducted%20at%20a%20tertiary%20care%20referral%20center%20in%20Mexico%20City.%20We%20estimated%20the%20incidence%20of%20IRIS%2C%20hospitalizations%20and%20death%20rates%20during%20the%20first%202%20years%20of%20HAART.%20The%20relative%20risk%20of%20death%20%28RR%29%20and%20hospitalization%20for%20patients%20with%20IRIS%20were%20adjusted%20for%20relevant%20covariates%20using%20regression%20methods.%5CnRESULTS%3A%20During%20the%202-year%20follow-up%20period%2C%2027%25%20of%20patients%20developed%20IRIS%20%2814%20IRIS%20cases%20per%20100%20person-years%29.%20The%20relative%20risk%20of%20death%20among%20patients%20who%20developed%20IRIS%20was%203%20times%20higher%20%2895%25%20confidence%20interval%20%28CI%29%201.19-7.65%2C%20p%20%3D%200.03%29.%20After%20adjusting%20for%20previous%20opportunistic%20infections%20we%20still%20observed%20a%20higher%20death%20rate%20among%20patients%20with%20IRIS%20%28RR%202.3%2C%2095%25%20CI%200.9-5.9%2C%20p%3D0.09%29.%20An%20effect%20modification%20of%20IRIS%20over%20mortality%20was%20observed%20by%20previous%20opportunistic%20infection.%5CnCONCLUSIONS%3A%20IRIS-associated%20mortality%20is%20strongly%20confounded%20by%20previous%20opportunistic%20infection.%20Patients%20with%20AIDS%20who%20eventually%20developed%20IRIS%20had%20the%20highest%20risk%20of%20death%20at%20the%202-year%20follow-up.%22%2C%22date%22%3A%22Jun%202011%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2011.02.007%22%2C%22ISSN%22%3A%221878-3511%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3732828%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222014-08-27T01%3A49%3A25Z%22%7D%7D%2C%7B%22key%22%3A%229429H4JD%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fink%20et%20al.%22%2C%22parsedDate%22%3A%222011-04-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFink%20VI%2C%20Shepherd%20BE%2C%20Cesar%20C%2C%20Krolewiecki%20A%2C%20Wehbe%20F%2C%20Cortes%20CP%2C%20et%20al.%20Cancer%20in%20HIV-infected%20Persons%20from%20the%20Caribbean%2C%20Central%20and%20South%20America.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202011%20Apr%2015%20%5Bcited%202013%20Jul%204%5D%3B56%285%29%3A467%26%23x2013%3B73.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3293455%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3293455%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D9429H4JD%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer%20in%20HIV-infected%20Persons%20from%20the%20Caribbean%2C%20Central%20and%20South%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20I.%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%22%2C%22lastName%22%3A%22Krolewiecki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firas%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryam%22%2C%22lastName%22%3A%22Shafaee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauro%22%2C%22lastName%22%3A%22Schechter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Bacon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Masys%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnHIV%20infected%20individuals%20have%20heightened%20cancer%20risk.%20With%20the%20advent%20of%20HAART%2C%20the%20frequency%20of%20some%20AIDS%20defining%20cancers%20%28ADC%29%20has%20decreased%20while%20certain%20non-AIDS%20defining%20cancers%20%28NADC%29%20are%20becoming%20more%20frequent.%20Cancers%20among%20HIV-infected%20individuals%20in%20Latin%20American%20and%20the%20Caribbean%20have%20not%20yet%20been%20carefully%20studied.%5Cn%5CnMethods%5CnCancer%20cases%20among%20the%20Caribbean%2C%20Central%20and%20South%20American%20network%20for%20HIV%20Research%20%28CCASAnet%29%20cohort%20were%20identified%20reviewing%20clinical%20records%20and%20preexisting%20databases.%5Cn%5CnResults%5CnThere%20were%20406%20cancers%20reported%3A%20331%20ADC%20%28224%20Kaposi%5Cu00b4s%20sarcomas%20and%2098%20non%20Hodgkin%20lymphomas%29.%20Most%20frequent%20NADC%20%28n%3D75%29%20were%20Hodgkin%20lymphoma%20and%20skin%20cancers.%20Seventy-three%20percent%20of%20NADC%20and%2045%25%20of%20ADC%20were%20diagnosed%20%3E1%20year%20after%20HIV%20diagnosis.%2056%25%20of%20ADC%20occurred%20before%20HAART%20start.%20Median%20time%20from%20HAART%20start%20until%20cancer%20diagnosis%20was%202.5%20years%20for%20NADC%20and%200.5%20years%20for%20ADC%20%28p%3D%3C0.001%29.%20Within%203372%20HAART%20starters%2C%20158%20were%20diagnosed%20with%20165%20cancers%20%2882.4%25%20ADC%29%3B%2085%20cases%20were%20previous%20to%20or%20concomitant%20with%20HAART%20initiation.%20Incidence%20of%20cancer%20after%20HAART%20initiation%20in%208080%20person-years%20of%20follow-up%20was%207.2%20per%201000%20person-years%20%2895%25CI%3D%205.5%5Cu20139.3%29%20for%20ADC%20and%202.7%20%2895%25CI%3D%201.8%5Cu20134.1%29%20for%20NADC%3B%20incidence%20was%20higher%20in%20the%20first%20two%20months%2C%20particularly%20for%20ADC%20%2847.6%29.%20A%20pre-HAART%20ADC%20was%20a%20predictor%20of%20mortality%20after%20adjusting%20for%20age%2C%20sex%2C%20and%20CD4%20at%20HAART%20initiation.%5Cn%5CnConclusions%5CnADC%20were%20the%20most%20frequent%20cancers%20in%20this%20region%20and%20were%20often%20diagnosed%20close%20to%20HIV%20diagnosis%20and%20HAART%20start.%20Incidence%20of%20cancer%20was%20highest%20around%20HAART%20initiation.%22%2C%22date%22%3A%222011-4-15%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0b013e31820bb1c3%22%2C%22ISSN%22%3A%221525-4135%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3293455%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A48%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22HPQHA2CQ%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabtree-Ram%5Cu00edrez%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECrabtree-Ram%26%23xED%3Brez%20B%2C%20Caro-Vega%20Y%2C%20Shepherd%20BE%2C%20Wehbe%20F%2C%20Cesar%20C%2C%20Cort%26%23xE9%3Bs%20C%2C%20et%20al.%20Cross-sectional%20analysis%20of%20late%20HAART%20initiation%20in%20Latin%20America%20and%20the%20Caribbean%3A%20late%20testers%20and%20late%20presenters.%20PLoS%20ONE%20%5BInternet%5D.%202011%20%5Bcited%202013%20Jul%204%5D%3B6%285%29%3Ae20272.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3102699%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3102699%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DHPQHA2CQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cross-sectional%20analysis%20of%20late%20HAART%20initiation%20in%20Latin%20America%20and%20the%20Caribbean%3A%20late%20testers%20and%20late%20presenters%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenda%22%2C%22lastName%22%3A%22Crabtree-Ram%5Cu00edrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanink%22%2C%22lastName%22%3A%22Caro-Vega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firas%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Cort%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%22%2C%22lastName%22%3A%22Koenig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sierra-Madero%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%5Cn%5CnStarting%20HAART%20in%20a%20very%20advanced%20stage%20of%20disease%20is%20assumed%20to%20be%20the%20most%20prevalent%20form%20of%20initiation%20in%20HIV-infected%20subjects%20in%20developing%20countries.%20Data%20from%20Latin%20America%20and%20the%20Caribbean%20is%20still%20lacking.%20Our%20main%20objective%20was%20to%20determine%20the%20frequency%2C%20risk%20factors%20and%20trends%20in%20time%20for%20being%20late%20HAART%20initiator%20%28LHI%29%20in%20this%20region.%5Cn%5Cn%5CnMETHODOLOGY%5Cn%5CnCross-sectional%20analysis%20from%209817%20HIV-infected%20treatment-na%5Cu00efve%20patients%20initiating%20HAART%20at%206%20sites%20%28Argentina%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Peru%20and%20Mexico%29%20from%20October%201999%20to%20July%202010.%20LHI%20had%20CD4%28%2B%29%20count%20%5Cu2264200%20cells%5C%2Fmm%283%29%20prior%20to%20HAART.%20Late%20testers%20%28LT%29%20were%20those%20LHI%20who%20initiated%20HAART%20within%206%20months%20of%20HIV%20diagnosis.%20Late%20presenters%20%28LP%29%20initiated%20after%206%20months%20of%20diagnosis.%20Prevalence%2C%20risk%20factors%20and%20trends%20over%20time%20were%20analyzed.%5Cn%5Cn%5CnPRINCIPAL%20FINDINGS%5Cn%5CnAmong%20subjects%20starting%20HAART%20%28n%5Cu200a%3D%5Cu200a9817%29%20who%20had%20baseline%20CD4%28%2B%29%20available%20%28n%5Cu200a%3D%5Cu200a8515%29%2C%2076%25%20were%20LHI%3A%20Argentina%20%2856%25%5B95%25CI%3A52-59%5D%29%2C%20Chile%20%2880%25%5B95%25CI%3A77-82%5D%29%2C%20Haiti%20%2876%25%5B95%25CI%3A74-77%5D%29%2C%20Honduras%20%2891%25%5B95%25CI%3A87-94%5D%29%2C%20Mexico%20%2879%25%5B95%25CI%3A75-83%5D%29%2C%20Peru%20%2886%25%5B95%25CI%3A84-88%5D%29.%20The%20proportion%20of%20LHI%20statistically%20changed%20over%20time%20%28except%20in%20Honduras%29%20%28p%5Cu22640.02%3B%20Honduras%20p%5Cu200a%3D%5Cu200a0.7%29%2C%20with%20a%20tendency%20towards%20lower%20rates%20in%20recent%20years.%20Males%20had%20increased%20risk%20of%20LHI%20in%20Chile%2C%20Haiti%2C%20Peru%2C%20and%20in%20the%20combined%20site%20analyses%20%28CSA%29.%20Older%20patients%20were%20more%20likely%20LHI%20in%20Argentina%20and%20Peru%20%28OR%201.21%20per%20%2B10-year%20of%20age%2C%2095%25CI%3A1.02-1.45%3B%20OR%201.20%2C%2095%25CI%3A1.02-1.43%3B%20respectively%29%2C%20but%20not%20in%20CSA%20%28OR%201.07%2C%2095%25CI%3A0.94-1.21%29.%20Higher%20education%20was%20associated%20with%20decreased%20risk%20for%20LHI%20in%20Chile%20%28OR%200.92%20per%20%2B1-year%20of%20education%2C%2095%25CI%3A0.87-0.98%29%20%28similar%20trends%20in%20Mexico%2C%20Peru%2C%20and%20CSA%29.%20LHI%20with%20date%20of%20HIV-diagnosis%20available%2C%2055%25%20were%20LT%20and%2045%25%20LP.%5Cn%5Cn%5CnCONCLUSION%5Cn%5CnLHI%20was%20highly%20prevalent%20in%20CCASAnet%20sites%2C%20mostly%20due%20to%20LT%3B%20the%20main%20risk%20factors%20associated%20were%20being%20male%20and%20older%20age.%20Earlier%20HIV-diagnosis%20and%20earlier%20treatment%20initiation%20are%20needed%20to%20maximize%20benefits%20from%20HAART%20in%20the%20region.%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0020272%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3102699%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A48%3A57Z%22%7D%7D%5D%7D
1.
Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, et al. Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America. PLoS Med [Internet]. 2011 Oct 25 [cited 2013 Jul 4];8(10):e1001111. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201937/ Cite
1.
Shepherd BE, Yu C. Accounting for data errors discovered from an audit in multiple linear regression. Biometrics [Internet]. 2011 Sep [cited 2013 Jul 4];67(3):1083–91. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092800/ Cite
1.
Hoyo-Ulloa I, Belaunzarán-Zamudio PF, Crabtree-Ramirez B, Galindo-Fraga A, Pérez-Aguinaga ME, Sierra-Madero JG. Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico. Int J Infect Dis [Internet]. 2011 Jun;15(6):e408-414. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732828/ Cite
1.
Fink VI, Shepherd BE, Cesar C, Krolewiecki A, Wehbe F, Cortes CP, et al. Cancer in HIV-infected Persons from the Caribbean, Central and South America. J Acquir Immune Defic Syndr [Internet]. 2011 Apr 15 [cited 2013 Jul 4];56(5):467–73. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293455/ Cite
1.
Crabtree-Ramírez B, Caro-Vega Y, Shepherd BE, Wehbe F, Cesar C, Cortés C, et al. Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS ONE [Internet]. 2011 [cited 2013 Jul 4];6(5):e20272. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102699/ Cite
2010
76770
IP6F4TRX
2010
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b3e5dab88d891e67db3338ce5cb12b9b%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22SJUU3PAC%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cesar%20et%20al.%22%2C%22parsedDate%22%3A%222010-06-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECesar%20C%2C%20Shepherd%20BE%2C%20Krolewiecki%20AJ%2C%20Fink%20VI%2C%20Schechter%20M%2C%20Tuboi%20SH%2C%20et%20al.%20Rates%20and%20Reasons%20for%20Early%20Change%20of%20First%20HAART%20in%20HIV-1-Infected%20Patients%20in%207%20Sites%20throughout%20the%20Caribbean%20and%20Latin%20America.%20PLoS%20ONE%20%5BInternet%5D.%202010%20Jun%201%20%5Bcited%202013%20Jul%204%5D%3B5%286%29%3Ae10490.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2879360%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2879360%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DSJUU3PAC%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rates%20and%20Reasons%20for%20Early%20Change%20of%20First%20HAART%20in%20HIV-1-Infected%20Patients%20in%207%20Sites%20throughout%20the%20Caribbean%20and%20Latin%20America%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%20J.%22%2C%22lastName%22%3A%22Krolewiecki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20I.%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauro%22%2C%22lastName%22%3A%22Schechter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suely%20H.%22%2C%22lastName%22%3A%22Tuboi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Leger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R.%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%20E.%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22for%20The%20Caribbean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Central%20and%20South%20America%20Network%20for%20HIV%20Research%20%28CCASAnet%29%20Collaboration%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Program%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%5CnHAART%20rollout%20in%20Latin%20America%20and%20the%20Caribbean%20has%20increased%20from%20approximately%20210%2C000%20in%202003%20to%20390%2C000%20patients%20in%202007%2C%20covering%2062%25%20%2851%25%5Cu201370%25%29%20of%20eligible%20patients%2C%20with%20considerable%20variation%20among%20countries.%20No%20multi-cohort%20study%20has%20examined%20rates%20of%20and%20reasons%20for%20change%20of%20initial%20HAART%20in%20this%20region.%20%5Cn%20%5CnMethodology%20%5CnAntiretroviral-na%5Cu00efve%20patients%20%3E%5Cu200a%3D%5Cu200a18%20years%20who%20started%20HAART%20between%201996%20and%202007%20and%20had%20at%20least%20one%20follow-up%20visit%20from%20sites%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%20and%20Peru%20were%20included.%20Time%20from%20HAART%20initiation%20to%20change%20%28stopping%20or%20switching%20any%20antiretrovirals%29%20was%20estimated%20using%20Kaplan-Meier%20techniques.%20Cox%20proportional%20hazards%20modeled%20the%20associations%20between%20change%20and%20demographics%2C%20initial%20regimen%2C%20baseline%20CD4%20count%2C%20and%20clinical%20stage.%20%5Cn%20%5CnPrincipal%20Findings%20%5CnOf%205026%20HIV-infected%20patients%2C%2035%25%20were%20female%2C%20median%20age%20at%20HAART%20initiation%20was%2037%20years%20%28interquartile%20range%20%5BIQR%5D%2C%2031%5Cu201344%29%2C%20and%20median%20CD4%20count%20was%20105%20cells%5C%2FuL%20%28IQR%2C%2038%5Cu2013200%29.%20Estimated%20probabilities%20of%20changing%20within%203%20months%20and%20one%20year%20of%20HAART%20initiation%20were%2016%25%20%2895%25%20confidence%20interval%20%28CI%29%2015%5Cu201317%25%29%20and%2028%25%20%2895%25%20CI%2027%5Cu201329%25%29%2C%20respectively.%20Efavirenz-based%20regimens%20and%20no%20clinical%20AIDS%20at%20HAART%20initiation%20were%20associated%20with%20lower%20risk%20of%20change%20%28hazard%20ratio%20%28HR%29%5Cu200a%3D%5Cu200a1.7%20%2895%25%20CI%201.1%5Cu20132.6%29%20and%202.1%20%2895%25%20CI%201.7%5Cu20132.5%29%20comparing%20neverapine-based%20regimens%20and%20other%20regimens%20to%20efavirenz%2C%20respectively%3B%20HR%5Cu200a%3D%5Cu200a1.3%20%2895%25%20CI%201.1%5Cu20131.5%29%20for%20clinical%20AIDS%20at%20HAART%20initiation%29.%20The%20primary%20reason%20for%20change%20among%20HAART%20initiators%20were%20adverse%20events%20%2814%25%29%2C%20death%20%285.7%25%29%20and%20failure%20%281.3%25%29%20with%20specific%20toxicities%20varying%20among%20sites.%20After%20change%2C%20most%20patients%20remained%20in%20first%20line%20regimens.%20%5Cn%20%5CnConclusions%20%5CnAdverse%20events%20were%20the%20leading%20cause%20for%20changing%20initial%20HAART.%20Predictors%20for%20change%20due%20to%20any%20reason%20were%20AIDS%20at%20baseline%20and%20the%20use%20of%20a%20non-efavirenz%20containing%20regimen.%20Differences%20between%20participant%20sites%20were%20observed%20and%20require%20further%20investigation.%22%2C%22date%22%3A%22June%201%2C%202010%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0010490%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2879360%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A53%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22F3GIGP8M%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22The%20Antiretroviral%20Therapy%20in%20Low%20Income%20Countries%20%28ART-LINC%29%20Collaboration%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%2C%22parsedDate%22%3A%222010-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EThe%20Antiretroviral%20Therapy%20in%20Low%20Income%20Countries%20%28ART-LINC%29%20Collaboration%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29.%20Mortality%20Associated%20With%20Discordant%20Responses%20to%20Antiretroviral%20Therapy%20in%20Resource-Constrained%20Settings.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202010%20Jan%201%20%5Bcited%202013%20Jun%2022%5D%3B53%281%29%3A70%26%23x2013%3B7.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2802453%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2802453%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DF3GIGP8M%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20Associated%20With%20Discordant%20Responses%20to%20Antiretroviral%20Therapy%20in%20Resource-Constrained%20Settings%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22The%20Antiretroviral%20Therapy%20in%20Low%20Income%20Countries%20%28ART-LINC%29%20Collaboration%20of%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%5CnWe%20assessed%20mortality%20associated%20with%20immunologic%20and%20virologic%20patterns%20of%20response%20at%206%20months%20of%20highly%20active%20antiretroviral%20therapy%20%28HAART%29%20in%20HIV-infected%20individuals%20from%20resource-limited%20countries%20in%20Africa%20and%20South%20America.%5Cn%5CnMethods%5CnPatients%20who%20initiated%20HAART%20between%201996%20and%202007%2C%20were%20aged%2016%20years%20or%20older%2C%20and%20had%20at%20least%20one%20measurement%20%28HIV-1%20RNA%20plasma%20viral%20load%20or%20CD4%20cell%20count%29%20at%206%20months%20of%20therapy%20%283%20to%209%20month%20window%29%20were%20included.%20Therapy%20response%20was%20categorized%20as%20complete%2C%20discordant%20%28virologic-%20or%20immunologic-only%29%2C%20and%20absent.%20Associations%20between%206-month%20response%20to%20therapy%20and%20all-cause%20mortality%20were%20assessed%20by%20Cox%20proportional%20hazards%20regression.%20Robust%20standard%20errors%20were%20calculated%20to%20account%20for%20intra-site%20correlation.%5Cn%5CnResults%5CnA%20total%20of%207%2C160%20patients%2C%20corresponding%20to%2015%2C107%20person-years%2C%20was%20analyzed.%20In%20multivariable%20analysis%20adjusted%20for%20age%20at%20HAART%20initiation%2C%20baseline%20clinical%20stage%20and%20CD4%20cell%20count%2C%20year%20of%20HAART%20initiation%2C%20clinic%2C%20occurrence%20of%20an%20AIDS%20defining%20condition%20within%20the%20first%206%20months%20of%20treatment%2C%20discordant%20and%20absent%20responses%20were%20associated%20with%20increased%20risk%20of%20death.%5Cn%5CnConclusions%5CnSimilar%20to%20reports%20from%20high-income%20countries%2C%20discordant%20immunologic%20and%20virologic%20responses%20were%20associated%20with%20intermediate%20risk%20of%20death%20compared%20with%20complete%20and%20no%20response%20in%20this%20large%20cohort%20of%20HIV-1%20patients%20from%20resource-limited%20countries.%20Our%20results%20support%20a%20recommendation%20for%20wider%20availability%20of%20plasma%20viral%20load%20testing%20to%20monitor%20antiretroviral%20therapy%20in%20these%20settings.%22%2C%22date%22%3A%222010-1-1%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0b013e3181c22d19%22%2C%22ISSN%22%3A%221525-4135%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2802453%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-06-29T14%3A39%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22RMCKWMMR%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tuboi%20et%20al.%22%2C%22parsedDate%22%3A%222010-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETuboi%20S%2C%20Pacheco%20A%2C%20Harrison%20L%2C%20Stone%20R%2C%20May%20M%2C%20Brinkhof%20M%2C%20et%20al.%20Mortality%20associated%20with%20discordant%20responses%20to%20antiretroviral%20therapy%20in%20resource-constrained%20settings.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202010%20Jan%3B53%281%29%3A70%26%23x2013%3B7.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2802453%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2802453%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DRMCKWMMR%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20associated%20with%20discordant%20responses%20to%20antiretroviral%20therapy%20in%20resource-constrained%20settings%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SH%22%2C%22lastName%22%3A%22Tuboi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AG%22%2C%22lastName%22%3A%22Pacheco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22LH%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22RA%22%2C%22lastName%22%3A%22Stone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22May%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MW%22%2C%22lastName%22%3A%22Brinkhof%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Dabis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Bangsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Braitstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CT%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Sprinz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Schechter%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22January%202010%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2802453%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222017-07-24T16%3A59%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22NXT7T8E8%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222010%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20SN%2C%20Wehbe%20FH%2C%20Gadd%20CS.%20Desiderata%20for%20a%20computer-assisted%20audit%20tool%20for%20clinical%20data%20source%20verification%20audits.%20Stud%20Health%20Technol%20Inform%20%5BInternet%5D.%202010%20%5Bcited%202012%20Apr%2029%5D%3B160%28Pt%202%29%3A894%26%23x2013%3B8.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F20841814%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F20841814%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DNXT7T8E8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Desiderata%20for%20a%20computer-assisted%20audit%20tool%20for%20clinical%20data%20source%20verification%20audits%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Firas%20H%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%20S%22%2C%22lastName%22%3A%22Gadd%22%7D%5D%2C%22abstractNote%22%3A%22Clinical%20data%20auditing%20often%20requires%20validating%20the%20contents%20of%20clinical%20research%20databases%20against%20source%20documents%20available%20in%20health%20care%20settings.%20Currently%20available%20data%20audit%20software%2C%20however%2C%20does%20not%20provide%20features%20necessary%20to%20compare%20the%20contents%20of%20such%20databases%20to%20source%20data%20in%20paper%20medical%20records.%20This%20work%20enumerates%20the%20primary%20weaknesses%20of%20using%20paper%20forms%20for%20clinical%20data%20audits%20and%20identifies%20the%20shortcomings%20of%20existing%20data%20audit%20software%2C%20as%20informed%20by%20the%20experiences%20of%20an%20audit%20team%20evaluating%20data%20quality%20for%20an%20international%20research%20consortium.%20The%20authors%20propose%20a%20set%20of%20attributes%20to%20guide%20the%20development%20of%20a%20computer-assisted%20clinical%20data%20audit%20tool%20to%20simplify%20and%20standardize%20the%20audit%20process.%22%2C%22date%22%3A%222010%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220926-9630%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F20841814%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222012-04-29T03%3A54%3A32Z%22%7D%7D%5D%7D
1.
Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, Tuboi SH, et al. Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America. PLoS ONE [Internet]. 2010 Jun 1 [cited 2013 Jul 4];5(6):e10490. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879360/ Cite
1.
The Antiretroviral Therapy in Low Income Countries (ART-LINC) Collaboration of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings. J Acquir Immune Defic Syndr [Internet]. 2010 Jan 1 [cited 2013 Jun 22];53(1):70–7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802453/ Cite
1.
Tuboi S, Pacheco A, Harrison L, Stone R, May M, Brinkhof M, et al. Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. J Acquir Immune Defic Syndr [Internet]. 2010 Jan;53(1):70–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802453/ Cite
1.
Duda SN, Wehbe FH, Gadd CS. Desiderata for a computer-assisted audit tool for clinical data source verification audits. Stud Health Technol Inform [Internet]. 2010 [cited 2012 Apr 29];160(Pt 2):894–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20841814 Cite
2009
76770
IP6F4TRX
2009
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-3d5dfc3465322399bc101b50082d1dc1%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZPC39W7K%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dorjgochoo%20et%20al.%22%2C%22parsedDate%22%3A%222009-12-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDorjgochoo%20T%2C%20Noel%20F%2C%20Deschamps%20MM%2C%20Theodore%20H%2C%20Charles%20S%2C%20Dupont%20W%2C%20et%20al.%20Risk%20factors%20for%20HIV%20infection%20among%20Haitian%20adolescents%20and%20young%20adults%20seeking%20counseling%20and%20testing%20in%20Port-au-Prince.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202009%20Dec%201%20%5Bcited%202013%20Jul%204%5D%3B52%284%29%3A498%26%23x2013%3B508.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3196358%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3196358%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DZPC39W7K%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Risk%20factors%20for%20HIV%20infection%20among%20Haitian%20adolescents%20and%20young%20adults%20seeking%20counseling%20and%20testing%20in%20Port-au-Prince%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tsogzolmaa%22%2C%22lastName%22%3A%22Dorjgochoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francine%22%2C%22lastName%22%3A%22Noel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Marcel%22%2C%22lastName%22%3A%22Deschamps%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harry%22%2C%22lastName%22%3A%22Theodore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabine%22%2C%22lastName%22%3A%22Charles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Dupont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F%22%2C%22lastName%22%3A%22Wright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%20W%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sten%20H%22%2C%22lastName%22%3A%22Vermund%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W%22%2C%22lastName%22%3A%22Pape%22%7D%5D%2C%22abstractNote%22%3A%22Many%20Haitian%20adolescents%20are%20highly%20vulnerable%20to%20HIV%20infection.%20Among%203%2C391%20sexually%20active%2013-25-year-olds%20in%20our%20Voluntary%20Counseling%20and%20Testing%20%28VCT%29%20Center%20in%20Port-au-Prince%20from%20October%202005%20to%20September%202006%2C%20we%20assessed%20associations%20between%20demographic%20and%20behavioral%20factors%20and%20HIV%20status%20using%20multivariable%20logistic%20regression%20analyses.%20We%20diagnosed%20HIV%20infection%20in%206.3%25%20of%202%2C533%20females%20and%205.5%25%20of%20858%20males.%20Age-specific%20prevalence%20was%203.4%25%20for%2013-15-year-olds%2C%204.7%25%20for%2016-19%2C%20and%206.8%25%20for%2020-25%20%28P%3D0.02%29.%20Poor%20education%2C%20not%20residing%20with%20parents%2C%20currently%20or%20formerly%20married%2C%20having%20a%20child%2C%20and%20being%20self-referred%20to%20VCT%20services%20by%20others%20were%20significant%20predictors%20of%20HIV%20in%20females.%20HIV%20infection%20was%20associated%20with%20considering%20oneself%20at%20higher%20risk%2C%20though%20most%20youth%20did%20not%20recognize%20this%20risk.%20HIV%20in%20females%20was%20also%20associated%20with%20suspected%5C%2Fconfirmed%20sexually%20transmitted%20infection%20%28STI%29%2C%20especially%20genital%20ulcers%20%28ORadj%3D2.28%2C%2095%25CI%3A1.26-4.13%29%2C%20years%20of%20sexual%20activity%20%28Ptrend%3D0.07%29%2C%20and%20suspicion%20that%20partners%20had%20other%20partners%20or%20an%20STI.%20Among%20males%2C%20HIV%20was%20associated%20with%20drug%20use%20%28though%20uncommon%29%2C%20as%20well%20as%20sexual%20debut%20with%20a%20casual%5C%2Funknown%20person%20%28ORadj%3D3.18%2C%2095%25CI%3A1.58-6.42%29.%20HIV-infected%20young%20people%20were%20more%20likely%20to%20be%20RPR%20positive%20and%20less%20likely%20to%20use%20condoms.%20Young%20Haitians%20are%20a%20key%20target%20for%20HIV%20prevention%20and%20care%20and%20avail%20themselves%20readily%20of%20youth-focused%20VCT%20services.%22%2C%22date%22%3A%222009-12-1%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0b013e3181ac12a8%22%2C%22ISSN%22%3A%221525-4135%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3196358%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A54%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22RPKHE8ZT%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tuboi%20et%20al.%22%2C%22parsedDate%22%3A%222009-08-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETuboi%20SH%2C%20Schechter%20M%2C%20McGowan%20CC%2C%20Cesar%20C%2C%20Krolewiecki%20A%2C%20Cahn%20P%2C%20et%20al.%20Mortality%20during%20the%20first%20year%20of%20potent%20antiretroviral%20therapy%20in%20HIV-1-infected%20patients%20in%207%20sites%20throughout%20Latin%20America%20and%20the%20Caribbean.%20J%20Acquir%20Immune%20Defic%20Syndr%20%5BInternet%5D.%202009%20Aug%2015%20%5Bcited%202013%20Jul%204%5D%3B51%285%29%3A615%26%23x2013%3B23.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2780368%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2780368%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DRPKHE8ZT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mortality%20during%20the%20first%20year%20of%20potent%20antiretroviral%20therapy%20in%20HIV-1-infected%20patients%20in%207%20sites%20throughout%20Latin%20America%20and%20the%20Caribbean%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suely%20H%22%2C%22lastName%22%3A%22Tuboi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauro%22%2C%22lastName%22%3A%22Schechter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20C%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carina%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandro%22%2C%22lastName%22%3A%22Krolewiecki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcelo%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Sierra%22%2C%22lastName%22%3A%22Madero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20E%22%2C%22lastName%22%3A%22Shepherd%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Although%20nearly%202%20million%20people%20live%20with%20HIV%20in%20Latin%20America%20and%20the%20Caribbean%2C%20mortality%20rates%20after%20initiation%20of%20highly%20active%20antiretroviral%20therapy%20%28HAART%29%20have%20not%20been%20well%20described.%5CnMETHODS%3A%20Five%20thousand%20one%20hundred%20fifty-two%20HIV-infected%2C%20antiretroviral-naive%20adults%20from%20clinics%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%2C%20and%20Peru%20starting%20HAART%20during%201996-2007%20were%20included.%20First-year%20mortality%20rates%20and%20their%20association%20with%20demographics%2C%20regimen%2C%20baseline%20CD4%2C%20and%20clinical%20stage%20were%20assessed.%5CnRESULTS%3A%20Overall%201-year%20mortality%20rate%20was%208.3%25%20%5B95%25%20confidence%20interval%20%28CI%29%3A%207.6%25%20to%209.1%25%5D%2C%20although%20variable%20across%20sites%3A%202.6%25%2C%203.7%25%2C%206.0%25%2C%2013.0%25%2C%2010.8%25%2C%203.5%25%2C%20and%209.8%25%20for%20clinics%20in%20Argentina%2C%20Brazil%2C%20Chile%2C%20Haiti%2C%20Honduras%2C%20Mexico%2C%20and%20Peru%2C%20respectively.%20Eighty%20percent%20of%20deaths%20occurred%20within%20the%20first%206%20months.%20Median%20baseline%20CD4%20was%20107%20cells%20per%20milliliter%2C%20ranging%20from%2079%20%28Peru%29%20to%20163%20%28Argentina%29.%20Mortality%20estimates%20adjusting%20for%20CD4%20were%20similar%20across%20sites%20%281.1%25-2.8%25%20for%20CD4%20%3D%20200%29%2C%20except%20for%20Haiti%2C%207.5%25%2C%20and%20Honduras%2C%207.0%25.%20Death%20was%20associated%20with%20lower%20CD4%20%5Badjusted%20hazard%20ratio%20for%20CD4%20%3D%20200%20vs.%20CD4%20%3D%2050%20was%200.58%3B%2095%25%20CI%3A%200.40%20to%200.85%5D%20and%20clinical%20AIDS%20%28hazard%20ratio%20%3D%203.1%3B%2095%25%20CI%3A%202.1%20to%204.5%29.%5CnCONCLUSIONS%3A%20Mortality%20rates%20were%20similar%20to%20those%20reported%20elsewhere%20for%20resource-limited%20settings.%20Disease%20stage%20at%20HAART%20initiation%2C%20treatment%20eligibility%20criteria%2C%20program%20age%2C%20and%20background%20mortality%20rates%20may%20explain%20some%20variability%20in%20prognosis%20between%20sites.%22%2C%22date%22%3A%22Aug%2015%2C%202009%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAI.0b013e3181a44f0a%22%2C%22ISSN%22%3A%221525-4135%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2780368%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A53%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22GIXZBEHU%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Masys%20et%20al.%22%2C%22parsedDate%22%3A%222009-06-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMasys%20DR%2C%20Fang%20F%2C%20Ye%20I%2C%20Fink%20V%2C%20Gotuzzo%20E%2C%20Padgett%20D%2C%20et%20al.%20Preliminary%20findings%20on%20cancer%20incidence%20in%20HIV-infected%20persons%20from%20six%20countries%20in%20Central%20and%20South%20America%20and%20the%20Caribbean.%20Infectious%20Agents%20and%20Cancer%20%5BInternet%5D.%202009%20Jun%2017%20%5Bcited%202013%20May%208%5D%3B4%28Suppl%202%29%3AO18.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.infectagentscancer.com%5C%2Fcontent%5C%2F4%5C%2FS2%5C%2FO18%27%3Ehttp%3A%5C%2F%5C%2Fwww.infectagentscancer.com%5C%2Fcontent%5C%2F4%5C%2FS2%5C%2FO18%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DGIXZBEHU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preliminary%20findings%20on%20cancer%20incidence%20in%20HIV-infected%20persons%20from%20six%20countries%20in%20Central%20and%20South%20America%20and%20the%20Caribbean%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20R.%22%2C%22lastName%22%3A%22Masys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Fink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bacon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Schechter%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222009-06-17%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1186%5C%2F1750-9378-4-S2-O18%22%2C%22ISSN%22%3A%221750-9378%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.infectagentscancer.com%5C%2Fcontent%5C%2F4%5C%2FS2%5C%2FO18%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-05-08T00%3A19%3A36Z%22%7D%7D%5D%7D
1.
Dorjgochoo T, Noel F, Deschamps MM, Theodore H, Charles S, Dupont W, et al. Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-Prince. J Acquir Immune Defic Syndr [Internet]. 2009 Dec 1 [cited 2013 Jul 4];52(4):498–508. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196358/ Cite
1.
Tuboi SH, Schechter M, McGowan CC, Cesar C, Krolewiecki A, Cahn P, et al. Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr [Internet]. 2009 Aug 15 [cited 2013 Jul 4];51(5):615–23. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780368/ Cite
1.
Masys DR, Fang F, Ye I, Fink V, Gotuzzo E, Padgett D, et al. Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean. Infectious Agents and Cancer [Internet]. 2009 Jun 17 [cited 2013 May 8];4(Suppl 2):O18. Available from: http://www.infectagentscancer.com/content/4/S2/O18 Cite
2008
76770
IP6F4TRX
2008
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-02b076a2791b8b2d3f7bab705608025d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22D3VINS9W%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pacheco%20et%20al.%22%2C%22parsedDate%22%3A%222008-12-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPacheco%20AG%2C%20Saraceni%20V%2C%20Tuboi%20SH%2C%20Moulton%20LH%2C%20Chaisson%20RE%2C%20Cavalcante%20SC%2C%20et%20al.%20Validation%20of%20a%20Hierarchical%20Deterministic%20Record-Linkage%20Algorithm%20Using%20Data%20From%202%20Different%20Cohorts%20of%20Human%20Immunodeficiency%20Virus-Infected%20Persons%20and%20Mortality%20Databases%20in%20Brazil.%20Am%20J%20Epidemiol%20%5BInternet%5D.%202008%20Dec%201%20%5Bcited%202013%20Jul%204%5D%3B168%2811%29%3A1326%26%23x2013%3B32.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2638543%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2638543%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DD3VINS9W%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Validation%20of%20a%20Hierarchical%20Deterministic%20Record-Linkage%20Algorithm%20Using%20Data%20From%202%20Different%20Cohorts%20of%20Human%20Immunodeficiency%20Virus-Infected%20Persons%20and%20Mortality%20Databases%20in%20Brazil%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%20G.%22%2C%22lastName%22%3A%22Pacheco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Saraceni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suely%20H.%22%2C%22lastName%22%3A%22Tuboi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%20H.%22%2C%22lastName%22%3A%22Moulton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20E.%22%2C%22lastName%22%3A%22Chaisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Solange%20C.%22%2C%22lastName%22%3A%22Cavalcante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Betina%22%2C%22lastName%22%3A%22Durovni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20C.%22%2C%22lastName%22%3A%22Faulhaber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20E.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bonnie%22%2C%22lastName%22%3A%22King%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauro%22%2C%22lastName%22%3A%22Schechter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%20H.%22%2C%22lastName%22%3A%22Harrison%22%7D%5D%2C%22abstractNote%22%3A%22Loss%20to%20follow-up%20is%20a%20major%20source%20of%20bias%20in%20cohorts%20of%20patients%20with%20human%20immunodeficiency%20virus%20%28HIV%29%20and%20could%20lead%20to%20underestimation%20of%20mortality.%20The%20authors%20developed%20a%20hierarchical%20deterministic%20linkage%20algorithm%20to%20be%20used%20primarily%20with%20cohorts%20of%20HIV-infected%20persons%20to%20recover%20vital%20status%20information%20for%20patients%20lost%20to%20follow-up.%20Data%20from%20patients%20known%20to%20be%20deceased%20in%202%20cohorts%20in%20Rio%20de%20Janeiro%2C%20Brazil%2C%20and%20data%20from%20the%20Rio%20de%20Janeiro%20State%20mortality%20database%20for%201999%5Cu20132006%20were%20used%20to%20validate%20the%20algorithm.%20A%20fully%20automated%20procedure%20yielded%20a%20sensitivity%20of%2092.9%25%20and%20specificity%20of%20100%25%20when%20no%20information%20was%20missing.%20When%20the%20automated%20procedure%20was%20combined%20with%20clerical%20review%2C%20in%20a%20scenario%20of%205%25%20death%20prevalence%20and%2020%25%20missing%20mothers%5Cu2019%20names%2C%20sensitivity%20reached%2096.5%25%20and%20specificity%20100%25.%20In%20a%20practical%20application%2C%20the%20algorithm%20significantly%20increased%20death%20rates%20and%20decreased%20the%20rate%20of%20loss%20to%20follow-up%20in%20the%20cohorts.%20The%20finding%20that%2023.9%25%20of%20matched%20records%20did%20not%20give%20HIV%20or%20acquired%20immunodeficiency%20syndrome%20as%20the%20cause%20of%20death%20reinforces%20the%20need%20to%20search%20all-cause%20mortality%20databases%20and%20alerts%20for%20possible%20underestimation%20of%20death%20rates.%20These%20results%20indicate%20that%20the%20algorithm%20is%20accurate%20enough%20to%20recover%20vital%20status%20information%20on%20patients%20lost%20to%20follow-up%20in%20cohort%20studies.%22%2C%22date%22%3A%222008-12-1%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Faje%5C%2Fkwn249%22%2C%22ISSN%22%3A%220002-9262%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2638543%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A54%3A53Z%22%7D%7D%2C%7B%22key%22%3A%227JRS7ZAH%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Noel%20et%20al.%22%2C%22parsedDate%22%3A%222008-11-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ENoel%20F%2C%20Mehta%20S%2C%20Zhu%20Y%2C%20Rouzier%20PDM%2C%20Marcelin%20A%2C%20Shi%20JR%2C%20et%20al.%20Improving%20Outcomes%20in%20Infants%20of%20HIV-Infected%20Women%20in%20a%20Developing%20Country%20Setting.%20PLoS%20ONE%20%5BInternet%5D.%202008%20Nov%2014%20%5Bcited%202013%20Jul%204%5D%3B3%2811%29%3Ae3723.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2580032%5C%2F%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2580032%5C%2F%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7JRS7ZAH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improving%20Outcomes%20in%20Infants%20of%20HIV-Infected%20Women%20in%20a%20Developing%20Country%20Setting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francine%22%2C%22lastName%22%3A%22Noel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sapna%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuwei%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%20De%20Matteis%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdias%22%2C%22lastName%22%3A%22Marcelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jian%20R.%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Nolte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Severe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Marcelle%22%2C%22lastName%22%3A%22Deschamps%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20W.%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Warren%20D.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Wright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%5CnSince%201999%20GHESKIO%2C%20a%20large%20voluntary%20counseling%20and%20HIV%20testing%20center%20in%20Port-au-Prince%2C%20Haiti%2C%20has%20had%20an%20ongoing%20collaboration%20with%20the%20Haitian%20Ministry%20of%20Health%20to%20reduce%20the%20rate%20of%20mother%20to%20child%20HIV%20transmission.%20There%20are%20limited%20data%20on%20the%20ability%20to%20administer%20complex%20regimens%20for%20reducing%20mother%20to%20child%20transmission%20and%20on%20risk%20factors%20for%20continued%20transmission%20and%20infant%20mortality%20within%20programmatic%20settings%20in%20developing%20countries.%20%5Cn%20%5CnMethods%20and%20Findings%20%5CnWe%20analyzed%20data%20from%20551%20infants%20born%20to%20HIV-infected%20mothers%20seen%20at%20GHESKIO%2C%20between%201999%20and%202005.%20HIV-infected%20mothers%20and%20their%20infants%20were%20given%20%5Cu201cshort-course%5Cu201d%20monotherapy%20with%20antiretrovirals%20for%20prophylaxis%3B%20and%2C%20since%202003%2C%20highly%20active%20antiretroviral%20therapy%20%28HAART%29%20when%20clinical%20or%20laboratory%20indications%20were%20met.%20Infected%20women%20seen%20in%20the%20pre-treatment%20era%20had%2027%25%20transmission%20rates%2C%20falling%20to%2010%25%20in%20this%20cohort%20of%20551%20infants%2C%20and%20to%20only%201.9%25%20in%20infants%20of%20women%20on%20HAART.%20Mortality%20rate%20after%20HAART%20introduction%20%280.12%20per%20year%20of%20follow-up%20%5B0.08%5Cu20130.16%5D%29%20was%20significantly%20lower%20than%20the%20period%20before%20the%20availability%20of%20such%20therapy%20%280.23%20%5B0.16%5Cu20130.30%5D%2C%20P%3C0.0001%29.%20The%20effects%20of%20maternal%20health%2C%20infant%20feeding%2C%20completeness%20of%20prophylaxis%2C%20and%20birth%20weight%20on%20mortality%20and%20transmission%20were%20determined%20using%20univariate%20and%20multivariate%20analysis.%20Infant%20HIV-1%20infection%20and%20low%20birth%20weight%20were%20associated%20with%20infant%20mortality%20in%20less%20than%2015%20month%20olds%20in%20multivariate%20analysis.%20%5Cn%20%5CnConclusions%20%5CnOur%20findings%20demonstrate%20success%20in%20prevention%20of%20mother-to-child%20HIV%20transmission%20and%20mortality%20in%20a%20highly%20resource%20constrained%20setting.%20Elements%20contributing%20to%20programmatic%20success%20include%20provision%20of%20HAART%20in%20the%20context%20of%20a%20comprehensive%20program%20with%20pre%20and%20postnatal%20care%20for%20both%20mother%20and%20infant.%22%2C%22date%22%3A%22November%2014%2C%202008%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0003723%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2580032%5C%2F%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A55%3A39Z%22%7D%7D%2C%7B%22key%22%3A%227D6T9T9P%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222008-07-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20S%2C%20McGowan%20C%2C%20Wehbe%20F%2C%20Masys%20D.%20White%20paper%3A%20The%20CCASAnet%20Data%20Audit%20Process.%20Distributed%20to%20the%20IeDEA%20network%20July%202008.%20%5BInternet%5D.%202008%20Jul%20p.%209.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fuploads%5C%2F2013%5C%2F05%5C%2FCCASAnet_Audit_Process.pdf%27%3Ehttp%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fuploads%5C%2F2013%5C%2F05%5C%2FCCASAnet_Audit_Process.pdf%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D7D6T9T9P%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22report%22%2C%22title%22%3A%22White%20paper%3A%20The%20CCASAnet%20Data%20Audit%20Process.%20Distributed%20to%20the%20IeDEA%20network%20July%202008.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22SN%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22CC%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22FH%22%2C%22lastName%22%3A%22Wehbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22DR%22%2C%22lastName%22%3A%22Masys%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22reportNumber%22%3A%22%22%2C%22reportType%22%3A%22%22%2C%22institution%22%3A%22%22%2C%22date%22%3A%221%20July%202008%22%2C%22language%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fuploads%5C%2F2013%5C%2F05%5C%2FCCASAnet_Audit_Process.pdf%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-26T21%3A39%3A46Z%22%7D%7D%5D%7D
1.
Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, et al. Validation of a Hierarchical Deterministic Record-Linkage Algorithm Using Data From 2 Different Cohorts of Human Immunodeficiency Virus-Infected Persons and Mortality Databases in Brazil. Am J Epidemiol [Internet]. 2008 Dec 1 [cited 2013 Jul 4];168(11):1326–32. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638543/ Cite
1.
Noel F, Mehta S, Zhu Y, Rouzier PDM, Marcelin A, Shi JR, et al. Improving Outcomes in Infants of HIV-Infected Women in a Developing Country Setting. PLoS ONE [Internet]. 2008 Nov 14 [cited 2013 Jul 4];3(11):e3723. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580032/ Cite
1.
Duda S, McGowan C, Wehbe F, Masys D. White paper: The CCASAnet Data Audit Process. Distributed to the IeDEA network July 2008. [Internet]. 2008 Jul p. 9. Available from: http://www.ccasanet.org/wp-content/uploads/2013/05/CCASAnet_Audit_Process.pdf Cite
2007
76770
IP6F4TRX
2007
items
1
nlm
0
year
desc
1
1
161
https://www.ccasanet.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5b9292dadf6d1517e7308291df4233d6%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JRS3GX3T%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22McGowan%20et%20al.%22%2C%22parsedDate%22%3A%222007-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMcGowan%20CC%2C%20Cahn%20P%2C%20Gotuzzo%20E%2C%20Padgett%20D%2C%20Pape%20JW%2C%20Wolff%20M%2C%20et%20al.%20Cohort%20Profile%3A%20Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20research%20%28CCASAnet%29%20collaboration%20within%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20programme.%20Int%20J%20Epidemiol%20%5BInternet%5D.%202007%20Oct%20%5Bcited%202013%20Jul%204%5D%3B36%285%29%3A969%26%23x2013%3B76.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fije.oxfordjournals.org%5C%2Fcontent%5C%2F36%5C%2F5%5C%2F969.full%27%3Ehttp%3A%5C%2F%5C%2Fije.oxfordjournals.org%5C%2Fcontent%5C%2F36%5C%2F5%5C%2F969.full%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3DJRS3GX3T%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cohort%20Profile%3A%20Caribbean%2C%20Central%20and%20South%20America%20Network%20for%20HIV%20research%20%28CCASAnet%29%20collaboration%20within%20the%20International%20Epidemiologic%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20programme%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Cahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Gotuzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Padgett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Schechter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.R.%22%2C%22lastName%22%3A%22Masys%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22October%202007%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fije.oxfordjournals.org%5C%2Fcontent%5C%2F36%5C%2F5%5C%2F969.full%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222013-07-04T14%3A58%3A00Z%22%7D%7D%2C%7B%22key%22%3A%222TW9STKS%22%2C%22library%22%3A%7B%22id%22%3A76770%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duda%20et%20al.%22%2C%22parsedDate%22%3A%222007%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDuda%20SN%2C%20Cushman%20C%2C%20Masys%20DR.%20An%20XML%20model%20of%20an%20enhanced%20data%20dictionary%20to%20facilitate%20the%20exchange%20of%20pre-existing%20clinical%20research%20data%20in%20international%20studies.%20Stud%20Health%20Technol%20Inform%20%5BInternet%5D.%202007%20%5Bcited%202012%20Apr%2029%5D%3B129%28Pt%201%29%3A449%26%23x2013%3B53.%20Available%20from%3A%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F17911757%27%3Ehttp%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F17911757%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.ccasanet.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D76770%26amp%3Bitem_key%3D2TW9STKS%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20XML%20model%20of%20an%20enhanced%20data%20dictionary%20to%20facilitate%20the%20exchange%20of%20pre-existing%20clinical%20research%20data%20in%20international%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clint%22%2C%22lastName%22%3A%22Cushman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20R%22%2C%22lastName%22%3A%22Masys%22%7D%5D%2C%22abstractNote%22%3A%22Pre-existing%20clinical%20research%20data%20sets%20exchanged%20in%20international%20epidemiology%20research%20often%20lack%20the%20elements%20needed%20to%20assess%20their%20suitability%20for%20use%20in%20multi-region%20meta-analyses%20or%20other%20clinical%20studies.%20While%20the%20missing%20information%20is%20generally%20known%20to%20local%20investigators%2C%20it%20is%20not%20contained%20in%20the%20files%20exchanged%20between%20sites.%20Instead%2C%20such%20content%20must%20be%20solicited%20by%20the%20study%20coordinating%20center%20though%20a%20series%20of%20lengthy%20phone%20and%20electronic%20communications%3A%20an%20informal%20process%20whose%20reproducibility%20and%20accuracy%20decays%20over%20time.%20This%20report%20describes%20a%20set%20of%20supplemental%20information%20needed%20to%20assess%20whether%20clinical%20research%20data%20from%20diverse%20research%20sites%20are%20truly%20comparable%2C%20and%20what%20metadata%20%28%5C%22data%20about%20the%20data%5C%22%29%20should%20be%20preserved%20when%20a%20data%20set%20is%20archived%20for%20future%20use.%20We%20propose%20a%20structured%20Extensible%20Markup%20Language%20%28XML%29%20model%20that%20captures%20this%20information.%20The%20authors%20hope%20this%20model%20will%20be%20a%20first%20step%20towards%20preserving%20the%20metadata%20associated%20with%20clinical%20research%20data%20sets%2C%20thereby%20improving%20the%20quality%20of%20international%20data%20exchange%2C%20data%20archiving%2C%20and%20merged-data%20research%20using%20data%20collected%20in%20many%20different%20countries%2C%20languages%20and%20care%20settings.%22%2C%22date%22%3A%222007%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220926-9630%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpubmed%5C%2F17911757%22%2C%22collections%22%3A%5B%22IP6F4TRX%22%5D%2C%22dateModified%22%3A%222012-04-29T03%3A54%3A37Z%22%7D%7D%5D%7D
1.
McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, et al. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol [Internet]. 2007 Oct [cited 2013 Jul 4];36(5):969–76. Available from: http://ije.oxfordjournals.org/content/36/5/969.full Cite
1.
Duda SN, Cushman C, Masys DR. An XML model of an enhanced data dictionary to facilitate the exchange of pre-existing clinical research data in international studies. Stud Health Technol Inform [Internet]. 2007 [cited 2012 Apr 29];129(Pt 1):449–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17911757 Cite